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Market failure typically arises from the provision of public goods in private markets due to 
their being non-excludable and non-rivalry in consumption. Consequently, public goods will 
generally be under-provided in private markets and government intervention is 
commonplace to help ensure efficient provision. Programmes for prevention in health can 
be considered public goods. Prevention largely falls within remit of public health which, since 
2013, has been the responsibility of local authorities (LAs) in England.  
Due to limited resources to fund public health activities in England, the prioritisation of 
resources is paramount. Economic evaluation can assist in guiding resource allocation 
decisions. Recommendations for economic evaluation methods to appraise public health 
interventions are less clear than for health technologies. Identifying relevant methodologies 
for public health appraisal is important to address the complexity of public health 
programmes and the LA setting of public health decisions in England. This study aimed to 
engage public health decision-makers (PHDMs) to identify the most beneficial economic 
evaluation tool(s) to meet their needs.  
This research focused on a sub-sect of public health: interventions related to alcohol 
consumption. A systematic review was conducted to identify economic evaluations of 
interventions to reduce alcohol misuse since 2006. The majority of evaluations identified 
were cost-utility analyses (CUAs). Limited consideration of methodological challenges 
specific to public health was found. 
A qualitative interview study with PHDMs in North-East England was then conducted which 
identified limited use and knowledge of health economic tools amongst the PHDMs. A desire 
for the incorporation of broader outcomes in evaluations to incorporate the local decision-
making context was established.  
Building on the outcomes from the review and qualitative study, a cost-benefit analysis 
(CBA) and social return on investment (SROI) were conducted to evaluate a brief alcohol 
intervention in schools. In order to conduct the CBA, a contingent valuation (CV) study was 
carried out to obtain a monetised measure of benefit. Despite debate in the literature on the 
suitability of the CV method to elicit true economic values for public goods, particularly for 
goods offering limited private consumption value, CV has been used in the field of 
environmental economics for decades to ascertain non-use values for goods. The method 
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has also been used to value healthcare goods. The outcomes of the CV survey additionally 
provided information on the mechanics of the decisions made by the public via examination 
of predictors of willingness-to-pay for the intervention. It can also help elucidate reasons 
given in support of the intervention (or lack of), potentially relevant to PHDMs. Such 
examination help bridge the gap between the fields of health economics and psychology.  
Both the CBA and SROI identified positive societal benefit from the intervention. These 
results were shown to PHDMs at a workshop, alongside results from a previously conducted 
CUA and a cost-consequence analysis (CCA) of the same intervention. The workshop elicited 
PHDM attendees’ preferences for the practical use of methodologies. SROI was most 
preferred, yet concern remained over its use and interpretation by PHDMs. A “one-tool-fits-
all” approach was doubted as being appropriate by some attendees. Combining CCA 
alongside another evaluation was proposed favourably by PHDMs. Providing locally relevant 
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The overall aim of this doctoral research project is to identify the most beneficial health 
economic evaluation tool(s) to meet the needs of public health decision-makers (PHDMs). 
Whilst the relevance of various economic evaluation tools to aid decision-making can be 
debated by health economists on the methods’ academic and theoretical merits, these 
arguments may pose less relevance to everyday decision-making. It is equally important that 
the end-users of economic evaluation evidence are able to use the information in a manner 
that serves the purposes of those making resource allocation decisions. Therefore, this thesis 
seeks to explore the decision-making needs of PHDMs to add to the debate from the 
perspective of the end-users of the information.  
This chapter begins by presenting a background of the developments in public health in 
England over the past decade. Changes to the context of contemporary public health 
decision-making have brought to the fore the complexities surrounding the health economic 
appraisal of public health programmes. These complexities are outlined in section 1.1 and 
insights from current literature on potential approaches to address them are presented. 
Section 1.2 describes the motivation for this research, drawing on existing guidance for the 
appraisal of public health interventions and outlines remaining areas for enquiry. The 
research questions posed for the thesis are presented in section 1.3. This is followed by a 
brief introduction to the case study examined for the empirical work in section 1.4. The final 
section outlines the structure of the thesis. 
 Public health in England 
The focus of public health in the United Kingdom (UK) has shifted several times since its 
inception in the nineteenth century; moving from improving environmental conditions to 
tackling infectious disease and then to embedding the welfare state in post-war Britain. 
Twenty-first century public health has evolved yet again, moving away from a focus on 
communicable disease towards tackling non-communicable disease by concentrating on the 
behavioural, environmental and socioeconomic factors that influence health (2). Public 
health was defined by Sir Donald Acheson as “…the science and art of preventing disease, 
prolonging life and promoting health through the organised efforts of society.” (3). 
Interest in the wider, socioeconomic determinants of health was partly the catalyst for the 
shift in responsibilities of public health provision in England. These responsibilities were 
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returned to local authorities (LAs) in 2013 having resided within the NHS since 1974. The 
reform was intended to enable the wider public health needs of local communities to be 
best met by integrating public health with the broader LA functions, such as provision of 
social care, housing, environmental health, leisure and transport services (4). Although the 
new responsibilities were welcomed by local councils (5), agents unaccustomed to public 
health decision-making, such as locally elected politicians, need to be supported in their 
roles. Consequently, new approaches to evaluation and prioritisation of public health 
(dis)investments may be required in the LA setting.  
Resources available to fund public health activities are, however, limited. This is pertinent 
given the continual UK government cuts to the ring-fenced public health grant provided to 
LAs in England. In 2016, an announcement was made stating that the grant would be 
reduced by 3.9% on average in real-terms per annum between 2016 and 2020 (6). As of the 
2019/20 public health grant, this amounted to a cash reduction of £250 million to English 
LAs since 2016 (7). Whilst LAs are able to invest in public health initiatives using other LA 
funds, the cuts to the ring-fenced public health grant represent only part of a larger suite of 
austerity measures. Local government grants have been subjected to substantial cuts over 
the past decade (8). Additionally, funding diverted towards public health initiatives using 
non-public health grant finance has an opportunity cost for other LA responsibilities. Funds 
spent on public health programmes cannot also be used to finance initiatives in other 
sectors which LAs are accountable for such as housing, transport infrastructure, and 
environmental protection. Although, there may be overlap between public health initiatives 
and those within other LA sectors, for example, providing cycle-lanes may straddle both 
public health and transport infrastructure improvements. This presents an additional 
challenge to public health agents and puts greater pressure on decision-makers to efficiently 
allocate scarce resources. An approach that can aid decisions over resource allocation is 
economic evaluation. 
1.1.1 Public health appraisal and prioritisation 
Economic evaluation is defined as “the comparative analysis of alternative courses of action 
in terms of both their costs and consequences” (9, p.4) and is ingrained in the analysis of 
health technologies in the UK as a means to assist the efficient allocation of resources (10). 
Limited resources to fund healthcare and public health initiatives require that decisions have 
to be made over which programmes and services are financed and supported and which are 
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not. Health technology assessment (HTA) in the UK has traditionally aimed to maximise 
health subject to an exogenous budget constraint via the application of a “reference case” 
approach to the appraisal of health technologies (11). This approach, outlined by the 
National Institute for Health and Care Excellence (NICE), uses formal economic evaluation in 
the form of cost-effectiveness analysis (CEA) in which technologies are appraised based on 
their associated costs and health outcomes, measured as quality adjusted life years (QALYs). 
The QALY measure combines quantity and quality of life into a single outcome (9). The sub-
set of economic evaluation in which QALYs constitute the outcome measure is typically 
referred to as cost-utility analysis (CUA) (see Chapter Three for further discussion of these 
frameworks).  
Additional factors besides cost-effectiveness also have to be considered when appraising any 
intervention but arguably especially public health programmes, such as equity and social 
justice concerns (12-14), and burden of disease (15). Furthermore, within the context of LAs, 
public health constitutes a wider remit than providing health and care services; public health 
concerns improving the well-being of the population. It encompasses securing economic 
prosperity, educational achievement, and occupational prospects to name but a few (16). 
Therefore, aiming for health maximisation may be inappropriate given the additional 
concerns of local PHDMs and the need to additionally capture intervention impacts on non-
health outcomes (17). Consequently, the reference case approach for HTA proposed by NICE 
with its focus on health (as measured by QALYs) (11) is unlikely to be appropriate for the 
appraisal of public health interventions (18). The relevance of the current CUA framework to 
public health appraisal has also been questioned by scholars in the field (19-23). Academics 
have thus been exploring ways in which the CEA framework may be adapted for public 
health interventions in light of these additional considerations. Advances such as adjusting 
the way in which the QALY is currently derived in order to incorporate wider outcomes (24), 
developing outcome measures which capture capability wellbeing rather than health (25), 
and developing methods of incorporating health equity concerns into CEA (26, 27) have all 
been suggested, yet these approaches remain absent from routine practice (28).  
Beyond the CEA framework, alternative approaches have also been considered. The UK 
treasury has recommended frameworks such as cost-benefit analysis (CBA) for the 
evaluation of public sector policies and projects for over a decade in order to capture a 
broad range of impacts such as economic, environmental, and social (29, 30). NICE also 
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broadened its recommended approach to evaluating public health programmes in the third 
edition of the methods guidance for public health appraisal (31). In the updated edition, 
greater emphasis is placed on the use of methods such as CBA and cost-consequence 
analysis (CCA) for the evaluation of public health interventions in light of the transfer of 
responsibility for public health commissioning to LAs. However, CEA and CUA remain 
essential to guidance, with CBA and CCA forming secondary analyses.  
Evaluative frameworks from beyond the standard health economic sector, such as return on 
investment (ROI) and its broader counterpart, social return on investment (SROI) (32, 33), 
have also gained popularity for public health priority-setting. A desire to promote 
investment in prevention via public health initiatives has resulted in the examination of the 
ROI of public health programmes by academics (34) and Public Health England (PHE) (35). 
However, caution has been raised regarding the potential risks to resource allocation of 
basing decisions on ROI outcomes insofar as evidence of cost-saving (i.e. a positive ROI) may 
become a necessary condition on which public health programmes are to be implemented 
(36).  
Prioritisation tools such as Programme Budgeting Marginal Analysis (PBMA) (37-39) and 
Multi Criteria Decision Analysis (MCDA) (15, 40) have also garnered interest for assisting 
public health decision-making in recent years. MCDA has particularly been considered due to 
its ability to balance evidence on the cost-effectiveness of public health programmes with 
other evidence relevant to LA decision-making (41).  
1.1.2 The complexity of public health interventions 
The public health system is multi-sectoral in that interventions in other sectors, such as 
housing or the environment, can affect the health of the population, or conversely, 
interventions designed to improve health can impact other sectors as a consequence in the 
change of the public’s behaviours and actions (42). Public health interventions are thus often 
described as complex (43) due to the inclusion of multiple components, which act 
independently and inter-dependently (44). For example, Petticrew (45) describes “urban 
regeneration” programmes as an example of complex interventions due to the integration of 
several components from educational to housing interventions, each contributing to the 
overall programme.  
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Furthermore, public health interventions, which may not be considered complex in 
themselves, may operate within complex systems such as primary care, hospitals, or schools 
(46). These contexts are considered complex as it is often difficult to distinguish intervention 
impact from other influencing factors within the system. 
This complexity presents additional issues for the evaluation of public health programmes 
compared to health technologies. The challenges associated with evaluating complex public 
health programmes have been considered by academics for over a decade (20, 46-49). Yet, 
there remains limited guidance for public health appraisal. A review of guidance for the 
economic evaluation of public health interventions published in 2013 (17) identified a need 
for further guidance in the field of public health given the many challenges that face those 
attempting economic evaluations. Edwards et al. (17) suggested that those undertaking 
evaluations of public health interventions should think beyond the traditional health 
economist’s tools and consider health effects as part of a wider set of relevant outcome 
measures, such as health inequalities, social and environmental impacts (17). Since the 
review by Edwards et al. was published (17), NICE updated their manual for producing 
guidance to amalgamate guidance for health technologies, public health and social care 
interventions. Consequently, the reference case was amended to include guidance on the 
economic evaluation of public health interventions (10). The recommendations with respect 
to economic evaluation frameworks, however, remain largely unchanged from those stated 
in the earlier version of guidance (31). 
 Motivation for research 
Despite the exploration of new approaches to evaluate public health interventions over the 
past decade, evaluation using the standard CUA framework (9) has remained the most 
commonly drawn on evidence for NICE public health guidance (21). Perhaps more 
importantly, studies have shown that local policy-making in healthcare often overlooks 
economic evaluation evidence during prioritisation (50-52). There are several barriers to the 
use of economic evaluations in the decision-making process ranging from the technical to 
the political. The transfer of public health responsibilities to LAs has brought political factors 
to the forefront of priority setting. Context and values are now more influential than ever 
before in public health priority-setting (53), particularly given the involvement of locally 
elected council members. Their requirements to satisfy stakeholders, including their 
constituents, and their own professional interests, such as future re-election (54), contribute 
7 
to the reported limited role played by economic evaluation evidence in local public health 
decision-making. Furthermore, experience-driven knowledge is often privileged over 
academic evidence when council members address local policy interests (54). 
It is unclear what criteria are used for public health decision-making, particularly at the LA 
level, and what role economic evaluation plays in those decisions. Consequently, research is 
needed to investigate how economic evaluation evidence can be best generated and relayed 
to PHDMs in order to aid decision-making and prioritisation of the limited public health 
funding. Prior to the move back to LAs, Phillips et al. (19) explored the role of economics in 
public health prioritisation. CBA and CUA were identified as preferred to CEA or CCA in 
Phillips et al.’s study (19), however, the research was limited in terms of the very small 
sample of policy-makers included (n=8). Consequently, the authors recommended further 
research in conjunction with policy-makers in order to build on their findings. Furthermore, 
the applicability of the study findings to the current state-of-play of public health decision-
making in a LA context may have to be considered, given that different agents now fill the 
roles of PHDMs.  
 Thesis aim and research questions 
Since the onset of the doctoral research reported in this thesis there have been some further 
developments in the field of economic evaluation and prioritisation in public health (55-58). 
However, the question of the most appropriate economic evaluation framework for aiding 
public health prioritisation decisions remains unresolved. Therefore, this research aims to 
add to the literature and shed light on this issue.  
In order to achieve this aim, three research questions are posed: 
1. With respect to current economic evaluation and priority-setting tools: 
a. What evidence is currently available and which methods are used by the health 
economic research community to evaluate public health interventions?  
b. Does the quality of evidence produced meet recommendations for health 
economic evaluations of public health interventions from the available 
guidance? 
2. With respect to the use of health economic evidence by PHDMs: 
a. To what extent is health economic evidence used by PHDMs to aid decision-
making? 
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b. To what extent do PHDMs have sufficient knowledge of health economic tools 
to appropriately use the available evidence? 
c. What barriers do PHDMs perceive exist to the use of health economic evidence 
as it is currently produced? 
3. Is a particular method of economic evaluation, or combination of methods, most 
beneficial to PHDMs for their decision-making needs? 
The systematic review reported in Chapter Four addresses research question one. The 
qualitative interview study with PHDMs reported in Chapter Five addresses question two. 
Finally, the findings form a workshop with PHDMs reported in Chapter Ten addresses 
question three. 
 Introduction to the empirical case study 
The empirical work conducted for this doctoral research project is based on a case study of a 
public health intervention. Details of the case study are discussed in greater detail in Chapter 
Six with a brief overview presented here. The intervention chosen was a school-based 
alcohol screening and brief intervention (ASBI) programme for students in Year 10 (ages 14-
15), which aimed to prevent misuse of alcohol in young people. The intervention was 
evaluated in a UK based, randomised controlled trial (RCT), SIPS Jr HIGH. Details of the 
intervention and the trial findings are reported in Giles et al., 2019 (59). This case study 
provided an example of a complex public health issue, due to the potentially negative 
impacts of alcohol on young people ranging from health impacts (60) to anti-social 
behavioural problems (61) and educational attainment (62). Consequently, this case study 
was relevant to exploring the benefits of various economic evaluation frameworks for 
evaluating complex public health interventions. 
 Thesis structure 
This thesis is comprised of three parts. Part One introduces the thesis, outlines the economic 
theory underpinning economic evaluation and reviews the relevant literature. It concludes 
with a qualitative interview study, which informs the choice of economic evaluation 
methods that are the focus of the second part of the thesis. Part Two outlines the empirical 
work conducted to prepare economic evaluation evidence to present to PHDMs in a 
workshop. Part Three discusses the findings from a workshop that was held to elicit 
feedback on alternative methods of economic evaluation which could be used to appraise 
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public health interventions. The thesis concludes with a discussion of all the empirical work 
conducted. A synopsis of each chapter is presented below. 
Part One 
The subsequent chapters in Part One are outlined as follows: 
Chapter Two outlines the economic theory underpinning the methodologies presented in 
this thesis. This consists of an overview of consumer choice theory and the welfarist and 
extra-welfarist theoretical paradigms. The implications of each of these schools of thought 
for contemporary economic evaluation and addressing questions of efficiency in resource 
allocation are presented.   
Chapter Three outlines each economic evaluation and priority-setting methodology 
considered in this thesis. Four of the standard methods of economic evaluation used to 
appraise health technologies are outlined (CEA, CUA, CCA and CBA) in addition to SROI. 
Priority-setting frameworks such as MCDA and PBMA are also outlined. The explanation of 
CBA also includes a brief discussion of the various approaches to monetising benefits and 
outlines approaches that can be used to elicit stated preferences, such as contingent 
valuation (CV) and discrete choice experiments (DCEs).  
Chapter Four describes the conduct of a systematic review which explores the use of the 
methods discussed in Chapter Three in the published literature. The review focuses on the 
use of tools to appraise interventions to prevent alcohol misuse, in accordance with the case 
study used as the basis for the empirical work conducted in this thesis. 
Chapter Five investigates the use of economic evaluation evidence to aid priority-setting by 
PHDMs. A broad range of PHDMs are interviewed for the study, ranging from Directors of 
Public Health (DsPH) to locally elected council members with a health brief. Particular 
attention is paid to barriers and enablers to the use of health economic evidence and the 
current state of PHDMs’ knowledge of health economic concepts. The chapter explores 
whether local PHDMs have any strong views on the merits of particular economic evaluation 
and priority-setting tools. The findings from the chapter direct the remainder of the 
empirical work in Part Two by focussing attention on four methods of economic evaluation: 
CUA, CCA, CBA and SROI.  
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Part Two 
Chapter Six describes the development of a contingent valuation (CV) survey which was 
used to elicit a value of willingness-to-pay (WTP) in order to conduct a CBA. The SIPS Jr HIGH 
case study is also described in detail. 
Chapter Seven outlines the methods of recruitment and analysis used to examine the 
information gathered from the CV survey. The chapter also discusses the results of the CV 
study described in Chapter Six. This chapter estimates a mean value of WTP which is used in 
the CBA conducted in Chapter Eight.  
Chapter Eight reports the methods and results of both a CBA and SROI analysis appraising 
the ASBI programme examined by the SIPS Jr HIGH trial. The results from both of these 
evaluations fed into the workshop with PHDMs in order to provide examples of how each 
method can be used to evaluate a public health intervention. Short reports of each method 
of economic evaluation were produced for the workshop with PHDMs in order to provide 
examples of the sort of information that could be produced using each approach.  
Chapter Nine outlines the adaptation of the novel CBA and SROI evaluations, and a CUA and 
CCA that had been previously conducted for the within-trial health economic analysis of the 
SIPS Jr HIGH study, into a short report form. Each report outlined the methods, results and 
sensitivity analyses that were conducted for each of the four evaluations.   
Part Three 
Chapter Ten provides details of the workshop and the process of obtaining feedback on the 
four methods of economic evaluation presented for review. The chapter also outlines the 
findings with respect to PHDMs’ opinions of the merits and demerits of each method for 
aiding local public health decision-making. The implications of the findings for conducting 
and presenting economic evaluations of public health interventions are also discussed.  
Chapter Eleven summarises the thesis findings with respect to each of the research 
questions posed in section 1.3. The implications of the research for practice are outlined 
alongside areas where a need for further research has been identified. The chapter also 
discusses the limitations of the overall doctoral research project and ends with some 
concluding remarks.  
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 Economic theory underpinning economic evaluation 
This chapter outlines the theoretical basis of economic evaluation and its variants which are 
used in this thesis. The chapter begins with an explanation of consumer choice theory and its 
assumptions. This leads to a description of the archetypal economic problem of utility 
maximisation. Section 2.2 moves towards applying the principles outlined at a societal level 
within the economic framework of welfare economics. Following this, the decision-rules for 
optimising social welfare determined by welfare economic theory are discussed. An 
alternative framework, extra-welfarism, is introduced in section 2.3, and section 2.4 outlines 
the problem of market failure in healthcare and public health provision. The final section 
draws out the implications of each school of thought for methods of economic evaluation. 
 Consumer choice theory 
Microeconomic theory provides a framework for decision-making in relation to consumption 
for a rational consumer. Consumer choice theory is built on the central tenet of 
optimisation: of the numerous combinations (bundles) of goods1 that an individual can 
consume, he/she will choose the bundle that he/she most prefers. In economics, the term 
utility is used to denote a ‘subjective sensation associated with the consumption of goods 
(e.g. satisfaction, satiation of need etc.)’ (63, p.16). Thus, the bundle of goods which provides 
the consumer with the greatest utility is that which he/she will most prefer. 
2.1.1 Preference axioms 
In order for consumer choice theory to be upheld, several axioms of preferences are 
assumed (63). 
1. Complete preferences 
It is assumed that preferences for bundles of goods form a closed loop such that for any two 
bundles of goods (A and B) one of the following statements is always true: 
i. A is preferred to B 
ii. B is preferred to A 
iii. A is indifferent to B 
                                                     
1 The term goods is used in this sense to denote anything that an individual may wish to consume, including 
both good and services 
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2. Transitivity 
Preferences are transitive so that of three bundles of goods, A, B and C, if A is preferred to B 
and B is preferred to C then A will also be preferred to C. Thus, preferences regarding goods 
are consistent. 
3. Reflexivity 
Reflexivity ensures that any bundle of goods is indifferent to itself.  
4. Continuity 
If bundle A is preferred to bundle B and a third bundle, C, is sufficiently close to B to be 
comparable then A will also be preferred to C. 
5. Non-satiation 
This assumption implies that consumers will never be satiated with goods; more is always 
preferred to less. If two bundles, A and B, consist of varying quantities of two goods, x and y, 
the bundle which has a greater quantity of good x and no less of good y will always be 
preferred. The most preferred bundle will, thus, lie on a higher indifference curve2 than the 
least preferred bundle, since for the same quantity of good y, the preferred bundle contains 
a greater quantity of good x. This axiom holds for all goods which are not considered “bad” 
by the consumer, i.e. things that one might prefer to have less of.  
6. Diminishing rates of marginal substitution 
Taking a bundle containing two goods, x and y, as the quantity of x is increased, the quantity 
of y foregone to retain indifference within the bundle gets less. The rate of substitution of 
good y for x, therefore, diminishes as the quantity of good x within the bundle increases. The 
implication of this axiom is that indifference curves are convex to the origin and that a 
consumer never prefers to forego all of one good in favour of another.  
2.1.2 Utility maximisation 
Consumers choose between bundles of goods such that they maximise their own utility. 
Typically, however, utility maximisation is constrained by a budget. Therefore, the problem 
becomes maximising utility subject to this budget constraint. For a hypothetical world where 
                                                     
2 An indifference curve is a line on a graph of two goods that represents different combinations of consumption 
of each good for which a consumer is indifferent between, which generate a given level of utility.  
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only two competing goods exist, X and Y, this can be described algebraically. Equation 2.1 
sets this out for a rational consumer, where Ui denotes the utility function of consumer i, 
income is represented by M and Px and Py denoted the price of goods X and Y, respectively 
(63). 
 Max (Ui) = f(X,Y) subject to M≥ 𝑷𝑷xX + PyY      (2.1) 
Maximising utility subject to a budget constraint can also be demonstrated graphically, 
taking account of each of the axioms of preferences described in section 2.1.1. Figure 2.1 
illustrates utility maximisation in the hypothetical, two-good world where consumer i’s 
income imposes a budget constraint shown by BL. All points along BL represent levels of 
consumption of goods X and Y which exhaust consumer i’s income. Assuming one cannot be 
in debt, points above BL are not feasible, whilst any point below BL is within the consumer’s 
budget. 
Figure 2.1 Utility maximisation subject to a budget constraint 
 
An indifference curve is a line which displays all combinations of goods in which a consumer 
is indifferent between, i.e. a rational consumer derives the same level of utility from any 
combination of goods along the curve (64). Figure 2.1 shows two indifference curves: IC0 and 
IC1. Goods bundle A on indifference curve IC0 is operating within consumer i’s budget since 
IC0 is below BL. Bundle B corresponds to an increase in consumption of both goods X and Y 
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compared to A (X0 to X1, Y0 to Y1), thus, increasing consumer i’s utility from consumption of 
both goods. The increase in utility is represented by a higher indifference curve, IC1. Utility is 
maximised at bundle B because it is the point of tangency between BL and IC1; any 
movement along the indifference curve IC1will result in an increase in one good at the 
expense of the other but as it is above BL it cannot be afforded (64).   
 Welfare economics 
The theory of consumer choice described in the previous section is concerned with one 
individual. However, when concerned with the allocation of public resources, such as 
healthcare, the scope is much broader towards that of society. Welfare economics can be 
defined as the analysis of social desirability of states of the world, or allocations of 
resources, in terms of the utility gained from such allocations by individuals in the society 
(65, p.205) and is the theoretical basis of economic evaluation.  
The normative analysis of healthcare is based on four tenets of neo-classical welfare 
economics (66, 67): utility maximisation, individual sovereignty, consequentialism, and 
welfarism. Utility maximisation, as described in section 2.1.2, is achieved when a rational 
consumer chooses between bundles of goods to maximise his/her utility. Individual 
sovereignty implies that individuals can best appraise their own welfare and, consequently, 
this rejects paternalistic judgements about individual welfare. Consequentialism, a 
normative ethical stance which states that actions should be judged based solely on their 
consequences, is here applied to economic actions. Thus, the appropriateness of economic 
policies or actions should be based on their outcomes, not the process involved in producing 
the resultant effects. Finally, welfarism extends the consequentialist stance in relation to 
individual utility; therefore, actions, such as resource allocation, should be appraised on the 
utility generated to individuals affected by the action.  
2.2.1 Pareto optimality 
The classical school of welfare economics considered utilities to be cardinally measurable 
(i.e. that consumption bundles can be given a measurable value) and comparable across 
members of a society (66). Within this school of thought, societal welfare could be optimised 
by maximising the utilities of all members of society. The assumption that utilities possessed 
cardinal properties was relaxed with the introduction of neo-classical welfare economics and 
ordinal utility theory (i.e. that consumption bundles can be ranked by preference but 
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without the need to attach a measurable value). The solution to the problem of optimising 
societal resource allocation was, thus, replaced with Pareto optimality (66).  
Pareto optimality is achieved via the consideration of Pareto improvement. A “weak” Pareto 
improvement is said to have occurred if an economic change, such as a reallocation of 
resources, increases the utility of society as a whole. A “strong” Pareto improvement 
constitutes a reallocation of resources which makes at least one person better off without 
making any one person worse off. The strength of each improvement reflects the value 
judgement required to agree that the course of action is beneficial to society. Thus, the 
“weak” improvement, in which all individuals benefit from some action, is less objectionable 
than the “strong” improvement, in which only one individual is required to benefit (65). An 
allocation of resources is, therefore, Pareto optimal at the point in which any further 
allocation that could improve one individual’s utility could only be made at the expense of 
another individual’s utility. In other words, no further movement can be made that is a 
strong Pareto improvement.  
Several different distributions of resources could simultaneously be considered Pareto 
optimal, yet the Pareto optimality criterion fails to provide guidance on which distribution of 
resources should be applied (assuming allocations are mutually exclusive). The value 
judgements made when adhering to Pareto principles do not include judgments on equitable 
distributions of resources but are concerned solely with the relative size of societal gains and 
ensuring no person is left worse-off (68). Distributional concerns, nevertheless, are often 
held in regard by society, as demonstrated by government instituted income redistribution 
schemes such as progressive taxation and benefit payments (64).  
Furthermore, few policy decisions in reality adhere to Pareto conditions, necessitating a 
further evolution of Pareto principles if they are to be applicable to real-world policy 
decisions (65, 68). The notion of potential Pareto improvement was developed in order to 
allow individuals who lose out from some economic action to be compensated by those who 
gain to ensure there is no net loss from an action (68). In a simplified world constituting two 
people, a policy would be potentially Pareto improving if the utility gain to Person A is larger 
than the loss of utility to Person B. Person A could, therefore, compensate person B the 
exact amount of utility lost from policy implementation (so that Person B’s utility level 
remains unchanged) whilst Person A maintains a utility gain compared to their pre-policy 
utility level.  
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Ensuring compensation is adequately distributed from winners to losers of policy action is, in 
reality, difficult. To this end, two economists, John Hicks and Nicholas Kaldor, proposed 
variants of the notion of potential Pareto improvement, commonly referred to as the Kaldor-
Hicks criterion. The Kaldor-Hicks criterion allows Pareto conditions to be operationalised in a 
more realistic economic context whereby no actual compensation needs to be paid for an 
action to be considered potentially Pareto improving (69, 70). Pareto principles are 
considered to be maintained in policy action, so long as utility losses could be hypothetically 
compensated from the utility gains.  
Given how ubiquitous money is, discussions surrounding the use of potential Pareto 
improvement to guide policy decisions have commonly centred on the ability to compensate 
individuals in monetary terms rather than directly compensating utility. This can be reasoned 
from the notion that utility cannot be directly observed or compared, therefore, money is 
used as a proxy for utility since it can be used to purchase goods, which contribute to 
improvements in utility via the consumption of those goods (65). However, this relies on an 
implicit assumption that a unit of currency contains equal social value amongst winners and 
losers (68).  
Since money is used as a proxy for measuring welfare change (i.e. the change in utility levels) 
from policy action, two concepts are drawn upon to measure changes in utility using money: 
compensating variation and equivalent variation. Both concepts can be considered from the 
perspective of some economic action producing either gains or losses to an individual (see 
Table 2.1). Compensating variation requires income changes made from an ex-post 
perspective relative to policy action, in order to return an individual to their original utility 
level. Equivalent variation requires income changes made from an ex-ante perspective 
relative to policy action, in order to equate an individual’s original utility level to the new 
level that would be obtained following policy action. Both of these concepts are further 
illustrated graphically in Figures 2.2 and 2.3.  
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Table 2.1 Compensating and equivalent variation for gains and losses from policy action 
 For policy action which generates 
gain in utility for an individual 
For policy action which generates a 
loss in utility for an individual 
Compensating 
variation  
The amount of income taken 
away from a person following 
policy action to return that person 
to their pre-policy level of utility 
The amount of income required to 
be given to a person following 
policy action to return that person 
to their pre-policy level of utility 
Equivalent 
variation  
The amount of income required 
to be given to a person prior to 
policy implementation to raise 
their pre-policy utility to the same 
level as would be realised if the 
policy is implemented. 
The amount of money required to 
be taken away from a person prior 
to policy implementation that 
would lower their pre-policy utility 
to the same level that would be 
realised if the policy is 
implemented. 
Table adapted from Table 9.1 in Morris et al. (2012)(65) 
2.2.2 Compensating variation 
The concept of compensating variation following a policy action which generates a gain for 
an individual is graphically represented in Figure 2.2. In Figure 2.2, two indifference curves, 
IC0 and IC1 demonstrate levels of utility in relation to a combination of provision of a public 
good (e.g. healthcare) and expenditure on private goods (measured in monetary units). IC1, 
which is north-east of IC0, represents a higher utility level. Suppose the individual is initially 
on IC0 and spends Y0 on private goods whilst enjoying X0 of a public good (point A). If some 
policy action increases the quantity of the public good provided from X0 to X1 and the 
individual maintains his/her current consumption of expenditure on private goods (Y0), 
he/she would move to point B on indifference curve IC1. In order to return the individual to 
his/her original level of utility (IC0) whilst enjoying X1 consumption of the public good, his/her 
income would need to be reduced by the amount BC, which would reduce his/her 
expenditure on private goods. Thus, BC represents the compensating variation, which is to 
say the amount of income taken away to compensate for the increase in the public good. 
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The link between compensating variation and willingness-to-pay (WTP) is illustrated in Figure 
2.2 since the amount BC can be viewed as the amount that the consumer is willing to pay 
(i.e. expenditure which could otherwise have been used to consume private goods) in order 
to increase the provision of the public good to X1.  
2.2.3 Equivalent variation 
Equivalent variation can be demonstrated using the same individual’s preferences as the 
compensating variation example above. The same indifference curves as Figure 2.2 are 
depicted in Figure 2.3 and, as before, the individual starts at point A spending Y0 on private 
goods whilst enjoying X0 of a public good. In a scenario in which a policy could be 
implemented that would result in a gain for the individual with respect to his/her 
consumption of the public good, equivalent variation represents the income that would 
need to be given to the individual so that his/her expenditure on private goods would be 
equally preferred to the increase in the public good from X0 to X1. As in Figure 2.2, an 
increase in public good provision to X1 would place the individual at point B on indifference 
curve IC1 if he/she were to maintain his current expenditure on private goods (Y0). At the 
higher level of utility represented by IC1, the individual could spend Y1 on private goods for 
Figure adapted from Bateman et al., 2002 (1) 
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the pre-policy provision of the public good, X0 (point D). Since points B and D are both on IC1, 
the amount of expenditure DA on private goods is equally preferred to the increase in public 
good provision of the amount AB. Equivalent variation is, therefore, depicted by DA, which is 
to say the amount of income that would need to be given to the individual in order to raise 
his/her original utility to an equivalent level to that which would be obtained following the 
policy implementation. 
Figure 2.3 Equivalent variation 
 
 
Equivalent variation can be linked to the notion of willingness-to-accept (WTA), since DA is 
the amount the consumer is willing to accept (i.e. extra expenditure for the consumption of 
private goods) in order to forego the increase in the provision of the public good to X1 and 
retain the same increased level of utility. 
In situations where markets are available for goods, market forces achieve equilibrium 
between the supply and demand for goods via the mechanism of prices. This theory was first 
set out by Adam Smith in 1776 in his book An Inquiry into the Nature and Causes of the 
Wealth of Nations, and is a central tenet to the idea that market forces will achieve an 
efficient allocation of resources, i.e. neither under nor over-provision of goods (55). In a 
perfectly competitive market, neither producers nor consumers of goods believe that their 
action will influence the price of goods (63). Under the First Theorem of Welfare Economics, 
Figure adapted from Bateman et al., 2002 (1) 
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market equilibrium will be Pareto optimal providing that all goods which constitute to 
individual utility exist within a competitive market (for detailed proof of this, please refer to 
Gravelle & Rees., 2004, Chapter 13 (63)). However, where market forces are weak, or no 
market exists, eliciting measures of WTP or WTA can be used to value non-market goods (1). 
For example, if a new policy is introduced which will generate gains for some members of 
society and losses for others, the notions of compensating and equivalent variation can be 
applied to value the welfare changes resulting from the policy. Illustrating this using 
compensating variation (see Figure 2.2), individuals who would gain from the policy can be 
asked their WTP for the policy to be implemented, taking into account their expected 
increase in utility level as a result of policy implementation. Whereas individuals who would 
experience a loss in utility from the policy could be asked their WTA the policy 
implementation, considering the compensation required to maintain their original utility 
level.  
 The rise of extra-welfarism 
Welfare economic theory has its critics when it is applied to evaluating resource allocation 
related to healthcare. Much of the criticism lies with the assumptions required for welfare 
economic theory to hold (see the four tenets described in section 2.2). For example, the 
tenet of individual sovereignty has been rejected on the argument that individuals are not 
necessarily the best judge of their own welfare with regards to healthcare due to insufficient 
information (71).  
Perhaps most prominently, however, is a rejection of the fourth tenet, welfarism. An 
argument against welfarism follows that measuring social welfare on the basis of individual 
utility is an overly narrow approach to considering social welfare (67, 72). Rather, criticism of 
the welfarist approach in economics was noted as far back as 1979 by economist and 
philosopher, Amartya Sen (73), chiefly arguing that it is overly narrow in its consideration of 
only welfare related to the consumption of goods and services, excluding non-utility 
information. In agreement with Sen, Tony Culyer (74) proposed that such non-utility aspects 
are wholly relevant to judgements over healthcare resources, for instance, “non-goods 
characteristics of individuals (like whether they are happy, out of pain, etc.)” (p.36). Due to 
this extension to the welfarism axiom, the framework proposed by Culyer has been termed 
extra-welfarist; following this new framework, within the healthcare sector, quantifiable 
measures of health benefit should be considered most important (74, 75).  
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However, in the context of health and healthcare, the limited utility criticism can be 
countered on the basis that demand for health has been presented as a derived demand via 
its impact on individual utility (i.e. a rational individual will gain greater utility from 
experiencing good health compared to poor health) (76). Following this argument, utility is a 
function of both consumption (e.g. of healthcare goods and services) and health as a goal 
itself. 
Nevertheless, a question has been raised over the critical normative assumptions required to 
use Paretian welfare economic theory to measure social welfare when WTP (or WTA) is used 
to value welfare changes. These consist of the assumptions of constant marginal returns to 
income across individuals in society (65, 68, 77) and equal weight to welfare changes across 
society (65). An ethical judgment is required to address these issues and in the absence of 
established judgement they often remain ignored (65, 77).  
Thus, extra-welfarism integrates two new concepts for evaluation within the realm of health 
services: need (rather than demand) for healthcare and health (as opposed to utility) 
outcomes. In principle, extra-welfarism need not be viewed only in the confines of health 
but as a framework that incorporates any relevant information for decisions on societal 
welfare beyond utility. However, in practice, it has placed an almost exclusive focus on 
health outcomes (66).  
 Market failure in the provision of healthcare and public health programmes 
The market for healthcare is not a competitive market. Certain properties of healthcare 
generate market failure, such as demand for healthcare as a derived demand for health 
(mentioned previously); it produces externalities (e.g. vaccinated individuals positively 
impact the rest of society via herd immunity); there is asymmetry of information between 
providers and healthcare recipients (doctors know far more about disease and treatment 
than patients); and uncertainty exists regarding the need for healthcare and its effectiveness 
(66).  
Furthermore, market failure is also present with respect to public health programmes, which 
may extend beyond healthcare, for instance improvements in transport infrastructure or air 
quality. Goods such as clean air and cycle lanes are considered public goods because they 
are non-rivalry, in other words consumption by one individual does not prevent or reduce its 
consumption others (63). Additionally, public goods are often non-excludable, meaning that 
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their consumption by any individual cannot be prevented, which can lead to “free-riders” 
enjoying the benefits of a public health programme without contributing to its provision 
(63). Public health prevention activities could also be considered public goods since many of 
such programmes naturally exhibit the characteristics of public goods, i.e. they are non-
rivalry and are non-excludable. For example: water fluoridation programmes to prevent 
tooth decay and taxes on sugar in drinks to reduce sugar consumption as an obesity 
prevention measure. The consumption of neither fluoride in water nor drinks subject to 
additional tax precludes consumption by others (i.e. they are non-rivalry) and no individual 
can be prevented from accessing either fluoridated water or tax-imposed sugary drinks (i.e. 
they are non-exludable).  
The market failure present in healthcare and public health goods markets justifies 
government intervention for their provision. Left to market forces, market failure would lead 
to an inefficient allocation of healthcare and public health service resources (63). Therefore, 
governments can take over the role of provision to attempt to improve the efficiency of 
production of healthcare and public health goods (63). However, given finite resources 
available to governments, decisions are required on the quantity and diversity of healthcare 
and public health goods to provide. Economic evaluation can assist in making these 
decisions. 
 The implication of welfarism and extra-welfarism for economic evaluation 
Due to market failure in healthcare and public health, the valuation of goods in this field 
cannot be left to market pricing. Welfare economics laid the foundation for economic 
evaluation via its introduction of WTP to value welfare change in circumstances where 
market prices cannot be used. The Paretian approach to economic evaluation, i.e. via CBA, is 
therefore grounded in welfarism in which measures of benefit derived from the provision of 
healthcare and public health goods can be elicited from society via methods such as CV (see 
Chapter Three for further discussion of CV). Even in instances of preventive action in which 
an individual may not feel he/she derives any personal benefit (e.g. a sugar tax for 
individuals who do not routinely consume sugar-containing beverages), altruistic behaviour 
towards prevention can be observed from those willing to pay for such goods (78).  
Under the CBA framework, all costs and benefits are valued and compared in order to 
identify potential Pareto improvements in the provision of services. This approach is 
concerned with efficiency; do the benefits to society outweigh the costs? Distributional 
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concerns, such as whether a potential Pareto improvement is equitable, are not addressed 
by CBA; such concerns require social value judgements which do not relate to efficiency. This 
framework for economic evaluation is typically associated with addressing questions of 
overall allocative efficiency, i.e. whether something is worth doing, irrespective of any 
budget constraint. Allocative efficiency concerns the production and allocation of resources 
in order to produce optimal levels of output, distributed in a way to meet consumers’ values 
(55, 66).  
Supporters of CBA advocate the method for its theoretical foundations in welfare economics 
and its ability to determine whether an action is warranted on the basis of societal 
preferences (1, 79). However, CBA is used far less extensively for the evaluation of health-
related interventions, particularly since the introduction of CEA in health economics.  The 
measurement and valuation of all societal costs and benefits in order to identify potential 
Pareto improvements is not simple. Therefore, partial CBAs, in which some aspects of costs 
or benefits are not valued, may still provide information relevant to decision-making in the 
field of healthcare (80). CEA, in which costs are valued but benefits are not, can be viewed as 
a partial CBA (80). Whilst this constrained version of CBA may be unable to address issues of 
overall allocative efficiency, it could still contribute to examining production allocative 
efficiency and technical efficiency (80). Under production allocative efficiency, inputs are 
valued but outputs remain in physical units (80) whilst technical efficiency is concerned with 
organising the production of goods so that inputs are minimised for the production of a 
given output (66). Healthcare is typically provided within the constraint of finite resources, 
particularly in England where government funding for healthcare is constrained by a fixed 
budget. Therefore, in the context of aiming to improve technical efficiency, CEA may be 
sufficient (77).  
Following the development of extra-welfarism and the argument that welfare changes 
resulting from healthcare should be evaluated with respect to changes in health (rather than 
overall utility) (74), a new form of economic evaluation gained precedence for the evaluation 
of healthcare goods (and, later, also public health programmes). This framework was CUA 
and is considered to be an extension of CEA, however, it can also be considered a “non-
welfarist”, simplified form of CBA since both its inputs and outputs are valued (80). Whilst 
the outputs of a CUA are not valued commensurate to costs, as is the case in CBA, attaching 
a relevant monetary value to the output of a CUA allows for a direct comparison between 
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costs and benefits. Thus, CUA could theoretically assess overall allocative efficiency to judge 
whether an action is worthwhile, irrespective of a budget constraint, provided that a 
monetary value estimated from individuals’ willingness to pay can be identified for the CUA 
output. However, in practice, CUA is typically used to examine technical efficiency (81) via 
the objective of maximising health from available resources (82).  
CUA most commonly values health benefits using a tool such as the QALY (9). A QALY is a 
composite measure of mortality and morbidity, combining estimated length of life with an 
estimate of health-related quality of life (the QALY is discussed further in Chapter Three). 
This measure maximises a notion of health rather than utility, in keeping with the extra-
welfarist framework for the allocation of healthcare resources.  
Chapter One introduced alternative tools that may play a role in evaluating public health 
interventions, which have not traditionally been used to evaluate healthcare technologies, 
such as SROI and ROI and prioritisation tools such as MCDA and PBMA (55). These 
approaches to evaluation have been introduced as practical tools to aid decisions regarding 
complex interventions, rather than by virtue of any theoretical superiority, or even 
equivalence, to economic evaluation methods conventionally applied in HTA.  
These tools are yet to be broadly discussed with respect to the welfarist/extra-welfarist 
debate, however, SROI is said to have its roots in CBA (83, p.128). Nicholls (83) outlines 
similarities between CBA and SROI, such as their objective of valuing change resulting from 
action related to wellbeing and their use of money as a proxy for the value of change. 
However, the “rigour” of SROI analyses need not be as substantial as that of CBA, provided 
that the analysis is accountable and “good enough for the decision it is being used to inform” 
(83, p.130). Furthermore, the use of WTP values for non-market goods is recommended for 
SROI (84), which would place it within the welfarist camp (17, 55). Nevertheless, whether 
elements of SROI are considered to align with the welfarist paradigm, SROI remains 
described as less theoretical than CBA (33); its development drew on various schools of 
thought, including sustainable accounting and financial accounting, in addition to CBA (83).  
The following chapter (Chapter Three) will formally introduce each of the evaluative 
approaches relevant to this doctoral project. 
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 Economic evaluation methodology 
Chapter Two provided an outline of the economic theory underpinning methods of 
economic evaluation. The grounding in welfarism and extra-welfarism of contemporary 
economic evaluation was discussed. In addition, the contrast between CBA and CEA/CUA in 
relation to how each addresses questions of efficiency was outlined. Whilst distinct from 
economic evaluation methodologies, priority-setting tools are also potentially relevant for 
assisting in public health decision-making. This chapter introduces each of the economic 
evaluation and priority-setting methods discussed in this thesis in greater detail.  
The following methods are described: CEA and CUA, CCA, CBA (including an outline of 
methods to value benefit, which are relevant to the empirical work reported later in Chapter 
Seven), SROI, PBMA, and MDCA. 
 Cost-effectiveness analysis and cost-utility analysis 
CEA is a form of economic evaluation which uses non-monetary measures of benefit in the 
form of natural units, for example: life years gained for a treatment for cardiovascular 
disease, kilograms lost for an obesity-reduction intervention, or units of alcohol consumed 
for a minimum alcohol pricing intervention. A variation of CEA that has gained popularity in 
recent years is CUA. CUA is recommended as the primary method of analysis for healthcare 
interventions by several institutions such as NICE in England (10) and by key commentators 
internationally (85, 86). CUA measures benefit using a measure of weighted health gain, 
which comprises both a mortality and morbidity component. The term “utility” in CUA refers 
to individual or societal preferences for health outcomes (9); within the CUA framework, 
utility differs from the economic sense of the term introduced in Chapter Two which 
underpins welfare economic theory. 
Outcomes for a CEA come directly from clinical or epidemiological evidence, whilst CUAs use 
a valued measure of health improvement. The health improvement measure incorporates a 
health-related quality of life score for the state of health achieved by an intervention which 
is then used to weight the length of life that is affected by the intervention’s outcome (9). 
The most commonly used generic measure for CUA is the QALY (87), however, alternative 
measures have also been developed such as the Disability Adjusted Life Year (DALY) or the 
Healthy Years Equivalent (HYE) (88, 89). However, claims made by Mehrez & Gafni (88) that 
the HYE is theoretically superior to the QALY have been widely criticised (90) and its 
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superiority to the QALY challenged (91). As such, the HYE has not been considered feasible in 
practice (92) although, the DALY is in use as the preferred outcome measure for CUA by the 
World Health Organisation (93).  
There are several tools available to measure the health-related quality of life component of a 
QALY, such as the EQ-5D (94) (favoured by NICE (10)), the SF-6D (95), or the Health Utilities 
Index (96). These tools measure generic quality of life, which are not specific to a particular 
disease area. As such, generic QALYs are generated. However, in certain cases a generic 
measure may be insufficient to capture health improvement and a condition specific 
measure of health-related quality of life may be more relevant (97). Condition specific 
measures have been developed to generate QALYs for several health conditions, such as 
oncology (98), epilepsy (99), and multiple sclerosis (100).   
The use of QALYs in CUA allows the cost-effectiveness of interventions for varying health 
conditions to be compared, whereas CEA restricts comparisons to those between similar 
interventions in which the same outcome measure can be obtained. It is this ability to make 
broad comparisons that has promoted CUA to become the preferred method of analysis for 
HTA in several countries (101). 
3.1.1 Decision rules in CEA and CUA 
Both CEA and CUA combine health outcomes with the costs of action to assess the 
worthiness of some intervention. Where an intervention generates additional health benefit 
for an additional cost (compared to some alternative course of action), the results of both 
methods of analysis are typically reported in the same manner: an incremental cost-
effectiveness ratio (ICER). An ICER represents the additional cost required to achieve a one-
unit improvement in health when comparing the outcomes of one course of action against 
an alternative. An ICER is calculated once dominant alternatives (i.e. those which are both 
less costly and more effective than the alternative courses of action) and dominated (i.e. 
those that are both more costly and less effective) have been removed from the available 
courses of action for comparison. The ICER calculation for two alternatives is illustrated in 
Equation 3.1, where CB and CA represent the total costs for alternatives B and A, respectively 
and where EB and EA represent the total effects associated with each alternative. In the ICER 
calculation CB > CA because the comparison is always made for the most expensive 
alternative compared to the next most expensive.  
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ICER = ∆C∆E  = 
CB − CA
𝑬𝑬𝑩𝑩− 𝑬𝑬𝑨𝑨
  (3.1) 
The results from a CUA or CEA can be displayed graphically on a cost-effectiveness plane 
(Figure 3.1) (9) in which incremental effectiveness is displayed along the x axis and 
incremental cost along the y axis. The point estimate of incremental cost and effectiveness 
of the intervention is represented by point A and the origin of the plane represents the 
comparator. The ICER of the new intervention compared to the comparator is, therefore, the 
slope of the line OA.  
Figure 3.1 Representation of an ICER on a cost-effectiveness plane 
 
A decision rule is then applied to interpret whether the findings justify using resources in a 
particular way. Decisions are based on subjective judgements of the value of the outcome, 
or alternatively, a relative comparison can be made between ICERs of substitutable 
interventions which have used the same outcome measure during the evaluation process. In 
CUA, relative comparisons can also be used, however, relative comparison in both CEA and 
CUA relies on the assumption that there are constant returns to scale with respect to cost-
effectiveness (102). In other words, an assumption is made that scaling provision of the 
intervention to meet societal need does not reduce cost-effectiveness and that the ICER 
remains constant.  
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Deciding whether an action represents an acceptable use of resources within a constrained 
budget requires a threshold value of a cost per outcome. When addressing questions of 
technical efficiency (introduced in Chapter Two), the threshold value should represent some 
notion of opportunity cost, given that any resources used for one programme cannot be 
used for another (103). The cost-effectiveness threshold is depicted as the dotted line 
crossing through the origin of the cost-effectiveness plane in Figure 3.1. The slope of this line 
represents the threshold ratio to which acceptable cost-effectiveness is compared. In 
England, an acceptable cost for the gain of one QALY is typically considered to be between 
£20,000 and £30,000 for healthcare interventions (10), however, alternative values have 
been deliberated in extenuating circumstances, for instance: life-extending treatment for 
terminal diseases at the end of life (up to £50,000 per QALY) or for very rare diseases 
(between £100,000 and £300,000 per QALY) (104). The region of cost-effectiveness on a 
cost-effectiveness plane is the area below the threshold line. In Figure 3.1, point A is above 
the threshold line and, thus, outside of the area of cost-effectiveness.  
Whilst CUA has gained general acceptance for the evaluation of healthcare interventions, its 
use for public health appraisal is not accepted so consensually. There has been a call for 
greater consideration of CBA or for the consideration of alternative evaluative approaches 
such as CCA (82) and SROI (17, 32). Additionally, academics seeking to capture a broader 
measure of well-being, as opposed to health, have considered the capability approach as a 
potential alternative to traditional CUA using QALYs as the outcome measure (25, 105). The 
capabilities approach was theorised by Amartya Sen in the 1980s (106) and academics have 
since attempted to operationalise Sen’s ideas into tools able to capture and measure 
capability, i.e. what an individual can do rather than what he/she actually does. Tools such as 
the ICECAP-A (ICEpop CAPability measure for Adults) (107) and ICECAP-O (ICEpop CAPability 
measure for Older people) (108) or the OCAP-18 (Operationalising the CAPabilities approach 
using a questionnaire of 18 capabilities-specific items) (109) and OxCAP-MH (an instrument 
specifically designed to operationalise the capabilities approach in mental health) (110) have 
been developed to capture capability well-being. However, developing these tools for use in 
economic evaluations remains to be established (109, 111). Due to the limited practical use 
of the capabilities approach within the economic evaluation paradigm currently, it is not 
discussed in great detail in this chapter or included as an alternative evaluative approach in 
the empirical work contained in this thesis.  
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 Cost-consequence analysis 
CCA is a method of setting out all the relevant costs and outcomes of an intervention in a 
clear format. Unlike other methods of economic evaluation, CCA does not aggregate the 
costs and outcomes into a single value representing cost-effectiveness. For this reason, there 
is no real decision rule in CCA. The purpose of the method is to provide a broad array of 
information to decision-makers on the impacts of an intervention (impacts can include any 
effect of relevance, both health-related and non-health-related). However, subjective 
judgement over the relative importance of the outcomes and costs presented is required on 
behalf of the decision-maker due to the lack of aggregation.  
CCA has been termed a “balance sheet” approach by some commentators (112) due to the 
disaggregated nature of the method in which costs and benefits are presented. According to 
McIntosh (112), the “balance sheet” approach is a form of CBA since the same guidance 
should be followed with respect to the identification of all costs and benefits incurred by an 
intervention. However, CCA differs in that the valuation of benefits stage of a CBA is not 
conducted. 
CCA can be a useful tool to comprehensively introduce relevant outcomes and costs and, 
therefore, be approachable to a range of different decision-makers who may have diverse 
perspectives (113). However, decisions made solely using CCA can lack transparency and 
could be open to criticism for “cherry-picking” results to fit an agenda (114) that may not be 
in society’s best interests (115).  
 Cost-benefit analysis  
Chapter Two introduced CBA as emerging from welfare economic theory, for which the focal 
concern is that of societal welfare. A well-constructed CBA, therefore, considers all costs and 
benefits, on whomsoever they fall, associated with a course of action (116). In this method 
of economic evaluation, both benefits and costs are measured in commensurate units, 
typically monetary units, to enable direct comparison. This enables a simple decision rule 
such that an action can be considered worthwhile if benefits outweigh costs. The decision-
rule follows from the Hicks-Kaldor criterion which states that societal gainers could 
theoretically compensate losers and society would remain better off; thus, so long as 
aggregate benefits are greater than aggregate costs, welfare should be improved on a 
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societal level. Equation 3.2 displays the calculation of net societal benefit (NSB) for 
programme 𝑖𝑖.  




𝒕𝒕=𝟏𝟏  (3.2) 
When a programme is evaluated for longer than one year, the present value of the NSB is 
calculated where 𝑏𝑏𝑖𝑖(𝑡𝑡) is the discounted monetary benefit for programme 𝑖𝑖 in year t, 𝑐𝑐𝑖𝑖(𝑡𝑡) is 
the monetary costs of programme 𝑖𝑖 in year t, 1/(1 + 𝑟𝑟)𝑡𝑡−1 is the discount factor for interest 
rate r, and n is the time-horizon of the programme. The formula for NSB is simplified if the 
time-horizon of a programme is 12 months or less since no discounting is required. The NSB 
calculation for programme 𝑖𝑖, thus, becomes Equation 3.3. 
 𝑵𝑵𝑵𝑵𝑩𝑩𝒊𝒊 =  ∑𝒃𝒃𝒊𝒊 − 𝒄𝒄𝒊𝒊 (3.3) 
CBA aims to identify whether NSB > 0, i.e. the net benefit to society is greater than the costs. 
The outcome of a CBA can also be presented as a benefit-cost ratio (BCR) in which total 
benefits are divided by total costs. Equation 3.4 displays the CBA decision rule using a BCR. 
 𝒃𝒃𝒊𝒊
𝒄𝒄𝒊𝒊
> 𝟏𝟏 (3.4) 
Both the NSB and BCR can be used to appraise whether a programme is valuable to society, 
however, Keating & Keating (117) stress caution when using the BCR since maximising the 
difference between cost and benefits (NSB) is not necessarily equitable to maximising the 
BCR (117). It is for this reason they recommend using BCRs to eliminate projects that would 
never be worthwhile implementing (from an allocative efficiency standpoint) (i.e. BCR<1). 
However, when deciding between multiple projects, the NSB would be the better indicator 
of maximising benefit. 
3.3.1 Valuing benefit in CBA 
The use of monetised benefits in CBA necessitates monetary values to be placed on 
outcomes for which no market value exists. In health economic CBAs this includes health 
outcomes. At the methodology’s initial foray into health economics in the 1960s and 1970s, 
the human capital approach was used to capture benefit (118). This approach considers 
health impacts in terms of reduced healthcare costs and increased productivity costs (or 
prevention of reduced productivity). However, it has many limitations such as discriminating 
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against those outside the workforce (81), ignoring quality of life (119), and a lack of 
theoretical grounding in welfare economics (120).   
Another method that has been used in evaluations of healthcare interventions is a financial 
value of a QALY. Similar to the human capital approach, monetised QALYs are not grounded 
in welfare economic theory, nonetheless, evaluations using this method are considered CBAs 
because costs and benefits are measured in commensurate units. However, it could be 
argued that this approach is not valuing all benefits associated with an action, particularly a 
public health intervention for which benefits may extend beyond those captured by the 
QALY measure. 
The welfare economic theoretical framework implies that benefits should be measured using 
a value of WTP or WTA, derived from the notions of compensating variation and equivalent 
variation outlined in Chapter Two. WTP and WTA can be measured using two approaches: 
revealed preferences or stated preferences. The revealed preference approach elicits WTP 
or WTA via observed behaviour such as choosing occupations associated with a high risk of 
injury for a stated salary (119). However, it is often difficult to ascertain an appropriate value 
using revealed preference techniques for non-marketed goods. In many developed 
countries, such as the UK, healthcare is not provided in the market place, therefore, 
observing individual preferences for healthcare services using purchase observation is 
difficult.  
An alternative method for ascertaining WTP or WTA uses the stated preference approach. 
This technique elicits values through the use of hypothetical scenarios in which individuals 
state their WTP for some defined benefit-inducing action (or their WTA compensation to 
forego the benefit generated from some action). Theoretically, the value of WTP or WTA 
should be near equivalent in the absence of income effects, however, studies examining this 
have found this may not necessarily be the case (121). A variety of explanations for the 
disparity between WTP and WTA have been proposed from degrees of substitutability 
between non-market and market goods (122) to the impact of “loss aversion” (i.e. weighing 
losses greater than gains) (123). Consequently, it is typically recommended to elicit WTP 
over WTA where possible (124). 
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3.3.2 Contingent valuation 
Stated preference valuations are generally established using survey methods such as the 
contingent valuation method (1). Environmental and transport economics initiated the use 
of CV to measure WTP (125-127). CV methodology creates hypothetical scenarios within 
which individuals are requested to provide the maximum monetary value that they would be 
“willing-to-pay” for the action described in the scenario, contingent on a suitable market 
existing. The amount an individual states that he/she is willing to pay indicates strength of 
preference for the good being valued.  
Although initially introduced via the environmental and transport economic fields, CV has 
been used to value healthcare since the 1970s (128) and has gained popularity for valuing a 
range of healthcare goods and services such as healthcare management, medical 
treatments, surgery, and pharmaceuticals (129). However, several methodological issues 
surround the CV method regarding its hypothetical survey design, the vehicle of 
(hypothetical) payment employed in the surveys, the various methods of eliciting WTP 
within the CV framework, and whether CV elicits true economic values from respondents. 
These criticisms of CV are discussed briefly below, however, for full discussions of these 
issues please refer to Bateman et al., 2002 (1), Mitchell et al., 2013 (124), and McIntosh et 
al., 2010 (130). 
Hypothetical design 
Critics of the CV method have argued that the hypothetical nature of CV surveys is unduly 
removed from real-world behaviour to elicit reliable WTP preferences. Testing this argument 
has, however, produced mixed results with some studies eliciting different WTP outcomes 
using revealed and hypothetical approaches e.g. Carson et al., 1996 (131), whilst more 
recent studies have indicated that valuations elicited via either approach may be similar 
(132) particularly if responses are adjusted for certainty (133).  
Elicitation method 
The CV method is “not an unique methodology” (134, p.103) due to the numerous ways in 
which WTP can be elicited, each having unique methodological advantages and 
disadvantages. Originally, either a bidding game or open-ended question format was 
employed (135). Bidding-games follow an auction style arrangement in which several 
monetary amounts are sequentially presented to respondents, either increasing or 
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decreasing in value, based on the response to the previous value. This would continue until 
the respondent’s maximum WTP was established, or a predetermined range of values had 
been exhausted. On the other hand, open-ended questions simply ask a respondent for their 
maximum WTP value. 
Criticism of the open-ended format lies with the perception that outright questions on WTP 
with no reference can be difficult for respondents to answer (1), thus leading to large 
proportions of non-responses, zero valuations, and outliers (124). The bidding-game format 
can equally generate biased responses due to the potential influence on final valuations 
caused by the choice of starting bid value (136).  
Alternative elicitation techniques were developed in response to the issues with the bidding-
game and open-ended formats. The dichotomous choice method, also referred to as “take-
it-or-leave-it” because a single value is offered and respondents either agree to pay that 
value or refuse, gained popularity as it most closely represents how individuals are 
accustomed to making payment decisions. The method is, however, insensitive to an 
individual’s maximum WTP. Hanemann (137) suggested a double-bounded variation which 
aimed to improve statistical efficiency by offering a second payment value in response to the 
respondent’s first response. Whilst dichotomous choice approaches are less burdensome for 
respondents compared to a bidding-game exercise, the limited information provided on the 
respondent’s actual maximum WTP necessitates large sample sizes in order to obtain a 
precise estimate of average, maximum WTP (1).  
A further elicitation approach, the payment card method, was developed by Mitchell & 
Carson (138) as an alternative to open-ended and bidding-game formats and quickly gained 
popularity amongst CV researchers to elicit health benefits (139, 140). The payment card 
approach encourages respondents to choose their maximum WTP from a list of possible 
values. The approach is able to provide more sensitive detail on a respondent’s maximum 
WTP than the bidding-game method, whilst being less burdensome for both respondents 
and researchers. Nevertheless, this approach is also subject to biases related to the range of 
values presented (1). In order to minimise range bias from the payment card format, an 
adaptation of the approach was developed, the random card sort, in which payment cards 
are presented in a random order to respondents rather than as a list. Mixed reports have 
been observed using this method (139), however, studies have shown it to pass theoretical 
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validity tests (141) and it has been argued to be preferable compared with the standard 
payment card format (142). 
Nevertheless, there remains debate over the most appropriate method of elicitation to use 
in CV studies. Research on the variation in WTP responses using different elicitation methods 
revealed that the method chosen can have a significant impact on the resultant WTP (143, 
144), therefore, careful consideration of which method to use must be given.  
Payment vehicle 
The payment vehicle refers to the way in which the hypothetical payment would be taken; 
this can be framed in numerous ways such as additional taxation, increased insurance 
premiums, increases to utility bills, or a one-off (voluntary) payment. Research has 
demonstrated that the choice of payment vehicle can impact WTP values (145-147).  
Whether a payment is framed as either a voluntary or mandatory (collective) contribution 
has been argued to have an impact on WTP values (148). Voluntary payments may inflate 
WTP responses if respondents wish to reflect an interest in having the option to purchase 
the good/service at a later date. Conversely, collective payments (e.g. mandatory tax 
payment for all payers) may extract respondents’ true WTP in the knowledge that their 
response is consequential (149).  
The most appropriate vehicle will be dependent on the context of the CV question, 
considering both the sample population and the item under scrutiny (150). For example, a 
healthcare good being valued by a general public sample who are accustomed to receiving 
healthcare, which has been funded via taxes, may be more familiar with a contribution 
towards taxation, whereas individuals who are accustomed to an insurance-based 
healthcare system may respond better to a payment in the form of an increased insurance 
premium.  
Elicitation of true economic value 
A key premise of the use of CV to measure benefit for use in a CBA is that the WTP value 
derived reflects the value of the change in welfare to the respondent. This premise is based 
on the economic notions of compensating and equivalent variation discussed in Chapter Two 
(see Sections 2.2.2 and 2.2.3). When valuing public goods, however, this premise has been 
called into question, particularly in the arena of valuing environmental goods for which an 
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individual may receive no private consumption benefit (for example, preservation of a 
national park that an individual never plans to visit). In such examples, the value elicited 
from a CV reflects existence value, in which a good represents value to an individual merely 
due to its existence, regardless of any intention or ability to use it (151, 152). 
Kahneman et al. (78) presented a psychological study of WTP and argue that respondents 
follow a “contribution model” in their decision on the amount they are WTP, rather than a 
“purchase model” assumed by the economic theory underpinning CV which represents the 
economic value at which an individual is truly indifferent between a state of the world in 
which a good is provided or not provided (78, pp.310-11). The upshot of this argument is 
that the outcome of a CV measuring the value of a public good does not truly reflect the 
economic value of the good to society but reflects an expression of attitude that the good 
should be provided. This conclusion is drawn from a comparison with charitable 
contributions in which individuals are willing to contribute some amount to support a cause, 
with the expectation that some action will occur regardless of their WTP (78, p.311). 
The aforementioned study by Kahneman et al. (78) specifically discussed public 
environmental goods, rather than public health goods, and by the authors’ admission was 
insufficient to permit inferences about the CV method (p.314). However, their study 
suggests that WTP values elicited for public goods should be considered carefully and care 
should be taken to demonstrate that derived WTP represents economic value rather than 
just attitudes. Nevertheless, expressions of attitude towards public programmes obtained 
from a CV study, whether revealing true economic value or just some form of contribution 
value in support of action, may still be important in order to guide the allocation of public 
resources. Particularly in the arena of public goods where decisions are made for the 
wellbeing of society, aligning resource allocation with public attitudes may be relevant. To 
investigate further the support of the public, the mechanism of WTP decisions can be 
explored by examining the characterisitcs of the public which predict positive WTP, or if WTP 
is assumed to represent attitude rather than economic value, which groups of society value 
the provision of the public good in question.  
3.3.3 Discrete choice experiments 
An alternative method for eliciting WTP is a discrete choice experiment (DCE). DCEs have 
gained popularity amongst health economists since the 1990s (153-155). DCEs have a 
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foundation in choice behaviour theory, specifically random utility theory (see Louviere et al., 
2010 (156) for more detail on random utility theory). DCE surveys present hypothetical 
scenarios which provide information on a selection of attributes of the item under valuation. 
Each scenario offers two or more options in which the levels of the attributes are varied; 
each option will consist of identical attributes, however, the level associated with each 
attribute will be varied. In order to ascertain the value of WTP from DCEs, one of the 
attributes must be price or an appropriate approximation for price. From respondents’ 
responses to several choice sets, researchers can indirectly estimate values of WTP via 
statistical modelling of responses (157, 158). For further detail on DCEs please see Ryan et 
al., 2007 (153) and Johnson et al., 2013 (159). 
DCEs have been cited with the ability to overcome some of the biases attributed to the CV 
method (160) and are potentially more informative than CV surveys because relevant 
information is gained on respondents’ preferences for various attributes of a good or 
service, rather than a preference for a composite good. Additionally, the indirect valuation 
may be preferable in healthcare contexts given a general aversion to paying for healthcare 
directly (153). 
However, there is a trade-off between achieving greater information and complexity. DCEs 
can be cognitively burdensome for respondents; it has been shown that informational 
fatigue can occur during DCEs, which can lead to irrational responses (160). As such, CV 
remains a valid tool for measuring WTP, particularly where an overall value for intervention 
is sufficient and information on varied attributes is not necessary (153). 
 Social return on investment 
SROI has been described as “a framework for measuring and accounting for [a] broader 
concept of value” (84, p. 8). This approach to economic evaluation has generated traction as 
a holistic method of assessing value for money (32). The scope of SROI is broader than the 
other forms of economic evaluation reported in this chapter, with the exception of CBA; an 
SROI can include costs and effects from improvements in wellbeing to social and 
environmental impacts (84). The broad scope of outcomes that can be included in an SROI 
makes the approach particularly relevant to public policy.  
The decision rule used in SROI is similar to that used in CBA because all costs and outcomes 
are monetised. The results of an SROI are presented as a ratio of investment to impact (see 
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Equation 3.5). A ratio value greater than one indicates an activity that is socially beneficial 
for the given level of investment.  
 SROI = Net present value of impactNet present value of investment   (3.5) 
The SROI ratio can be closely compared with the BCR (Equation 3.4), however, there is a 
significant difference between the two calculations with regard to the contents of the 
numerator and denominator. In a BCR, the denominator includes cost-savings (e.g. via 
reductions in healthcare service use) in addition to costs associated with implementing the 
programme. In the SROI ratio, however, the investment (i.e. the denominator) only includes 
the cost of implementing the programme. Cost-savings are included in the value of the 
programme’s impact (i.e. the numerator), alongside any other monetarised benefits that the 
SROI analysis may have identified. In the BCR, however, the numerator only includes 
monetised benefits. 
SROI encourages the involvement of stakeholders during the evaluative process to aid the 
identification of relevant impacts and as a source of information on key aspects of impacts 
necessary for evaluation, such as the duration of an outcome and the likely outcome in the 
absence of intervention (32, 161). Stakeholders can also be used to identify relevant sources 
of value for intervention impacts. Whilst the use of stakeholders is not unique to SROI, 
within The Seven Principles of Social Value (83), stakeholder engagement is implicit in the 
SROI analysis process. Researchers conducting CUAs and CBAs may engage with stakeholders 
for certain elements of analysis, e.g. conceptualising models (162) or forming attributes for a 
DCE study (163), however, stakeholder engagement is not implicit in these evaluations, 
rather it has emerged as good-practice.  
Value is attributed to outcomes in SROI using financial proxies. For some outcomes, market 
prices for a suitable proxy may be available, for example, cost-savings due to reduced visits 
to a General Practitioner (GP) can use the average cost of attendance to a GP as a proxy 
value. For non-market outcomes, revealed and stated preference techniques can be used to 
elicit values in a similar manner to CBAs (84). Monetised QALYs have also been suggested as 
an appropriate measure of health outcome by PHE (164). 
An SROI evaluation consists of a six-stage process beginning with identifying the scope of the 
evaluation and identifying relevant stakeholders and closing with the final reporting of 
results. The six stages are as follows: 
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1. Establishing scope and identifying key stakeholders 
2. Mapping outcomes 
3. Evidencing outcomes and applying values 
4. Establishing impact 
5. Calculating the SROI 
6. Reporting and embedding results 
The six stages of an SROI represent a process that any economic evaluation researcher 
would find familiar. The key difference between SROI and other modes of economic 
evaluation is in the rigor necessary for the analysis. Whilst a CUA or CBA would typically 
obtain estimates of effect from an RCT or, in the case of a public health initiative, perhaps a 
natural experiment (22). However, impact can be estimated using less scientifically regarded 
sources for an SROI, such as asking beneficiaries what the counterfactual would have been 
had they not been recipients of an initiative (83).   
An in-depth exploration of each of the six steps of an SROI analysis is beyond the scope of 
this chapter, however, Nicholls et al. (84) provide an extensive guide explaining the practical 
requirements for each of these stages alongside an in-depth explanation behind the 
rationale of each step. Nonetheless, the fourth stage, in which the methods of data analysis 
are initiated, will be outlined briefly here. 
In order to avoid over-estimation in SROI analyses, four factors are considered in the 
estimation of impact: (i) deadweight (DW), (ii) displacement (DI), (iii) attribution (A), and (iv) 
drop-off (DO). Firstly, deadweight is calculated to represent the counterfactual of the 
intervention, i.e. the expected outcome in the absence of any action. Secondly, 
displacement refers to the movement of outcomes from one area to another as a result of 
the action, e.g. moving crime from one area to another as a result of an intervention at a 
specific location (33). Thirdly, the level of outcome that can be reasonably attributed to the 
intervention is assessed. Finally, drop-off accounts for the reduction of intervention impacts 
over time (84, 165). The total impact of an action is, therefore, a function of each of the 
above four factors, as depicted in Equation 3.6. 
Impact value = ( Fiscal impact + social impact ) - DW - DI - A - DO (3.6) 
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 Priority-setting tools 
An alternative approach to resource allocation decisions, particularly within the confines of a 
budget, is the use of priority-setting tools. Whilst economic evaluations can inform decision-
makers about the relative efficiency of competing programmes, priority-setting tools can be 
used on a larger scale. Tools such as programme budgeting and marginal analysis (PBMA) 
and multi-criteria decision analysis (MCDA) can examine a whole host of programmes to 
which a decision-maker may wish to allocate the resources available within a given budget. 
Priority-setting tools can be beneficial for decision-makers by providing a rational framework 
in which decisions to invest (and disinvest) can be made with legitimacy (166). PBMA and 
MCDA tools have received particular interest within the research community since the turn 
of the century (15, 37, 166-168). Both approaches are described below. 
3.5.1 Programme budgeting and marginal analysis 
PBMA is a framework that can assist the allocation of resources in order to meet the needs 
and priorities of either a local or national agenda. The process can be considered in two 
parts: programme budgeting in which current and past budget allocations are appraised to 
provide a baseline for future allocations, and marginal analysis in which the marginal 
impacts on costs and outcomes as a result of a proposed investment or disinvestment are 
examined (39). The concept of opportunity cost plays a prominent role in PBMA since it is 
necessary to understand the impact on the benefits foregone as a result of any change in 
resource allocation (167).  
Conducting a PBMA is an inclusive and transparent process involving a multi-disciplinary 
panel consisting of a broad range of individuals, for example, clinicians, local government 
representatives, third sector stakeholders, etc. A first stage is to divide the budget into broad 
programmes covering different areas of care (e.g. smoking cessation, treatment for alcohol 
misuse, sexual health, etc. in the case of an entire public health budget). Information can 
then be compiled on the resources and costs of all programmes under investigation, which 
can be combined with the level of activity within each programme (e.g. number of service 
users) in order to identify the programme budget (166). The multi-disciplinary panel then 
works collaboratively to propose potential changes to the current arrangement of resources 
identified during the programme budgeting stage in terms of areas of reduction and areas 
for expansion. These proposed actions are then scored and ranked based on pre-determined 
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criteria (38). The scoring and ranking are supported by examination of relevant evidence 
(which could include economic evaluation evidence, such as CUA, CBA, SROI, etc.) providing 
information from which each criterion can be considered.   
The marginal analysis is then operationalised using the ranked list of actions in order to 
adjust resource allocation from those areas ranked lowest to those ranked highest. This 
process should generate a formulation that best meets the desired objectives of the local or 
national agenda. Alternatively, a less formulaic approach is to compare each option that was 
shortlisted for expansion against the areas for reduction. An explicit valuing of each option 
of growth against the shortlisted areas for reduction would need to be undertaken until no 
further reallocation of resources is estimated to produce further marginal gains.   
3.5.2 Multi-criteria decision analysis 
MCDA is another technique which introduces rationality and transparency into decision-
making in order to avoid adhoc processes which may lead to resource allocations which fail 
to maximise social welfare (15). MCDA can be particularly pertinent for public health 
decision-making in local government settings since both health economic and non-health 
economic outcomes can be considered (40). This allows a broad range of outcomes to be 
compared simultaneously in order to address the varied priorities of public health decision-
makers.  
MCDA consists of four key steps: (i) identifying alternatives to be appraised, (ii) agreeing 
criteria with which to appraise alternatives, (iii) examining the alternatives against the 
criteria to produce criteria scores, and (iv) weighting the criteria scores to reflect the relative 
importance of each criteria to the overall objective and ultimately produce a holistic 
assessment of each alternative (40, 169). The criteria considered can be as broad as 
necessary; some examples to illustrate the breadth of possible criteria are: clinical 
effectiveness, cost-effectiveness, ease of implementation, burden of disease, equity, impact 
on familial relationships, crime, environmental damage, certainty of outcomes, and quality 
of evidence (15, 40, 170). The criteria here demonstrate that MCDA need not necessarily be 
viewed as a substitute to economic evaluation since evidence of intervention value is often a 
key criterion; however, MCDA can expand the decision space to include elements beyond 
evidence on cost-effectiveness to place value alongside supplementary priorities such as 
distributive justice, social cohesion, and reducing health inequalities. 
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 Summary 
This chapter has outlined a variety of economic evaluation and priority-setting tools 
available to researchers evaluating public health interventions. CEA, CUA, CBA, and CCA have 
been used, or at least acknowledged, within the health economic field as alternative tools 
for the appraisal of healthcare technologies for several decades (9). CUA using QALYs as the 
outcome measure has become increasingly accepted since the 1990s (82) and has become a 
favoured evaluative approach for HTA (101) and public health appraisal (10). The complex 
challenges associated with valuing public health initiatives, both methodologically and 
contextually (introduced in Chapter One), have generated exploration and consideration of 
alternative approaches to appraising public health programmes. Therefore, tools such as 
SROI and formal approaches to prioritisation (e.g. via the use of MCDA or PBMA 
frameworks) have been introduced to the health economist’s toolkit in recent years. The 
following chapter examines whether, and if so how, the tools discussed in this chapter have 
been adopted by public health economists over the past decade. 
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 A systematic review of public health interventions to prevent 
alcohol misuse 
Chapter Four reports an investigation of the existing economic evaluation evidence for 
public health interventions to prevent alcohol misuse. A version of this chapter has been 
published (114) which reports on studies published between 2006 and 2016. This chapter, 
however, also includes the results of an updated search (in March 2019) to account for 
studies published since 2016.  
This chapter addresses the first research question of the thesis outlined in Chapter One. The 
systematic review reported in this chapter explores the economic evaluation and priority-
setting tools evidence currently available for public health interventions. Furthermore, the 
quality of the available evidence is also examined in relation to the inclusion of 
methodological elements that have been identified previously as relevant to the appraisal of 
public health interventions (48). The first section of this chapter outlines the rationale for 
conducting the review and section 4.2 outlines the review objectives. The methods used to 
conduct the review are reported in section 4.3 and section 4.4 reports the review findings. 
The final section discusses the study results with regard to the review objectives and 
considers the implications for further empirical work. 
 Review rationale 
The previous chapter outlined methods of economic evaluation available to assess the 
relative value of public health interventions. As discussed in Chapter One, public health 
interventions can be complex, interacting with sectors beyond healthcare, and often impact 
individuals who are not the direct recipients of the intervention. These unique 
characteristics may necessitate alternative approaches to evaluation compared to those 
adopted to evaluate healthcare technologies (17, 171).  
A previous review of economic evaluations from the public health field, which were 
published up to 2005 (48), identified the predominance of CEA and CUA studies (63%) and 
the remaining literature consisted of CCA studies (27%); no CBA studies were identified. 
Weatherly and colleagues (48) regarded four methodological challenges as being inherent 
when evaluating public health interventions: (i) attribution of effects, (ii) measuring and 
valuing outcomes, (iii) identifying intersectoral costs and consequences, and (iv) 
incorporating equity considerations. The authors concluded that: 
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“The existing empirical literature is very disappointing, offering few insights on how to 
respond to these challenges. This severely limits the usefulness of economic evaluation 
in this field.” (48, p.92) 
Whilst comprehensive, and inclusive of salient methodological considerations regarding the 
economic evaluation of public health interventions, the review has limitations. Firstly, only 
one source of evidence was used to identify literature (the NHS Economic Evaluations 
Database (NHS EED)). Although the NHS EED is a relevant database for economic 
evaluations, it does not include evidence of SROI, ROI, or priority-setting methods which 
Chapter Three identified as potentially relevant for evaluating public health interventions. 
Secondly, the included literature is limited to the year 2005, the same year in which the 
academic discussion on evaluating public health interventions was initiated in fervour by 
Michael Kelly and colleagues (171). Although a review examining guidance for the economic 
evaluation of public health interventions (17) identified some published literature prior to 
2005, the majority of relevant guidance was published post-2005.  
The timeline of evidence identified by Edwards and colleagues (17) indicates that many of 
the methodological issues raised regarding the evaluation of public health interventions may 
not have been considered by the study authors identified in the review by Weatherly et al. 
(48). Therefore, in order to examine whether the academic arguments posed for a shift from 
the economic evaluation paradigm set up for healthcare technologies towards more holistic 
evaluative approaches for public health have been supported in practice, an updated 
literature review is required.  
 Review objectives 
There has been significant growth in published health economic evaluations over the past 50 
years as the field of health economics has developed; a bibliometric review of health 
economic publications demonstrates the near-exponential cumulative increase in articles 
since the 1960s (172). Due to this trend in the growth of economic evaluation publications, it 
was expected that the number of potentially relevant articles spanning the past decade over 
the entirety of public health would be beyond the scope of this thesis to examine. As such, 
the focus of the review covered in this chapter was narrowed to one area within public 
health: prevention of alcohol misuse.  
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Prevention of alcohol misuse was considered pertinent due to its importance in English 
public health priorities (173). Additionally, alcohol misuse is associated with significant 
negative-externalities to individuals and society beyond those immediately affected and 
falling on non-health-specific sectors (e.g. via anti-social behaviour (174), traffic accidents 
(174), familial relations (175) etc.). Consequently, interventions to prevent alcohol misuse 
typically exhibit characteristics suited to a broader perspective of evaluation. Given the 
recent interest, discussed in Chapter One, in capturing the value of health and non-health 
outcomes from public health interventions, prevention of alcohol misuse was thus perceived 
as a relevant focus for review.  
This review aims to explore whether the limited guidance for the economic evaluation of 
public interventions, discussed in section 4.1 and Chapter One, has led to the adoption of 
alternative economic evaluation frameworks in lieu of the relative status-quo of CUA 
favoured for HTAs in England (10). Additionally, it will consider whether Weatherly et al.’s 
(48) conclusions regarding their disappointment in the literature’s response to 
methodological challenges is still pertinent. Hence, this study has two objectives which 
address the first overarching research question of the thesis (see Chapter One, section 1.3): 
1. To identify methods of economic evaluation and priority-setting used to evaluate 
interventions to prevent or reduce alcohol misuse  
2. To examine the quality of studies in relation to the extent at which authors address 
the public health specific methodological challenges identified by Weatherly et al. 
(48) 
 Review methods 
A protocol for the review was registered in May 2016 with PROSPERO (176). 
4.3.1 Eligibility criteria 
Economic evaluations were defined for this review as the comparative analysis of 
alternatives with respect to their associated costs and consequences, including, but not 
confined to, health consequences. Priority-setting methods were defined as a systematic 
method of deciding where investments (and disinvestments) should be made to best meet 
the needs of communities.  
Studies were eligible for inclusion if they met the following criteria: 
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• Economic evaluations or methods of priority-setting with a focus on preventing 
alcohol misuse or reducing excessive alcohol consumption 
• The study population was non-treatment seeking and not currently engaged in 
treatment for alcohol dependency 
• Published in English 
Studies were ineligible for inclusion if they met the following conditions: 
• Evaluations of pharmacotherapies as these would fall within HTA, rather than public 
health evaluation, which often uses far more prescriptive methodology, with the 
dominant method being CUA (11)   
• Evaluations of treatments for alcohol dependency, e.g. detoxification or 
rehabilitation, as these would not be considered preventive. An exception was made 
for treatments part of a preventive regime, such as screening and brief intervention 
for non-treatment seeking individuals 
• Evaluations of interventions to prevent harm or injury caused as a result of alcohol 
consumption, such as traffic accidents resulting from drink-driving, unless the 
primary objective of the study was reducing alcohol consumption 
• The study focussed on a narrow population by virtue of a clinical condition e.g. HIV 
positive individuals, for whom the interventions may be tailored towards improving 
specific clinical conditions  
• Evaluations of interventions to improve general health unless alcohol consumption 
was the primary focus and alcohol-related outcomes were reported independently 
4.3.2 Search strategy (January 2006-May 2016) 
A literature search was undertaken using NHS EED and Scopus to identify studies published 
between January 2006 and May 2016. As discussed in section 4.1, NHS EED is a useful 
resource to identify economic evaluations, however, alternative methods are unlikely to be 
identified; therefore, an additional search was conducted in Scopus to capture additional 
SROI and priority-setting studies. The use of multiple databases to identify economic 
evaluation studies in systematic reviews is recommended in order to reduce database bias, 
i.e. to reduce the likelihood that a relevant record will be missed (177). 
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The NHS EED database ceased to be updated from 31st December 2014, therefore, a further 
search was conducted using Medline, Embase, psychINFO and Cinahl to capture studies 
published between January 2015 and May 2016 (full search strategies for each database can 
be viewed in Appendix A). A hand search of relevant health economics and economics 
journals was conducted alongside reference and citation searches of included items. Journals 
chosen for hand-searching were identified from an initial scoping search for items reporting 
priority-setting methods for any area of public health.  
Grey literature sources, in the form of public health/health economic conference abstracts, 
OpenGrey, governmental departments’ websites, voluntary organisations’ websites, and 
dissertation and thesis abstracts via ProQuest, were also searched for additional records.  
The main search strategy used to identify records from NHS EED was developed with 
assistance from an information specialist (Shannon Robalino). Research has shown that the 
inclusion of an information specialist or librarian in systematic reviews is associated with 
higher quality search strategies compared to reviews conducted without specialist assistance 
(178). Keywords were identified from an initial scoping search in PubMed. Key words used 
for the NHS EED search are listed in Box 4.1. 
Box 4.1 Key terms used in literature searches 
ROI 









drinking behaviour   
alcohol use disorder 
alcohol abuse  
alcohol beverages  
alcohol addiction  












multi criteria decision analysis 
program budgeting marginal analysis 
priority setting method 
social return on investment 
SROI 
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4.3.3 Search strategy (May 2016-March 2019) 
To ensure the literature reported in this chapter is as up to date as possible, a 
supplementary search was conducted in March 2019 using the same search terms described 
in section 4.3.2. An additional search was conducted in PubMed for studies published by first 
authors of the items identified in the initial review. It was hypothesised that those authors 
may have published recently in the same field. An internet search of key search terms and 
study authors from the previous review was also conducted to identify potentially relevant 
grey literature.  
4.3.4 Data collection 
Results from each search were imported into an Endnote library and duplicates removed 
prior to screening titles and abstracts for inclusion. Two researchers, Yemi Oluboyede (YO) 
and I (SH), independently reviewed all titles and abstracts against the inclusion and exclusion 
criteria listed in section 4.3.1, as recommended by the Cochrane Handbook for conducting 
systematic reviews (179). Any divergence in opinion regarding inclusion was discussed and 
agreed on without the need for third-party involvement. I reviewed the full-texts of 
shortlisted studies from the title and abstract screen in order to assess eligibility. YO verified 
the studies selected for inclusion, checking for accuracy and eligibility (180). Results of the 
screening process are described in section 4.4.1. 
The review conducted by Weatherly et al. (48) discussed earlier in this chapter was also 
published in greater depth as a report for the Public Health Research Consortium (181). The 
report included full details of the data extraction form developed for the review. Since the 
review reported here was examining similar details to those examined by Weatherly and 
colleagues (48), the data extraction items reported by Drummond et al. (181) provided a 
basis for data extraction of the review reported in this chapter. Items relevant to this study 
specifically, such as methods of priority-setting adopted, enhanced the data extraction.  
The finalised data for extraction included: intervention and comparators, type of study, 
population and setting, follow-up length, time-horizon for analysis, discounting, perspective, 
method of economic evaluation or priority-setting, extrapolation of data, reported 
justification of economic evaluation method, strengths and weaknesses of methods used, 
outcomes measured, costs included by sector, whether productivity changes were 
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accounted for, equity considerations, any reported implications for policy from results, and 
how to use results. The data extraction form can be viewed in Appendix C.    
The data extraction process was simplified for the updated review since newly identified 
items would not be used to inform further empirical studies in this thesis. For example, 
detail regarding reported implications for policy and how to use the results from the 
evaluation, would not be utilised and, therefore, were excluded. The simplified data 
extraction form can be viewed in Appendix C.    
I completed the data extraction and a second reviewer validated the extraction of all 
included studies to ensure the initial data extraction was accurate and complete (180).  
4.3.5 Quality assessment 
Quality of study reporting was conducted based on the Consolidated Health Economic 
Evaluation Reporting Standards (CHEERS) checklist (182). Several checklists are available for 
the assessment of economic evaluation studies (183-185), however, the CHEERS checklist 
has become comparatively popular since its development in 2013 (186). It was developed to 
optimise economic evaluation reporting in published studies by consolidating the multitude 
of checklists and guidelines available into a unique reporting guide. 
The CHEERS checklist was designed to critique the quality of reporting rather than the 
quality of the study, however, the two are intimately linked. Due to the purpose of the 
checklist, various criteria specific to the writing of abstracts, titles, and discussion are 
included but were not considered relevant to this review, therefore, they were excluded 
from the quality assessment. Weatherly et al. (48) identified that CBAs were often mis-
reported in the literature and that the reporting of a societal perspective was not always 
consistent due to differences in the interpretation of societal perspectives by commentators 
from the UK (187) and the United States (US) (85). Therefore, two additional criteria were 
added to examine elements occasionally reported inconsistently:  
1. Accuracy of economic evaluation method reported 
2. Accuracy of perspective reported 
The full list of checklist items is reported in Box 4.2. 
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Box 4.2 List of items for study quality assessment, based on CHEERS checklist 
 
4.3.6 Synthesis of data 
When neither meta-analysis nor qualitative analysis are appropriate methods to synthesise 
data, the Cochrane Handbook (188) recommends the use of narrative synthesis. Thus, a 
narrative synthesis was conducted to examine the identified studies based on the 
methodological challenges reported in section 4.1. Critics of narrative syntheses have 
exhibited concern over the introduction of bias due to the potential to focus attention on a 
select few studies (189). Examining each study according to the methodological challenges, 
identified a priori, minimised the introduction of such bias.  
1. Form of economic evaluation (or priority setting) clearly reported 
1a. Reported form of economic evaluation is accurate 
2. Target population and subgroups are reported 
3. Setting of evaluation is reported 
4. Study perspective is reported 
4a. Reported perspective is accurate 
5. Comparator interventions reported 
6. Time horizon for evaluation is reported 
7. Discount rate is reported * 
8. Relevance of outcomes measures is reported 
9. Measurement of effectiveness described 
10. Methods of valuation of preference-based outcomes is described * 
11. Methods of estimating resource use are described 
12. Methods of valuing resources in terms of unit costs are reported 
13. Details of currency and price adjustments for inflation or currency conversion 
are given 
14. Description and justification of decision-analytic model (or other type of 
model) are provided * 
15. Assumptions related to model are described and explained * 
16. Analytic methods to support evaluation are reported (e.g. statistical analysis to 
address skewed data, missing data, extrapolation etc.) 
17. Values and ranges of each component of cost and outcome are reported 
18. Incremental analysis is reported (mean values of costs and outcomes and mean 
differences provided) 
19. Uncertainty characterised via sensitivity analysis on key parameters 
20. Heterogeneity characterised via discussion of results in  
*Refers to items that may not be applicable to all studies to subgroups and/or other 
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  Results 
4.4.1 Literature search results 
The initial search (January 2006-May 2016) identified 771 records; after deduplication 619 
titles and abstracts were screened for eligibility. The search update (May 2016-March 2019) 
identified 1560 records, which was reduced to 1521 after duplicates were removed. Despite 
the second search covering a shorter time-period, over twice the number of records were 
identified. The reduced number of records in the initial search is suspected due to the use of 
the NHS EED, which is a database of economic evaluations collated via weekly searches of 
several literature databases (Medline, EMBASE, PsychINFO, CINAHL and PubMed). The use 
of NHS EED dramatically reduces the number of irrelevant records identified from search 
terms used to detect economic evaluations. Since the NHS EED has not been updated since 
December 2014, both the March 2019 search and the final year of the May 2016 search 
conducted equivalent literature searches of the databases used to identify records for the 
NHS EED (see section 4.3.2). The final year of the May 2016 search contributed to a 
significant proportion of the total 771 records identified since only 127 items were retrieved 
from NHS EED for the period January 2006-December 2014. Consequently, the inability to 
use the NHS EED for the almost three-year period of the review update resulted in a 
comparatively large number of records being retrieved from the four databases listed in 
section 4.3.2. 
The process of screening titles and abstracts selected 45 records considered to be potentially 
eligible for inclusion from the May 2016 review. However, further examination of the full-
text was necessary in order to confidently include studies in the review. The process was 
repeated for the March 2019 search, in which 1492 records were excluded and the full-texts 
of 29 were examined.  
The final screening process of examining the selected full-texts against the eligibility criteria 
reported in section 4.3.1 shortlisted 23 records for inclusion in the 2016 review and six 
records for the 2019 search update. One of the records identified in the 2019 review (190) 
was a publication of a report included in the 2016 review (191) and provided no additional 
information, therefore, was excluded to prevent duplication of evidence.  
In addition to those records retrieved from the database searches, the additional hand-
search of relevant journals and search of grey literature for the 2016 review identified five 
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potentially relevant studies, of which full-texts were examined. Of those five, two were 
considered eligible. A further two eligible studies were discovered by examining the 
reference lists of the other included records. A total of 27 studies were included in the 2016 
review from the combined peer-reviewed and grey literature sources.   
The updated search in 2019 included an exploration of records published by authors of 
studies included in the initial 2016 review; this identified three additional records eligible for 
inclusion.  
The grey literature search of authors also identified a number of reports produced by the 
Sheffield Alcohol Research Group (192). These reports applied the Sheffield Alcohol Policy 
Model (SAPM) to a range of alcohol policies and in several country settings. Reports listed 
for Canada and Northern Ireland could not be accessed, therefore, assessment of those 
studies was not possible. Due to advances in the SAPM over time, multiple versions of the 
same study were reported in some cases; in these instances, only the most recent report 
was included to avoid repetition. Consequently, seven records were considered eligible from 
the grey literature search. A total of 15 records were included in the 2019 review from both 
the peer-reviews and grey literature sources.  
A PRISMA flow diagram that describes the search processes for both reviews is presented in 
Figure 4.1. 
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Figure 4.1 PRISMA flow diagram of the literature search process 
 
4.4.2 Overview of studies 
The included studies were published between the years 2006 and 2019; Figure 4.2 
demonstrates the distribution of publications across this time period. Relatively few studies 
were identified between 2017 and 2019, which may be due to a time lag between article 
submission and publication, given that the literature search was conducted at the beginning 
of the year in 2019. The lighter shaded bars in Figure 4.2 demonstrate reports identified 
from searches of grey literature. 
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Figure 4.2 Distribution of items by publication year 
 
Studies evaluated interventions in the following countries3: UK (including studies focussing 
on England, Scotland, Wales or Northern Ireland individually) (n=12), USA (n=9), Australia 
(n=5), Netherlands (n=5), Denmark (n=2), Canada (n=2), and the following countries each 
featured once: Estonia, Italy, Sweden, New Zealand, Czech Republic, Germany, Republic of 
Ireland, Thailand, Poland, Europe (all EU countries). One study (193) was conducted in a 
“Western context” with no country specified.  
The distribution of economic evaluation and priority-setting methods by publication year is 
shown in Figure 4.3 to demonstrate their distribution of use over time. The modal methods 
of economic evaluation used were CUA (n=24) followed by CEA (n=12) and CBA (n=8). Few 
instances of ROI (n=2), CCA (n=1), SROI (n=1) and MCDA (n=1) were identified. The two 
examples of MCDA and SROI were published in the year prior to the 2019 review, no studies 
using a priority-setting technique or SROI were identified in the 2016 review. The ROI 
evaluations conducted in 2007 and 2017 considered only financial intervention costs and 
associated financial savings from intervention implementation and included neither a broad 
series of societal costs and benefits integral to an SROI, nor a monetary valuation of health 
                                                     
3 The total number of items reported by country is greater than the number of reports included in 





















*2019 only includes studies published January - March inclusive 
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consequences necessitated for a welfare economic grounded CBA (81). All CBA cases 
featured in this review valued health gains via a monetarisation of QALYs, no examples were 
found of benefits valued via approaches consistent with welfare economic theory (i.e. stated 
or revealed preferences) or human capital valuations (see Chapter Three for detail on CBA 
benefit valuation methods). 
The modal intervention evaluated was ASBI, which was assessed in 16 (38%) studies, 
followed by tax increases on alcohol (n=9, 21%) and minimum unit pricing (n=7, 17%). Figure 
4.4 displays the interventions evaluated and their associated frequencies. 
  
 
Figure 4.3 Methods of economic evaluation of priority-setting used by year 
 
*2019 only includes studies published January - March inclusive 




































Figure 4.4 Frequency of interventions evaluated 
*The cumulative frequency of interventions exceeds the total quantity of included records since several studies evaluated multiple 
interventions 
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4.4.3 Quality of studies 
Table B.1 and Table B.2 in Appendix B report the results from the quality assessment based 
on the CHEERS checklist. Scores are presented in the table as the proportion of eligible items 
reported in each study. The items contributing to each score have not been weighted. No 
recommendations are made for scoring studies using the CHEERS checklist; therefore, no 
formal attempt has been made to do so. The proportionate scores are merely illustrative of 
the range of items included in each study and cannot necessarily be used to compare quality 
relative to other studies.  
All studies reported over 50% of the items in the checklist, with the lowest proportion being 
57% (see Table B.1 and Table B.2 in Appendix B). No studies included all eligible checklist 
items. 
Notably, none of the records included a preference-based outcomes valuation, preferring to 
use readily available tariffs for outcome measures; although, one study (194) reported using 
utilities for alcohol-related health states, which had been previously elicited by colleagues of 
the authors.  
Two criteria were added to the checklist to interrogate accuracy in reporting of economic 
evaluation type and study perspective. Ten studies did not clearly define the form of 
economic evaluation undertaken (i.e. CEA, CUA, etc.) (Table B.1 and Table B.2 in Appendix 
B). For each study, the accurate form of analysis was deduced via examination of the 
outcome measures and methods of aggregating costs and outcomes. For example, a study 
reporting an aggregated outcome as an incremental cost per QALY would be considered a 
CUA. Of those studies that reported the form of analysis, three reported the method 
inaccurately (195-197). Miller et al. (196) and Li et al. (197) each describe conducting a CBA, 
however, an examination of the measures of benefit indicated that the evaluations would be 
better described as financial ROIs (see section 4.4.2). Mansdotter et al. (195) report 
conducting a CEA, however, there is no final aggregation of costs and outcomes, therefore, it 
was considered a CCA. 
Thirteen of the studies (191, 194, 198-208) reported undertaking a CEA despite measuring 
health consequences in either QALYs or Disability Adjusted Life Years (DALYs). Whilst not 
entirely inaccurate, since CUA is a specific form of CEA, precise reporting would distinguish 
these studies from those which use natural units as an outcome measure.  
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Nine of the studies did not report the perspective of analysis (193, 209-216). Of the studies 
that reported an analytic perspective, one reported the perspective inaccurately (195); 
despite the authors claiming to follow a societal perspective it would be better interpreted 
as a payer perspective since only costs to the employer implementing the intervention were 
considered. The societal perspective is recommended by both the first and second 
Washington panels on cost-effectiveness in health and medicine (85, 86); however, none of 
the studies reporting to adhere to a societal perspective included all costs regardless of who 
incurs them, as stipulated in the first panel’s definition of this perspective (85). Neither did 
any of those studies provide any justification for legitimately excluding costs that would be 
considered necessary to represent a societal perspective; a list of those costs can be found in 
a published summary of the second panel’s recommendations (217). Equally, a handful of 
studies (200-202, 204, 218) claiming to have followed a healthcare sector perspective 
included a broader range of costs than recommended (217), such as the inclusion of 
governmental costs to implement changes in alcohol tax rate.  
Productivity costs (defined as work productivity lost from illness) were excluded from two 
studies reporting a societal perspective (219, 220). Explicitly accounting for productivity is a 
topic of debate with some experts arguing for this approach (187, 221) whilst others arguing 
that productivity is implicitly accounted for in the generation of QALYs (11, 85). Whilst it is 
beyond the scope of this thesis to argue for a side in the productivity costs debate, what is 
apparent is a need for clear and consistent guidance on this issue if evaluations are to be 
comparable. 
4.4.4 Attributing effects of public health interventions 
Intervention effects may be observed directly from trials of the intervention, from natural 
experiments, or before-and-after studies, although results from the latter should be 
considered cautiously (222). Alternatively, models can simulate intervention effects by 
drawing on data from secondary sources. Across the literature from both reviews nine 
randomised, and one non-randomised, controlled trials featured and one before-and-after 
study (Table 4.1). The majority of the trials (n=9) were identified in the 2016 review, whilst 
the peer-reviewed literature identified in the 2019 update constituted predominantly 
modelling studies. The only RCT identified in the 2019 review (223) used intervention effects 
obtained from the trial to populate the SAPM model in order to ascertain estimates of cost-
effectiveness. Only one of eight RCTs identified in the 2016 review followed a similar 
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approach; Neighbors et al. (219), used trial outcomes to develop a decision-analytic model 
to generate cost-effectiveness estimates.  
Thirty of the records identified between 2006 and 2019 were purely modelling studies (Table 
4.1). A range of modelling approaches were used: decision-analytic models, Markov 
microsimulation models, statistical and mathematical models, disease models such as the 
Chronic Disease Model (see Appendix A in van Baal et al., 2008 (224)), the ALCMOD alcohol 
model (225), the SAPM (226), and a “meta-model” approach (227). Data to populate the 
models were taken from epidemiological literature, results from previous trials, longitudinal 
studies, national surveys and databases, and meta-analyses in order to estimate future costs 
and outcomes.  
Cobiac et al. (200) did not expand on the data sources used to populate their model, 
therefore, the quality of their data sources could not be examined. The remaining modelling 
studies reported utilising appropriate data with reference to the population of interest, for 
example seeking sources from the same country and age group. However, a handful 
reported the use of data from other countries where relevant data was unavailable for the 
location of study (194, 198, 201, 206, 212, 227-229). Where data from different contexts 
were used, two studies reported some form of adjustment to improve relevance to the 
country of study (212, 229). 
 
 






analysisa Study type Time Horizon Perspective 





2014 Italy Cost-effectiveness of a programme 
of screening and brief interventions 
for alcohol in primary care in Italy 





2014 Republic of 
Ireland 
Model-based appraisal of minimum 
unit pricing for alcohol in the 
Republic of Ireland 
CBA Model 20 years Unspecified Healthcare 
Criminal justice 
Angus et al. 2015 England Modelling the impact of Minimum 
Unit Price and Identification and 
Brief Advice policies using the 









Angus et al. 2016 Europe Estimating the cost-effectiveness of 
brief interventions for heavy 
drinking in primary healthcare 
across Europe 
CUA Model Unspecified Healthcare 
sector 
Healthcare 
Angus et al. 2018 Wales Model-based appraisal of the 
comparative impact of Minimum 
Unit Pricing and taxation policies in 
Wales: Final report 
CBA Model 20 years Unspecified Healthcare 
Criminal Justice 
Angus et al. 2019 England, 
Poland and 
Netherlands 
Cost-effectiveness of strategies to 
improve delivery of brief 
interventions for heavy drinking in 
primary care: results from the 
ODHIN trial 
CEA & CUA Model 
alongside 
RCT 












analysisa Study type Time Horizon Perspective 







The cost-effectiveness of alcohol 
screening, brief intervention and 
referral to treatment in emergency 
and outpatient medical settings 














Cost-effectiveness of screening and 
referral to an alcohol health worker 
in alcohol misusing patients 
attending an A&E department 






2009 England Independent review of the effects of 
alcohol pricing and promotion: Part 
B 
CBA Model 10 years Unspecified Healthcare 
Criminal justice 
Employment 
Byrnes et al. 2010 Australia Cost-effectiveness of volumetric 
alcohol taxation in Australia 




Cobiac et al. 2009 Australia Cost-effectiveness of interventions 
to prevent alcohol-related disease 
and injury in Australia 






Cobiac et al. 2018 New Zealand Cost-effectiveness of raising alcohol 
excise taxes to reduce the injury 
burden of road traffic crashes 








Cowell et al. 2012 United 
States 
Cost-effectiveness analysis of 
motivational interviewing with 
feedback to reduce drinking among 
a sample of college students 
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The clinical and cost-effectiveness of 
brief advice for excessive alcohol 
consumption among people 
attending sexual health clinics: a 
randomised controlled trial 
CUA RCT 6 months Healthcare 
sector  
(NHS & PSS) 
Healthcare 
Social care 
De Wit et al. 2016 Netherlands Social cost-benefit analysis of 
regulatory policies to reduce alcohol 
use in The Netherlands 









Effectiveness and cost-effectiveness 
of a stepped care intervention for 
alcohol use disorders in primary 
care: pilot study 







2012 Australia Randomized Controlled Trial of 
Mailed Personalized Feedback for 
Problem Drinkers in the Emergency 
Department: The Short-Term Impact 
CEA RCT 6 weeks Provider Healthcare 
Holm et al. 
(a) 
2014 Denmark Cost-effectiveness of changes in 
alcohol taxation in Denmark: A 
Modelling study 





Holm et al. 
(b) 
2014 Denmark Cost-Effectiveness of Preventive 
Interventions to Reduce Alcohol 
Consumption in Denmark 
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analysis 
Ingels et al. 2013 United 
States 
Cost-effectiveness of the strong 
African American families-teen 
program: 1-year follow-up 
CEA RCT 12 months Societal Social care 
Voluntary sector 






Cost-effectiveness of screening for 
unhealthy alcohol use with % 
carbohydrate deficient transferrin: 
results from a literature-based 
decision analytic computer Model 
CUA Model Lifetime Societal Healthcare 
Out of pocket 
costs 
Lai et al.  2007 Estonia Costs, health effects and cost-
effectiveness of alcohol and tobacco 
control strategies in Estonia 
CUA Model 100 years Societal Healthcare 
Law enforcement 
Out of pocket 
costs 
Government 
Li et al. 2017 USA Economic Analyses of an Alcohol 
Misconduct Prevention Program in a 
Military Setting 
CEA & ROI Before-and-
after study 







2007 Sweden A cost-effectiveness analysis of 
alcohol prevention targeting 
licensed premises 
CCA & CA Non-
randomised 
study  
5 years Payerb Law enforcement 
Private 
Meng et al. 2012 Scotland Model-based appraisal of alcohol 
minimum pricing and off-licensed 
trade discount bans in Scotland 
using the Sheffield alcohol policy 
Model (V2) 
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Meng et al.  2013 England Modelled income group-specific 
impacts of alcohol minimum unit 
pricing in England 2014/15: Policy 
appraisals using new developments 
to the Sheffield Alcohol Policy 
Model (v2.5) 
CBA Model 10 years Unspecified Healthcare 
Criminal justice 
Miller et al. 2007 United 
States 
Effectiveness and benefit-cost of 
peer-based workplace substance 
abuse prevention coupled with 
random testing 









Substance Abuse Prevention Dollars 
and Cents: A Cost-Benefit Analysis 










2011 Australia  The potential cost-effectiveness of 
general practitioner delivered brief 
intervention for alcohol misuse: 
evidence from rural Australia 





Cost-effectiveness of a motivational 
intervention for alcohol-involved 
youth in a hospital emergency 
department 
CUA & CEA Model 
alongside 
RCT 
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2009 England Modelling to assess the 
effectiveness and cost-effectiveness 
of public health related strategies 
and interventions to reduce alcohol 
attributable harm in England using 
the Sheffield Alcohol Policy Model 
version 2.0 
CUA Model 30 years Healthcare 
sector  










Modelling the cost-effectiveness of 
alcohol screening and brief 
interventions in primary care in 
England 
CUA Model 30 years Healthcare 
sector  











A new approach to formulating and 
appraising drug policy: A multi-
criterion decision analysis applied to 
alcohol and cannabis regulation 
MCDA MCDA Unspecified Unspecified Healthcare 
Government 
Law enforcement 





Health and economic impacts 
of key alcohol policy options 




2006 Australia Modelling the costs and outcomes 
of changing rates of screening for 
alcohol misuse by GPs in the 
Australian context 






Table 4.1 cont. Overview of studies included in the review and key details 
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Smit et al.  2011 Netherlands Modelling the cost-effectiveness of 
healthcare systems for alcohol use 
disorders: how implementation of 
eHealth interventions improves 
cost-effectiveness 







Primary care intervention to reduce 
alcohol misuse: ranking its health 
impact and cost effectiveness 












2019 Thailand Integrated treatment program for 
alcohol related problems in 
community hospitals, Songkhla 
province of Thailand: A social return 




5 years Societal Healthcare 
Out of pocket 
costs 
Tariq et al. 2009 Netherlands Cost-effectiveness of an 
opportunistic screening programme 
and brief intervention for excessive 
alcohol use in primary care 




Berg et al. 
2008 Netherlands The cost-effectiveness of increasing 
alcohol taxes: a modelling study 
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AESOPS: a randomised controlled 
trial of the clinical effectiveness and 
cost-effectiveness of opportunistic 
screening and stepped care 
interventions for older hazardous 
alcohol users in primary care 
CUA RCT 12 months Healthcare 
sector  
(NHS & PSS) 
Healthcare 
Social care 
Zur & Zaric 2016 Canada A microsimulation cost–utility 
analysis of alcohol screening and 
brief intervention to reduce heavy 
alcohol consumption in Canada 
CUA Model Lifetime Health payer Healthcare 
a Analysis method interpreted by SH, study authors' stated methods sometimes differed from those stated here 





4.4.5 Extrapolating long-run outcomes 
Nine of the studies (193, 195-197, 218, 219, 227, 230, 231) failed to clearly report the time 
horizon used in the analysis, however, an estimate could be inferred for four of those (195, 
196, 227, 230) (Table 4.1). The majority of the studies using modelling techniques (n=24, 
75%) (Table 4.1) employed a time-horizon of 10 years or longer, 16 of those extrapolated 
intervention impacts beyond 30 years to ensure the long-term effects of the interventions 
were captured.  
The trial-based studies typically conducted analyses for follow-up periods of 12 months or 
less (Table 4.1) (195, 232). Exceptions to this were Ingels et al. (232) whose analyses 
extended to 18 months and Mansdotter et al. (195) whose analysis extended to five years, 
although, as mentioned earlier in this section, the precise time-horizon considered was 
unclear for the latter study.   
Tanaree et al. (233) reported a five-year time horizon with the justification that after this 
period drinking problems tend to relapse; it is assumed that repeat intervention may be 
required at this point, although this was not explicitly discussed by the study authors.  
4.4.6 Outcome measures 
Within identical economic evaluation formats there remains inconsistency amongst the 
outcome measures used. A range of natural units related to alcohol was used in the CEA 
studies (e.g. per unit reduction in alcohol consumption, or per one-day decrease in heavy 
drinking days).  
Within the CUA framework, there are far fewer options for relevant outcome measures, 
however, some studies used QALYs (favoured by NICE) whilst others used DALYs 
(recommended by the WHO). Even within the QALY paradigm, all QALY measures may not 
be entirely comparable if the quality of life element has been derived from a different 
measure. Within the included studies, QALYs were generated using a range of methods: the 
EQ-5D (e.g. Crawford et al. 2015 (234)), SF-12 (209), Health and Activities Limitation Index 
(HALex) (219), the Health Utilities Index (HUI) (229) and by condition-specific utility values 
(194) (see section 3.1).  
However, different countries and organisations recommend different tools for the 
measurement of quality of life when calculating QALYs; for example, NICE in England 
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recommends the EQ-5D (10) whilst the Canadian Agency for Drugs and Technologies in 
Health (CADTH) recommends the use of any generic classification system, e.g. EQ-5D, SF-6D 
or HUI (235). Therefore, the use of the HUI by Zur & Zaric (229) would be considered 
appropriate for the setting of their evaluation (Canada), even though it may not be 
considered ideal in England.  
The CBA, ROI and SROI studies reported outcomes in monetary units, as is standard for these 
analyses. As highlighted earlier in this chapter (section 4.4.2), the identified CBAs across the 
two reviews used a monetised value of a QALY to determine the worth of health-related 
benefits. Values ranged from €45,000 (approximately £38,300 in 2014 prices4, e.g. Angus et 
al., 2014 (216)) to £60,000 (in 2014 prices) (e.g. Angus et al., 2015 (207)). Miller & Hendrie 
(236) did not report how the benefit value was calculated for their CBA, however, QALY data 
were reported thus an assumption that QALYs were monetised was made on this basis. The 
SROI study (233) provided the only example of revealed preference methods being used to 
value outcomes, whereby the market value of an item similar to the outcome of interest is 
assigned to approximate the worth the non-marketed outcome. 
4.4.7 Intersectoral costs and consequences 
Authors considered costs from 10 unique sectors plus additional costs related to automobile 
accidents, Airforce staff costs and property damage costs (Table 4.1). Approximately one 
third of the studies across the 2006-2019 period (n=13, 31%) explicitly refer to taking a 
societal perspective (Table 4.1). Nine studies did not specify the perspective used, however, 
examining the costs reported in those studies, a broad or public sector perspective could be 
assumed for six (209, 212-216). Health service perspectives were followed by 17 studies 
(40%) and nine studies reported employer, government, or payer perspectives (Table 4.1). 
Several studies (196, 199, 206-208, 219, 220, 236) reported analyses according to multiple 
perspectives, to provide flexibility in the use of their findings depending on the audience. 
The reported MCDA (193) does not adhere to an analytical perspective, however, the 
authors state the importance of the MCDA criteria acknowledging perspectives of “users, 
their surroundings and broader society” (193, p.147). The criteria included: the financial cost 
                                                     
4 Conversion from 2013 Euros to 2014 pounds sterling facilitated by the CEMG - EPPI-Centre Cost Converter 
available at https://eppi.ioe.ac.uk/costconversion/default.aspx 
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of implementing and enforcing policies, generating state revenue, and reducing public costs 
indirectly related to the policy (e.g. spillover on health policy budgets).  
None of the studies from the 2016 review included any non-health related consequences, 
although, three of the studies from the 2019 review (193, 233, 237) considered non-health 
outcomes. Those evaluated by Tanaree and colleagues (233) ranged from the interventional 
effect on recipients’ wellbeing to the impact on family members and reductions in alcohol-
related traffic accidents. De Wit and colleagues (237) examined benefits to alcohol 
consumers, producers and retailers, the tax authority, and healthcare whilst Rogeberg et al. 
(193) assessed the merits of various policies according to their impact on health, social 
aspects, the political environment, crime, and public wellbeing.  
Additionally, six of the SAPM reviews (207, 208, 212-215) accounted for the health-related 
impact of injuries attributed to alcohol use in their calculation of the costs of crime. These 
studies used published estimates of QALY losses associated with a range of crime types (e.g. 
assault, rape, etc.) to which a financial value of a “crime QALY” was applied (238). Whilst use 
of these crime QALYs accounts for the indirect impacts of alcohol use, compared to the 
direct effects on alcohol users, they remain health-related outcomes. 
4.4.8 Examining population heterogeneity and inferences for equity 
Equity was rarely discussed in any of the identified studies; however, some authors report a 
limited examination of the effects of population heterogeneity. An inference may be drawn 
from some of the stratified analyses with regards to the greatest value gain via sub-group 
targeting of interventions. 
Several studies reported results stratified by either gender, age, or drinking status. The 
findings from Angus et al. (198) and Neighbors et al. (219) indicate that value to society 
could be improved by targeting interventions at males, due to significantly different cost-
effectiveness estimates for subgroups of men and women. Conversely Zur & Zaric (229) 
found little difference in cost-effectiveness between males and females. Tanaree et al. (233) 
estimated the most favourable SROI for high-risk, non-dependent drinkers compared to 
those with dependency issues, whilst the SAMP reports (208, 212-215) generally reported 
the greatest reductions in alcohol consumption, and associated health-gains, in harmful 
drinkers relative to moderate or hazardous consumers. Kapoor et al. (194) examined cost-
utility outcomes by age-cohort and demonstrated significantly reduced cost-effectiveness in 
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a 75-year-old cohort. This finding is unsurprising given the calculation of QALYs includes 
improvements in length of life, which naturally disadvantages older individuals, ceteris 
parabis, and is a common argument in the QALY paradigm debate (239, 240).  
Three additional records (195, 204, 211) reported some model parameters stratified 
according to population characteristics, however, the heterogeneity was not reflected in the 
overall analysis of cost-effectiveness.  
The only inclusion of equity considerations was found in four of the SAPM reports, which 
included an analysis of intervention outcomes according to socioeconomic status or income 
level (207, 213, 215, 216). The analyses concluded that the interventions examined 
(primarily minimum unit pricing or other tax increases on alcohol) reduced health 
inequalities, mechanised by the greatest concentration of effect falling on the most deprived 
groups.  
 Discussion 
This review aimed to address the first overarching research question of the thesis by 
examining the methods of economic evaluation and priority-setting used in the current 
literature base and critiquing the quality of the identified studies. The review succeeded in 
this aim by exploring whether the literature dating back to 2006 indicates an adoption of 
alternative economic evaluation techniques by the public health economic research field 
with a particular focus on interventions to prevent alcohol misuse. Furthermore, the quality 
of the current literature regarding public health specific methodological challenges was 
critiqued. The following section of this chapter discusses the study results with regard to 
each of these two study objectives. Furthermore, implications for further empirical work will 
be discussed based on the findings of the 2016 review, reflecting only the data available at 
the time the empirical work was conducted.  
Although this review focused exclusively on alcohol-related interventions, it is reasonable to 
expect that the findings would also be applicable to other areas within the jurisdiction of 
public health, since Weatherly and colleagues’ previous review (48) examining public health 
broadly did not suggest a unique quality differential for evaluations of alcohol-related 
interventions. 
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4.5.1 Methods of economic evaluation 
Across all literature identified in this review (January 2006 – March 2019), CUA remains the 
most prevalent evaluative method. However, Figure 4.3 depicts a relative decline in the 
proportion of CUA studies since 2015 and more regularity in the use of CBAs from 2012. The 
final two years and three months’ (2017- March 2019, inclusive) worth of published 
literature revealed the greatest diversity in methods used (Figure 4.3); the only examples of 
MCDA and SROI identified in this literature review were published during this time. The 
distribution of economic evaluation methods over the time-period reviewed indicates some 
movement towards the adoption of alternative economic evaluation techniques. Whilst 
over-interpretation of the limited evidence found in this study must be avoided, given the 
relative domination of CUA and CEA in the first decade of review (2006-2016), the 
introduction of alternative techniques suggests a shift in research precedence may be 
occurring. However, it is worth noting that neither the SROI nor MCDA studies identified 
were conducted in the UK. It is, therefore, unlikely that the adoption of these methods was 
influenced by the guidance documents introduced in Chapter One, specifically the most 
recent NICE guidance for public health evaluations (10), as posited in section 4.2.  
Although an example of a study using priority-setting methods was identified in the 2019 
review (193), they remain considerably rare in the published literature in this field. Methods 
such as PBMA and MCDA can be advantageous to decision-makers by assisting resource 
allocation decisions using a systematic and transparent approach. These approaches allow 
for the consideration of multiple criteria relevant to decision-makers’ specific needs and 
priorities, which is particularly pertinent to a PHDM whose interests likely extend beyond 
purely health maximisation. The ability of these tools to incorporate the particular needs of 
decision-makers undertaking the prioritisation exercise is one of their merits and may 
explain the paucity of these studies in the published literature. Due to the individual nature 
of priority-setting exercises, they may be used in practice within local government or other 
agencies but not reported in the academic literature. Therefore, the limited number of 
studies identified in this review is expected to be an underestimate of the number of 
priority-setting exercises being conducted in this field.    
73 
4.5.2 Methodological development 
The second objective of this review was to reflect on the identified literature with regards to 
the four methodological challenges for evaluating public health interventions, originally 
reported by Weatherly and colleagues (48). By way of reminder, these challenges were: (i) 
attribution of effects, (ii) measuring and valuing outcomes, (iii) identifying intersectoral costs 
and consequences, and (iv) incorporating equity considerations. This section will consider 
whether the current literature demonstrates any methodological improvement in these four 
areas, following the “disappointment” expressed by Weatherly et al. (48) at the state of 
insight into the challenges from the empirical base they identified.  
Attributing effects 
The proportion of RCT studies identified over the entirety of this review (n=9, 22%) is 
substantially less than that identified by Weatherly et al. (48) (38%); however, extrapolating 
long-run outcomes from trial data appears to be a consistent challenge, with only one of the 
studies (223) able to extrapolate outcomes to a significant time horizon (30 years). Angus 
and colleagues (55) used trial outcomes to populate a version of the SAPM, supplementing 
with country-specific baseline data from the literature. The uncertainty imposed by any 
assumptions made in order to complete the model was assessed in a series of deterministic 
sensitivity analyses. This study was first published online in September 2018, and, as one of 
the most recent studies identified in the updated review, may indicate the beginning of a 
change in the way in which trials of public health interventions are evaluated.   
The remaining study distribution in Weatherly et al.’s review (48) was divided evenly 
between non-randomised and review studies (31% for each) and the authors reported the 
use of modelling in the majority of these. The proportion of studies using modelling 
techniques in this current review is greater (75%) than that identified by Weatherly et al. 
(48), who stressed the need for further research into methods of evidence synthesis to 
identify all relevant data for modelling. One novel approach to synthesising evidence for 
modelling outcomes in different settings was the “meta-model” developed by Angus et al. 
(227), identified in the 2019 review update. This technique allowed cost-effectiveness 
outcomes for universal screening and brief intervention to be estimated for all countries in 
Europe, based on data available from a small sample of five countries, via the identification 
of key parameters believed to impact on estimates of cost-effectiveness. This approach 
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could prove beneficial for public health decision-making in the UK if tailored to provide 
outcomes for local communities based on data identified in smaller, localised samples.  
Measuring and valuing outcomes 
None of the studies reviewed by Weatherly et al. (48) considered outcomes beyond health 
or valued outcomes using a direct measure of WTP. A similar conclusion would be made for 
the studies identified in the 2016 search of this review; however, some recent examples of 
more holistic evaluations were identified in the 2019 update. Absent use of WTP to directly 
value outcomes, however, remains constant throughout the entirety of this current review. 
Two economic evaluations (233, 237) considered a range of outcomes including, and going 
beyond, health in an attempt to capture the full impact to society and intervention 
recipients. Whilst health outcomes examined by De Wit et al. (237) were monetised in the 
same way as the other CBAs identified by this review, using a financial value of QALYs, 
Tanaree and colleagues (233) made use of revealed preference techniques to assign values 
to impacts without market values (see Chapter Three for details on revealed preference 
methods). The use of proxy valuation can introduce uncertainty into results; however, it 
enables the inclusion of outcomes that would otherwise be overlooked.  
The previous review (48) argued for more extensive use of WTP methods to value outcomes 
or at a minimum, sector-specific generic outcomes such as crime QALYs and education 
QALYs. Some evidence of improvement was identified in this current review on that latter 
point with the inclusion of “crime QALYs” in six of the SAPM reports (207, 208, 212-215). The 
“crime QALYs” were monetised using a value of £81,000 per QALY, which was calculated 
from the value of a statistical life estimated by Carthy et al. (241) using a combination of 
contingent valuation and standard gamble techniques. The UK based CBA studies that 
monetised QALYs (207, 212-214), also reported using a value, recommended by the 
Department of Health (242), which is based on estimates obtained using stated preference 
techniques.  
Earlier in this section it was stated that none of the identified studies used WTP to directly 
value outcomes, which is an important distinction when the financial values used to 
monetise QALYs are examined. WTP techniques were in actuality incorporated into the 
CBAs, via the indirect route of providing financial values of QALYs. Two points are worth 
making here. Firstly, the use of WTP in these instances does not nullify the argument made 
earlier that current CBAs using monetised QALYs are preventing the full realisation of the 
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potential of this methodology, since the use of QALYs is still restricting the outcomes to 
consider only health outcomes. Secondly, the use of CV methods, or other techniques to 
obtain WTP estimates such as DCEs, should not be lacking in the CBA literature due to an 
objection to the mode of valuation, since this method has been accepted as an indirect 
valuation of health outcomes. It is possible that a generic, monetised value of a QALY is used 
rather than eliciting a bespoke WTP valuation due to the resources required to undertake a 
stated preference study, a point raised by the Department of Health (242). 
Alternatively, Weatherly et al. (48) suggested the use of MCDA techniques to value a broad 
range of costs and outcomes, none of which were identified in their review of the public 
health literature. One example of a relevant MCDA was identified in the 2019 update (193) 
to explore different policy options available for the regulation of drugs and alcohol. Thus, 
some progress in the measuring and valuation of public health outcomes does seem 
apparent, although they appear only in their infancy being published in the final two years of 
the review update. 
Intersectoral costs and consequences 
Weatherly and colleagues (48) reported negligible evidence of intersectoral consideration, as 
did this current review. Utilising CCA to apportion impact on other sectors was 
recommended by the previous review authors (48), yet no comprehensive use of this 
technique was identified in this current review. The general equilibrium approach of 
simultaneously considering the consequences of interventions across an array of different 
sectors proposed by Weatherly et al. (48) to incorporate intersectoral consequences, does 
not appear to have been used by any of the study authors identified in this literature review. 
The range of costs considered is determined by the perspective of analysis chosen, the 
broadest of which being societal. The Washington panel on cost-effectiveness in health and 
medicine proposes the use of the societal perspective in economic evaluations (85, 217) and 
NICE (10) recommends either a public sector or local government perspective for evaluations 
of public health interventions. A similar proportion of studies reported to adhere to a 
societal perspective in both this review and that undertaken by Weatherly et al. (48) (31% in 
both), however, broad perspectives could be inferred from a number of studies that did not 
report the perspective adhered to (see section 4.4.7).  
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A lack of consensus is evident in this review amongst the approaches taken for societal 
perspectives. As highlighted in section 4.4.3, several studies presented a narrow 
interpretation of this perspective and discrepancy exists over the inclusion of productivity 
costs. There are, however, time and resource constraints which may prevent a 
comprehensive collection of data required to truly reflect a societal perspective (243) and 
some costs and benefits may be difficult to capture, such as productivity costs or benefits to 
family members or carers who do not directly benefit from an intervention.  
Equity  
Incorporating equity in economic evaluations was rarely considered in the studied literature 
from both this review and that by Weatherly et al. (48), despite being a globally recognised 
area of need (244). Only four studies, identified in the 2019 grey-literature search, 
mentioned potential impacts on inequalities resulting from intervention implementation 
(207, 213, 215, 216).  
Methods of incorporating equity are still in relative infancy in the health economics 
literature, therefore, it is unsurprising that this element is largely missing from the 
evaluations identified in this review. Research into methods to incorporate equity 
considerations into economic evaluations via CEA has been published recently (26, 27) and 
an investigation into the equity impacts of public health interventions has also been recently 
published (245). It is beyond the scope of this study to elaborate at length the methods that 
are available within economic evaluation to incorporate equity considerations. However, it is 
evident that the studies identified in this review fall short in this area.  
4.5.3 Limitations of the review 
Whilst all reasonable effort was made to ensure rigour in this review, it is not without some 
limitations. Grey literature was examined in the initial 2016 review, however, the 
identification of unpublished reports dating back to 2009 during the 2019 update suggests 
the original review may not have captured all sources of unpublished data. However, it is 
likely that the majority of the readily available literature for this area has now been captured 
following the updated searches.   
The scope of this review was limited to interventions that directly aim to reduce or prevent 
the misuse of alcohol and did not include interventions to prevent harm as a result of 
consuming alcohol. Areas such as transport economics and sexual health would likely include 
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economic evaluations relevant to this broader scope of alcohol-induced harm and would 
provide a worthwhile area for exploration in future research. Additionally, the exclusion of 
non-English studies due to limited resources for translation may have restricted the studies 
examined in the review.  
Limitations related to the choice of a narrative review should also be recognised. This 
method of synthesis was chosen due to the heterogeneity of interventions and methods 
allowed in included studies, however, the approach has been criticised for its potential lack 
of transparency and introduction of bias via the focus on a select few studies (189). 
Therefore, it is possible that this choice of analysis introduced bias into the review, however, 
proactive attempts to minimise bias were put in place by structuring the review around 
elements of economic evaluation methodology identified as pertinent to public health in the 
previous review by Weatherly et al. (48). Each study was examined for relevance to each 
methodological challenge to ensure equal representation of all the literature during the 
review.  
4.5.4 Implications for further empirical work 
The findings from this review informed both the qualitative interview study (Chapter Five) 
and later economic evaluations (Chapters Six to Eight). At the time, only literature identified 
by the initial review in May 2016 was available, therefore, the following implications draw 
only upon the data obtained in the early review. Four points of further investigation were 
identified and are listed below.  
This review has been unable to identify a clear trend in the adoption of alternative economic 
evaluation methods. Figure 4.3 demonstrates the maintenance of the CUA prominence until 
2016. A slight proportional decline in studies reporting a CUA is evident from 2015 and from 
2012 onwards CBAs were published with more regularity. Nevertheless, there is insufficient 
evidence to determine whether this is the beginning of a genuine movement away from the 
precedence of CUA, a temporal anomaly, or just natural variation. If, as some contemporary 
literature suggests (17, 171), CUA potentially lacks relevant scope for current public health 
decision-making, the continued reliance on this technique by health economists is 
concerning for the applied use of evidence. Interest in CUA and alternative techniques 
should, therefore, be explored with PHDMs during the qualitative interview study reported 
in Chapter Five.  
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No evidence of priority-setting techniques was found in the 2016 review. As discussed in 
section 4.5.1, this does not preclude their use in the field but merely suggests projects may 
remain unpublished. The use of priority-setting techniques within local public health 
contexts should, thus, also be an area of exploration during the qualitative interviews with 
PHDMs. 
Equity considerations remain a rarity in the literature. Some evidence of sub-group analysis 
was found; however, none of the literature from the 2016 review explicitly discussed equity 
implications. The importance of this to PHDMs should be examined and any sub-group 
analysis relevant to decision-making identified.  
In a similar fashion to the lack of equity considerations, intersectoral costs and 
consequences were also not prevalent in the retrieved literature. Whether the incorporation 
of non-health outcomes into health economic evaluations in public health is important to 
decision-makers should be established. If so, this will require some radical change to the 
current economic evaluation paradigm.  
4.5.5 Validation of empirical work using the review update 
Decisions were made for the further empirical work in this thesis on the basis of the initial 
May 2016 review, however, the updated review is able to validate to some extent these 
choices. Recent literature has brought into focus the use of more holistic methods able to 
incorporate broader consequences such as SROI, CBA, and MDCA. Interest in these 
methodologies justifies exploring these methods in later empirical work (elaborated on in 
Part Two of this thesis). 
4.5.6 Remaining gaps in the evidence base 
Taking into account all literature identified between 2006 and 2019, there remain gaps in 
the evidence base for economic evaluations of preventive alcohol interventions. Monetary 
valuation of outcomes directly using WTP estimates is still lacking amongst studies 
conducting a CBA. The reliance on financial values of QALYs to value non-market goods such 
as health may put evaluations at risk of excluding potentially relevant value and failing to 
extract the full potential from the CBA method. Additionally, the use of SROI and priority-
setting methods is minimal. The context of the only identified SROI is fairly narrow, reporting 
an evaluation of a hospital-based intervention, which required the presentation of drinkers 
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into the hospital setting. No SROI studies were identified in community or non-healthcare 
settings, which, arguably, may be better suited to evaluate interventions attempting early 
prevention of alcohol misuse.  
The identified literature also conducted minimal exploration of drinking in underage groups. 
Only Ingels et al. (232) evaluated an intervention targeting adolescents and Sassi et al. (211) 
included a school-based programme within their multiple interventions. Whilst not targeted 
at young people, three of the SAPM reports included an underage population of either 11-17 
years (208, 214) or 16-17 years (213) for sub-group analysis of the alcohol policies evaluated. 
If early prevention of alcohol misuse is a key priority, more research focussed in this area 
would be recommended. 
 Summary 
This review has identified a stronger prevalence of alternative methods of economic 
evaluations being used in recent years with CUA remaining the modal choice. Some 
improvement has been observed with reference to the methodological challenges 
introduced by Weatherly et al. (48), such as the use of modelling alongside RCTs, 
incorporation of broader outcomes, the use of sector-specific QALYs, and the consideration 
of equity implications in a small number of studies. However, gaps remain with reference to 
addressing methodological challenges, such as the non-existent use of WTP values for 
outcomes, and also with reference to the evidence base for preventive alcohol 
interventions, for instance, interventions targeting underage drinkers.  
Finally, the review findings implied four areas for further empirical consideration in this 
thesis: PHDM’s interest in CUA and alternative techniques, the use of priority-setting 
techniques within local public health contexts, the importance to PHDMs of equity 




 The use of health economic tools by public health decision-
makers: a qualitative study 
This chapter reports on a qualitative investigation of the understanding and use of health 
economic tools to aid decision-making by PHDMs in North-East England. The study guided 
the further empirical work presented later in this thesis in the following ways: (i) further 
informing the selection of economic evaluation methods to present at the workshop 
(described in Chapter Ten), and (ii) affirming the decision to focus the remainder of this 
thesis on economic evaluation methods to the exclusion of other priority-setting techniques. 
This chapter also addresses the second overarching research question of the thesis outlined 
in Chapter One. This chapter, therefore, explores the extent of use and understanding of 
health economic tools, and investigates barriers to the use of health economic evidence by 
PHDMs. 
The first section of this chapter provides the rationale for conducting the qualitative study, 
followed by an outline of the aims and objectives of the interviews in section 5.2. Section 5.3 
describes the methods followed in order to recruit participants and collect data. It also 
describes and justifies the analytical approach used to synthesise findings. This is followed by 
a presentation of the study findings in section 5.4 and the final section discusses these 
findings in relation to current literature and explores the implications for further research.  
 Introduction 
Public health in England has experienced radical change within the past decade. As described 
in Chapter One, English public health departments transferred from the NHS back into local 
government in April 2013. Consequently, public health decisions are being made by agents 
operating in a different culture compared to that of the previous 40 years, who have 
priorities that extend beyond population health to the broader well-being of the populace. 
The relocation of the function brought questions over how resource allocation decisions are 
made for public health interventions, and by whom, into sharp focus.  
The move of public health back to LAs has triggered qualitative research into the process and 
context of decision-making in public health. Willmott et al. (246) explored the experiences of  
DsPH who have been advocating for public health investment in LAs amidst cuts to local 
government funding. The study raised the importance of having reliable evidence of the 
impact of investment, particularly that which demonstrates savings to the LA. The authors 
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additionally identified a need for research on the impact of public health initiatives on other 
sectors within the LA remit. Oliver & de Vocht (247) surveyed policy-makers in Greater 
Manchester in order to understand how evidence is defined and used to influence policy. 
Their findings revealed extensive use, and attributed value, of local data. Such data includes 
epidemiological, historical and interpersonal information. Academic research evidence, such 
as meta-analyses, systematic reviews and clinical trial reports, was reportedly less influential 
in the sample of 82 surveyed. However, in this study no mention was made of health 
economic evidence.  
Furthermore, Wye et al. (248) also identified a preference for local data over national data 
or research evidence. Their study highlighted the highly pragmatic nature of local 
commissioners, with a preference for using evidence able to create compelling cases for 
action. Wye et al. (248) concluded that “we may need to adapt our role as researchers” 
(p.10) in order to produce evidence of use to commissioners. Marks et al. (53) similarly 
reported the importance of local knowledge in public health priority-setting. The authors 
also highlighted the impact of the LA context on priority-setting decisions in public health 
from needing decisions to be accountable to the local electorate to prioritising public health 
initiatives within the LA’s broader responsibility for health and well-being. 
Several other studies examined the use of evidence in local public health decision-making 
(249-251), reporting similar findings to those noted earlier (53, 246-248). A common finding 
from all of this research is that researchers need to take greater responsibility for producing 
relevant evidence by gaining a deeper understanding of decision-makers’ requirements, 
rather than assuming policy-makers will dedicate time and effort to develop the skills 
necessary to comprehend the evidence provided. Due to this distinction between the 
presentation and grasp of evidence, Denford et al. (250) reported it being underused by 
public health practitioners.  
The existing literature proposes the importance of understanding the evidence requirements 
of those with decision-making roles and observes a divide between the information provided 
and what is perceived by decision-makers to be relevant. Whilst the existing qualitative 
evidence base in this area does not consider health economic tools specifically, one could 
expect a similar case of asymmetry amongst health economic researchers and PHDMs.  
In order to investigate the use of health economic tools by PHDMs and their needs with 
respect to the information provided by health economic evidence, a qualitative exploration 
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was undertaken using semi-structured interviews with local PHDMs in North-East England. 
Furthermore, which, if any, of the tools used to generate such evidence may prove most 
beneficial to PHDMs work was also investigated. 
  Aims and objectives 
The previous chapter (Chapter Four) identified four points for further consideration based 
on the current evidence base on the use of economic evaluations of public health 
interventions: (i) exploring PHDMs’ interest in CUA and alternative techniques, (ii) exploring 
the use of priority-setting techniques within local public health contexts, (iii) exploring the 
importance to PHDMs of equity considerations in economic evaluations, and (iv) 
understanding the relevance to public health decision-making of incorporating non-health 
outcomes. These four points contributed to shaping the discussions with PHDMs during the 
semi-structured interviews. Points (i) and (ii) were addressed by objective two, below, and 
points (iii) and (iv) were incorporated into objective four. 
The aim of the qualitative research reported in this chapter was to address the second 
overarching research question of the thesis. In so doing, the study intended to explore the 
extent of PHDMs’ use, knowledge, and perceived barriers to use of health economic 
evidence for decision-making. Furthermore, the study aimed to identify whether one or 
more health economic evaluation tools could be identified as most beneficial to current local 
PHDMs. Five objectives were addressed to meet these aims: 
Objective 1: To understand the local public health decision-making context and how that 
impacts on the use of economic evaluation evidence 
Objective 2: To explore current understanding and knowledge of health economic 
evaluation tools amongst PHDMs 
Objective 3: To explore how extensively PHDMs use economic evaluation evidence to aid 
decision-making 
Objective 4: To identify information requirements for public health decision-making  
Objective 5: To explore barriers to the use of health economic evidence to aid decision-
making as perceived by PHDMs. 
 Methods 
This qualitative study used a thematic framework analysis of semi-structured one-to-one in-
depth interviews with PHDMs in the North-East region of England. This chapter reports the 
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study according to the best-practice Standards for Reporting Qualitative Research (SRQR) 
checklist (252); the completed SRQR checklist for this study is reported in Appendix D.  
5.3.1 Study population and sample selection 
The study population for the semi-structured interviews comprised individuals with the 
capacity to influence public health decisions in North-East England. A purposive sample of 
individuals was recruited to cover a diverse range of roles within public health decision-
making. A purposive sample is a non-random selection of information-rich cases for in-depth 
study (253). Purposive sampling can provide a resource-effective means of accessing 
information relevant to exploring the question of study. Given the wide range of individuals 
in roles which influence local public health decision-making (54), purposive sampling 
provided an efficient means of gathering pertinent data and minimised the risk of bias from 
the exclusion of relevant participants.   
A sampling frame determines individuals who are eligible for inclusion in a qualitative study, 
taken from the study population (254). The sampling frame for this study was divided into 
three branches of individuals from North-East England: public health specialists, public 
health practitioners, and LA councillors with a health brief. Specialists held roles such as 
DsPH and public health consultants who had undertaken specialist public health training. 
Practitioner roles included commissioning and leading speciality area portfolios (e.g. drugs 
and alcohol). Individuals in these roles do not typically receive the equivalent specialist 
training as DsPH or consultants, although, they remain involved in public health decisions via 
the commissioning and oversight of public health services. Councillors with a health brief 
were the elected leads for a public health-related portfolio and were actively engaged in 
public health decision-making in their LAs.  
Reaching an appropriate sample size in qualitative research is typically decided 
retrospectively on the basis of achieving “redundancy” or “saturation coverage” of data, a 
point at which no new themes emerge during data collection and concepts are repeated 
multiple times (255). Consequently, an approximate sample size of between 15 and 20 
individuals was estimated to be sufficient with the final sample anticipated to be driven by 
the data and individuals’ willingness and availability to participate (256). 
A purposive sample of individuals from the sample frame described earlier was identified 
from local council web pages, contacts known to my supervisory team, and individuals 
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suggested by the interviewees themselves. Individuals selected for recruitment were sent a 
copy of the study information sheet (available in Appendix E) along with an invitation to 
participate via e-mail. Individuals who did not respond to the e-mail after two weeks were 
sent a follow-up email. Non-response to the follow-up email was taken to mean that the 
study was not of interest to the individual concerned and no further contact was made. 
Recruitment ran from October 2016 to August 2017. 
5.3.2 Pilot testing 
Prior to the commencement of the interviews, four pre-study pilot interviews were 
conducted with two public health registrars, one member of Newcastle City Council’s Health 
and Wellbeing Board (Wellbeing for life), and a member of a local alcohol campaign group 
which collaborates with LAs on relevant campaigns. The aim of the pilot interviews was to 
develop the topic guide, test the interview schedule and interview techniques, and to aid in 
the identification of potential participants for the main study. The data from the pilot 
interviews were not included in the final analysis, although, they provided useful contextual 
information which helped guide the main study interviews.  
5.3.3 Data collection 
In-depth semi-structured interviews were conducted using open-ended questions, enabling 
full accounts of the views and experiences of participants to be expressed (257). Semi-
structured interviews follow a predetermined set of questions which can be asked in any 
order to allow participants flexibility in their responses and interviews are designed to 
“unfold in a conversational manner” (258, p.143). An interview schedule was developed to 
guide the interviews, which encapsulated a topic guide for questions covering the areas 
outlined in the study objectives (section 5.2). Development of the topic guide drew on data 
from pre-study pilot interviews. The topic guide comprised of six topic areas which covered 
each of the study objectives; these are outlined in Table 5.1. The interview schedule 
containing the final version of the topic guide is reproduced in Appendix F.  
The flexibility of the semi-structured interview method allowed additional questions to be 
posed in order to explore emergent issues and experiences that may not have been 
anticipated prior to conducting the interviews. Consequently, whilst each interview followed 
the topic guide, the precise questions and ordering differed between interviews according to 
the interviewee’s own responses to the predetermined questions.  
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Table 5.1 The five topics addressed by the topic guide 
Study objective Topic from topic guide 
1 Role in decision-making 
1 Decision-making process 
2 Understanding of health economic evidence 
3 Use and opinions of health economic tools 
4 Information required to inform decisions  
5 Barriers to use of health economic tools 
 
All the interviews were conducted either in person or over the telephone according to the 
interviewees’ preferences. Each interviewee was sent an electronic “glossary of definitions” 
document (Appendix G), which covered simple definitions of economic evaluation and 
priority-setting tools which would be discussed during the interview. Interview participants 
were invited to read through the short document in advance of the interview; reassurance 
was given that prior knowledge of the tools listed in the glossary was not a necessary 
requirement for taking part in the interview. 
The interviews were audio recorded and each recording was transcribed verbatim by SH. 
Following transcription, each recording was replayed to ensure congruence between the 
written transcripts and audio. Transcripts were anonymised replacing interview participant 
names with a study identification number; geographical locations and LA names were also 
removed from transcripts. Audio recordings were subsequently deleted following 
transcription to maintain participant anonymity.  
5.3.4 Data analysis 
Analysis of the interview transcripts followed a thematic framework approach (259, 260). 
The framework method was developed for social policy research but has seen recent 
popularity in health research and is a common approach to thematic analysis of semi-
structured interview data (260).  
The framework method provides a systematic approach to analysis and thematic analysis is a 
method to identify, analyse and report patterns within qualitative data (261).  Whilst the 
current study adopted a thematic approach, comparisons between individuals in the three 
branches of the sampling frame (described in section 5.3.1) are also discussed. The analysis 
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entailed six stages (familiarisation, coding, developing a thematic framework, indexing, 
charting, and mapping and interpretation). They are each described below. 
Step 1: Familiarisation  
The initial stage of analysis is familiarisation with the material gathered to place instincts 
about the data that emerged during data collection in the context of the material as a whole 
(259). Immersion in the data was achieved through transcription of interviews, re-reading 
transcripts, and making notes on emerging patterns in interviewees’ responses.  
Step 2: Coding  
A code in qualitative thematic analysis refers to a concise label which displays the essence of 
a meaningful segment of raw data (262). Codes convey the analyst’s interpretation of 
importance within data, regarding interviewees’ actions, behaviours, incidents, beliefs, or 
emotions, or can refer to impressionistic elements observed by the analyst (e.g. a participant 
misusing terminology) (260). Transcripts were carefully examined and codes applied to 
sections of text until all the data were coded. Supplementary coding of two (10%) randomly 
selected transcripts was conducted by a qualitative expert within my supervisory team, 
Emily Henderson (EH), early in the coding process. A discussion of the codes developed by 
EH and I directed the coding process for the remainder of the transcripts.  
Step 3: Developing the framework  
A thematic framework was developed using the codes generated in Step 2. Codes were 
examined both within and between transcripts and were refined based on their similarities. 
Refined codes reflecting views or experiences on a similar issue or phenomena were 
categorised in groups to form themes (260). The framework then comprised a set of distinct 
themes, each containing several common codes. Specialist qualitative software (Nvivo11 
QSR International) was used during the coding process. Use of computer software is not 
essential but can be beneficial for editing and refining existing codes. 
Step 4: Indexing  
The framework was developed using codes from a small sample of interview transcripts. The 
collated codes were then applied to the subsequent transcripts (this process is formally 
referred to as indexing (259)). During the indexing process, additional codes emerged as new 
perspectives and experiences were revealed by interview participants. The framework was, 
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thus, a fluid entity that was refined during the indexing process until all transcripts had been 
analysed (259). All transcripts were revisited once using the final, refined framework to 
ensure the indexing was consistent across all transcripts. To validate the indexing process, a 
copy of the framework and an indexed transcript were distributed amongst my supervisory 
team for examination.    
Step 5: Charting  
A framework matrix was generated to contain the coded data from each transcript. A 
separate matrix was created for each theme in the thematic framework. This process is 
formally referred to as charting (259, 260). Each row in a matrix represented an interview 
participant and each column designated a code within the theme. An example of the matrix 
layout is presented in Table 5.2. Transcript data belonging to each code was summarised 
from the transcripts and recorded in the appropriate cell of the matrix (represented by the 
shaded area in Table 5.2). The use of Nvivo simplified this task as the exact transcript text 
belonging to each code could be easily identified. Charting the data enabled it to be viewed 
as a whole and allowed cases to be compared and contrasted by reading down each column 
(259). 
Step 6: Interpretation  
The conclusive step in any qualitative analysis is interpreting the findings. The data matrix 
and additional notes made throughout the analysis process were examined to synthesise the 
data in order to produce a narrative which addressed the study objectives (section 5.2). Key 
objectives and features of qualitative research, such as mapping the range of phenomena, 
defining concepts, finding associations, and providing explanations (259) were attempted to 
synthesise the data. Discussions with my supervisory team throughout the synthesis process 
were beneficial to encourage critical reflection on the interpretation of the data, as 
recommended for qualitative research (260).  
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Table 5.2 An example of a framework matrix 
 Theme 1 
Context 







   
Interviewee 2  
(Practitioner) 
   
Interviewee 3  
(Specialist) 
   
Interviewee 4 
(Practitioner) 
   
 
5.3.5 Characteristics of study sample 
A total of 20 individuals were invited to take part in the study; 15 agreed to be interviewed, 
three declined, and two did not respond after a follow-up invitation. Between October 2016 
and August 2017, 18 interviews were conducted, which included three follow-up interviews 
with three respondents. The characteristics of the study sample (n=15) are reported in Table 




Table 5.3 Table of study sample characteristics 
Characteristic N (%)  
Gender   
Male  8 (53%)  
Female 7 (47%)  
Role 
  
Specialist 6 (40%)  
Practitioner 6 (40%)  
Councillor 3 (20%)  
Location 
  
Newcastle 3 (20%)  
Gateshead 3 (20%)  
Durham 1 (7%)  
Sunderland 2 (13%)  
South Tyneside 1 (7%)  
Teesside 2 (13%)  
Northumberland 2 (13%)  
Hackney, 
London* 
1 (7%)  
Mode of interview 
  
In person 11 (73%)  
Over the phone 4   (27%)  
*This participant was included purposefully, despite not being located in North-East England, after 
meeting at a workshop organised by Fuse (The Centre for Translational Research in Public Health) 
owing to his revealed experience with priority-setting methods at the workshop. The participant met 
all other inclusion criteria. 
  
5.3.6 Ethical approval and consent 
Ethical approval was granted for this study by Newcastle University Research Office 
(Reference: 1640/2015). Written consent to participate in the study and to be audio 
recorded was confirmed at the start of each interview. A copy of the consent form can be 
viewed in Appendix H. 
 Results 
The results are presented in the following sub-sections according to each of the study 
objectives: the local public health decision-making context (section 5.4.1), current 
understanding and knowledge of health economic evaluation tools amongst PHDMs (section 
5.4.2), PHDMs’ use of economic evaluation evidence to aid decision-making (section 5.4.3), 
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informational requirements for public health decision-making (section 5.4.4), and barriers to 
the use of health economic evidence to aid decision-making (section 5.4.5). 
5.4.1 Objective 1: The local public health decision-making context 
Two of the domains from the thematic framework were relevant to exploring the context of 
local public health decision-making (Context and Integration with wider systems).  
Whilst politics has always been a factor affecting decisions in healthcare and public health, 
interview participants reported that post-transfer of public health to local government “the 
politics is much more direct” [Interviewee 7, Specialist].  
The directness of the politics emanates largely from the influence of elected members. They 
were described as the key decision-makers in a LA, responsible for all major decisions 
regarding public health expenditure, including the public health budget. However, a discord 
between the NHS and LAs with regards to addressing issues of public health was expressed 
by one of the specialists.  
“I still worry that local government at senior levels doesn’t quite understand the 
business of health. And yet they have responsibilities for commissioning health services. 
And in the same way…equally, the NHS clearly doesn’t understand local government.” 
[Interviewee 10, Specialist] 
The opinion of interviewee 10 was, in part, shared by one of the elected members. 
“…one thing that a lot of people in the NHS don’t get about local government is local 
and government. You know, we’re not a national organisation, therefore, it’s not a one-
size fits all approach. The other bit is about it’s a form of government. And government 
means that we actually, we’re a political organisation.” [Interviewee 11, Councillor] 
Given the role of elected members in the decision-making process, public health officers 
(including both specialists and practitioners) must consider, and take account of, members’ 
priorities in order to gain support for public health initiatives. Public health officers’ 
recommendations must, therefore, be considered “palatable to elected members” 
[Interviewee 6, Practitioner], an issue which became apparent during discussions on certain 
alcohol policies for which evidence exhibited positive health impacts, yet the political 
support was not forthcoming due to other concerns. 
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“…there’s been I think quite a lot of…a lot of negativity from politicians about it. I think 
they [elected members] are kind of worried about impact in particular on tourism 
industry so they are quite keen to understand what is the nature of the benefits in 
terms of impact on the system?” [Interviewee 9, Specialist]   
Financial pressure on LAs has also been a relevant contextual factor evident in public health 
decision-making. Significant reductions in the financial settlement with local government 
since 2010 have instilled a cost-saving mentality in elected members and officers alike. 
Despite public health teams bringing a ring-fenced public health grant with them following 
the function’s transfer, austerity remains a major concern throughout LAs, as one councillor 
explained: 
“Saving money [is] at the forefront of council decisions currently” [Interviewee 12, 
Councillor]  
Consequently, public health officers described feeling under pressure to demonstrate cost-
savings, or specifically “illustrate actual cashable return” [Interviewee 7, Specialist] from 
their actions. 
As a result of financial constraints, the trade-off between implementing policies focussed on 
prevention on the one hand and programmes for treatment of current ill-health on the 
other, has heightened.   
“Everybody knows that prevention’s the right thing to do but how do you do prevention 
when you’re managing the fires that are happening now?” [Interviewee 1, Specialist]  
The difficulty in diverting funding towards preventive activities was additionally described 
from a political viewpoint, where it was considered “brave to put money in prevention 
because you don't see the results straight away” [Interviewee 13, Councillor].  
Austerity measures were not, however, always viewed in a distinctly negative light. For some 
respondents they were seen as a facilitator for change.  
“But it [austerity] has also, it does also create some opportunities for thinking 
differently about the way things are done.” [Interviewee 5, Specialist] 
Other consequences of austerity measures were described, such as the role of the public 
health department as a rescue service for projects the council can no longer afford. Several 
interviewees offered examples of services, not traditionally belonging to the remit of the 
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public health department, obtaining funding via the public health grant in order to prevent 
their abandonment.  
"I think people are finding creative ways of spending the public health grant on all 
things we wouldn’t have traditionally spent it on and wouldn’t necessarily want to 
spend it on either" [Interviewee 8, Practitioner] 
Whilst not approved of by some officers, this was not always met with pessimism. The 
opportunity to broaden the remit of public health departments towards a greater focus on 
health determinants that was more closely aligned with the origins and purpose of public 
health was welcomed. One interviewee described the importance of the integration of the 
public health department with the wider council remit as follows: 
“…the LA is the public health body rather than the public health department” 
[Interviewee 5, Specialist] 
5.4.2 Objective 2: Current understanding and knowledge of health economic evaluation 
tools amongst PHDMs  
The second objective examines PHDMs’ comprehension of health economic concepts and 
familiarity with the various health economic tools (i.e. economic evaluation methods and 
priority-setting techniques) available to aid decision-making. Data from the understanding 
and knowledge theme from the framework are drawn on to illustrate this discussion.   
Interviewees of all roles displayed a general appreciation of principles of efficiency and 
health economic concepts, including councillors who expressed a desire for reassurance that 
action is cost-effective. 
“I would ask for when things are presented to me I would sort of say, “is there evidence 
that it’s cost-effective?” [Interviewee 12, Councillor] 
However, while the concepts underpinning health economic tools, described in the glossary 
of terms presented to each interviewee, were often professed to be familiar, the health 
economic vocabulary was not necessarily known.  
“You know some of the bits in there [in the glossary of definitions], I won’t say all of 
them, that I thought “yeah that goes through your thinking” but I didn’t know you’d 
call it this particular thing.” [Interviewee 11, Councillor]  
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In some cases, the disparity between an interviewee’s use of a concept and its use by an 
expert was apparent to the individual. 
“I’m not a public health professional so when I say “cost-effective” I might mean 
something slightly different to what an economist or erm a health economist might 
mean.” [Interviewee 12, Councillor] 
On the other hand, it was expressed that all public health team members should have a basic 
understanding of health economics.  
“…you know everyone’s [colleagues in public health] got a level of knowledge around 
health economics and broader evaluation” [Interviewee 9, Specialist] 
There did, however, appear to be a division between interviewees in different roles 
regarding their understanding of health economics. Specialists were better able to 
demonstrate comprehension of the tools and how they might be used than practitioners, 
who claimed to be familiar with the terms but did not display a true understanding of 
concepts when discussed further. The quotation below from a practitioner exemplifies the 
limited ability to differentiate between the nuances of the different tools available. 
“Everybody has their own definitions of them [health economic tools], they all mean 
the same thing really, don’t they? Pretty much.” [Interviewee 2, Practitioner] 
Additionally, specialists displayed familiarity with certain tools, such as CUA, and accurate 
knowledge of other tools, such as CCA. 
“I suppose I’ve leant on other bits of work I’ve done in other areas…so what we know 
maybe about cost per QALY, so the cost-utility analysis, but then also I suppose 
…otherwise think of it as cost-consequence analysis, you know here are the costs and 
here is a range of benefits and then we’ll make some subjective judgements between 
the services about, to agree if that delivers value for money.” [Interviewee 9, Specialist] 
Specialists’ knowledge of other methods, such as CBA and SROI, was admittedly scarce. 
“Erm, I’m less familiar with the broader categories you’ve got on your cheat sheet here 
because we don’t do those at the moment.” [Interviewee 5, Specialist] 
However, non-specialists’ use of health economic terms suggested minimal command of the 
tools’ methodological nuances and terminology was used colloquially to describe any benefit 
resulting from an action.  
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“So it’s that thing of that cost-benefit analysis of like, you do work upstream that will 
create benefit for you further down the line, maybe in terms of people don’t fall into a 
ditch” [Interviewee 6, Practitioner] 
5.4.3 Objective 3: PHDMs’ use of economic evaluation evidence to aid decision-making 
Following closely on from PHDMs’ understanding of health economic tools is their use in 
decision-making. This third objective draws on data from the Economic evaluation use theme 
of the framework to consider how economic evaluation evidence is used to inform current 
public health decisions.  
Health economic data was regarded as important. In response to a question on how much of 
a place economic evaluation has in public health, one interview participant replied: 
“Oh, critical place. We need to do more. More and more and more” [Interviewee 10, 
Specialist] 
LAs’ financial situation was cited as a reason to focus attention on determining the value of 
public health programmes. 
“And actually, cost-effectiveness is an important one given the budget challenges that 
we’ve got at the moment” [Interviewee 1, Specialist] 
However, despite an aspiration to use economic evaluation evidence, in practice it was not 
always deemed appropriate to aid decisions on the ground, therefore, limiting its use in 
practical matters around commissioning services. 
“So that’s sort of an esoteric, academic way of thinking about things then actually… 
Sometimes there’s a gap between marrying up you know, what the evidence says and 
how you actually make something work in a practical way.” [Interviewee 6, 
Practitioner] 
Where health economic evidence was used, the tools used appeared to differ between roles 
in the public health department. The previous section (5.4.2) touched on specialists’ use of 
CUA, which was often via consultation of reports produced by NICE. However, it was 
acknowledged that QALYs, as a measurement of value, have become less beneficial since 
public health departments transferred to local government. 
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“…we tend to use NICE quite a lot to make a case and they tend to use the QALYs, you 
know and that sort of thing. But again, I think NICE is more understood in NHS terms 
than necessarily in local government.” [Interviewee 1, Specialist] 
“Well at the moment we use cost-utility analysis because those data tend to be 
available and they are helpful, but they are less helpful in a broader context than the 
NHS” [Interviewee 5, Specialist] 
Despite claims that CUA is less helpful in LA settings, the preceding quotation describes using 
it over other tools typically on the basis of availability; a situation in which CUA was held 
applicable was when conversing with stakeholders with a clinical background, such as 
Clinical Commissioning Groups (CCGs). However, one Specialist suggested a desire by NICE to 
incorporate alternative methodologies despite a current paucity of relevant evidence. 
“…they’re [NICE] wanting for public health to move towards broader, much less 
focussed, more cost-benefit or cost-consequence analysis. I haven’t really, I haven’t 
particularly seen that there’s been a great shift in that way, yet… I mean yeah, there 
aren’t many cost-benefit analyses that I have to say I’ve found I’ve been able to use and 
I think mainly that’s...the lack of them.” [Interviewee 9, Specialist] 
On the other hand, practitioners most commonly referred to using ROI/SROI and CBA. It 
transpired that these interviewees were referring to evaluations integrated into a 
commissioning tool for drug and alcohol treatment services as part of the National Drug 
Treatment Monitoring System (NDTMS).  
“So we’d definitely be using the cost-benefit analysis, social return on investment, 
definitely. We’d be using cost-effectiveness analysis… and those are all tools that have 
been developed specifically to use alongside the datasets that we use.” [Interviewee 
14, Practitioner] 
Part of the NDTMS toolkit embedded a CEA and CBA, and recently a separate SROI tool. 
Access to the toolkit is strictly monitored, however, a discussion with a PHE employee who 
helped develop the toolkit indicated that the CBA uses a monetised value of the QALY in its 
calculations.  
The glossary of definitions was also used to gain insight into interviewees’ opinions of the 
potential for adopting health economic methods that may not be currently in use. Specialists 
discussed interest in CBA and SROI due to their ability to cover a wider scope of benefits.  
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“Well, I think cost-effectiveness analysis is very important. I also think cost-benefit 
analysis the more of those the better. I think social return on investment is very 
important and I would like to see more emphasis given on that. …because I think it 
[CBA], for me, my understanding of it is it’s more, looks at more parameters than 
simply cost-effective analysis.” [Interviewee 10, Specialist] 
Some interviewees, however, had some concerns about CBA:  
“Erm, but it obviously doesn’t account for quality-adjusted life within that so er, I think 
the QALY is the better tool to use.” [Interviewee 7, Specialist] 
The preceding quotation indicates a limit to the understanding of CBA, since a CBA has the 
potential to capture all relevant benefit arising from some action. Providing the benefit 
valuation is designed appropriately, a CBA has the ability to account for quality-adjusted life. 
For instance, stated preferences could be elicited for the outcome of a programme in which 
changes to quality of life are explicitly defined in the scenario being valued (see Chapter 
Three for detail of stated preference elicitation).   
An alternative method for incorporating a wide range of outcomes is MCDA, which was 
reportedly used in some LAs, and was typically appreciated by those interviewees 
experienced with the priority-setting technique. The following quotation reflects both the 
positive and negative experiences of the process required to conduct an MCDA. 
“…it increased everyone’s knowledge of everyone else’s work areas, it provided actually 
some really good summaries…of what value are we getting from our interventions, it’s 
informed our budget and recommendations to the, to cabinet and to the portfolio 
holder. It’s made us much clearer about the evidence base, and I think it’s given a kind 
of confidence within the team that everyone has been involved in assessing the value of 
different services and programmes…I guess the difficulties were the kind of time and 
resource it takes” [Interviewee 9, Specialist] 
5.4.4 Objective 4: Informational requirements for public health decision-making 
The fourth objective of this study was to elicit information considered necessary, or highly 
beneficial, to aiding public health decisions. The intention behind this objective was to 
ascertain whether any of the existing economic evaluation tools are best-suited to fulfil the 
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requirements expressed by PHDMs or whether current tools could be adapted to provide 
relevant information. 
Some elements of beneficial evidence have already been addressed in the previous sections, 
such as returns from investment to other LA departments (section 5.4.1) and demonstrable 
cost savings to the council compared to savings to other health-care sectors like the NHS. 
“…all of these savings on health, well that’s brilliant, but they’re all savings which will 
be achieved by the NHS and the CCG. Where are the savings to the LA?” [Interviewee 8, 
Practitioner] 
Addressing health inequalities was frequently declared as a top priority for the council. The 
ability to differentiate the impact of an intervention on various subgroups within society 
was, thus, reported as important. 
“The resources are scarcer and scarcer and scarcer, we’ve got to be targeting where 
they’re going to have the most impact in terms of reducing inequalities.” [Interviewee 
11, Councillor] 
Considering long-term impact was also described as imperative to PHDMs. The difficulty 
promoting prevention was highlighted earlier, in section 5.4.1, and is reiterated again here.  
“…but we’re better off putting our focus there even though we know that’s really long-
term stuff. You know, it doesn’t have that immediate impact but actually if we’re 
thinking about population health that’s really what we need to be thinking of.” 
[Interviewee 1, Specialist] 
The quote below from a councillor exemplifies the need for reliable evidence on the long-
term impact of interventions to be available, particularly in the current financial climate, to 
make a case for preventive interventions, which may not realise benefits until some future 
point in time. 
“…the challenge there is for public health teams to explain why erm, investing in 
prevention is a sensible thing to do when money is tight” [Interviewee 12, Councillor] 
5.4.5 Objective 5: Barriers to the use of health economic evidence to aid decision-making 
The final objective of this study was to examine barriers reported, or implied, to the use of 
health economic tools to aid public health decision-making. The findings reported in this 
section were identified in the final domain of the thematic framework, barriers to economic 
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evaluation. Several of the barriers presented here have been identified in earlier sections of 
this chapter so will only be covered briefly. 
Objective 3 (section 5.4.3) discussed the availability of evidence precluding the use of certain 
health economic tools. For example, specialists reported limited published evidence of CBAs 
or SROIs, therefore, resulting in sub-optimal use of those tools, as interpreted by 
interviewees’ proposed interest in alternative evaluative methods. The evidence available, 
additionally, was reported as not always relevant to LA decisions, thus, reducing its benefit 
to local decisions.  
“…it’s about taking that evidence from academics and NICE and Cochrane review and 
all that and using all that and localising it because when we have commissioned some 
services that are based on massive literature reviews and evidence, I think they don’t 
then necessarily work at a local level” [Interviewee 8, Specialist] 
Section 5.4.2 examined the limited understanding of health economic tools amongst some 
PHDMs. One interviewee even expressed concern that important skills have been lost 
amongst some public health officers he had encountered.  
“…in terms of literature searching, reviewing evidence, critically appraising evidence, 
understanding of the hierarchy of evidence. Some of the things that I sort of took for 
granted a few times…I’ve possibly just been a bit surprised that they haven’t 
necessarily had the knowledge and understanding…we get so bogged down with 
politics, in not having enough time to spend looking at published evidence that I think, 
you know some of these skills do get lost.” [Interviewee 9, Specialist] 
The above quotation implies that not only is the narrow appreciation of health economic 
tools amongst many public health officers a barrier to their use, but a further obstacle may 
also lie with more basic evidence interpretation skills.  
If the barriers of evidence availability and capacity to effectively use the evidence to inform 
decisions are overcome, that still does not mean that economic evaluation evidence will 
ultimately direct action. There remain further factors which determine public health 
decisions, notably, politics and priorities. 
The political context discussed earlier in section 5.4.1 described a decision-making hierarchy 
in LAs, with elected members being the ultimate decision-makers. The approach to 
evidence-informed decision-making by elected members, however, is not necessarily the 
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same as the one understood by public health officers. As one specialist described, elected 
members respond to different types of evidence, potentially leading to disconnect if 
economic evaluation evidence conflicts with other evidence privileged by elected members.  
“I mean elected members are very much guided by the information they get from their 
officers as well as their own opinions and what they get from the public...I think it’s 
probably different evidence as well. So, it’s not so much kind of, clinical evidence or 
solid public health evidence, it also incorporates a kind of, what does it mean to 
citizens? What does it mean to members of the public?” [Interviewee 7, Specialist] 
Thus, in addition to ensuring political acceptability of proposals, as discussed in section 5.4.1, 
officers must also present evidence provided using health economic tools in a way which is 
acceptable to elected members and appeals to their preferences. Examples were provided 
during the interviews of instances where elected members' personal priorities have 
influenced the funding of interventions which public health officers did not recommend or 
opposed based on effectiveness grounds. The following quote from a specialist described 
one experience of recommending the withdrawal of a popular service for which evidence on 
its effectiveness and cost-effectiveness did not support its continuation.  
“…if a service is very popular with members you either can’t touch it because you’re 
never going to get the decision through or you’re going to have to do a lot of work with 
members to educate them as to why you’re doing that, get them on board” 
[Interviewee 15, Specialist] 
Furthermore, even if health economic evidence is available and has been identified by public 
health officers, there was a perception that the evidence was superfluous to the outcome of 
the decision. In the case reported by Interviewee 9, below, the economic evidence didn’t 
necessarily support implementation of the service compared to alternative options. 
However, a case had already been made to direct funding towards the programme, 
therefore, it went ahead regardless of the economic evaluation evidence.  
“...but broadly it [health economic evidence] was mainly from the NICE guideline that I 
used, mainly, cost-utility analysis erm, information but I suppose the interesting thing is 
I’m not quite sure what kind of impact it had. Essentially the agenda...there was to get 
a specialised service up and running because he’d put in a business case for it and he 
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wanted to make sure this helped. Well, it came up somewhere in the middle...Well, 
there was new money for it, the new money was earmarked for this. 
Yeah [the outcome had already been decided], you know...the degree to which it made 
an impact I don’t know.” [Interviewee 9, Specialist] 
 Discussion 
This chapter reports a qualitative investigation with PHDMs. The findings reported in this 
chapter address the second overarching research question of the thesis via a discussion of 
the extent of use and understanding of health economic tools, and the identification of 
barriers to the use of health economic evidence, by PHDMs. The study additionally explored 
the needs of PHDMs with regards to health economic evidence and investigated which 
economic evaluation methods may prove most useful in assisting decision-making. The study 
investigated these issues using semi-structured interviews with 15 individuals from a range 
of roles relevant to public health decision-making in LAs in the North-East of England.  
Variation in evidence use and knowledge of health economic tools was identified between 
individuals of different roles in the LAs. Additionally, throughout the interviews, the political 
nature of LAs was referenced as heavily impacting the evidence base used to inform 
decisions. Several informational requirements, addressing the four points for consideration 
identified by the systematic review in Chapter Four (see section 5.2), were identified 
alongside a range of barriers to the use of economic evaluation hailing from the political 
context and the supply of relevant evidence. These results are discussed in detail below, 
drawing on comparisons with existing literature. Finally, implications for further research are 
provided. 
5.5.1 Summary of findings and their relation to existing literature 
An overarching finding from this qualitative study is the complexity surrounding the 
decision-making processes in LAs. Public health decisions draw on a spectrum of evidence 
from academic research, public opinion, and political preferences. Additionally, the multi-
sectoral nature of LAs, which are responsible for a myriad of functions besides public health 
such as education, transport, and planning, necessitates public health decisions being made 
in a context which considers, and takes into account, their impact on broader council 
objectives. This stems from an understanding that funding to one area of the LA forgoes 
funding in another; the cuts to local government budgets since 2010, commented on 
101 
extensively by interviewees, stresses the opportunity cost of funding initiatives for any LA 
department to an even greater extent.   
Economic evaluation has emerged and developed to provide information on the relative 
value of different courses of action, and has been used to inform healthcare decisions made 
in a budget-constrained environment by organisations such as NICE (11). NICE have also 
drawn on economic evaluation evidence to inform their public health guidance (31). On 
paper, economic evaluation should also be a valuable aid to local public health decisions. 
However, the findings reported in this chapter show that whilst health economic evidence is 
viewed as important, and public health officers aspire to use it more, several barriers 
prevent its optimal use.  
The complex process of decision-making in public health creates obstacles to the use of 
economic evaluation evidence. To begin with, the direct political influence impacting on 
public health decisions since the transfer of responsibility back to LAs in England has been 
referenced extensively by interviewees throughout this study. Factors such as council 
priorities, elected members’ preferences, and distinct features of the local area are all 
reported to have a bearing on public health decisions. These additional criteria were 
reported as at times coming into conflict with each other if the political will to enact a policy 
did not align with the evidence supplied by public health officers, or if the health economic 
evidence suggested disinvestment in a programme which had significant backing from the 
public and other stakeholders, whose preferences elected members valued greatly.  
Existing literature reports similar findings with respect to the discovery that economic 
evaluation evidence in its current format insufficiently provides information required to 
guide local public health decisions. Several commentators (56, 247, 248, 263) have reported 
discrepancies between the evidence available, often reporting outcomes on a national scale, 
and the local evidence valued by local decision-makers. Views were expressed in the current 
study, and in wider literature, that translating existing evidence into the practical needs of 
local authorities is difficult and can act as a barrier to the use of academic evidence, 
including economic evaluation evidence, in decision-making. Furthermore, a review 
examining evidence use in English LAs arrived at the conclusion that available evidence is 
insufficiently sensitive to the heterogeneity of local decision-making cultures (249), echoing 
the findings from this study that greater emphasis is needed to provide locally relevant 
information as opposed to national level data. 
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However, previous literature examining the application of economic evaluation evidence in 
local healthcare decision-making when public health remained the responsibility of the NHS 
(264) also demonstrated limited use of economic evaluation approaches. Therefore, whilst 
the direct political context of current public health decision-making has undoubtedly 
affected the use of health economics in LAs, the onus cannot be placed solely on political 
influence. The unique complexities of decision-making in a public health context also play a 
large role in health economic evidence use.  
Reflections from the interview participants revealed a narrow use of health economic 
evidence and provide insight into how tools may be improved to add value to public health 
decisions. Unique aspects of public health interventions relevant to decision-making were 
revealed during the interviews, several of which concern the four areas outlined for further 
consideration in Chapter Four. Two of the points were closely linked: PHDMs’ use and 
opinion of CUA and whether incorporating broader outcomes is important. The findings 
from this study suggest that PHDMs, most often specialists, do use evidence from CUA, yet 
express views that this tool is perhaps insufficient for public health decisions due to the 
multi-sectoral nature of the interventions they are scrutinising. Health economic methods 
that are better suited to incorporating a wider breadth of outcomes were viewed as 
providing value in the LA context, yet the absence of evidence utilising those methods was 
cited as the main barrier. The lack of exposure to published evidence such as CBA and SROI 
certainly had an impact on interviewees’ familiarity with the tools; however, interest in using 
the tools if available was expressed in several instances.  
Another consideration from the systematic review in the previous chapter was the use of 
priority-setting techniques, which have featured minimally in the published literature. Two 
priority-setting techniques were discussed during the interviews, PBMA and MCDA, with 
only MCDA reported to have been used. Several of the interview participants from different 
LAs (Interviewees 7, 9, 12, and 15) described undertaking an MCDA in their public health 
department and all remarked favourably on the tool, principally because it provided a 
transparent and systematic tool to deal with difficult decisions, such as areas where 
disinvestment is needed to adjust to budget cuts.  
Despite the time and resource commitment reported by interviewees to complete an MCDA, 
an advantage of priority-setting techniques is the breadth of criteria that can be considered, 
thus enabling a broad spectrum of outcomes to be compared. Several comments were 
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raised during the interviews regarding the value gained from the process of undertaking an 
MCDA as much as the outcomes from the exercise, such as engaging the wider public health 
team and providing transparency to decision-making practices. Much of the priority-setting 
action observed locally was part of the “Shifting the Gravity of Spending” research project, 
which explored priority-setting techniques in LA public health teams (54, 58). Furthermore, a 
prioritisation framework, which draws primarily on MCDA techniques, has recently been 
developed by PHE (265) and evaluated as an extension of the previously mentioned research 
project (266). The framework was developed for in-house use within teams based in LAs, 
therefore, suggesting that the hypothesis stated in Chapter Four, that the published 
literature base underestimates the amount of priority-setting work being conducted, is likely 
correct.   
The importance of incorporating impacts on equity in economic evaluations was the final 
point for consideration from Chapter Four. Reducing inequity was confirmed in this study as 
a top priority for LAs and the work around public health particularly in ensuring access to 
services and targeting scarce funding towards members of the population most in need. 
Economic evaluation evidence that is able to account for heterogeneity in the population 
relevant to health inequalities, perhaps by socio-economic status or other identifiable 
criteria, could be beneficial for targeting scarce resources if value differentials are identified 
between the different sub-populations. Incorporation of impacts on equity in economic 
evaluation evidence would require subjective judgements on the part of decision-makers 
where trade-offs are identified between maximising overall population benefit and 
addressing equity issues. Tools such as MCDA can assist in making these judgements via the 
act of consensual weighting of decision criteria, therefore, reducing some of the subjective 
nature of difficult decisions.    
A complementary qualitative study, published since the completion of the study reported in 
this chapter, examined the use of health economics in public health in an English LA (56). 
The study, conducted in the West Midlands between May 2016 and June 2017, identified 
similar findings to those reported in this chapter with regards to the politicised decision-
making context, the requirement for a broader scope in outcomes evaluated, and limited 
knowledge of health economics amongst those working in LAs. Frew & Breheny (56) focused 
on the context of decision-making and the barriers to use of economic evidence, with less 
regard paid to the appropriateness of specific economic evaluation or priority-setting 
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methods, which this chapter has sought to explore. The complementary findings from Frew 
& Breheny (56), however, usefully serve to validate those reported in this chapter. 
Given the interest expressed by PHDMs to incorporate economic evidence to a greater 
extent in their decision-making and the inadequacies of the current evidence base reported 
in this study and others (56, 249), it is imperative that research progresses in this area to 
establish how to make health economic evidence more accessible to PHDMs. The findings 
discussed here justify the continued exploration of economic evaluation methods and ways 
in which that evidence is disseminated that are better able to address the complexities of 
local public health decision-making processes.  
5.5.2 Reflexive statement 
The nature of qualitative interviews involves an “exchange between researcher and the 
researched” (267, p.111). As such, the impact of the researcher on the ensuing conversations 
cannot be overlooked. Each interview participant was aware that the study was interested in 
examining the use of economic evaluation evidence, and may, therefore, have felt pressure, 
however unintentional, to over-emphasise their interest in health economics or over-state 
familiarity with tools in order to appear better-informed (268). By way of minimising any 
imposed bias, interviewees were reassured that no prior knowledge of the health economic 
concepts discussed was a pre-requisite to being interviewed. 
The knowledge that the interview findings would contribute to the writing of this thesis, and 
that the interviews were being audio-recorded, may have led respondents to be less candid 
in their responses, particularly councillors who are spokespeople for their local council. 
However, the assurance that all data would be used anonymously with any identifiable 
features removed should have reduced this effect.  
Additionally, the themes drawn out from the transcript data may have been influenced by 
my background in health economics. Data discussions with the non-health economist 
members of my supervisory team were intended to mitigate against this risk, and to dilute 
any unintended focus on select issues at the expense of alternatively valuable insights 
revealed by the data. 
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5.5.3 Strengths and limitations 
In exploring the demand for economic evidence in public health decision-making, Kneale et 
al. (249) note that relevant studies lacked exploration of the awareness and use of available 
decision-support tools. This empirical study has addressed an identified gap in the literature 
and has provided a unique investigation of PHDMs’ knowledge and awareness of a range of 
health economic decision tools.  
This study included interviewees from a range of LA roles, from specialist public health 
officers to locally elected members of the council, which ensured the viewpoints of 
individuals from all perspectives of the local decision-making process could be explored. 
Purposive sampling, however, ensured that breadth was not sought at the expense of 
sufficient depth. 
However, this study is also subject to possible limitations. Firstly, the findings are a 
manifestation of the perspectives of decision-makers from LAs in one region in England (with 
the exception of one councillor). LAs across the country are subject to unique contextual 
factors based on their specific political leadership and decision-making processes have been 
demonstrated to be particular or specific to each organisation (53). As a result, this study 
cannot generalise results to other areas in England. However, as noted above, the findings 
from Frew & Breheny (56) suggest that LAs across England may share similarities in their 
decision-making cultures and evidence use, therefore, the findings reported in the chapter 
should have a wider relevance.  
Secondly, the relatively small sample size of 15 interview participants may be considered a 
potential limitation. Recruitment for the qualitative research was, however, determined by 
reaching “redundancy” (255) regarding the study objectives. With regards to the sample of 
specialists and practitioners, redundancy was considered to have been achieved when no 
new codes emerged in the transcripts. Data from the sub-group of councillors were less 
convergent, therefore, saturation of the perspectives of elected members cannot be 
claimed. Nevertheless, this component of the doctoral research was intended as a modest 
study to surface issues for subsequent inquiry. To that extent, the 15 interview participants 
were sufficient to generate information to meet the purposes of the study and provided 
direction for the doctoral project.  
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5.5.4 Implications for further research  
The findings from the study reported in this chapter have implications for the direction of 
the remainder of this doctoral research.  
Given the recent and substantial research into priority-setting tools through the Shifting the 
Gravity of Spending project (58, 266), the remainder of the research in this doctoral project 
concentrates exclusively on methods of economic evaluation. This decision was based, 
additionally, on the findings from this empirical study, which suggest the use of priority-
setting tools is an interactive process conducted within public health teams. The use of 
existing evidence, including economic evaluations, is part of the MCDA process. Therefore, 
improving the evidence base of economic evaluations, which should, in turn, enable 
effective prioritisation of resources, was deemed the most beneficial course of action to aid 
public health decision-making. 
No single method of economic evaluation prevailed with regards to preferences expressed 
by the interview participants. However, interest was expressed in exploring alternative 
methodologies, which are better suited to examine the multi-sectoral context of local public 
health decisions. Therefore, CBA and SROI were identified as suitable candidates for further 
exploration, neither of which were identified as prominent in the economic evaluation of 
public health intervention literature featured in the systematic review reported in Chapter 
Four. CCA additionally holds promise for examining multi-sectoral impacts of public health 
programmes, due to its ability to present a broad range of costs and effects, although its lack 
of an aggregated outcome may cause concern for PHDMs. Consequently, these three 
economic evaluation frameworks would benefit from further exploration, especially given 
PHDMs’ reported limited exposure to them.  
Interviewees also expressed a desire for locally relevant information, therefore, evaluations 
conducted in Part Two of this thesis should consider local analyses where possible. 
Furthermore, the limited appreciation of the nuances of health economic tools imply 
communication of economic evaluation evidence should be presented in a suitable non-
technical fashion to enable engagement from PHDMs.  
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5.5.5 Summary 
This study provided a qualitative exploration of the use of various economic evaluation and 
priority-setting methods in multiple LAs in North-East England. This research was timely 
given the transfer of public health responsibilities back to local government in 2013 and 
PHE’s current interest in advocating prioritisation frameworks.  
The interview study reported varying degrees of understanding of health economic tools 
amongst the interview participants and narrow use of published economic evaluations, 
typically due to issues regarding literature availability. Toolkits designed specifically for the 
commissioning of drug and alcohol treatment services were claimed to report CEA and CBA 
(using monetised QALYs) outcomes. However, the quality of these tools could not be 
verified, and their coverage is severely limited compared to the wider public health remit. 
The political culture of LAs was noted to have affected decision-making in public health from 
both an evidence standpoint, i.e. necessitating novel sources of evidence, and a procedural 
standpoint, i.e. ensuring recommendations are acceptable, and in keeping with the 
priorities, of elected council members. Furthermore, interviewees reported it necessary to 
incorporate broader outcomes into economic evaluations and emphasise demonstrating 
cost-savings to the council due to unprecedented fiscal constraints.  
This study has provided relevant evidence for subsequent empirical work reported in Part 
Two. The remainder of this thesis focuses exclusively on economic evaluation methods, in 
particular exploring the relevance to PHDMs of CBA, SROI, and CCA compared to CUA, which 















PART II. Economic evaluation empirical work 
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 Development of the contingent valuation survey 
The qualitative study reported in the previous chapter did not identify a preferred health 
economic tool for evaluating public health interventions. However, interest was expressed 
by the PHDM interviewees in exploring tools that can incorporate a more holistic range of 
outcomes than solely health benefits, as these would better appeal to the multi-sectoral 
context of LAs. Frameworks such as SROI (84), CBA (81), and CCA (113) were identified as 
potentially relevant economic evaluation methods to meet these needs.  
The PHDMs interviewed were, however, largely unfamiliar with the nuances of these tools. 
To establish whether these largely unknown techniques would be valuable to public health 
decision-making, an initial empirical study was conducted that involved introducing 
examples of the methods to PHDMs. The aim of the remaining empirical work presented in 
this thesis is, therefore, to produce exemplars of each of the economic evaluation methods 
shortlisted as potentially beneficial and to present PHDMs with the resulting evidence. 
Feedback on the appropriateness and usability of each tool for decision-making can be 
assessed after exposure to each method. 
The systematic review reported in Chapter Four identified a paucity of studies utilising SROI, 
CBA, or CCA methods. Although a small number of CBA studies were identified, none valued 
benefits according to a method that is consistent with economic welfare theory, as outlined 
in Chapter Two, in which CBA is grounded. To measure benefit in a way that captures the 
holistic nature of many public health interventions, valuing benefit using stated preference 
techniques may be preferable to monetising QALYs, which only capture health-related 
outcomes (269).   
Consequently, it was necessary to conduct new economic evaluations using the methods 
mentioned earlier. To conduct a CBA capturing a holistic measure of benefit, a study to first 
elicit stated preferences was required. Chapter Three detailed methods able to elicit stated 
preferences: CV surveys and DCEs. A CV survey was chosen for the empirical work conducted 
for this thesis since an overall measure of benefit was sufficient for conducting a CBA to 
present to PHDMs and a CV survey can be less cognitively burdensome for respondents than 
a DCE (160).  
The qualitative study also suggested that PHDMs were more familiar with CUAs than 
alternative methods of economic evaluation and, additionally, CUA was the most prominent 
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type of economic evaluation identified in the systematic review reported in Chapter Four. 
Therefore, presenting a CUA alongside the SROI, CBA and CCA could provide a reference 
point to compare the alternative methods against. For a fair comparison of the four 
techniques, basing each evaluation on the same case study is preferable. Doing so ensures 
that PHDMs’ assessment of the methods is influenced only by factors related to the 
techniques and any preference based on the intervention evaluated is avoided.  
The first section of this chapter, therefore, outlines the case study used for all four 
evaluations. Section 6.2 introduces the survey setting and sample. Section 6.3 outlines the 
development of the CV survey and the pre-testing and pilot stages. Section 6.4 illustrates the 
structure of the overall survey. Section 6.5 outlines the ethical approval for the survey and 
section 6.6 summarises the chapter. The results of the CV study are reported in Chapter 
Seven.  
 The case study: SIPS Jr HIGH 
The Screening and Intervention Programme for Sensible Drinking (SIPS) Jr HIGH study (59) is 
an RCT evaluating an ASBI programme in a school setting for young people aged 14-15 (Year 
10 in English school years). The trial compares ASBI for risky drinkers with standard practice 
for alcohol issues in schools in four locations in England (North-East, North-West, South-East 
and London).  
Secondary prevention interventions are adopted during the early stages of a disease to treat 
and minimise the damage incurred. ASBI is considered secondary prevention because it 
specifically targets those who already consume alcohol, potentially increasing the salience of 
intervention compared with prevention that is aimed at all individuals regardless of alcohol 
consumption status (270). The effectiveness of ASBI at reducing alcohol consumption across 
a broad definition of young people (10-21 years) has been demonstrated previously (62). 
However, no ASBI studies had been conducted previously in a UK school setting; therefore, 
the SIPS Jr HIGH trial aimed to evaluate the effectiveness and cost-effectiveness of this form 
of secondary prevention in a select group of young people in a school setting.  
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6.1.1 The intervention 
Students were eligible to take part in the trial if they were aged 14-15 and scored positively 
on the Adolescent Single Alcohol Question (A-SAQ)5, demonstrating risky drinking behaviour. 
The A-SAQ was developed by the SIPS project team as a modified version of the Single 
Alcohol Screening Question (271) that is suitable for adolescents. Eligible and consenting 
students were randomised into either the control group or intervention group. The control 
group received a healthy lifestyles leaflet, which provided information on healthy eating and 
physical activity. The lifestyles leaflet contained no information on alcohol and students 
were not provided with any feedback from their alcohol screening. The intervention group 
received a brief intervention with a trained learning mentor, which comprised of a 30-
minute interactive session. During the session, students were provided with feedback on 
their alcohol screen results and engaged in an interactive discussion intended to raise 
awareness of the risks of alcohol consumption and encourage students to consider 
motivations for altering their behaviour around alcohol.    
6.1.2 Economic analysis 
Students were followed-up after 12-months to examine whether the intervention had 
affected the alcohol consumption of the students in the trial. Additionally, a range of 
secondary outcomes such as alcohol-related problems, smoking status, health-related 
quality of life (measured using the EQ-5D-3L6) and psychological wellbeing were also 
assessed (for the full list of outcome measures see Giles et al., 2019 (59)).  
A health economic evaluation was undertaken as part of the SIPS Jr HIGH project to examine 
the cost-effectiveness of the ASBI intervention. The economic evaluation consisted of both a 
CCA and CUA using QALYs (derived from responses by the students to the EQ-5D-3L) as the 
outcome measure. The CUA was conducted from the perspective of the UK public sector, 
therefore, costs (and savings) associated with service use were estimated based on self-
reported use of health, social, and other public sector services (as is common practice in 
economic evaluation (272)). The collection of data related to public sector service use for the 
                                                     
5 A positive score was a response to the A-SAQ of any of the following regarding frequency of alcohol 
consumption over the past six-months: ‘4 or more times but not every month’, ‘at least once a month but not 
every week’, ‘every week but not every day’, or ‘every day’ 
6 The EQ-5D-3L questionnaire was chosen over the version specifically designed for young people (EQ-5D-Y) 
because the EQ-5D-Y currently has no value sets which are necessary for the calculation of QALYs and EQ-5D-3L 
state it is possible to use the EQ-5L-3L for young people over the age of 12 years (94). 
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calculation of costs made this project an attractive study for a CBA and SROI because this 
information could be utilised to inform evaluations considering a holistic measure of 
outcomes.  
The pre-existing CUA and CCA evaluations (59) were adapted in order to present to the 
PHDMs alongside the novel CBA and SROI evaluations. The CV study that was conducted to 
provide a measure of benefit for the CBA used data collected from the trial to create the 
hypothetical scenarios from which WTP can be elicited. The remainder of this chapter 
outlines the development process of the CV study. 
 CV survey setting and sample 
Hanemann and Arrow (273, 274) recommend that CV surveys are conducted face-to-face for 
optimum reliability, however, the practicalities of conducting interviews in person often limit 
sample size. A relatively large sample (between several hundred and several thousand) is 
generally necessary to elicit a mean WTP value that is generalisable to the population of 
interest, particularly for public goods (275). A compromise was sought for this study by using 
an online survey. The online format enabled data collection from a large and varied sample 
and allowed sufficient information to be provided to participants in a cost-effective manner. 
An external market research company specialising in hosting online surveys (ResearchNow7) 
was used to host the CV survey as they were able to access a broad sample of the UK 
population. Furthermore, they have been used to host CV surveys by other researchers, e.g. 
Somers et al., 2019 (276). The accessibility of the survey was tested on a variety of mediums 
(mobile phones, tablets, laptops, and desktop computers) using a range of operating 
systems (Microsoft, Macintosh, Apple OS and Android) to ensure that participants would be 
able to complete the survey on whichever device they own in order to reduce non-response 
and sample selection biases (124).  
6.2.1 Study sample  
A UK general adult (over 18 years old) population sample was chosen for the CV study, 
although this sample would not be direct recipients of the ASBI. Obtaining WTP valuations 
from Year 10 students would be have been complex for several reasons. Firstly, 14 and 15-
year-old Year 10 students in the UK are unaccustomed to paying for services due to a greater 
                                                     
7 ResearchNow is now known as Dynata (https://www.dynata.com) 
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proportion of goods offered free to young people under the age of 18 and in full-time 
education (e.g. medication prescriptions, eye-sight tests etc.). Additionally, this population is 
unlikely to have a significant financial budget which is crucial to provide a concept of 
opportunity cost when considering WTP. Finally, accessing survey participants under the age 
of 18 using an online survey may not have been appropriate from either the viewpoint of 
obtaining appropriate consent or ensuring understanding of the stated-preference task. 
Therefore, alternative means such as face-to-face interviews would have been required, 
which are resource-intensive and, as stated in section 6.2, would have restricted the sample 
size. 
The choice of a general population sample has implications for the perspective of the WTP 
study because the CV survey respondents are not the population who would receive the 
intervention (Year 10 school students). WTP valuations can reflect different values 
depending on the relation of the respondent to the good being valued; they can either 
reflect use or non-use values (1, 124). Since the intervention recipients are not included in 
the CV study sample the majority of WTP values elicited are expected to reflect non-use 
values, although recipients may also perceive the intervention to generate personal value 
indirectly through positive externalities arising from the intervention outcomes. 
Nevertheless, a large component of WTP responses are anticipated to be driven by altruistic, 
non-use value (1, 277), either by recipients who have adolescent or young children and 
perceive future value for their offspring, or non-parents who wish for the intervention to be 
available for young people in general. Fortunately, stated preference techniques are suitable 
for eliciting both use and non-use values (1) and the ability of CV to obtain non-use value is, 
in fact, an asset quoted by supporters of the method (124). 
6.2.2 Sample size calculation 
A Bayesian approach to calculating sample sizes for CV studies has been suggested as 
superior to an ad hoc decision based on available resources (278), however, prior knowledge 
of WTP values is required for this approach. No published studies could be found eliciting a 
general population WTP for an ASBI, therefore, the literature was examined to find examples 
of CV studies from the broader area of public health, including alcohol treatment. Since it 
was explained in section 6.2 that the mode of survey conduction may have an impact on the 
sample size collected, literature specifically recruiting online samples was examined to 
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ensure relevance to this study. Sample sizes ranged from approximately n=312 (279) to 
n=2146 (280). 
Mitchell & Carson (124) set out an alternative approach to determine sample size which can 
be applied when priors are unknown. Their approach is based on three factors: deviation 
from true WTP (∆), relative error (V) and confidence levels (1-α). Equation 6.1 outlines the 
sample size calculation where Z represents the Z-score from a standard normal distribution 







If no prior evidence is available, the authors (124) recommend assuming a value of 2 for 
relative error (V). Therefore, taking a significance level of α=0.05, equivalent to a two-sided 
95% confidence interval, and deviation from true WTP ∆=0.15, the mid-point of reasonable 
values (0.05-0.3) suggested by Mitchell & Carson (124), a sample size can be estimated. 
Substituting the values stated above into Equation 6.1 results in a sample size of 683 
(Equation 6.2), which is located within the range of sample sizes identified in the similar 





= 683  (6.2) 
Mitchell & Carson (124) recommend inflating the sample size to allow for non-responses and 
protest responses. Since non-responses do not contribute to the sample quota collected by 
the online survey, considering these was not necessary to estimate the sample size. Protest 
responses, however, can be difficult to anticipate in advance. Of the similar CV literature 
reported earlier, only one study (279) reported evidence of protest responses, relaying that 
3.2% of their sample gave protest zero responses. Alternatively, other health-related CV 
studies have reported proportions of protest zeros of between 6%-10% (281) and 
approximately 24% (282). Given this range in protest zeros, an average of the identified 
proportions of protesting (~12%) was used to estimate the inflated sample size. A sample 
size of approximately 765 complete responses was, therefore, considered appropriate for 
this study.  
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 Developing the survey, pre-testing and piloting 
A series of hypothetical scenarios were developed to describe the intervention and its 
outcomes. The CV survey aimed to establish the general public’s WTP for the ASBI 
programme contingent on specified outcomes. The outcomes presented in the scenarios 
were based on those obtained from the SIPS Jr HIGH trial (section 6.1). 
The trial primary outcome was alcohol intake over the previous month, measured as units of 
alcohol. Data were also collected on secondary outcomes, which included both clinical and 
non-clinical effects. The purpose of conducting a CBA was to include a holistic composition 
of outcomes, including those broader than health; therefore, the trial primary outcome and 
two of the secondary outcomes were incorporated in the scenario. The secondary outcomes 
included were police arrests and school absenteeism. These outcomes were considered 
relevant in order to incorporate examples of multi-sectoral impacts (e.g. the criminal justice 
sector), represent the broader impact on young people’s general wellbeing, and may also be 
perceived by survey respondents to produce positive externalities for society if reducing 
arrests and absenteeism are considered proxy measures for lessening anti-social behaviour.  
School absenteeism was classified as five or more days missed from school over six months. 
Therefore, a student was only considered to have been absent from school if they reported 
missing a minimum of five days from school (the equivalent of one-week of missed school). 
The minimum criterion of five days was a distinction made by the SIPS Jr HIGH researchers 
based on literature which suggests that recurrent absenteeism produces the most damaging 
effects for student performance compared to infrequent absenteeism (283, 284). Sälzer and 
Heine (285) additionally demonstrate that young people with regular truancy achieve lower 
scores on numeracy and literacy tests compared to their peers.  
The SIPS Jr HIGH trial had not been powered to detect significant differences in the 
secondary outcomes, therefore, the arrest and absenteeism outcomes presented in the CV 
scenario should be considered illustrative rather than definitive. However, the outcomes 
used were considered appropriate for generating the hypothetical CV scenarios to ultimately 
conduct a CBA that is comparable to the CUA and CCA evaluations conducted as part of the 
trial. 
Three different scenarios for the intervention were developed. The first scenario depicted 
outcomes directly obtained from the trial results; the second scenario depicted the same 
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outcomes as Scenario 1 but also included potential long-run outcomes; the third scenario 
presented the same information as Scenario 2 but with a greater improvement in alcohol 
reduction. The purpose of including three scenarios was to examine whether the explicit 
recognition of long-run outcomes increases the value of the ASBI to respondents (i.e. 
Scenario 2 compared to Scenario 1) and whether an improvement in a health-related 
outcome (reduction in alcohol consumption) increases the value of the ASBI compared to 
only improvement in non-health outcomes (arrests and school absenteeism, i.e. Scenario 3 
compared to Scenario 2). 
Longer term outcomes were estimated using available literature on long-run effects of 
school absenteeism and arrests in young people. Findings from several studies (286-291) 
were adapted to present potential long-run outcomes from the intervention with respect to 
the likelihood of being arrested as an adult, the likelihood of completing further education 
and future earnings potential. Due to the uncertainty of long-run outcomes and 
heterogeneity identified in the literature in terms of long-run impact, the outcomes included 
in the CV scenarios were presented as increased or decreased chances rather than reporting 
absolute figures so as not to misrepresent the potential long-run effects of the intervention.  
6.3.1 Pre-testing 
Several rounds of testing the CV survey were conducted to determine that the payment 
vehicle and elicitation method were appropriate, to finalise the design of the hypothetical 
scenarios, and to ensure clarity of the survey instructions. Since the CV survey was to be 
administered online, respondents would have no opportunity to ask for points of 
clarification, therefore, it was imperative that the instructions were unambiguous to ensure 
the validity of the survey outcomes.  
The first round of pre-testing was conducted with two colleagues who were familiar with the 
CV approach, in order to obtain expert opinions on the methodological aspects of the 
survey, such as the elicitation method and payment vehicle. The survey was then tested on 
five non-economist colleagues and eight members of the general public to ensure the 
scenarios were relatable and that the instructions could be clearly understood. Following 
completion of the survey design, incorporating feedback from the pre-testing stage, a pilot 
test was conducted via a soft-launch of the online survey. This final pilot was critical to 
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assessing how the general public engaged with the online survey since the pre-testing had 
been completed face-to-face using printed materials rather than the online version. 
6.3.2 Testing scenario presentation 
Initially, the intervention outcomes were presented textually, either as a percentage change, 
a proportion of students achieving an outcome, or descriptively (e.g. “significantly fewer 
arrests”). Feedback from the pre-testing indicated that none of the presentation variants 
successfully provided information that was easily understood. One of the volunteers testing 
the material suggested representing the information graphically may be more intuitive to 
respondents.  
The scenarios were adapted to present the outcomes in the form of simple bar charts, which 
illustrated the change from baseline to 12-month follow-up for both the intervention and 
control groups. The graphic version was tested alongside the original text versions for 
comparison. Feedback indicated a clear preference for the graphic version; however, lay 
public volunteers, who were unaccustomed with trials, were confused about why changes in 
outcomes were seen in both the control and outcome groups. As a result, some lay 
volunteers reported mistrusting the results. Consultation with the supervisory team led to 
the decision to include only the difference between control and intervention groups at 12-
month follow-up as this is the most poignant outcome and should minimise confusion for 
respondents, especially during the online survey when explanation and reassurance cannot 
be provided. A small reduction in accuracy of the outcomes reported was considered a 
suitable trade-off to create a scenario which was understandable to respondents and which 
may elicit greater engagement with the survey.  
Throughout the pre-tests, particularly those with members of the public, the wording of the 
scenarios, instructions and background information was assessed for readability. Any text 
that was unfamiliar or unclear was altered and advice was sought from the pre-test 
volunteers as to appropriate alternative wording. One issue raised during the pre-testing 
stage was that the similarity of Scenarios 2 and 3 led to several pre-testers failing to notice 
that Scenario 3 depicted a change in alcohol consumption compared to Scenarios 1 and 2. To 
make this distinction clear, the colours used in the bar charts, which displayed each 
outcome, were varied. Where a difference in outcome is observed between the control and 
intervention groups (i.e. for arrests and school absenteeism in all scenarios and alcohol 
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consumption in Scenario 3 only), the control group was displayed in blue and the 
intervention group in orange. Whereas, in Scenarios 1 and 2, where no difference is 
observed in the consumption of alcohol between the intervention and control groups, both 
bars were coloured in shades of blue. This made it easier for respondents to visually discern 
a difference in the alcohol consumption outcome in Scenario 3 compared to Scenario 1 and 
Scenario 2. The final versions of the scenarios are displayed Figures 6.1 to 6.3.  
  
 
Figure 6.1 Scenario one as shown to survey respondents 
 
Twelve months after the brief alcohol intervention (screening plus a 30-minute interactive session), the following outcomes could be expected for 
risky drinking young people who received the intervention compared with those who do not receive the intervention. 
Outcomes are based on high quality research of how well the intervention works. 
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Figure 6.2 Scenario two as shown to survey respondents 
 
Twelve months after the brief alcohol intervention (screening plus a 30-minute interactive session), the following outcomes could be expected for 
risky drinking young people who received the intervention compared with those who do not receive the intervention. 
Outcomes are based on high quality research of how well the intervention works. 
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Figure 6.3 Scenario three as shown to survey respondent 
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Twelve months after the brief alcohol intervention (screening plus a 30-minute interactive session), the following outcomes could be expected for 
risky drinking young people who received the intervention compared with those who do not receive the intervention. 
Outcomes are based on high quality research of how well the intervention works. 
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6.3.3 Testing the payment vehicle 
The choice of additional monthly taxation as the payment vehicle was affirmed during the 
pre-test with expert colleagues. This mode of payment was chosen on the basis that the 
intervention being valued is a public health good, which would typically be funded via 
general taxation in the UK. Individuals in the UK do not routinely pay at the point of access 
for public health services and the majority of the general adult population are familiar with 
paying taxes in some form. In keeping with this cultural context, it was, therefore, 
considered most appropriate to frame payments as an additional monthly tax contribution 
which would be used directly to fund the ASBI.  
The outcomes of the ASBI in the hypothetical scenario reflected the intervention impact 
after 12 months of implementation. Thus, to remain consistent with the scenario outcomes, 
a one-year time horizon was also used for the payment vehicle. The one-year duration was 
compared with a four-year duration8 during the pre-test stage; a greater likelihood of WTP 
was observed with a one-year payment period, thus supporting the monthly tax for one 
year.   
The payment question posed to respondents following exposure to each hypothetical 
scenario was as follows:  
“Thinking about the intervention and outcomes that have just been shown to you, 
would you be willing to pay anything for the brief alcohol intervention to be provided to 
‘Year 10’ students in schools in the UK? A payment would be made in the form of extra 
monthly taxation for one year which would be used to directly fund the intervention.” 
A “yes” response would take respondents to the WTP task, which is described in section 
6.3.4 below, and a “no” response would end the WTP task (see section 6.3.5 for detail on 
responses indicating unwillingness to pay). 
6.3.4 Testing the elicitation method 
The pre-testing phase with expert colleagues affirmed the choice of elicitation method as 
the random card sort followed by an open-ended question to obtain a maximum WTP value 
                                                     
8 Four years is the duration of a term for a locally elected member of council. This period would, therefore, 
reflect the time-frame that individual elected members may consider for an investment, given the uncertainty 
of re-election at the end of each term. 
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(see Chapter Three for detail on possible alternative elicitation methods). The initial range of 
values presented during the random card sort (per month: £0.50, £1, £1.50, £2, £5, £7.50, 
£10, £15, £20, £30, £50 and £100) was examined in all pre-tests and, consequently, 
additional values were added to the lower end of the random card sort scale and the highest 
value was removed. Doing so aimed to improve the sensitivity of WTP responses since the 
majority of the pre-tests provided WTP values in the lower region of the random card sort 
scale. The final range of random card sort values used in the survey was: (per month) £0.50, 
£1, £1.50, £2, £3.50, £5, £7.50, £12.50, £15, £25 and £50. It was clearly stated in the survey 
that the duration of tax payments would be one year; to ensure this was not overlooked by 
respondents, the annual equivalent value of each monthly payment was also indicated on 
each random card sort payment card (see Figure 6.4). 
Figure 6.4 A screenshot of the random card sort task showing a £2 payment card 
appearing in a random order and the participant moving it to their preferred box: 
Definitely would pay 
 
The random card sort was designed to display each of the payment card values in a random 
order. Respondents who had previously stated that they would be willing to pay for the 
intervention were instructed to place each payment card in a box relative to the 
*This example demonstrates an illogical placement of cards (£0.50 in the “Definitely would not pay” box 
where higher values have been placed in the “Definitely would pay” box). This would be identified once all 
cards had been sorted and the participant would be asked to check their card placements before moving 
on. 
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respondent’s certainty of willingness or unwillingness to pay. A reminder was also given to 
consider what would be feasible to pay given the respondent’s budget constraint, to ensure 
the opportunity cost of their valuation was considered.  
“You said you would be willing to pay something through extra taxation that would be 
used to directly fund the intervention.  
What is the maximum amount that you would be willing to pay every month for the 
next year? In order to help you decide you will be shown different amounts of money. 
For each amount please decide if you “definitely WOULD pay”, “definitely WOULD NOT 
pay” and “would MAYBE pay”. 
When you are thinking about this, please think about what you would be prepared to 
pay, given your actual income and savings.” 
The random card sort task is illustrated in Figure 6.4. The online survey was programmed to 
identify illogical responses during the random card sort task, such as placing a higher value in 
the “definitely would pay” box than in the “definitely would not pay” box. Respondents 
would be unable to complete the random card sort task until changes were made to ensure 
their card sort was logical. Figure 6.4 provides an example of an illogical placement of cards.  
Following a logical placement of cards, respondents would be asked an open-ended WTP 
question, guided by their responses to the random card sort. The open-ended question 
would allow respondents to state their maximum WTP, bounded by the values they placed 
in the “definitely would pay” and “definitely would not pay” boxes. 
“From the list of amounts, you said the highest amount you “definitely WOULD pay” 
per month is [£X] and the lowest amount you “definitely WOULD NOT pay” per month 
is [£X].  
What is the MAXIMUM value you would be willing to pay as extra monthly taxation for 
the intervention? It could be one of these amounts or something in between. 
The open-ended question displayed above allowed respondents to state any value, within 
the given bounds, to generate a continuous value of WTP. Alternative instructions were 
given for the open-ended payment if no cards had been placed in either the “definitely 
would pay” or “definitely would not pay” boxes during the random card sort. The alternative 
versions can be viewed in Appendix I, section I.1. 
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6.3.5 Distinguishing unwillingness to pay from protesting  
Participants may overstate or understate their WTP for a good for strategic reasons. 
Strategic action is referred to as protesting when respondents (i) state unwillingness to pay 
despite valuing the good positively, or (ii) offer excessively high or low values which do not 
represent the respondent’s true WTP (130, 292). Individuals may provide protest responses 
of Type 1 if, for example, they believe that someone else should pay (e.g. the Government), 
and Type 2 if, for example, they believe that providing a large WTP value will result in a good 
being provided (130). 
In order to distinguish protest responses of Type 1 from zero valuations reflecting a genuine 
perception that the ASBI lacks value, it is recommended that respondents be asked to justify 
their unwillingness to pay (124, 275). The motivation for a value of zero can indicate whether 
the response is a true zero valuation or an act of protest. During the payment question 
described in section 6.3.3, if a respondent stated that they were not willing to pay anything 
for the intervention, the WTP task would end and the respondent would be asked to select 
the reason for their unwillingness to pay from a list of options. Box 6.1 lists the justification 
options that were developed to distinguish protest and true zero WTP valuations. The 
options were tested and amended using responses provided during the survey pre-test 
stages.  
Box 6.1 Unwillingness to pay justification options 
 
Responses 1 and 2 in Box 6.1 indicate that a respondent does not value the ASBI positively 
and response 3 indicates inability (as opposed to unwillingness) to pay, therefore, these 
responses are considered to represent true zero valuations. Identifying protest responses is 
a challenging task, due to the lack of a standard definition for what constitutes a protest 
response (281, 292-294). Frey et al. state that “A protest bid is defined as not stating the true 
WTP value for the good in question for whatever reason” (293, p.2).  
1. Other interventions are more valuable 
2. I am not concerned about the issue of risky drinking in young people 
3. I think the intervention is valuable, but I cannot afford it 
4. I think the intervention is valuable, but I do not think it should be 
funded from taxes 
5. Other tax payers, who are better off, should pay for it 
6. Parents/guardians of ‘Year 10’ students should pay for it.  
7. Other (please specify) 
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Responses 4-6 were considered to reflect protest action since they indicate that a 
respondent values the ASBI positively but has other motivations behind their unwillingness 
to pay, therefore, respondents selecting these responses are not stating their true WTP 
value. This categorisation is, however, subjective to the researcher, a reported issue in the 
literature regarding the treatment of protest responses (293, p.2). Response 4 indicates that 
respondents value the intervention positively but object to the vehicle of tax payments. 
Response 5 also indicates that respondents value the intervention (since they believe it 
should be funded by someone, namely wealthier taxpayers) but object to being responsible 
for this funding. Although this response could be seen as similar to being unable to afford to 
pay anything, response 5 is subtly different because the vehicle of tax payment is 
introduced. It was expected that respondents whose motivation for unwillingness to pay is 
purely inability to pay would select response 3, thus, response 5 was considered to 
represent protest action. Response 6 was also interpreted as respondents indicating that the 
ASBI has value (since they believe someone should fund it, namely parents or guardians of 
Year 10 students), however, they object to being asked to contribute towards 
implementation of the ASBI. As with response 5, genuine lack of interest in the issue of risky 
drinking in young people was expected to be identified from response 2. Thus, response 6 
was considered a protest response.  
Examination of the free-text specifications to response 7 was required to determine whether 
these responses reflect a true or protest zero valuation. 
Protest responses of Type 2 can be more difficult to identify, however offering respondents 
the opportunity to elaborate qualitatively on the amount they are willing to pay is 
recommended (130) to attempt to distinguish unreasonable WTP values that may indicate 
strategic responding. Optional comment boxes were, therefore, included in the CV survey to 
elicit this information.  
6.3.6 The final pilot test 
The final piloting stage was a soft launch of the online survey. The online version was 
completed by approximately 5% (n=32) of the desired survey sample size (see section 6.2.2). 
The results from the soft launch indicated public engagement with the survey and whether 
the payment vehicle was acceptable to most respondents.  
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Two-thirds (n=19) of the respondents left comments in an optional comment box, which 
asked for elaboration on respondents’ willingness or unwillingness to pay for the 
intervention. This was perceived as a good level of engagement with the survey since this 
section was not mandatory. One comment indicated mistrust in the motivation behind the 
survey. Consequently, an extra sentence was added to the information page to explain that 
the survey was being used exclusively for research purposes by researchers at Newcastle 
University and would not be used to increase taxes.  
There did not appear to be any significant objection to the tax payment vehicle from those 
who were unwilling to pay. However, information was not available regarding non-responses 
because data from only completed surveys were collected.  
Following the soft launch, no changes were made to the scenarios or payment vehicle. 
 Survey structure 
In addition to the WTP questions, a short questionnaire was presented to respondents to 
elicit demographic information and information that may be salient to WTP responses, such 
as whether an individual is a parent or guardian of a child under the age of 16 and the 
respondent’s alcohol consumption. Standard demographic details were requested such as 
age, location (by UK region), gender, household income, employment status, marital status, 
and education level. Respondent characteristics would be used as covariates during the WTP 
data analysis to test for predictors of WTP and to test the theoretical validity of the CV 
survey (see Chapter Seven for details on the WTP analysis).  
The structure of the online survey is outlined in Figure 6.5. The practice question used a 
more compact version of the random card sort and a hypothetical scenario unrelated to 
ASBIs. The purpose of the practice question was to introduce the elicitation method to 
participants in order to reduce errors in the main CV survey that may be caused due to 
unfamiliarity with the WTP task. The full survey, including the practice question, can be 
viewed in Appendix I.  
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Figure 6.5 The structure of the online survey 
 
 Ethics 
Ethical approval for the CV study was granted by the Newcastle University ethics committee 
(Reference number: 4106/2018) on 26/02/18. Respondents were provided with information 
at the start of the survey which explained the purpose of the survey, who was conducting 
the research, that participation was voluntary, and that responses would be anonymous. 
Continuation past the information page was considered informed consent to take part in the 
study.  
 Summary 
This chapter has outlined the case study (the SIPS Jr HIGH trial) that provided the context for 
the CV task. The development process required to generate a reliable CV survey has also 
been detailed, including justification of the online setting and the required sample size. The 
description of each stage of the online survey has been outlined including designing the 
hypothetical scenarios, determining the payment vehicle and elicitation method, and putting 
measures in place to distinguish protest responses. Each stage of the survey has been pre-
tested and piloted, and this process has also been recorded in the chapter. The following 
chapter (Chapter Seven) provides details on the analysis of the WTP data collected and 
discusses the survey results.  
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 Contingent valuation study 
Chapter Six outlined the development of the CV survey and the approach taken to collect 
data. This chapter details the results of the online data collection and the analysis that was 
conducted on the WTP data.  
The first section of this chapter outlines the objectives of the data analysis of the CV survey. 
Section 7.2 outlines the methods of analysis employed to explore the data. Section 7.3 
presents the results obtained from each analytical objective. Section 7.4 discusses the results 
in relation to the existing literature and outlines the limitations of the study and areas for 
further research. The final section provides a concluding summary of the study. 
 Analytical objectives 
The overarching aim of this CV study was to obtain a WTP benefit value for the ASBI 
programme for a CBA. In addition to this aim, the analysis of the WTP data had four 
objectives: 
1. Examine descriptive statistics of WTP for use in the cost-benefit analysis (CBA) 
2. Examine the difference between WTP for the three scenarios 
3. Examine predictors of WTP to test theoretical validity of the CV survey 
4. Identify protest responses and examine the characteristics of respondents who protest 
7.1.1 Objective 1 
The first objective was relatively simple since maximum WTP was elicited via an open-ended 
question following the random card sort task. The WTP values could, therefore, be treated 
as continuous variables necessitating no adjustment to ascertain mean and median values to 
be used in the CBA (295).  
7.1.2 Objective 2 
The second objective aimed to examine the relative value that the study sample, 
representative of the UK general public, placed on non-health and health impacts of the 
ASBI, and long-run outcomes compared with short-run outcomes. Both the consideration of 
effects broader than health and long-run outcomes are elements of public health 
interventions that have been documented as methodologically challenging to address in 
economic evaluations, as discussed in previous chapters (Chapters One and Four). Whether 
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these factors place any weight on public valuations of interventions was, therefore, of 
interest to explore. Supposing that these factors do affect valuations, it was hypothesised 
that: 
i. WTP values would be larger for Scenario 3 than Scenarios 1 and 2 because there was a 
reduction in the consumption of alcohol 
ii. WTP values would be larger for Scenario 2 than Scenario 1 because long-run outcomes 
were included which may present the outcomes with greater certainty and impact 
7.1.3 Objective 3 
The third objective was to examine the characteristics of respondents that might predict 
WTP. Certain theoretical expectations can be tested during this examination, for example, 
characteristics such as income and education level are generally theorised to impact WTP 
whilst factors specific to this study, such as being a parent, guardian or grandparent of a 
child under 16 years of age, may be associated with higher WTP. The aim of the third 
objective was to examine whether the WTP results reflect the a priori theoretical 
expectations.  
The hypothesised direction of impact on WTP of each characteristic is outlined below. 
Details on the mechanism for impact and theoretical evidence are provided in Table 7.1. 
Higher income was theorised to positively impact WTP via ability to pay; that is to say 
respondents with higher household income would be expected to offer higher WTP values. 
Higher educated respondents were similarly theorised to offer greater WTP for health-
related interventions due to either greater health literacy or, in the context of the current 
study, greater risk aversion. The association between education and risk may be more 
relevant given the breadth of outcomes in the hypothetical scenarios.  
Other demographic characteristics may affect respondents’ WTP, however, the direction of 
the effect is more ambiguous. The CV literature valuing other public or healthcare goods has 
demonstrated contrasting results regarding the effect of gender, age, and marital status on 
WTP, indicating that these factors are study specific (276, 279, 296, 297). Married or 
cohabiting individuals, however, may indicate greater likelihood of WTP due to greater 
financial security compared to single respondents. 
 
Table 7.1 Mechanism and theoretical evidence for impact of predictors on WTP 
 Predictor Hypothesised direction of 
impact on WTP 
Mechanism for impact 
Demographic 
characteristics 
Income Positive  Ability to pay. It has been previously documented that individuals on higher incomes would be 
expected to pay more than those on low incomes (298-300). 
Education Positive Greater health literacy and risk awareness. Higher educated individuals may have a greater 
awareness of the importance of good health. Additionally, alcohol consumption can lead to 
risky behaviour. Individuals who are more risk averse may be expected to pay more for an 
intervention that reduces risky behaviour, such as engaging in activities which results in being 




Positive for likelihood of 
WTP 
Married or cohabiting individuals may experience greater financial security if two incomes are 
contributing to one household.  
Gender Ambiguous Insufficient evidence of direction 




guardian of a 
child <16 years 
Positive Stronger altruistic motivation from parents compared with non-parents. Additionally, the 
potential for indirect benefit to parents from a possible positive change in their child’s 
behaviour as a result of the ASBI.  
Drinking 
frequency 
Ambiguous Frequent drinkers may regret the choices they made regarding alcohol consumption and, 
therefore, support early intervention; alternatively, they may not view their drinking behaviour 
as problematic and thus, not value the ASBI at all. 
Non-drinkers, who perhaps choose not to drink due to the effects they perceive from alcohol 




Two additional factors specifically related to this study were hypothesised to have an effect 
on WTP. Firstly, whether a respondent is a parent, guardian or grandparent of a child under 
the age of 16 was expected to be associated positively with WTP since parents of children 
who could benefit from the ASBI may value it more than either parents of older children who 
could not benefit, or individuals without children9.  
Secondly, drinking frequency was hypothesised to impact WTP, however, the direction is 
ambiguous. Non-drinkers may be expected to offer higher WTP in support of the ASBI due to 
their own drinking preferences, while frequent drinkers’ preferences may depend on their 
attitude towards their current level of alcohol consumption.  
7.1.4 Objective 4 
The final objective was to identify protest responses and examine the characteristics of 
protest responders. Examining the characteristics of respondents who protest is important 
to (i) identify characteristics that may predict these responses in future in order to minimise 
protesting, and (ii) consider whether the sample of protesters is different to the sample of 
non-protesters. The latter point is particularly important if protest responses are removed 
from the sample prior to analysis since sample bias may be introduced if there is a significant 
divergence in characteristics between protesters and non-protesters (302).  
Common practice in the literature has been to remove protest responses from study 
samples (124, 294, 303, 304) since it is argued that protest responses are not true reflections 
of the value a protest responder places on the good in question (294, 302). It is valid to 
consider that protesters who offer a zero value of WTP may value the ASBI positively, yet 
state unwillingness to pay due to a rejection of the method of payment or objection to the 
survey. Therefore, removing protest zeros from the sample can reduce downwards bias 
introduced to estimates of WTP by the “false” zero valuations (302). Conversely, removing 
protesters offering extremely high WTP values, due to the perception that stating value far 
above their true value may secure implementation of the intervention, can reduce upwards 
bias on WTP.  
                                                     
9 For simplicity and brevity, henceforth, parents, guardians, or grandparents of children over 16 years of age 
and individuals without children will be referred to as “non-parents”. Furthermore, parents, guardians, or 
grandparents of children under the age of 16 will be referred to simply as “parents”. 
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 Methods 
Each of the objectives outlined in section 7.1 require a particular analytical approach to 
examine the data. Each of these approaches will be outlined in turn below. All analysis was 
conducted using Stata 14 (305).   
7.2.1 Objective 1: Estimate measures of central tendency 
Mean and median WTP was estimated to obtain a measure of benefit that can be used to 
populate the CBA (reported in Chapter Eight). Prior to estimating WTP, responses that were 
identified as protests, using the approaches discussed in Chapter Six, were removed from 
the sample, as discussed in section 7.1.4. To examine the uncertainty of the estimate of 
mean WTP, confidence intervals at the 95% level (95% CI) and standard errors10 were 
estimated by bootstrapping the sample values using 10,000 repetitions11.   
Sensitivity analysis on the mean and median estimates of WTP was also conducted to 
examine the effect of trimming the data to exclude very large values which may distort the 
mean WTP, and to include protest responses in the sample since an alternative method of 
addressing protest responses is to include them in the sample as zero values (302). 
7.2.2 Objective 2: Examining differences in WTP between each scenario 
In order to examine whether WTP values differed significantly between each of the three 
scenarios, the non-parametric Skillings-Mack test (307) was used. Distributions of WTP data 
are often skewed (308), therefore, a non-parametric test, which does not require normality 
assumptions, was chosen. The Skillings-Mack test is able to account for many ties or equal 
ranks, which would be the case if there are a substantial number of true zero valuations or 
equivalent WTP values.  
                                                     
10 The standard error of the mean measures the distance of the sample mean from the likely true population 
mean. This measure can be used to validate the accuracy of the mean estimate calculated from the sample 
data. The 95% confidence interval represents a range of values that have a 95% chance of containing the true 
population mean.  
11 The appropriate number of bootstrap repetitions was determined following the methods reported by 
Statacorp (306). The use of 10,000 repetitions produced a minimised difference in the standard errors and 
confidence intervals of two different bootstrap random-number seeds when compared to 12,500 repetitions 
and 7,500 repetitions. 
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To further investigate the two hypotheses stated in section 7.1.2, pairwise comparisons of 
WTP were conducted between the scenarios using the non-parametric Wilcoxon matched-
pairs signed-rank test. 
7.2.3 Objective 3:  Examining predictors of WTP  
Regression analysis was used to examine predictors of WTP for each hypothetical scenario. 
Manipulation of the raw data was necessary to facilitate the regression analysis. The 
majority of the demographic data collected was ordinal or categorical, with a relatively large 
number of categories to increase response precision. For example, household income had 
been collected using eight income range categories plus an additional two for “unknown” 
and “prefer not to say”. The “tick-box” method of data collection is particularly useful for 
data such as income because individuals may not know, or wish to reveal, their precise 
income; therefore, providing income ranges can provide some ambiguity and potentially 
encourage fewer non-responses (see Appendix I for the full survey text). In order to make 
the data more manageable and meaningful during the regression analysis, the ordinal 
categories of household income, age, educational achievement, and drinking frequency 
were compressed into three categories per variable. Dummy variables were created for the 
remaining characteristics: gender, marital status, living in the UK outside of England, and 
parental status. Box 7.1 lists the final variables used in the regression analysis12.  
Several econometric models can be used to examine WTP data and choosing the most 
appropriate model depends on the elicitation method used and the distribution of the data. 
Limited dependent models, such as Tobit, selectivity, or two-part models, are recommended 
by Donaldson et al. 1998 (309) for WTP data elicited via open-ended elicitation methods 
which contain a significant proportion of zero valuations. As discussed in Chapter Six, 
although the random card sort technique was employed initially to assist respondents’ WTP 
decisions, maximum WTP was ultimately elicited via an open-ended question. Therefore, 
analytical approaches considered appropriate for data elicited via open-ended methods 
were used. A two-part model was employed to examine determinants of WTP for the ASBI 
due to its ability to account for values of zero WTP.  
                                                     
12 Data were collected on employment status, however this was excluded as an independent variable in the 
final analysis due to strong collinearity with income (χ2 test, p < 0.000). 
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To examine whether the results were sensitive to model specification sensitivity analysis was 
conducted using two regression approaches commonly used to analyse WTP data, Tobit and 
log-transformed ordinary least squares (OLS). Tobit models account for censored data and 
are therefore able to include values of zero WTP. Log OLS transforms the dependent variable 
(i.e. WTP) onto a log scale to reduce non-normality in the distribution of residuals, which is a 
necessary condition for unbiased OLS models13. However, zero values cannot be included in 
the analytic sample because “0” cannot be log transformed.  
Box 7.1 Variable specification for regression analysis 
Dummy variables  
PARENT_GUARDIAN  Parent, guardian or grand-parent of a child under 16 years of age; 
1 for parent, 0 for non-parents 
MALE  Gender; 1 for males, 0 for females 
MARRIED  Marital status; 1 for married/cohabiting, 0 for 
single/divorced/widowed 
NONDRINK  Frequency of alcohol consumption; 1 for drinker, 0 for non-drinker 
(categorised as consuming alcohol less than 1-2 times per month) 
NON_ENGLISH UK location; 1 for Scotland, Wales or Northern Ireland, 0 for 
England 
Ordinal variables  
AGE  Age; 0 for under 35, 1 for 35-65, 2 for over 65 
EDUCATION  Highest level of education; 0 for no formal qualifications, 1 for 
school level qualifications, 2 for higher education qualification 
INCOME  Household income; 0 for less than £20,000, 1 for £20,000-£40,000, 
2 for over £40,000 
Two-part models are particularly adept at analysing data with a cluster of zero values by 
dividing the analysis into two parts, as their name suggests. The first part considers the 
dependent variable as binary to analyse the probability of observing either zero or a positive 
value. The second part of the model analyses the effect of covariates on the dependent 
variable, conditional on the probability that the outcome is positive from the first part of the 
model. The second part of a two-part model, thus, treats the dependent variable as positive 
                                                     
13 Log transformation was applied to WTP because tests for heteroscedasticity (Breusch-Pagan (310 ) and Cook-
Weisberg (311)) on the raw WTP data suggested errors were heteroskedastic (p<0.05). Following log 
transformation, heteroscedasticity was no longer indicated using the same tests (p>0.05). 
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and continuous. A two-part model is suited to examining the determinants of both the 
likelihood of WTP and the value of WTP, given that the value is positive14.  
The first part of the two-part model employed a logit regression15 and the second part 
employed a Generalised Linear Model (GLM). A GLM was chosen for the second part in order 
to account for skewness in the data since this approach has been recommended as more 
robust than alternatives, such as log-transformed OLS, for skewed data distributions16 (314).  
A limited set of model specification tests are available for the two-part model (312), 
however the Pearson χ2 goodness-of-fit test was employed to test the specification of the 
logistic regression.  
7.2.4 Objective 4: Identifying and examining characteristics of protesters 
Protest responses were identified using the two approaches outlined in Chapter Six. Firstly, 
the justifications for unwillingness to pay were examined to identify Type 1 protest 
responses (respondents reporting unwillingness to pay despite valuing the good positively). 
Secondly, qualitative responses from respondents justifying their WTP decision were 
examined to identify Type 2 protest responses (respondents offering excessively high or low 
values which do not represent true WTP). Particular attention was paid to respondents 
offering high WTP values (considered over £20 per month, equivalent to over £240 per 
annum). Respondents identified as protesters were compared with non-protesting 
respondents for each scenario separately using logistic regression. A dummy variable was 
created to distinguish protest respondents and non-protest respondents for each 
hypothetical scenario. The protest dummy variable was held as the dependent variable 
during the regression analysis in order to estimate the odds of protesting dependent on the 
respondent’s characteristics, collected from the demographic survey questions. Statistical 
significance on any of the resultant odds ratios was examined to test whether the sample of 
protesters differed from the sample of non-protesters in a way that is unlikely to be caused 
by chance.  
                                                     
14 For further detail on the two-part model see Belotti et al., 2015 (312). 
15 A probit model would have been equally acceptable, either specification is recommended for use in a two-
part model (312). A logit model was chosen in order to present the outcome of the regression in odds-ratios, 
via the ‘or’ option in Stata. 
16 The GLM used a log link and a gamma distribution. The most appropriate link function and distribution family 
for the WTP data were identified using a Box cox approach to test the link function and the Modified Park test 
to determine the distribution family (313) 
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 Results 
The CV survey was conducted in June 2018. Responses were obtained from 766 people from 
the UK general public, which met the intended sample size of 765 (see Chapter Six). Table 
7.2 reports the characteristics of the study sample in addition to the characteristics of three 
sub-samples: (i) respondents who provided a positive WTP value for all three scenarios, (ii) 
respondents who were consistently unwilling to pay for the ASBI in all scenarios and offered 
true zero valuations and (iii) respondents consistently protesting in all scenarios. The sample 
was selected to be representative of the UK adult population in 2018 according to location, 
gender, and age. A little over one-quarter (27%) of the sample were parents and a small 
majority (57%) reported consuming alcohol on either a moderate or frequent basis (see Box 
7.1 for categorisation criteria). 
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 N % of sample N % of sample N % of sample N % of sample 
Gender         
Male 377 49% 97 48.5% 45 43% 114 52% 
Female 389 51% 103 51.5% 60 57% 107 48% 
Age          
Under 35 204 27% 50 25% 26 25% 40 18% 
35-65 409 53% 114 57% 66 63% 115 52% 
Over 65 153 20% 36 18% 13 12% 66 30% 
Marital status          
Single/divorced/ 
widowed 324 42% 66 33% 56 53% 99 45% 
Married/cohabiting 438 57% 134 67% 49 47% 121 55% 
Employment status         
Employed 416 40% 121 61% 52 50% 117 53% 
Unemployed 305 54% 69 35% 46 44% 91 41% 
Educational level          
No formal 
qualifications 35 5% 8 4% 6 6% 9 4% 
School level 
qualifications 375 49% 89 45% 55 52% 116 57% 
Higher education 
qualifications 353 46% 101 51% 44 42% 96 43% 
Annual household 
income         
Less than £20,000 229 30% 46 23% 44 42% 69 31% 
£20,000 - £40,000 276 36% 71 36% 32 30% 74 33% 
Greater than £40,000 198 26% 72 36% 17 16% 56 26% 
UK Location         
England 644 84% 164 82% 88 84% 195 88% 
Scotland, Wales or 
Northern Ireland 122 16% 36 18% 17 16% 26 12% 
Parent/guardian of a 
child under 16         
Parent 204 27% 62 31% 33 31% 42 19% 
Non-parent 562 73% 138 69% 72 69% 179 81% 
Alcohol consumption         
Drinker 436 57% 119 60% 61 58% 126 57% 
Non-drinker 328 43% 81 41% 44 42% 95 43% 
*Sub-samples of respondents consistently offering a positive WTP value, true zero, or protest zero 
for all three scenarios 
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7.3.1 Descriptive statistics of WTP  
The first analytical objective was to examine the survey results descriptively. As commonly 
found in WTP data (130), the distribution of WTP was highly right-skewed and remained so 
after removing protest responses (skewness = 3.34 - 4.25 across the scenarios, excluding 
protest zeros) (see Appendix J for histograms of the data demonstrating skew). Additionally, 
a large proportion of the sample (n=476 - 514, 62% - 67% across the scenarios) was unwilling 
to pay for the intervention. Once protest zero responses were identified, the proportion of 
the entire sample (n=766) that were true zero responses was still substantial for all scenarios 
(n=178 - 202, 23% - 26%). Since protest zeros were removed from the samples prior to 
analysis, the proportion of zero WTP values in the analysed samples (n=454 - 466) remained 
substantial (39% - 45%) producing a large spike in the WTP distribution at zero (protest 
responses are discussed in detail in section 7.3.4).  
The mean and median values of WTP for each scenario are reported in Table 7.3. Mean 
annual WTP for the ASBI is, therefore, estimated at between £65 and £68, scenario 
dependent. The mean values are substantially larger than the median (£24), due to the right 
skew of the data.  
The results of the sensitivity analyses conducted to explore the impact of excluding large 
values and including protest responses are also reported in Table 7.3. Trimming the highest 
1% of responses reduced mean WTP slightly to between £59 and £62 and had no effect on 
the median values. The trimmed mean WTP for Scenario 2 (£59), however, was less than 
Scenario 1 (£61), contrary to the direction of untrimmed means. Including responses coded 
as protest responses in the base case analysis had the most substantial impact on WTP 
results, reducing the mean to between £41 and £43, scenario dependent. The much greater 
proportion of zero values in the sensitivity analysis including protest responses also has a 
substantial effect on median WTP reducing it to £0 for all scenarios. 
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Table 7.3 Mean and median WTP for base case and sensitivity analyses  
 
7.3.2 Comparison of WTP between scenarios 
The second analytical objective was to examine the difference between mean WTP for each 
scenario, in order to consider the effect that long-run outcomes and a reduction of alcohol 
consumption had on respondents’ valuation of the ASBI. The Skillings-Mack test rejected the 
null hypothesis that the values of WTP for each scenario were equal (p=0.039), indicating 
that the WTP values from the three scenarios were different from each other. 
These results were further explored to consider the two hypotheses outlined in section 
7.1.2. Pairwise comparisons provided no evidence to support the first hypothesis that 
Scenario 3 would elicit larger WTP values than Scenarios 1 and 2. Neither test could reject 
the null hypothesis that distributions of WTP were equal between pairs of scenarios 
(p=0.648 and p=0.241 for Scenario 3 compared with 2 and 1, respectively). The Wilcoxon 
signed rank test did, however, support the second hypothesis that Scenario 2 would elicit 
larger WTP values than Scenario 1. The null hypothesis of the test, that the distribution of 
WTP values was equal between Scenarios 1 and 2, was rejected (p=0.021) and the sign of 
  Scenario 1 Scenario 2 Scenario 3 
WTP, £ N 454 462 466 
Mean (SD) 65 (126) 66 (119) 68 (112) 
Median (IQR) 24 (0-87) 24 (0-90) 24 (0-90) 





N 450 458 462 
Mean (SD) 61 (108) 59 (91) 62 (93) 
Median (IQR) 24 (0-84) 24 (0-90) 24 (0-90) 
95% CI 51 - 71 51 - 68 54 - 71 




N 766 766 766 
Mean (SD) 41 (111) 42 (107) 43 (103) 
Median (IQR) 0 (0-36) 0 (0-48) 0 (0-60) 
95% CI 33 - 48 35 - 50 36 - 51 
SD=standard deviation, IQR=interquartile range, SE=standard error of the mean, 95% CI=95% 
confidence interval. SE and 95% CI estimated using 10,000 bootstrap repetitions 
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ranked pair comparisons indicated that Scenario 2 elicited larger WTP values more 
frequently than Scenario 1. 
7.3.3 Examine predictors of WTP 
The third objective of this study was to examine predictors of WTP and test the theoretical 
validity of the CV study. Section 7.1.3 outlined several expectations with regards to how 
respondents might be expected to value the ASBI based on their characteristics.  
The results from the regression analysis of WTP for each scenario are reported in Table 7.4; 
the first part of the model reported outcomes as odds ratios whilst the second part reported 
coefficients representing percentage changes17. Statistically significant (at the 1%, 5% and 
10% levels) results are displayed in bold. The odds ratios from the logit model report the 
odds that a positive WTP value is observed (compared with a zero value) given exposure to 
each covariate compared to its base factor. The coefficients reported from the conditional 
GLM model estimate the effect of each covariate on the value of WTP offered, conditional 
that the value is positive.  
The results of the Pearson χ2 goodness-of-fit test are all greater than 0.05, therefore, the 
logit model cannot be rejected. This indicates the logit regression model is an appropriate fit 
for the data.   
The first notable observation about the predictors is the difference between which 
covariates we have evidence as being associated with WTP for the first and second parts of 
the two-part model for each scenario. The results from the regression analyses suggest that 
the decision to pay a positive amount (compared with zero) and the absolute value to place 
on the ASBI are influenced by different factors.  
  
                                                     
17 Due to the log link, the GLM produces an exponential mean which allows the coefficients to be interpreted as 
percentage changes. To identify the percentage change of a factor covariate the following formula must be 
applied: exp(β) – 1  
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Table 7.4 Two-part model regression results for each scenario – dependent variable WTP 
VariableA 
Scenario 1 Scenario 2 Scenario 3 

















EDUCATION    
No formal 
qualifications 
1.236 0.329 1.062 -0.060 1.190 -0.097 
(0.690) (0.416) (0.636) (0.401) (0.678) (0.379) 
Higher 
education  
1.015 -0.016 1.062 0.017 1.432 -0.098 
(0.218) (0.158) (0.235) (0.137) (0.316) (0.132) 
NON_ENGLISH    
Non-English 
UK nations 
1.156 -0.359* 0.817 -0.264 1.037 -0.311* 
(0.323) (0.190) (0.231) (0.177) (0.288) (0.162) 
AGE    
Under 35 
0.983 0.465** 1.107 0.177 1.181 0.293* 
(0.241) (0.187) (0.273) (0.164) (0.299) (0.160) 
Over 65 
0.946 -0.339* 1.434 -0.402** 1.061 -0.326* 
(0.283) (0.206) (0.464) (0.180) (0.331) (0.178) 
MALE    
Male 1.349 0.273* 0.914 0.013 0.882 0.207 (0.281) (0.144) (0.195) (0.134) (0.190) (0.128) 
INCOME    
Less than 
£20,000 
0.776 -0.148 0.601* 0.029 0.785 0.159 
(0.201) (0.194) (0.156) (0.175) (0.203) (0.168) 
Over £40,000 
1.604* 0.054 2.126*** 0.216 2.348*** 0.219 
(0.418) (0.185) (0.592) (0.162) (0.658) (0.152) 
PARENT_GUA
RDIAN    
Parent 
1.022 0.101 0.626* 0.188 0.575** 0.146 
(0.245) (0.171) (0.159) (0.156) (0.144) (0.148) 
MARRIED    
Married / 
Cohabiting 
1.523* 0.153 2.389*** -0.066 2.318*** 0.087 
(0.384) (0.188) (0.606) (0.170) (0.603) (0.160) 
NONDRINK    
No alcohol 
1.022 0.046 1.117 -0.197 1.439 -0.059 
(0.218) (0.162) (0.245) (0.146) (0.322) (0.141) 
Observations 414 231 422 248 426 262 
Pr>chi2 
goodness of fit 
test  
0.428 - 0.301 - 0.533 - 
A Base factors excluded from regression: (education) school level qualifications, (location) England, 
(age) 35-65, (gender) female, (income) £20,000-£40,000, (parent/guardian) non-parent, (marriage 
status) single/divorced/widowed, (drinking frequency) alcohol consumer  
B  Coefficients from the second (conditional) part of the 2PM 
*** p<0.01, ** p<0.05, * p<0.1 
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The odds of offering a positive value of WTP for the ASBI increase for respondents with a 
household income over £40,000 compared to respondents with a household income of 
£20,000-£40,000 for all three scenarios. The predictive association is slight (p<0.1) in 
Scenario 1 but strong (p<0.01) in Scenarios 2 and 3. In Scenario 2 there is also slight evidence 
of a (p<0.1) reduction in odds of households with an annual income of less than £20,000 
offering to pay a positive value of WTP compared with respondents with a household 
income of £20,000-£40,000. There is no evidence that the value of WTP offered is associated 
with income in any of the scenarios.  
There is no evidence that parental status is a predictor for WTP in Scenario 1 (p>0.1). 
However, in Scenarios 2 and 3, parental status is weakly and moderately (p<0.1 and p<0.05, 
respectively) associated with reduced odds of WTP for the ASBI.  There is no evidence that 
parental status is a predictor of the value offered, given positive WTP, for any of the 
scenarios.  
The final predictor of the probability of offering a positive value of WTP is being married or 
cohabiting compared to being single, divorced or widowed. There is strong evidence 
(p<0.01) that being married or cohabiting has an odds ratio that is different to 1 in Scenarios 
2 and 3. Whilst there is weak evidence (p<0.1) that the odds ratio for WTP is greater for 
married or cohabiting respondents compared with single, divorced or widowed respondents 
for Scenario 1.  
With respect to the value of WTP offered, conditional that it is positive, there is moderate to 
weak evidence that respondents of retirement age or older (over 65) have a WTP that is less 
in all three scenarios compared with respondents aged 35-65 (p<0.1 for Scenarios 1 and 3, 
p<0.05 for Scenario 2). Additionally, males and younger respondents (under 35 years) are 
willing to pay more (p<0.1 and p<0.05, respectively) than females and respondents in the 35-
65 age range for Scenario 1. The same association is observed for Scenario 3 for younger 
respondents, however, the evidence is weak (p<0.1). There is no evidence that gender and 
younger age are predictors of WTP value for Scenario 2.  
There is weak evidence for Scenarios 1 and 3 that the respondent’s location is a predictor of 
WTP. Living in either Scotland, Wales or Northern Ireland is weakly associated with a lower 
value of WTP compared with respondents living in England (p<0.1). 
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Sensitivity analysis was run using Tobit and log OLS regressions to test for sensitivity to 
model specification. Both models used in the sensitivity analysis report only the effect of 
covariates on the value of WTP offered for the entire sample. This differs from the two-part 
model which reports the effect of covariates on WTP values given that the observations are 
positive. Additionally, whilst the Tobit model is able to account for the existence of zero 
values, log OLS cannot. Thus substantially reducing the sample size analysed in the log OLS 
model compared to either the Tobit or two-part models. Therefore, the outputs of the two-
part model are not directly comparable with either the Tobit or log OLS. However, no 
evidence was found that additional covariates in either of the regression analyses were 
predictors of WTP.   
The Tobit model results reported moderate evidence that married respondents, compared 
to single, divorced or widowed respondents, are predictors for higher WTP in Scenarios 2 
and 3 (p=0.022 and p=0.011, respectively). Furthermore, there is strong evidence that having 
an annual household income greater than £40,000, compared to an income of £20,000-
£40,000, is associated with higher WTP in Scenarios 2 and 3 (p=0.003 and p=0.001, 
respectively). These findings are similar to those of the two-part model reported above 
(which identified both of these covariates as predictors for WTP).  
There is weak evidence from Scenario 3 only that younger respondents (under 35) also paid 
more than respondents in the 35-65 age range (p=0.089). The Tobit regression analysis of 
Scenario 1 identified only being male as being a predictor of WTP (p=0.034), this is similar to 
the two-part model which provided weak evidence that male gender was a predictor or WTP 
for Scenario 1. The Tobit regression provided evidence that fewer covariates were predictors 
of WTP than the two-part model, however the pattern of predictors identified in the Tobit 
model is similar to that of the two-part model. 
The log OLS model did not provide any evidence that there were any predictors of WTP for 
Scenario 3. However, for Scenario 1 there was moderate to weak evidence that WTP 
increased for younger respondents (under 35) (p=0.019) and for males (p=0.083) 
respectively. Older respondents (over 65) were associated with paying comparatively less 
than 35-65-year-old respondents in Scenario 2 (p=0.053). The log OLS model provided 
evidence that far fewer factors were predictors of WTP than either the Tobit or two-part 
models. However, the factors that appeared to be important in both the OLS and Tobit 
models were also predictors in the two-part model. 
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There is no evidence that the WTP results are sensitive to model specification. No findings 
from the sensitivity analysis contradict the base-case findings using the two-part model. The 
full regression outputs for the sensitivity analyses are reported in Appendix K. 
7.3.4 Examining protest responses 
The fourth objective of this chapter was to examine the reasons given for protest responses 
and identify whether the sample of protesters differed from the sample of non-protesters. 
Firstly, Table 7.5 reports the reasons reported for unwillingness to pay for the ASBI (see 
Chapter Six for justification behind selection of protest and true-zero responses). Responses 
considered to represent a protest of Type 1 (respondents reporting unwillingness to pay 
despite valuing the good positively) are displayed in bold in Table 7.5. The free-text 
responses to “Other” were examined and only those indicating a protest to the survey or 
method of payment were considered protest responses. Examples of “Other” responses 
categorised as protests are: 
“state should pay for health through general taxation.” 
“The money to pay for this should come from the tax that is already levied on alcohol 
(sic)” 
Examples of “Other” responses considered true zeros were: 
“there are no definite long-term benefits, so I don't think it's worth it” 
“Cause (sic) I only get money for a week” 
In total, 54% - 65% of “Other” responses were categorised as protests across the three 
scenarios.  
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Table 7.5 Reasons reported by survey respondents for unwillingness to pay for the ASBI 
Reason for unwillingness to pay 
Scenario 1 Scenario 2 Scenario 3 
N (%) N % N % 
Other interventions are more valuable 57 (11) 48 (10) 42 (9) 
I am not concerned about the issue of risky 
drinking in young people 40 (8) 48 (10) 42 (9) 
I think the intervention is valuable, but I 
cannot afford it 91 (18) 81 (16) 83 (17) 
I think the intervention is valuable, but I do 
not think it should be funded from taxes 96 (19) 86 (17) 93 (19) 
Other taxpayers, who are better off, 
should pay for it 21 (4) 23 (5) 27 (6) 
Parents/guardians of ‘Year 10’ students 
should pay for it 177 (34) 171 (35) 165 (35) 
Other 32 (6) 34 (7) 24 (5) 
Total true zeros 202 (39) 189 (38) 178 (37) 
Total protest zeros 312 (61) 302 (62) 298 (63) 
Total protest and true zeros 514 (100) 491 (100) 476 (100) 
 
Regardless of the scenario, the most commonly cited reason for unwillingness to pay was 
“parents and guardians of ‘Year 10’ students should pay for it”.  
The proportion of all zero responses (n=476 – 514) that were categorised as protests was 
fairly constant across the three scenarios at approximately 60% (Table 7.5). The proportion 
of the whole sample (n=766) categorised as offering protest zero responses was 
approximately 40% for each scenario. 
Protest responses of Type 2 (respondents offering excessively high or low values which do 
not represent true WTP) were identified via examination of the qualitative comments 
provided by respondents following the payment task for each scenario. Whilst it is difficult to 
detect protest responses of Type 2, attempts were made to identify whether extremely high 
WTP could be considered a protest response by considering the justification given by the 
respondent. Many of the respondents offering the highest WTP values (over £60 per month) 
did not provide any comments, therefore, precluding a decision on whether these values 
represent protest or true responses. Two respondents, however, could be identified as 
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protesting based on their responses. Both respondents indicated that their valuation of the 
ASBI was nominally high and perhaps did not reflect a true valuation of the ASBI but rather 
strategic action due to their strong support for intervention to help young people. Two 
example responses from the identified protesters are: 
“you can't put a price on a students (sic) life” 
“YOU CANNOT PUT APRICE (sic) ON HEALTH” [capitalisation by respondent] 
The results of the logistic regression that was run to examine differences between the 
samples of protesters and non-protesters identified evidence of differences on three 
variables: parental status, age and location (for Scenario 3 only). In all three scenarios, there 
was evidence of reduced odds of parents protesting compared with non-parents (p<0.01 for 
Scenario 1 and p<0.05 for Scenarios 2 and 3). For all three scenarios there was evidence that 
respondents over 65 years old were more likely to offer protest responses (p<0.1, p<0.05 
and p<0.1, respectively), whilst in Scenario 2 only, there was evidence that respondents 
under 35 were also less likely to protest (p<0.05).In Scenario 3 only there was weak evidence 
that non-English respondents were less likely to protest (p<0.1).  
No other evidence of differences between the protest and non-protest respondents was 
identified from the logistic regression; therefore, for the most part, the samples are very 
similar. However, it could not be stated that the samples of protesters and non-protesters 
are homogenous and as such the WTP value estimates excluding protest respondents may 
be biased towards the views of parents and respondents below retirement age.  
 Discussion 
The aim of this CV study was predominantly to obtain a WTP value for the ASBI which could 
be used to populate a CBA. The inclusion of three separate scenarios also allowed inferences 
to be made about the impact of certain elements of the intervention, such as the impact of 
health-related outcomes compared to non-health related outcomes and the inclusion of 
long-run outcomes compared to short-run outcomes. The theoretical validity of the survey 
has also been examined alongside the potential for bias of the WTP introduced by the study 
sample. Each of these points is discussed in greater detail below.  
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7.4.1 Estimates of WTP and the presence of zero valuations 
The survey elicited a positive mean value of WTP for the ASBI. The standard errors and 95% 
CIs calculated for the mean values of WTP suggest a high likelihood that the population 
mean annual WTP is positive and in the region of £50-£80. The sensitivity analyses 
conducted indicate that mean and median WTP are not extremely sensitive to the removal 
of the largest 1% of values. Furthermore, the uncertainty around the mean reported by the 
95% CIs is similar to the base analysis for each scenario.  
Including protest responses substantially reduced both the mean and median values of WTP, 
although, the lower bound of the 95% CIs remained greater than zero across all scenarios. 
Thus, accounting for uncertainty around the mean WTP estimate, the evidence suggests that 
mean WTP remains positive when protest responses are included as true WTP responses. 
This observation is due to the high proportion of the sample who were unwilling to pay 
anything for the ASBI. Including protest zeros, approximately two-thirds of the sample were 
unwilling to pay for the intervention, substantially reducing the mean WTP.   
The proportion of all zero valuations identified in this study, including both protest zeros and 
true zeros (62%-67%), is larger than has been reported previously in healthcare related CV 
surveys. Smith et al. (315) conducted a review of WTP studies and, where data were 
available, reported the proportion of zero responses in their identified studies. Two of the 18 
studies reporting relevant data had proportions of zero responses greater than 60%, whilst 
the majority reported 0%-5% (315). The authors (315) suggest that large numbers of zero-
responses may be due to self-completion of surveys from respondents since surveys 
conducted face-to-face elicited lower proportions of zero valuations. This could provide an 
explanation for the current study since the survey was completed online, however, given the 
reasons reported for unwillingness to pay it is likely that other factors were responsible.  
The survey sample did not constitute potential recipients of the ASBI, therefore, as discussed 
in Chapter Six, the values elicited would be non-use values and, thus, largely rely on altruistic 
valuations. Olsen and Donaldson (282), however, found that in a CV survey of healthcare 
programmes, altruistic motivations were greater predictors of WTP than “selfish” 
motivations (p.6), therefore, relying on altruism may not necessarily be a problem. Hence, 
the zero responses may be attributed to factors specific to the ASBI, such as its focus on 
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adolescents, rather than necessarily methodological issues with the survey design. Protest 
zero responses are discussed later in section 7.4.4. 
7.4.2 Inferences from the WTP differentials between scenarios 
The WTP values elicited for the three scenarios were identified as differing from each other 
by the Skillings-Mack test. The pair-wise comparisons show that this is largely driven by the 
comparison between the WTP responses to Scenarios 1 and 2. This result suggests that the 
inclusion of long-run outcomes in Scenario 2 had an impact on respondents’ WTP for the 
ASBI, as initially hypothesised (section 7.1.2). Whether this is due to the perception of 
greater certainty in the outcomes when long-run effects are presented, or whether 
respondents have a genuine preference for outcomes in the longer term would require 
further investigation to determine.  
A similar finding was not, however, identified for the comparison between Scenario 3 and 
Scenarios 1 and 2, suggesting that the reduction in alcohol consumption (included only in 
Scenario 3) did not increase WTP. The results do not provide evidence to suggest that health 
outcomes (i.e. a reduction in alcohol consumption) are valued by the UK public greater than 
non-health outcomes (i.e. reductions in arrests and missed school). This finding is contrary to 
the initial hypothesis. However, since the CV scenarios included three outcomes from the 
ASBI programme, this finding may be due to an embedding phenomenon. An argument 
follows that the sum of parts (i.e. each of the outcomes) valued individually may be greater 
than the sum of the whole (i.e. the scenario presenting all three outcomes simultaneously), 
and if this is the case in a CV study presenting several attributes it can be considered an 
embedding phenomenon (1). This effect can also be referred to as sub-additivity bias (316) 
or part-whole bias (317). 
Alternatively, the lack of significant differences between Scenario 3 and the other scenarios 
may represent a lack of scope on the alcohol-consumption outcome (1). Scope effects refer 
to increases in WTP for a good when the size of benefit increases. Scope insensitivity in WTP 
studies has been an area of contention in the CV literature (318) and to some opponents of 
CV methodology, lack of scope effects in WTP cast doubt on the suitability of the method 
(319). However, with reference to the reduction in alcohol consumption in this study, it may 
simply be the case that the modest change in the alcohol-consumption outcome was 
insufficient to test scope sensitivity.  
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7.4.3 Theoretical validity and predictors of WTP 
Section 7.2.3 outlined theoretical expectations regarding the effects of income, education, 
marital status, parental status and frequency of alcohol consumption. The two-part model 
regression analysis partly confirmed the a priori expectation regarding income such that 
respondents from higher-income households were more likely to offer to pay for the ASBI 
than moderate-income households and the reverse was observed for respondents from the 
lowest income households. However, with respect to the value of WTP offered by 
respondents who were willing-to-pay for the ASBI, there was no evidence that values offered 
varied as household income varied. This indicates that once a decision has been made to pay 
a positive amount, income does not greatly influence how much a respondent values the 
intervention.  
Education did not appear to be a predictor of WTP, suggesting that neither risk aversion nor 
higher health-literacy via the proxy of education level had an impact on WTP. This may be a 
result of the sample population since the study sample constituted non-users of the 
intervention; the theoretical expectations for the impact of education may only be 
appropriate to predict influence on use value. 
Marital status was hypothesised to influence the likelihood of WTP positively due to the 
potential for greater financial security in a two-person household, although, no expectation 
was posited for the impact on the value of WTP. This theoretical expectation appears to be 
validated by the results from the regression analysis since there was strong evidence that 
the odds of paying something for the ASBI were increased (p<0.01) if a respondent was 
married or cohabiting, yet there was no evidence of an influence on the positive value 
offered.  
The predictive ability of the parent covariate on WTP is also observed in the regression 
analysis, however, in the opposite direction to that hypothesised. It was expected a priori 
that parents would be WTP more than non-parents due to potentially stronger altruistic 
motivations; however, where there was evidence of a difference (i.e. in Scenarios 2 and 3) 
the odds of WTP for the intervention were lower for parents than non-parents.  
There are several possible explanations for this finding. Firstly, parents may be more 
sceptical of the intervention given their knowledge of their own children’s behaviour 
resulting in greater unwillingness to pay for the ASBI. Secondly, if parents in the sample do 
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not believe their children exhibit risky drinking behaviour, they may not view the 
intervention as beneficial. Thirdly, the finding may be the result of sample selection bias 
introduced by the removal of protest responders who were more likely to be non-parents, 
thus skewing the analytic sample population. However, the resultant proportion of parents 
in the analytic samples (30-31%) is not substantially different to the proportion of parents in 
the whole sample from which data were collected (27%). Therefore, potential sample bias is 
unlikely to be uniquely responsible for the association between parental status and 
unwillingness to pay for the ASBI. Fourthly, parents may have less disposable income 
compared to non-parents once spending on children is accounted for. Therefore, an income 
effect that is separate to the overall household income effect examined in this study may 
also contribute to this finding. Data were not collected on spending patterns; therefore, this 
hypothesis could not be examined. 
Finally, the expected direction of influence on WTP of alcohol consumption frequency was 
ambiguous prior to conducting the analysis. However, the results provide no evidence that 
this factor was a predictor of either WTP, or the value offered.  
With the exception of the parental status covariate, the CV survey findings generally appear 
theoretically valid in relation to the expected influence of factors on WTP. Other 
demographic factors (age, gender and location) were also significantly associated with WTP 
for which there were no theoretical expectations due to contrasting effects in the related 
literature.  
The ASBI also appears to be more valuable to respondents under the age of 35 and to males, 
although evidence for the latter is weak. Arrest rates in the UK are higher for males than 
females (320), therefore, the reduction in arrests outcome of the ASBI may be more salient 
to male than female respondents, leading to slightly increased WTP. Additionally, given the 
ASBI is targeted at adolescents aged 14-15, younger respondents may recall their own 
experiences, or those of others, with regards to drinking at that age to a greater extent than 
respondents over the age of 35. Consequently, the intervention and the reported outcomes 
may resonate more strongly with respondents closer in age to the potential ASBI recipients 
and, therefore, elicit higher WTP. The converse may also explain why respondents of 
retirement age (over 65) had a lower WTP compared with the 35-65 group.  
The sensitivity analysis conducted using the Tobit and Log OLS indicates that the data were 
sensitive to model choice. However, due to the distribution of the data, the two-part model 
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appeared better able to detect predictive factors of WTP by considering and reporting the 
two related decisions of WTP and the value offered separately. Whilst the Tobit model also 
considers WTP conditional on the probability of the outcome being positive (321), the 
regression output does not provide detailed feedback on the factors contributing to the two 
choices involved in WTP decisions. The log OLS regression was unable to account for zero 
values at all and so was considered less appropriate for the data.  This was reflected in the 
far fewer covariates having evidence that they were predicting WTP in the log OLS model. 
The two-part model could, therefore, be argued to be the most appropriate model choice 
for the data obtained. However, a more conservative evaluation of predictors of WTP would 
consider only those identified by both the Tobit and the two-part models. Considering such a 
perspective indicates that being married and having an annual household income of over 
£40,000 were the most consistently influential factors of WTP for the ASBI.  
7.4.4 Protest responses 
The proportion of the whole sample (n=766) who offered protests responses was 
approximately 40%. A meta-analysis of protest responses in environmental CV studies (322) 
estimated a mean proportion of samples offering protest responses of approximately 18%, 
although, the maximum identified proportion was 59%. Meyerhoff et al. (322) also examined 
protest responses according to factors such as the payment vehicle, thus, allowing a 
comparison to be drawn between the CV study reported in this chapter and a large body of 
literature. For studies using a tax payment vehicle, the range of protest proportions 
identified by Meyerhoff et al. was 1.5% - 47.7%, therefore, whilst at the high end of this 
range, the current study is still within the bounds of other similar literature. Nevertheless, 
compared with the proportion of protest zeros reported in similar health-related CV 
literature (between 3% and 24% of the total sample) (279, 281, 282), substantially more 
protest responses were identified in this study. It is important, therefore, to examine 
whether the high rate of protesting is a result of inappropriate survey design, or whether 
factors specific to the intervention can explain these findings. 
The use of tax-based payment vehicles is often considered a contributing factor for eliciting 
protest responses (293, 315, 323), however, objection to paying additional tax made up only 
19% of the reasons given for unwillingness to pay for the ASBI (Table 7.5). The most 
commonly cited reason for a zero valuation was “Parents/guardians of ‘Year 10’ students 
should pay for it”, making up approximately 35% of justifications for unwillingness to pay. 
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This justification is a greater reflection on the intervention being valued than, necessarily, 
issues with elements of the survey design. The concept that it is the responsibility of parents 
rather than the public to fund the ASBI is specific to this study where the recipients of the 
intervention are adolescents rather than the general public. Additionally, the intervention is 
one aimed at reducing alcohol consumption, a public health issue which has been 
demonstrated to elicit low WTP due to connotations of voluntary risk behaviour, e.g. 
Pellegrini & Jeanrenaud., 2001, cited in Jeanrenaud & Pellegrini., 2007 (324). Therefore, a 
combination of negative perceptions of individuals engaging in harmful alcohol consumption 
and the intervention recipients being adolescents, who are presumed to be under the 
guardianship of parents, are probable explanatory factors for the majority of protest 
responses. Therefore, design issues with the CV survey can be expected to contribute only 
partly to the high proportion of protest responses. 
The choice of eliciting WTP from a general public sample likely contributed to the number of 
protesters, given that the most common reason for unwillingness to pay was that parents 
should fund the ASBI. Additionally, approximately three-quarters of the sample (73%) were 
non-parents. Balancing the proportion of parents in the sample may have reduced the 
number of protest votes, however, the study sample would no longer be representative of 
the UK population.   
The logistic regression analysis comparing protestors to non-protestors indicated that the 
sample of protest respondents differed from non-protest respondents. It is not unusual for 
heterogeneity to be identified between samples of protest and non-protest respondents 
(293) and, unsurprisingly, the strongest indicator of a protester was being a non-parent. 
Heterogeneity between the two samples can be a cause of concern where the treatment of 
protest responses is to remove them from the sample, due to the potential for bias to be 
introduced affecting mean WTP (302). Examination of the proportion of parents in both the 
whole sample and analytic sample (excluding protesters), however, revealed that whilst 
there was evidence of a difference between both samples, the importance of that difference 
is debatable as the difference was not large (approximately 4 percentage points). Therefore, 
bias from removing protestors from the analytic sample may not be as great a cause of 
concern as the literature indicates.  
The direction of impact on mean WTP of excluding protest responses from the analytic 
sample is ambiguous without further research to elicit protesters’ true WTP for the ASBI, 
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therefore, whether the current estimates of mean WTP illustrate a conservative or 
overestimate of the mean cannot be established with any certainty. 
A final point for consideration is whether the categorisation of protest responses was 
appropriate. As discussed in Chapter Six, a standard definition for what constitutes a protest 
response is lacking amongst CV researchers (281, 292-294). Therefore, the judgement 
regarding which justifications for unwillingness to pay should be identified as protests (see 
section 7.3.4) may not be universally agreed upon. Responses 5 and 6, “Other tax payers, 
who are better off, should pay for it” and “Parents/guardians of ‘Year 10’ students should 
pay for it”, respectively, may be queried in particular.  
Response 6 could be questioned on the basis that non-parents who state that parents 
should pay for the ASBI may be reflecting that the programme offers no altruistic or option 
value (1, 277) to them; therefore, unwillingness to pay is a reflection of their values, rather 
than a protest. However, this does not account for existence value, in which a good 
represents value to an individual merely due to its existence regardless of any intention or 
ability to use it (151, 152). Without further investigation, distinguishing whether a response 
that “Parents/guardians of ‘Year 10’ students should pay for it” constitutes a true zero, 
reflecting a lack of altruistic or option value, or a protest response, on the basis that the 
respondent actually holds some existence value for the programme, cannot be determined. 
However, it is possible that by assuming all unwillingness to pay justification responses of 
“Parents/guardians of ‘Year 10’ students should pay for it” represent protest zeros, the 
proportion of protest responses has been overestimated.  
Making an alternative assumption to that made for the base-case results of this study, that 
the two justifications for unwillingness to pay discussed here in fact reflect true zero 
valuations, the consequence for mean WTP can be examined. The number of observations 
included in the analytic sample increase from between n=454 – 466 to a range of n=650 – 
658 across all three scenarios. Mean WTP reduces, as expected, due to the larger proportion 
of zero valuations in the analytic sample. Mean WTP under the new assumption ranges from 
approximately £45 (SD: 126; 95% CI: 37 to 54) to £48 (SD: 112; 95% CI: 41 to 56). Therefore, 
whilst the new assumption would have an impact on WTP, the conclusion that WTP is on 
average positive would not change.  
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7.4.5 Study limitations 
The CV study presented in this chapter represents a novel valuation of a school-based ASBI. 
Nevertheless, this study has limitations.  
The CV survey elicited a large proportion of zero valuations for the intervention, which has 
two significant implications for this study. Firstly, the distribution of the resulting WTP data 
was extremely skewed and precluded the use of standard regression analysis methods, such 
as OLS, to examine the predictors of WTP. A two-part model was used to address the unique 
distribution of data, however, the sample sizes for the second, conditional part of the model 
for all scenarios were relatively small (n=233 – 264) due to the prominence of zero 
valuations. Therefore, the predictive ability of the model was significantly reduced compared 
to the ideal sample size calculated a priori (n=683, see Chapter Six). The much larger 
proportion of protest responses identified (approximately 40%) than anticipated a priori 
(approximately 12%, see Chapter Six) is partly responsible for this. The sample size was 
inflated based on the expectation of a much lower proportion of protest responses. Given 
the proportion observed, a more appropriate sample size would have been approximately 
95018.  
Additionally, the relatively large proportion of respondents who were unwilling to pay for 
the ASBI could have implications for policy-makers; if the intervention were to be 
implemented based on the results of this CV study it would seem that a relatively large 
proportion of the UK general public may not be in support of the intervention, assuming 
generalisability of the study to the UK population. However, mean and median WTP, 
accounting for true zero valuations, was positive, therefore, an argument could be made 
that the intervention is still valued positively even accounting for those who do not value it 
at all.   
The decision to use an additional tax contribution as the payment vehicle may be considered 
a limitation since, although not the primary reason for protests responses, it was still a 
motivator for almost 20% of zero valuations (section 7.3.4). An alternative payment vehicle, 
such as voluntary payments may be preferable to responders and elicit fewer protest 
responses.  
                                                     
18 This is calculated by inflating 683 by 40% 
156 
Similarly, the use of a non-user sample population to value the ASBI was partly identified as 
a key motivator for unwillingness to pay for the intervention. The valuation of the ASBI relied 
predominantly on altruistic behaviour, which, whilst has been shown to have a positive 
impact on WTP in previous studies (282), did not appear to resonate well with the survey 
sample in this study. Altruistic behaviour per se may not be the root of the problem in this 
case, but rather the intervention case study. As discussed earlier in section 7.4.4, 
respondents may have taken issue with the intervention being centred on alcohol misuse or 
the fact that the recipients would be a small population in society. Therefore, the choice of 
case study to use for the study may be considered a limitation. Had a different case study 
been used which had a broader impact on the UK population, a larger sample of positive 
WTP responses may have been elicited. Alternatively, as suggested in section 7.4.4, a 
different study sample could have been selected, for instance, parents of children under 16 
or adolescents themselves. The latter of these suggestions, however, would bring additional 
complexities to the CV survey, as discussed in Chapter Six, therefore, may not be a viable or 
reliable alternative.  
Closely related to the previous two points, the method of addressing protest zeros could be 
viewed as a limiting factor of this study. There remains a lack of consensus about the 
appropriate treatment of protest responses (293) since the commonly used method of 
exclusion from the analytic sample can lead to sample selection problems (325). Sample-
selection models (323, 325) and multiple imputation methods (281) have been suggested as 
alternative approaches to treating protest zeros. Sample selection models can suffer from 
convergence problems (325), a problem confirmed during an attempt to employ such a 
model using the data from the current study, therefore, could not be utilised. The multiple 
imputation method described by Pennington and colleagues (281) requires that data are 
missing at random. As reported in section 7.3.4, this was not the case with in the protest 
sample, therefore, this method would unlikely have been viable.  
The two-part model used to examine predictors of WTP is also subject to limitations. Limited 
tests for model specification or heteroscedasticity can be conducted using the two-part 
model; therefore, it is difficult to establish model appropriateness using usual statistical 
tests. The first part of the model was tested for specification by running a separate logit 
regression, however, the second part of the model is conditional on the first part, and 
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therefore, testing a separate GLM of the data would not have been equitable to conducting 
statistical tests on the two-part model.  
Additionally, the data in the current study were modelled as continuous data, since 
maximum WTP was ultimately asked as an open-ended question. However, whilst the 
random card sort employed prior to the open-ended question was intended to assist in 
respondents’ open-ended valuation by providing some context for their valuations, the 
random card sort may have had a greater influence on respondents’ maximum WTP. If 
respondents consistently reported their maximum WTP as the highest payment card value 
they stated they “Definitely WOULD pay” during the random card sort, rather than stating a 
value between that and the lowest value stated that they “Definitely WOULD NOT pay”, the 
resulting WTP data could be considered interval rather than continuous (1). Consequently, 
analysing the data using interval regression could be an appropriate alternative. Standard 
interval regression, however, may be unable to account for the substantial proportion of 
zero WTP values present in the current dataset. Alternatively, Donaldson and colleagues 
(321) recommend a grouped data regression model for WTP data with a limited dependent 
variable elicited via the payment scale method.  
Finally, limitations may be observed with the descriptions of the hypothetical scenarios used 
in the CV survey. The outcomes reported in scenarios 1 and 2 (reduced arrests and school 
absenteeism rates in the intervention group and no change in alcohol consumption) may 
appear counter-intuitive and are likely a result of limited power in the SIPS Jr HIGH trial to 
detect a significant change in secondary outcomes, as discussed in Chapter Six. This point 
was reflected in a small number of free-text responses from respondents unwilling to pay for 
the ASBI who reported a lack of trust in the outcomes presented. However, Scenario 3 was 
presented as a potentially more intuitive scenario where an observable reduction in alcohol 
consumption was evident in addition to the other outcomes. If the reported intervention 
effects in Scenarios 1 and 2 were perceived as counter-intuitive and responsible for reduced 
WTP, a significant increase in WTP would be expected for Scenario 3. This was not the case; 
therefore, it does not appear that the scenario descriptions caused any observable 
problems. 
The lack of difference in WTP observed between Scenario 3 (incorporating a reduction in 
alcohol consumption) and Scenarios 1 and 2 (incorporating no change in alcohol 
consumption) may be due to scope effects or embedding phenomena, as discussed in 
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section 7.4.2. Although, this result may also be related to the presentation of the scenarios. 
Whilst efforts were made during the pre-test and piloting phases of survey development to 
ensure Scenarios 2 and 3 were visibly and clearly distinguishable (see Chapter Six) it is 
possible that some respondents did not observe the important difference in the alcohol 
consumption outcome. This could, therefore, explain the lack of evidence for a difference 
between the values of WTP offered for Scenarios 2 and 3. 
7.4.6 Further research 
Four areas for further research can be identified from the results of this survey. Each of 
these has been identified in the previous section and they are summarised below: 
1. Explore the impact of alternative payment vehicles on WTP and proportions of 
respondents unwilling to pay for the intervention 
2. Explore whether an alternative sample with a greater connection to the ASBI, for 
example, parents of adolescents, would offer fewer zero valuations and elicit 
significantly different values of WTP 
3. Address protest responses using alternative methods, such as multiple imputation or 
sample selection models 
4. Analyse WTP assuming data is interval rather than continuous using either interval 
regression of grouped data regression models 
 Summary 
This study has used the CV method to obtain a positive mean value of WTP for a school-
based ASBI for Year 10 students. Responses were obtained from a study sample 
representative of the UK general population stratified by age, gender, and location and the 
sample size satisfied the estimated sample size calculated in Chapter Six. However, a large 
proportion of the study sample was unwilling to pay for the ASBI, which has potential 
implications for policy regarding the implementation of the intervention. Nevertheless, 
accounting for non-protest zero responses, a positive mean value of WTP of between £65 
and £68 was estimated, which can be used to populate a CBA evaluation of the ASBI 
programme.  
Protest responses were identified in the data. The majority of protest responses were driven 
by the perception that parents of Year 10 students should fund the intervention. The 
motivation for protesting was, thus, largely attributed to factors specific to the case study, 
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rather than elements of survey design, although, use of an additional tax contribution as the 
payment vehicle also contributed to a proportion of the protest responses.  
Key predictors of WTP were identified as income, marital status, and age. The direction of 
the effect of income and marital status validates theoretical expectations. The effect of age 
on WTP was ambiguous a priori. The theoretical expectation for the impact of parental 
status, was, however, contradictory to that identified in the data.  
The mean value of WTP for Scenario 1 (£65) is taken forward for use in a CBA, which is 




  Economic evaluations of the alcohol screening and brief 
intervention from the SIPS Jr HIGH trial 
 Introduction 
This chapter outlines the conduct of two novel economic analyses of the ASBI programme 
for Year 10 students that was examined within the SIPS Jr HIGH trial (59). Whilst a CUA and a 
CCA were conducted alongside the trial (59), the qualitative interviews with PHDMs in 
Chapter Five indicated that more holistic economic evaluation methods may be of relevance 
and interest to PHDMs. Therefore, in response to these conjectures from PHDMs reported in 
Chapter Five, additional analyses using alternative economic evaluation methods were 
undertaken. This chapter reports two economic evaluation studies in turn; firstly, a CBA, and 
secondly, an SROI analysis. The results of these studies, alongside the existing CUA and CCA 
conducted within the SIPS Jr HIGH trial, could then be presented to PHDMs in a workshop for 
an informed comparison of methods.  
Details of the workshop are discussed later in Chapter Nine. The current chapter reports the 
two novel economic evaluations. The CBA is presented first, followed by the SROI analysis. 
The results and limitations of each evaluation are discussed separately. The final section of 
this chapter compares the two evaluations and draws out implications of their findings for 
the evidence to be presented at the workshop. 
 Cost-benefit analysis 
As described in Chapter Three, stated preference techniques can be used to value benefits in 
monetary terms. One of the most widely known stated preference techniques is CV (326) 
and it is this method that was used to obtain a monetary value of benefit for the school-
based ASBI programme from the SIPS Jr HIGH trial case study. The previous chapter outlines 
the results of the WTP study for three scenarios depicting slight variations in outcomes of 
the ASBI. Scenario 1 was designed to reflect the outcomes observed from the SIPS Jr HIGH 
trial. In order to ensure comparability with the economic evaluations conducted as part of 
the trial (CUA and CCA) (59), which were also presented to PHDMs, the WTP results for 
Scenario 1 were used to populate a CBA of the ASBI programme.  
The net benefit outcome from a CBA can be calculated using two approaches. The first 
approach is to examine net benefit on an individual level. Examples of this approach are 
most commonly found when conducting evaluations of healthcare, e.g. medical procedures 
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such as spinal surgery (327) or programmes of care (328). In the two aforementioned 
examples, both WTP and cost are measured at the patient level, therefore, the net benefit is 
calculated as mean WTP per patient minus mean cost per patient. The second approach is to 
aggregate WTP and cost at a higher level, for example, to a population level. This approach is 
commonly used in CBAs in the environmental field where action is valued for a public good 
or landmark to which action may impact society broadly, for example, water quality 
protection (329). This approach has also been used for the evaluation of public health 
initiatives, for example, strategies to prevent the West Nile Virus (330).  
The CBA reported in this chapter uses the latter approach and aggregates benefit to a broad 
societal scale. The reasons for this are twofold. Firstly, if implemented as a public health 
intervention the ASBI would likely be funded by taxes paid for by the general public, 
therefore, the WTP survey elicited values in the form of an additional tax contribution. 
Aggregating WTP to a societal level is, therefore, consistent with the approach of eliciting 
monetary value adopted in the CV study. A similar approach was taken by Eisen-Hecht et al. 
(329) in their CBA of water quality protection. Secondly, WTP was elicited for the ASBI 
programme based on overall trial outcomes, whilst the costs from the trial are measured at 
the level of an individual risky-drinking Year 10 student. Therefore, in order to ensure that 
the costs and benefits in the CBA are comparable, it was necessary to aggregate both the 
costs and the WTP value to an equivalent level.  
8.2.1 Methods of analysis 
Two analyses were conducted for the CBA to assess methodological uncertainty (331). A 
simple analysis was conducted initially, followed by a more complex analysis to compare 
whether complexity of analytic methods affected the results or conclusions drawn from the 
CBA. The simple analysis formed the example shown to PHDMs at the workshop (see 
Chapter Nine for details of the workshop). The PHDMs were non-economists who, based on 
the findings from the qualitative study reported in Chapter Five, were expected to be 
unfamiliar with CBA. Therefore, it was considered prudent to minimise the technicality of 
the reporting of the analysis in order to enable an accurate description of the methods used 
to obtain the results of the CBA presented at the workshop. Henceforth, the simple analysis 
will be referred to as the “primary analysis” and the more complex analysis will be referred 
to as the “validation analysis”. 
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The main difference between the primary and validation analyses was the treatment of the 
trial cost data. In the primary analysis, the difference in costs between the intervention and 
control groups was calculated using the raw costs collected over the 12-month follow-up 
period. This approach was commonly used in the 1990s and early 2000s (332, 333). The act 
of randomisation in RCTs is intended to distribute factors that may influence the outcomes 
of a trial evenly amongst control and intervention groups (334). Thus, theoretically, mean 
differences in costs and effects at follow-up should reflect differences incurred by the 
intervention. Even with randomisation, however, multivariable analyses can be employed in 
order to improve the power of between-group differences in costs by explaining cost 
variation due to factors other than the intervention (335). Therefore, econometric 
techniques can be used to adjust trial costs for baseline differences in a range of participant 
and contextual factors (332). This approach was followed in the validation analysis. The 
validation analysis is perhaps more consistent with contemporary economic evaluations 
conducted alongside trials (335). 
A UK public sector perspective was taken for both methods of analysis and a time horizon of 
12-months was considered in keeping with the time-horizon reported in the economic 
evaluation conducted within the SIPS Jr HIGH trial (59). The methods of analysis for each of 
the primary and validation analyses are described below.  
8.2.2 Primary analysis 
Benefits were estimated as annual mean WTP for the intervention to be provided in schools 
in the UK. The counterfactual was that the intervention was not to be provided in UK schools 
and the WTP for this was assumed to be zero. The mean WTP was used in preference to the 
median in accordance with best practice for CBA (336). Mean WTP at the individual level for 
Scenario 1 of the CV study was £65.  
As stated in section 8.2, it was necessary to aggregate WTP to a societal level. Since WTP has 
been elicited using additional tax contributions as the payment vehicle, the number of UK 
taxpayers was used as the scale factor for aggregating WTP to a societal level19. Government 
statistics estimate the number of UK individual taxpayers in 2017/18 to be approximately 
30.8 million (337). 
                                                     
19 The use of the tax-paying population as a scale factor for WTP has been reported in previous CBA studies, 
e.g. Eisen-Hecht et al., 2002 (329) 
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Costs for the CBA were taken from the economic evaluation conducted for the SIPS Jr HIGH 
trial. The costs calculated for the within-trial CUA consisted of: delivery costs related to 
intervention delivery, and resource costs related to subsequent use of health, social care and 
public services. Intervention delivery costs included: costs of materials for both screening 
and the interactive sessions, costs of training learning mentors to deliver the interactive 
sessions, and costs of learning mentor time to deliver the interactive sessions. Subsequent 
service use costs included those attributed to: GP visits, A&E visits, non-A&E hospital visits, 
social worker visits, school nurse visits, arrests and missed school days. The trial health 
economist identified unit costs for each service from trial records and online published 
sources (59).  
The costs associated with school absenteeism were calculated based on reduced future 
earnings as a result of time missed from school (59); these costs are, therefore, indirect costs 
considering longer-term outcomes from the intervention. No short-run costs were attributed 
to school absence. Scenario 1 of the CV survey explicitly stipulated only short-run outcomes 
of the ASBI identified during the trial, consequently, only short-run costs associated with the 
time-horizon of the trial were included in the primary analysis. Furthermore, absenteeism in 
older age groups is potentially less important that absenteeism in younger children (below 
the age considered in SIPS Jr HIGH trial) (283). Thus, the costs attributed to school 
absenteeism in the Year 10 age group may overestimate the value of missed school for the 
trial participants. The costs to an individual of reduced future earnings associated with 
school absenteeism were, therefore, excluded from the CBA base case analysis. 
In order to estimate costs on a level that would be comparable with the WTP value, as 
explained previously in section 8.2, costs were scaled by the number of risky drinking Year 10 
students in the UK. The trial found that, on average, approximately 23.5% of the Year 10 
school children screened positive for risky drinking behaviour (59); for the purposes of both 
the CV survey and the CBA it was assumed that this figure was representative of the 
proportion across the UK. The total number of Year 10 school children enrolled across the 
UK (or equivalent school group for children aged 14-15 in Scotland, Northern Ireland and 
Wales) was estimated using published data on school pupil numbers by school year for each 
nation in the UK in January 2018 (338-341). Approximately 702,740 pupils were identified in 
the published data leading to approximately 165,144 pupils estimated to exhibit risky 
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drinking behaviour in the UK, according to the definition of risky drinking adopted by the 
SIPS Jr HIGH trial (59). 
The difference in mean total cost per risky-drinking child at 12-months follow-up between 
the intervention and control groups was estimated using a two-sided, unequal t-test, which 
is the most common parametric test of raw costs (335)20. Bootstrapping using 2500 
repetitions was employed to estimate 95% CIs around the difference in costs estimated in 
the t-test. The use of the non-parametric bootstrap technique to estimate uncertainty 
around parameters from trial data is a well-established method (335, 342). A minimum of 
1000 bootstrap repetitions is commonly recommended to estimate confidence intervals 
(343), however, the precise number required to produce reliable estimates is dependent on 
the complexity of the estimator used (344); more complicated estimators require more 
replications21. The t-test is a relatively simple estimator; therefore, a moderate number of 
bootstrap repetitions was sufficient. On the other hand, regression analysis is considerably 
more complex, therefore, bootstrapping estimates in the validation analysis required a 
larger number of bootstrap repetitions (see section 8.2.3). 
Mean WTP value was also bootstrapped using 2500 repetitions. Thus, datasets were 
generated via bootstrapping for each of the benefit and cost parameters that had an equal 
number of observations (n=2500). This was required for the calculation of net societal 
benefit (NSB) 22 described below. All analyses were conducted using Stata 14 (305). 
A second perspective for the aggregation of costs and benefits was also considered for the 
CBA to be presented alongside the national level aggregation as a scenario analysis (331). An 
LA perspective was chosen for the scenario analysis to simulate the level at which local 
                                                     
20 In moderately large samples where the comparator samples (i.e. control and intervention groups) are of 
similar size and similar skewness, use of a t-test produces robust estimates even when violating the assumption 
of normality (335, p.93). The size of control and intervention groups in this analysis were similar (n=185 and 
n=161) as was skewness (3.03 and 2.44), therefore, the t-test was considered a suitable analytical tool for 
examining the raw cost difference between the intervention and control groups.  
21 The appropriate number of bootstrap repetitions was determined following the methods reported by 
Statacorp (306), as discussed in footnote 11. The use of normal or bias-corrected outcomes was determined by 
examining histograms and standardised normal probability plots of the bootstrap estimates. If the distribution 
of bootstrap repetitions was non-normal then bias-corrected values were used.   
22 The term “net societal benefit” is used over the standard terms “net benefit” or “net present value” to 
indicate (i) the societal level of the analysis as opposed to the individual level analysis conducted in many 
healthcare CBAs (see section 8.2), and (ii) reflect the fact that no discounting was required due to the 12-month 
time horizon. 
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public health decisions are made in England. As the CBA was to be presented at a workshop 
in North-East England, Newcastle City Council was chosen for the alternative analytic 
perspective. LA funding accrues mainly from council taxes and business rates (8). In order to 
improve relatability of the simulation to public health officers at the workshop, and to 
present a “worst-case scenario” in which the WTP value is scaled by a smaller factor relative 
to costs, it was assumed that any tax increases on a local level would be made progressively. 
Therefore, it was assumed that only households in the three highest council tax bands (F-H, 
inclusive) would be eligible to pay the additional tax estimated in the WTP study. The most 
recently published figures at the time of analysis (2017)23 on UK households contributing to 
council tax show that there are 4020 households in Newcastle in the three highest bands 
(345). 
One of the national locations included in the SIPS Jr HIGH trial was North-East England and 
the trial estimated a higher than average proportion of Year 10 students screened positive 
for risky drinking behaviour (27.4%) in this area. The number of Year 10 pupils in schools in 
Newcastle was estimated based on the average size of Year 10 groups in UK state schools 
(n=158 pupils) and the approximate size of independent school year groups in Newcastle 
(n=125 pupils) (346) multiplied by the number of secondary/senior state and independent 
schools in Newcastle (n=12 and n=6, respectively) (347)24. This provided an estimate of 2646 
Year 10 pupils in the Newcastle LA area. Taking the local proportion of risky drinkers 
established in the trial (27.4%), approximately 725 students in Newcastle were estimated to 
exhibit the SIPS Jr HIGH definition of risky drinking behaviour.  
Consequently, the values of mean WTP and mean difference in costs between the 
intervention and control groups were scaled by the number of households in higher council 
tax bands (n=4020) and the number of risky drinking Year 10 students in Newcastle (n=725) 
for the scenario analysis using the LA perspective.  
Costs and benefits were combined to calculate the NSB. The bootstrap estimates of the 
difference in mean costs between the control and intervention arms and the bootstrap 
estimates of the mean WTP value were combined into one dataset of 2500 observations for 
each parameter. The NSB was estimated by subtracting each estimate of mean cost 
                                                     
23 An updated version for 2018 has since been released, however the 2017 values were the most recent during 
the time of analysis. 
24 Special education schools excluded. Only schools taking pupils of age 14-15 included. 
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difference from each estimate of mean WTP. The mean of the 2500 NSB calculations was 
then calculated and 95% CIs around this value were estimated with further bootstrapping.  
The approach taken to calculate NSB replicates the stochastic process commonly applied to 
costs and outcomes in cost-effectiveness analyses of clinical trial data (348). Whilst point 
estimates of mean WTP and mean cost difference could have been used to calculate the 
NSB, this would not have allowed for characterisation of the uncertainty due to sampling 
variation around each of the parameters and the final outcome of the CBA, the NSB. On the 
other hand, employing a stochastic analysis using the bootstrap technique enabled 
uncertainty around the NSB value to be examined using the non-parametric distributions of 
each of the cost and outcome parameters. Consequently, a cost-benefit plane could be 
produced to graphically display the uncertainty around NSB. The same process was used for 
both the national and LA level analyses; the cost-benefit planes associated with each analysis 
are displayed in Figure 8.1 and Figure 8.2.  
Finally, further sensitivity analyses were conducted in order to estimate parameter 
uncertainty. Assumptions around key parameters (e.g. costs and outcomes) are often made 
due to limitations in the available data or ambiguity over the most appropriate value to use 
(349). Therefore, in order to estimate how significantly the assumptions made have affected 
the economic evaluation results, sensitivity analysis reproduces the analysis with different, 
possible values for uncertain parameters or using different assumptions (342). 
Simple one-way analysis was applied to both the national and LA level analyses. This is the 
most common form of sensitivity analysis (342) in which values of one parameter are 
changed whilst other parameters remain at their baseline values (331). The sensitivity 
analyses assessed truncated values of WTP and costs at the 95th percentile to reduce the 
influence of very large values in both parameters. An extreme scenario analysis (331, 342) 
was conducted to examine the impact of the assumption that the appropriate scale factor 
for WTP was the UK tax base. An alternative scenario used parents of Year 10 students as 
the scale factor for WTP in order to demonstrate a scenario where the intervention is funded 
from parental contributions rather than general, or local, taxation. This scenario was 
deemed appropriate given that the intervention’s positive externalities may fall largely on 
individuals closest to the students, such as their parents, and reflects a common view 
expressed by the CV survey respondents who were asked to value the ASBI (see Chapter 
Seven).   
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Additionally, two additional sensitivity analyses were conducted which were not presented 
to PHDMs. The additional analyses were (i) adjusting WTP to 2016 currency values and (ii) 
including indirect school absenteeism costs. The costs estimated for the CUA and CCA within 
trial economic evaluations were reported in 2016 prices and, in order to maintain 
consistency with the CUA and CCA evaluations, the price year of the costs was not altered. 
The WTP survey was conducted in 2018, therefore, introducing a small difference between 
the currency years of the costs and outcomes. It is not uncommon for WTP to be elicited at a 
later time than the price year reported for costs when a CBA is conducted alongside a clinical 
trial, e.g. Sanghera et al., 2015 (350), Haefeli et al., 2008 (327), and Ramsay et al., 2018 
(351). There is no precedent for adjusting WTP values in line with costs, therefore, the base-
case analysis did not adjust WTP. Although, arguably this approach is inconsistent with 
standard practice for an economic evaluation in which the reporting of all costs in the same 
price year is recommended (182).  
Although it has not been done in previous evaluations this could be thought to be a 
methodological weakness of such studies. Therefore, a sensitivity analysis was conducted 
adjusting the WTP value to 2016 currency values using the Consumer Price Index (CPI) (352). 
Costs in economic evaluations are commonly adjusted using the Hospital and Community 
Health Services pay and prices index which combines two indices, the pay cost index and the 
health service cost index, in order to capture inflation on both staff costs and medical goods 
and services (353, p.216), whereas the overall CPI was used for WTP to reflect the fact that 
the CV survey respondents providing WTP values would have been considering their 
spending on all goods and services when valuing the ASBI. 
The second additional sensitivity analysis included costs calculated during the SIPS Jr HIGH 
trial associated with school absenteeism. For the sensitivity analysis, costs indirectly 
attributed to school absenteeism that were calculated for the CUA that was part of the SIPS 
Jr HIGH trial were added to the total costs used in the base-case analysis. This analysis could 
be thought of as exploratory as the data on costs indirectly attributed to school absenteeism 
are uncertain.  
Other than the scenario analysis presenting the LA perspective in which alternative values 
for both costs and outcomes were analysed, no further multiway sensitivity analyses were 
conducted.  
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8.2.3 Methodological validation analysis 
The validation analysis altered only the estimation of costs, therefore, the methods applied 
to estimate benefit remain as described in the previous section. 
As described in section 8.2.1, econometric techniques can be applied to cost data to adjust 
for between-group baseline differences in the distribution of costs that may be present 
despite randomisation. Other participant characteristics and contextual factors related to 
the intervention setting may also influence costs, for example, males are typically arrested 
more frequently than females (354), thus, participant gender may impact on the costs 
associated with arrests independently of intervention effects. Therefore, in order to account 
for cost variation between the intervention and control groups that could be explained by 
alternative factors, a multivariable analysis was conducted (332).  
The cost estimator employed was a generalised linear model25 (GLM). A GLM was employed 
over alternative models, such as ordinary least squares (OLS) regression, due to the skewed 
distribution of the cost data. GLMs have been demonstrated to behave well when estimating 
predicted means of healthcare cost data (313, 356, 357) and it has been reported that they 
produce more robust estimates for skewed data than applying OLS to log-transformed costs 
(313), which is an alternative method to deal with skewed data. For these reasons, GLMs are 
well-accepted estimators of costs when analysing clinical trial data (332).  
Predicted total costs at follow-up were estimated adjusting for: trial arm, gender, location, 
baseline AUDIT (Alcohol Use Disorders Identification Test) score (358), race, smoking status 
at baseline, baseline EQ-5D-3L score (359), a dummy variable indicating that 12-month 
follow-up was either 30 days earlier or later than expected, and baseline total resource 
costs. The trial arm covariate was included in order to estimate the predicted difference in 
cost between control and intervention groups. Baseline costs were included to adjust for any 
differences in costs at the start of the trial between groups despite randomisation, as 
explained in the previous section. The dummy variable for late or early follow-up was 
included to adjust for the fact that some students were followed up after only 11 months or 
after 13 months rather than the intended 12 months in order to limit the impact of improper 
                                                     
25 The GLM used a log link and a gamma distribution. The most appropriate link function and distribution family 
for the cost data were identified using a Boxcox approach to test the link function and the Modified Park test to 
determine the distribution family (313). This combination of link function and family is recommended as a 
suitable approach by the ISPOR Good Research Practices Task Force (355). 
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adherence to trial protocol on costs. The remaining covariates were selected as potential 
predictors for differences in costs independent of the intervention. For example, participants 
with higher AUDIT scores at baseline may be more likely to be arrested or use healthcare 
services more frequently than participants with lower AUDIT scores.  
The regression-adjusted mean difference in total cost per risky-drinking student at follow-up 
between the intervention and control groups was estimated using Stata’s “margins” 
command. When applied to a binary covariate (i.e. the variable denoting intervention or 
control), the margins command displays the mean incremental difference between the 
values of the binary covariate (i.e. the difference between intervention and control groups’ 
costs)26. The value of the coefficient on the study arm covariate cannot be used directly to 
determine the incremental costs between the two groups since the use of a log link in the 
GLM estimator presents regression coefficients as percentage changes rather than absolute 
values. Obtaining estimations using the margins command is recommended to identify the 
outcome of incremental changes in binary covariates when using a GLM estimator (313). 
Bootstrapping using 20,000 repetitions27 was employed to estimate 95% CIs around the 
difference in costs estimated by the GLM regression analysis.  
The same procedures were followed to calculate the NSB and conduct sensitivity analyses as 
described in section 8.2.2. Cost-benefit planes were also generated using the stochastic 
analysis outcomes (See Figures 8.1 and 8.2).  
8.2.4 Primary analysis results 
The resource costs related to subsequent use of health, social care, and public services over 
the 12-month follow-up period of the SIPS Jr HIGH trial are displayed in Table 8.1. The mean 
delivery cost of the intervention across all students in the intervention arm was £22.20 (95% 
CI £21.80 to £22.60).  
                                                     
26 Specifically, the margins command estimates the difference in expected values of the dependent variable at 
each of the binary covariate values (i.e. for each of intervention and control) keeping all other covariates fixed 
(313) 
27 As described in section 8.2.2, the appropriate number of bootstrap repetitions is determined by the size and 
variation of the sample. The sample size included in the regression analysis is smaller than the raw data (due to 
the exclusion from the analysis of observations with missing data on independent variables), therefore, a 
greater number of bootstrap repetitions were required to estimate robust standard errors and CIs. The 
procedure as described in footnote 21 was employed to determine the appropriate number of bootstrap 
repetitions.  
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Table 8.1 Mean costs and cost differences between intervention and control groups for 
each area of resource use over the 12-month follow-up period 
 Cost (£), mean (n) Cost difference (£), 
mean (95% CI) 
Resource Intervention Control Intervention – Control  
GP visits 98 (173) 125 (190) -26  (-63 to 9) 
Social worker visits 27 (179) 9 (192) 18  (-12 to 49) 
School nurse visits 83 (175) 54 (191) 28  (-20 to 78) 
Hospital admissions 200 (178) 161 (193) 40  (-68 to 147) 
A&E attendance 91 (178) 76 (193) 16  (-23 to 54) 
Arrests 0.1 (179) 1 (194) -0.9 (-1.6 to -0.1) 
School absenteeism 1134 (181) 2083 (197) -950 (-4600 to 2700) 
Total resource cost A 501 (169) 403 (184) 98 (-66 to 262) 
Total resource cost B 1715 (169) 2634 (184) -919 (-4848 to 3010) 
95% CI = confidence interval at 5% level 
Costs over 12 months, not adjusted for participant characteristics 
Total resource cost A = excluding school absenteeism costs for base-case analysis, Total resource cost 
B = including school absenteeism costs for sensitivity analysis 
Mean costs, cost differences and CIs of the difference between the intervention and control groups 
are based on a comparison of means using an independent samples t-test with unequal variances 
 
The results of the base case analysis are presented below in Tables 8.2 to 8.4. The 
aggregation of mean WTP values used for both the national and LA level analyses is 
displayed in Table 8.2. The mean WTP value for the ASBI intervention prior to aggregation 
was £65. The pre-aggregated mean difference in costs per risky drinking student between 
the intervention and control groups determined by the two-sided, unequal t-test was 
£117.85. The 95% CI around the WTP value in both the national and LA cases is positive, 
indicating strong likelihood that the benefit value is greater than zero. On the other hand, 
Table 8.3 outlines the aggregation of costs for each level of analysis and the 95% CIs around 
the mean cost difference cross zero. Whilst the point estimates of the aggregated cost 
differences are positive (£19.5 million and £85,442), indicating that the intervention arm is, 
on average, costlier than the control arm, the CIs indicate that there is a substantial 
possibility that the intervention is, on average, less costly than control.  
The CBA results in the form of NSB for both the national level analysis and LA scenario 
analysis are displayed in Table 8.4. Both analyses result in a positive NSB with confidence 
intervals which do not cross zero. The NSB from the societal perspective is approximately £2 
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billion, whilst the NSB from the LA perspective is substantially smaller as would be expected 
given the difference in magnitude of the scale factors used for both costs and WTP. 
However, with an NSB of approximately £180,000, the LA scenario still indicates worth in the 
implementation of the ASBI. The outcome of the CBA could alternatively be reported as a 
BCR, in which the value of benefit is divided by the cost (see Chapter Three for further 
detail). Using this alternative metric, the outcome for the national level analysis would be 
103 (Equation 8.1) and the LA scenario analysis would be 3.07 (Equation 8.2). 
BCR = 2.007 billion19.5 million = 103  (8.1) 
   
 BCR = 261,93085,442 = 3.07  (8.2) 
 
The outcomes of the one-way sensitivity analyses adjusting costs and outcomes 
independently are reported in Table 8.5. There is no change in the direction of either costs 
or outcomes in any of the three sensitivity analyses shown to PHDMs (Year 10 parents 
providing the WTP scale factor and truncating WTP and costs at the 95% percentile). The 
only scenario which changes the direction of outcome is including school absenteeism costs. 
In this case, the mean cost difference is negative, indicating that the intervention arm is less 
costly on average than the control arm. However, reflecting the base-case analysis, the 95% 
CIs around the cost parameter in all five sensitivity analyses cross zero; this indicates 
substantial uncertainty around the cost estimate with regards to which trial arm is costlier. 
Whereas, the lower bound of all confidence intervals around the NSB outcome in each 
sensitivity analysis remain positive, suggesting with confidence that implementing the ASBI is 
worthwhile considering from either a national or local societal perspective. 
 
Table 8.2 Willingness to pay values scaled for both national and LA level base analyses 
 
 





Individual level from CV 




[95% CI] Scale 
factor, n  
Aggregated mean 
(SE) 





65 (6) [54 to 77] 30,800,000 2.007 billion (182 million) 
[1.649 billion to 





SE = Standard error; 95% CI = confidence interval at the 5% significance level; n = number of individuals 
CIs and SEs calculated using bootstrapping 
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SE = Standard error; 95% CI = confidence interval at the 5% significance level; n = number of individuals 




Table 8.4 Net societal benefit calculation for both national and local level analyses  
Table 8.5  Sensitivity analyses of NSB for both national and local level analyses   
 National level Local authority level 
Sensitivity 
analyses 
Benefit (WTP), £ 
(95% CI) 




Benefit (WTP), £ 
(95% CIa) 




Year 10 parents 
WTP scale factor 
45.8 million 
(37.6 m to 53.9 m) 
19.5 million 
(-8.05 m to 46.98 m) 
26.3 million 
(25.7 m to 26.8 m) 
172,404 
(142,000 to 203,000) 
85,442 
(-35,000 to 206,000) 
86,774 
(84,000 to 89,000) 
WTP truncated 1.319 billion (1.164 b to 1.494 b) 
19.5 million 
(-8.05 m to 46.98 m) 
1.298 billion 
(1.295 b to 1.301 b) 
172,169  
(150,000 to 194,000) 
85,442 
(-35,000 to 206,000) 
86,773 
(84,000 to 89,000) 
Cost truncated 2.007 billion (1.649 b to 2.364 b) 
1.18 million 
(-14.8 m to 17.2 m) 
2.000 billion 
(1.993 b to 2.007 b) 
261,930  
(215,000 to 309,000) 
5,216 
(-65,000 to 76,000) 
256,023 
(254,000 to 258,000) 
2016 WTP values 1.914 billion (1.597 b to 2.282 b) 
19.5 million 
(-8.05 m to 46.98 m) 
1.889 billion 
(1.882 b to 1.896 b) 
249,810 
(208,000 to 298,000) 
85,442 
(-35,000 to 206,000) 
163,968 




(1.649 b to 2.364 b) 
-138.4 m 
(-740 m to 501 m) 
2.148 billion 
(2.133 b to 2.164 b) 
261,930  
 (215,000 to 309,000) 
-607,612 
(-3.25 m to 2.20 m) 
907,846 
(849,000 to 969,000) 
95% CI = confidence interval at the 5% significance level; m = million; b = billion 
a to nearest £1000 
 
National level Local authority level 
Benefit, £ Cost, £ NSB (SE), £  [95% CI] Benefit, £ Cost, £ NSB (SE), £ [95% CI] 
2.007 billion 19.50 million 1.982 billion (3.68 million) 
[1.975 billion to  









The cost-benefit planes for both the national and LA analyses are displayed in Figure 8.1 and 
Figure 8.2, respectively. The crossed lines in the plane illustrate the 95% CIs around the cost 
difference and WTP parameters, as calculated by the bootstrap repetitions. All points are in 
the north-east and south-east quadrants of the plane demonstrating that benefit was 
positive in all repetitions. The majority of the repetitions are in the north-east quadrant 
(92%), indicating a greater likelihood of the intervention being costlier, however, a small 
cluster of bootstrap observations can be identified in the south-east quadrant (8%), 
representing instances where the intervention arm is less costly than control. Neither of the 
cost-benefit planes provide evidence of any extreme outliers; the majority of repetitions are 
clustered closely together around mean NSB. 
Figure 8.1 Cost-benefit plane for national level primary analysis with 95% CI illustrated 
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Figure 8.2 Cost-benefit plane for LA scenario analysis with 95% CIs illustrated 
 
 
8.2.5 Validation analysis results 
The results of the validation analyses using regression-adjusted costs are displayed in Table 
8.6 and Table 8.7. No change was made to the WTP values, therefore, the data displayed in 
Table 8.2 represents the benefit values also used for the validation analyses. The mean 
difference in costs between the intervention and control groups predicted by the GLM 
regression model is £86.28 (Table 8.6), which is smaller than the difference estimated using 
the unadjusted follow-up values. This is expected given that the regression analysis accounts 
for some of the variance in costs influenced by non-intervention factors. Therefore, the 
predicted cost difference can be attributed more closely to direct impacts of the 
intervention than the difference estimated using unadjusted costs. Similarly to the primary 
analysis, the 95% CI around costs crosses zero, suggesting that although the mean point 
estimate of the cost difference suggests that the intervention group costs are greater than 
the control group costs, it is possible that the control arm is costlier than the intervention 
arm.  
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The values of NSB estimated in the validated analyses are fairly similar to those estimated in 
the base analyses. Both the national level and LA scenario analyses have larger NSB values 
compared to the primary analysis (£1.989 billion compared to £1.982 billion and £192,398 
compared to £177,000, respectively) due to the smaller difference in costs estimated by the 
GLM regression. The 95% CIs around the NSB estimates are of a similar range to those in the 
primary analysis and none cross zero. The BCRs of the national and LA level analyses are 141 
and 4.19, respectively. As with the NSB, the ratios are slightly larger than the primary 
analysis due to the smaller cost difference relative to the WTP benefit value. 
 
Table 8.6 GLM regression-adjusted difference in cost between intervention and control arms scaled for both national and local level analyses 
 
 
Table 8.7 Net societal benefit calculation for both national and local level analyses using GLM regression-adjusted costs 
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[-23.97 million to 





SE = Standard error; 95% CI = confidence interval at the 5% significance level; n = number of individuals 
CIs and SEs calculated using bootstrapping 
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[1.985 billion to 









The one-way sensitivity analyses of the validated analysis is displayed in Table 8.8. The 
sensitivity analyses results are largely similar to those reported using the primary method of 
analysis but with slightly larger NSB values as a result of the smaller cost difference 
estimated by the GLM regression analysis (£86.28 compared to £117.85). There are, 
however, two notable differences between the sensitivity analyses using the primary and 
validation methods of analysis. Firstly, the mean estimate of the difference in regression-
adjusted costs truncated at the 95% percentile is negative, suggesting that the control arm is 
costlier than the intervention arm after the largest 5% of values are removed from the 
analysis. However, the 95% CIs indicate a lot of uncertainty around this point estimate, 
therefore, there is a substantial possibility that the intervention arm is in fact costlier on 
average. Secondly, whilst the direction of input parameters and NSB of the analysis including 
school absenteeism costs is the same using both the primary and validation methods of 
analyses, the NSB at both the national and LA levels is considerably larger in the validation 
analysis and there is considerably more uncertainty around the NSB based on the CIs. The 
95% CIs around NSB in the validation analysis do not cross zero, however the intervals are 
much larger compared to those estimated using the less complex estimator in the primary 
analysis. Explanation for these findings is proposed in section 8.2.6.   
 
 
Table 8.8 Sensitivity analyses of net societal benefit for both national and local level analyses using GLM regression-adjusted costs 
 National level Local authority level 
Sensitivity 
analyses 
Benefit (WTP), £ 
(95% CI) 




Benefit (WTP), £ 
(95% CIa) 








(37.71 m to 53.86 m) 
14.25 million 
(-23.97 m to 56.15 m) 
29.76 million 
(28.90 m to 30.62 m) 
172,404 
(144,000 to 205,000) 
62,556 
(-102,000 to 250,000) 
102,931 




(1.152 b to 1.486 b) 
14.25 million 
(-23.97 m to 56.15 m) 
1.303 billion 
(1.301 b to 1.305 b) 
172,169 
(150,000 to 194,000) 
62,556 
(-102,000 to 250,000) 
102,779 




(1.649 b to 2.364 b) 
-3.63 million 
(-28.5 m to 21.2 m) 
2.009 billion 
(2.006 b to 2.012 b) 
261,930  
(215,000 to 309,000) 
-15,930 
(-125,000 to 94,000) 
279,914 




(1.576 b to 2.252 b) 
14.25 million 
(-23.97 m to 56.15 m) 
1.896 billion 
(1.893 b to 1.899 b) 
249,811 
(206,000 to 294,000) 
62,556 
(-102,000 to 250,000) 
180,286 






(1.649 b to 2.364 b) 
-28.35 million 
(-445 m to 291 m) 
3.426 billion 
(1.963 b to 7.551 b) 
261,930  
(215,000 to 309,000) 
-124,463 
(-1.97 m to 1.28 m) 
58.40 million 
(305,000 to 219 m) 
95% CI = confidence interval at the 5% significance level; m = million; b = billion 




The cost-benefit planes using the bootstrap repetitions of the validation analysis are 
displayed in Figures 8.3 and 8.4 below. Unlike the primary analysis, there are a number of 
visible outliers on the cost parameter estimated by the GLM regression. However, as with 
the primary analysis, all points lie in either the north-east or south-east quadrants. A greater 
proportion reside in the north-east quadrant (81%), in which the intervention arm is costlier 
than the control arm, than the south-east quadrant (19%). Creating a cost-benefit plane of 
the sensitivity analyses in which costs are truncated at the 95th percentile removes the 
outlier observations visible in Figure 8.3 and Figure 8.4. The distribution of bootstrapped 
observations in the truncated cost-benefit planes (see Figure L.1 and Figure L.2 in Appendix 
L) appear much more similar to those in Figures 8.1 and 8.2, suggesting that the majority of 
the bootstrapped estimates are similar in both the validation and base analyses.  
Figure 8.3 Cost-benefit plane for national level validation analysis with 95% CI illustrated 
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Figure 8.4 Cost-benefit plane for LA validation analysis with 95% CI illustrated 
 
8.2.6 Discussion 
The results of the CBA indicate that the ASBI has a positive net societal benefit at both a 
national and LA level. The 95% CIs around the NSB outcomes do not cross zero in any of the 
base case or sensitivity analyses. This indicates that, given the assumptions made in the 
analysis, the benefits, as valued by the UK general public, outweigh the incremental costs of 
providing the ASBI compared with standard practice.   
The magnitude of the NSB estimated in this study is worthy of discussion here. The NSB at 
the national level in the primary analysis was estimated at approximately £2 billion, which is 
equivalent to approximately 0.1% of the UK Gross Domestic Product in 201828. The LA 
scenario NSB was estimated at approximately £180,000 which is approximately 0.8% of the 
public health ring-fenced grant awarded to Newcastle City Council in 201829. These figures 
are not inconsequential; therefore, their feasibility must be considered. The main cause of 
these large values is the disparity in scale factors used for the cost and benefit parameters. 
                                                     
28 According to the International Monetary Fund, UK Gross Domestic Product for 2018 was approximately 
£2.033 trillion (360) 
29 The public health ring-fenced grant in 2018 was approximately £23.5 million (361) 
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The use of the entire tax base as a scale factor for the benefit side of the equation at the 
national level could be argued against; however, the LA scenario utilised a more 
conservative scale factor of only the top three highest council banded households. 
Additionally, sensitivity analysis was conducted in which a plausible minimum scale factor of 
only parents of risky-drinking young children is used. In each of these scenarios the NSB is 
still positive, suggesting that regardless of which scale factor is used, the CBA results are 
robust to the conclusion that the ASBI has positive benefit for society compared to standard 
care. 
The other four sensitivity analyses also conclude that the NSB is positive and that this 
outcome is robust regardless of various assumptions. Nevertheless, the two observations 
regarding the sensitivity analyses conducted in the validation analysis raised in section 8.2.5 
require further discussion. Firstly, the change in direction of incremental costs following 
truncation at the 95th percentile in the validation analysis can be explained by a combination 
of two factors. Firstly, the smaller difference between estimated mean costs for the two trial 
arms after accounting for alternative sources of cost variance in the regression analysis, and 
secondly, almost twice as many observations in the top 5th percentile of costs were from the 
intervention arm compared to the control arm (n=11 and n=6, respectively). Thus, once the 
top 5th percentile of costs were removed, the impact on mean costs was greater in the 
intervention arm compared with the control arm. This had a substantial impact on the 
resulting cost difference between the two arms regardless of which analytic method was 
used. In the primary analysis the cost difference reduced to approximately £1 million 
compared to £19 million in the base case at the national level, and to approximately £5000 
from over £85,000 in the base-case at the LA level. Due to the smaller initial difference in 
mean costs in the validation analysis compared to the primary analysis (£86.28 compared to 
£117.85), it is likely that the truncation of costs resulted in the mean costs for the 
intervention arm reducing to below those of the control arm in the validation analysis.  
Secondly, the inclusion of missed school costs introduced a lot of variance to the total cost 
variable which had a profound impact on the regression analysis of costs in the validation 
analysis. The measures of skewness and kurtosis of the distribution of total costs prior to the 
inclusion of school absenteeism were 2.75 and 10.70, respectively. For comparison, a 
Gaussian normal distribution would have a value of 0 for skew and 3 for kurtosis. However, 
once school absenteeism costs are included, the total cost distribution is skewed much 
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further to the right resulting in a skewness measure of 10.56 and kurtosis of 112.66. 
Therefore, despite having chosen the GLM estimator for its ability to deal with skewed 
distributions, it is possible that the resulting distribution was too greatly skewed even for the 
GLM to provide efficient estimates. This can be observed from the results of the sensitivity 
analysis, in which the presence of a very small proportion (<1%) of extreme outliers in the 
bootstrap repetitions of cost difference have drastically affected the mean value of NSB.  
In both the national and local level analyses, the values of NSB for the sensitivity analysis 
including school absenteeism costs calculated using each pair of bootstrap repetitions for 
benefit and cost is far greater than the outcome of the point estimate of benefit minus the 
point estimate of cost difference as a result of the extremely large outliers that lie outside of 
the range of the 95% CIs. This explanation was verified by observing the difference in the 
NSB after removing outlier values30. This resulted in point estimates of mean NSB of £2.008 
billion and £344,103 for the national and local level scenarios, respectively. These values 
align much more closely to the values that would be observed by calculating NSB from point 
estimates of mean benefit and cost (£2.035 billion and £386,393, respectively).   
The inclusion of costs associated with school absenteeism resulted in some extreme 
outcomes due to the skewed distribution, particularly in the validation analysis. Whilst less 
extreme in the primary analysis, the NSB outcomes were still considerably larger than the 
base-case analysis, specifically for the LA scenario where NSB was five times larger than the 
base-case value. Whilst the choice to exclude school absenteeism costs from the base-case 
analysis were made on theoretical grounds, the extreme skew their addition introduced to 
the distribution of costs justifies this decision on statistical grounds. The sample size of the 
unadjusted costs sample (n=345) is unlikely to be sufficiently large to overcome the extreme 
skew introduced disproportionately between trial arms, therefore, t-tests might not be 
trusted to provide robust estimations of difference in costs. Additionally, as was 
demonstrated above, the regression analysis was also unable to provide reliable estimates.  
Nevertheless, the overall conclusion regarding the ASBI does not change depending on 
whether school absenteeism costs are included or excluded from the base-case analysis. The 
base-case analysis presented to the PHDMs could, therefore, be considered a conservative 
analysis. Typically, demonstrating a favourable outcome from a conservative analysis is 
                                                     
30 Outliers were defined as greater than two standard deviations from the mean. Two out of 17,031 
observations removed in total.  
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preferred to that of an optimistic analysis since decision-makers can have greater confidence 
that the outcome is truly efficient if the results show the intervention to be favourable 
compared with the comparator in the worst-case scenario.   
Overall, the validation analysis demonstrated that the outcome of the base-case CBA does 
not change dramatically depending on whether a simple or complex method of analysis was 
employed and the conclusion that the ASBI provides positive net benefit to society is stable. 
Additionally, the conclusions drawn by three sensitivity analyses presented to the PHDMs do 
not change. Therefore, from the point of view of presenting the simple model of the 
economic evaluation at the workshop, the results presented in this chapter confirm that this 
was a suitable decision.  
A comparison of the results identified in the current study against existing literature is 
difficult given the paucity of CBAs that have been published, even within the broader area of 
alcohol treatment or general prevention of alcohol misuse. The pool of literature is further 
restricted when comparing with evaluations that have used stated preference methods to 
value benefits (see Chapter Four, in which no studies were identified using CV methods). 
Comparing the current study results with one of the few CBA studies conducted in a similar 
area, which also aggregated costs and benefits on a national level, De Wit et al. (237) 
conducted CBAs of three alcohol policies (tax increases, alcohol outlet density reductions, 
and an advertising ban). Their analysis found an aggregated social benefit across the Dutch 
population of between €4 billion - €12 billion in 2013 euros, policy dependent (equivalent to 
approximately £3.83 billion - £10.4 billion in 2018 pounds sterling).  
It is difficult to directly compare De Wit et al.’s (237) results with those found in the current 
study, since the interventions and methods of calculating benefits differ; however, the social 
benefit value of the least effective intervention from the De Wit et al. (237) study is almost 
twice as large as the national-level NSB identified for the ASBI. Yet, given that De Wit et al. 
(231) report the net present benefit over 50 years and the current study considers the net 
benefit of the ASBI over only one year, it would be expected that the societal benefit of the 
Dutch alcohol policy would be larger than the societal benefit of the ASBI by more than a 
factor of two, even accounting for a four-fold difference in population size between the 
Netherlands and the UK31. This suggests that the estimate of the ASBI using all UK tax payers 
                                                     
31 De Wit et al. (237) report the size of the population in the Netherlands to be approximately 14.5 million, 
compared to the size of the UK population considered in the current study (approximately 66 million). 
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as a scale factor may be overestimating the benefit to society of the ASBI, as discussed 
previously in this section.  
8.2.7 Strengths and limitations 
A strength of the current study is its novelty as a CBA of an alcohol prevention intervention, 
particularly one in which stated preference measures have been used to value the 
intervention. However, there are some limitations with the study. Firstly, no alternative 
estimators were used to attempt to model costs when those associated with school 
absenteeism were included. Alternative econometric techniques may be better suited to 
extremely skewed distributions. However, the underlying problem is associated with the fact 
that clinical trials are not powered to detect significant differences in economic outcomes, 
therefore, econometrics may not be able to truly address the issue of insufficient data in 
certain outcomes (335). 
Additionally, excluding the sensitivity analysis demonstrating the impact of school 
absenteeism costs from the report shown to PHDMs could be considered a limitation. 
However, as explained in section 8.2.6, the analysis excluding school absenteeism costs is 
conservative, therefore, their inclusion would have strengthened the conclusions from the 
CBA; as such, there is no reason to suspect that the exclusion of this sensitivity analysis 
would have altered PHDMs’ impression of the CBA.  
Thirdly, the choice of the UK tax base as a scale factor could be considered a limitation, given 
that this method produced extremely large NSB. However, the sensitivity analyses presented 
alongside the base-case analysis provide sufficient indication that the conclusion remains 
the same even with a reduced scale factor. Similarly, for the LA analysis the use of the total 
households in the top three council-tax bands (n=4020) may be considered a small number 
(approximately 3% of all households in Newcastle). However, this offers a conservative 
analysis, since the benefit value is directly proportional to the size of the scale factor. 
Consequently, using the number of households in the top four or five council-tax bands 
would only strengthen the results reported here.  
Finally, costs for the national-level analysis were calculated based on the assumption that 
the average proportion of risky drinking Year 10 students across the UK is consistent with 
the average proportion identified in the SIPS Jr HIGH trial (23.5%). This average value was 
presented as fixed in the CV survey and elicited WTP values on such an assumption, whereas 
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in reality the trial identified a distribution of proportions amongst the trial site locations (59). 
This distribution in proportions was exploited for the LA level analysis in which the higher 
proportion of Year 10 risky drinkers for the North-East region (27.4%) was used to calculate 
the costs in a Newcastle LA scenario. A caveat of the LA analysis is, therefore, that mean 
WTP remains consistent when a slightly larger proportion of Year 10 students are 
categorised as risky drinkers.   
 Social return on investment 
SROI has become increasingly promoted in UK local government (33), which possibly 
explains the interest in the method by PHDMs interviewed during the qualitative study in 
Chapter Five. SROI has been promoted in policy-making arenas as a more pragmatic version 
of CBA from the perspective of an investor in health services (362), however, since it does 
not have the same theoretical grounding as CBA, health economists may still prefer CBA over 
SROI. Nevertheless, SROI has been proposed as potentially more relatable for policy makers 
at local or national levels because of the language familiarity of a pound-for-pound return on 
investment (33, p.296).  
At the time of conducting the SROI of the ASBI, no SROI literature in alcohol prevention had 
been identified, since then only one study on that topic has been identified, which was 
based in Thailand (233) (see Chapter Four). Minimal studies were, therefore, available to 
provide relevant guidance for methods. Additionally, where SROI studies in other areas 
could be identified (e.g. housing (165)) the methods could not be guaranteed to be 
consistent with other SROI studies. Methods for SROI have not yet been standardised (33) 
and whilst a select few guidance documents are available (84, 164) there exists no guidance 
or examples of an SROI conducted using clinical trial data. Therefore, this study represents 
the best possible interpretation of SROI methodology applied to the available data from the 
SIPS Jr HIGH trial.  
A cornerstone of SROI is broad stakeholder engagement throughout the process of 
evaluation from identifying outcomes, verifying appropriate indicators, and, where needed, 
extracting proxy financial values. Due to resource availability, stakeholder engagement was 
limited in the current study to that conducted for SIPS Jr HIGH economic evaluation and 
examination of the findings of the qualitative interview component of the project (59). 
Therefore, the evaluation presented here may be considered a limited SROI with respect to 
broad stakeholder engagement. 
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8.3.1 Stages of SROI analysis 
Chapter Three reports the six stages of conducting an SROI. The methods used for the 
current study are outlined below for each stage of analysis (stages 1-5).  
Stage 1: Establishing scope and identifying key stakeholders 
An evaluative SROI was conducted using outcomes from the SIPS Jr HIGH trial. A broad range 
of stakeholders was considered: The National Health Service & Personal Social Services (NHS 
& PSS), the LA, the students exhibiting risky drinking behaviour, and their parents. 
Qualitative interviews were conducted with parents of students in the trial as part of the 
SIPS Jr HIGH study (59). The qualitative findings were reviewed to identify any relevant 
outcomes for parent stakeholders, however, none were identified. Consequently, parents 
were removed for consideration as stakeholders in the SROI.  
Stage 2: Mapping outcomes 
Examination of the ASBI intervention as reported by the SIPS Jr HIGH trial and the outcomes 
of the trial assisted the outcomes mapping stage of the SROI. An impact map was developed 
to outline the linkages between the inputs and actions of the trial and final outcomes. In 
many cases, the final outcomes arrive via the intermediate outcome of reduced alcohol 
consumption, however, as the motivational interview component of the ASBI discussed a 
range of behaviours linked to alcohol consumption, it was proposed that several final 
outcomes could have also been affected independently of the intermediate outcome. For 
example, discussing the impact of alcohol consumption on concentration at school and the 
outcomes of this in relation to their educational attainment may have encouraged students 
to improve their engagement in class regardless of whether their alcohol consumption 
changed. The impact map is illustrated in Figure 8.5. The final outcomes were:  
1. Improvement in health-related quality of life 
2. Safer sexual behaviour  
3. Fewer alcohol related accidents and injuries 
4. A reduction in anti-social behaviour 
5. Improved focus and concentration at school 
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The final outcomes were anticipated to have an effect on several stakeholders; the different 
effects were captured and accounted for separately when values were placed on outcomes 
in the following stage. 
 
Figure 8.5 Impact map of the ASBI on all stakeholders 
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Stage 3: Establish indicators and applying values 
In order to place a monetary value on each outcome, relevant indicators have to be 
identified in order to account for the magnitude of each area of impact. The indicators 
identified for each outcome are displayed in Table 8.9. For the majority of the indicators 
chosen, data were available from the trial. However, data for the indicators for a reduction 
in risky sexual behaviour were not collected by the trial. The only related data collected were 
“engaging in regretted sexual intercourse” or “engaging in sexual intercourse without a 
condom” (59). Neither of these data alone could indicate whether negative repercussions 
occurred either with unwanted pregnancies or sexually transmitted infections. Additionally, 
the data collected were reported to be inconsistent, for instance students stating at follow-
up that they have “Never engaged in regretted sexual intercourse” yet reporting to have 
done so at baseline.  
Table 8.9 Indicators identified for each outcome of the SROI, by stakeholder 
 
The ideal indicator to capture the impact of the intervention on improved focus and 
concentration at school would be educational outcomes (e.g. exam results). However, data 
Stakeholder Outcome Indicator 
Student Improved quality of life  
(via both physical and mental 
health improvements) 
Improvement in EQ-5D-3L 
score 
 Improved focus and 
concentration at school 
Less school absenteeism A 
NHS & PSS Fewer accidents and injuries Fewer secondary care visits 
(including both A&E and in-
patient hospital care) 
 Improvement in student’s 
quality of life  
Fewer visits to GP 
Fewer visits to school nurse B 
  
 Less anti-social behaviour Fewer social worker visits 
Local Authority Less anti-social behaviour Fewer arrests and police 
cautions 
A Ideally, improvements in educational attainment would have been used as an indicator for improved 
concentration and focus in school, however, these data were not available, therefore, a less direct 
indicator of school absenteeism was considered. 
B Students may visit a school nurse to discuss physical health/mental health issues or to seek advice 
regarding substance misuse rather than visit a GP. School nurses may refer students to a GP if necessary, 
therefore, including both school nurse and GP visits is necessary to account for the full impact of the 
intervention on student’s HRQoL.  
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were not available on exam results or other measures of educational achievement within the 
12-month time frame of the trial follow-up. An indirect measure of improved focus and 
concentration in school might be school absenteeism, since it could be expected that 
students would attend school more frequently if they were better engaged in their classes; 
boredom and disengagement with teachers or subjects has been recognised as one of the 
key reasons for absenteeism amongst secondary school students (363). Since data were 
collected on days missed from school, this indicator was chosen.  
In order to value the impact that the ASBI intervention had on each of the identified 
outcomes, it was necessary to identify appropriate proxy financial values for each indicator. 
For each of the health and social service indicators, the cost of an attendance was used as a 
proxy for the financial value of the saving to the NHS and PSS resulting from a reduced use of 
services; this approach has been recommended for valuing outcomes in an SROI (33). As part 
of the SIPS Jr HIGH trial health economics component, unit costs had been identified from 
various sources for the health and social care, LA and student-related indicators listed above 
(see Table 20 in Giles et al., 2019 (59) for details on the sources used for each element of 
impact). The costs identified for each of those elements as part of the trial were used to 
populate the SROI where relevant. The savings in costs associated with arrests were taken 
from expert opinion as appropriate cost data were not available (59).  
A cost was attributed to substantial school absenteeism (i.e. five or more days missed from 
school in six-months) as part of the SIPS Jr HIGH trial. As discussed in section 8.2.2, the cost 
attributed to school absenteeism represented the present value of reduced future earnings 
as a result of lower educational attainment, therefore, capturing the impact of the 
intervention on educational attainment but using an alternative indicator. As an indirect 
cost, it was excluded from the CBA base-case analysis, however, the process used to place a 
value on school absenteeism is similar to the human capital approach of valuing health 
outcomes in which future productivity gains, based on future earnings, are considered an 
appropriate proxy value (alongside reductions in healthcare costs) for the accrued benefit 
(118). Although this approach to valuing health outcomes has largely been replaced by 
alternative methods that are less biased towards high-earners (81), the consideration of 
future productivity gains could be argued an appropriate proxy value for the impact of the 
ASBI on educational attainment specifically. Consequently, the cost estimated by the trial 
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health economist for substantial school absenteeism was used as the proxy financial value of 
improved educational attainment.  
No relevant valuations could be identified for the indicators available from the trial data 
relating to risky sexual behaviour. In order to place a value on “regretted sexual intercourse” 
eliciting a value via stated preferences could have enabled a value to be placed on the extent 
to which individuals would value avoiding regretted sexual intercourse. However, the 
resources were not available to undertake the necessary study and no relevant literature 
could be identified. Alternatively, costs related to teenage pregnancy or the contraction of 
sexually transmitted diseases could be roughly estimated from the trial data on intercourse 
without a condom. However, the proxy values attributed to these indicators would largely 
consist of additional health service use, which would result in double counting given that 
data collected on health service use during the trial was not restricted to attendances 
directly related to alcohol use. Therefore, any savings in costs attributed to reduced risky 
sexual behaviour were considered to be captured by health service use and were not 
estimated separately. 
The indicator assigned to the outcome of improvement in quality of life was the EQ-5D-3L. 
Participants’ EQ-5D-3L scores were combined with a time component representing the 
duration over which any improvement (or deterioration) in health-related quality of life was 
observed in order to estimate QALY gain over the 12-month period as a result of the ASBI. 
Monetary values can be applied to QALYs in order to estimate a proxy financial value for 
health improvement (164) and the value recommended for use in SROI by PHE is £60,000 
per QALY32 (164), a value originally recommended by the Department of Health (242).   
Step 4: Establishing impact 
The penultimate stage of the SROI analysis is to apply each of the financial proxy values to 
the indicators and account for deadweight, displacement, attribution, and drop-off to avoid 
over-estimation of impact (see Chapter Three for details on each of these elements). 
Deadweight refers to the counterfactual of any impact as a result of the intervention. The 
recommended approach to capture deadweight is via comparison with a control group (33). 
                                                     
32 This value is three-times the value of a QALY for which incremental cost-effectiveness ratios of interventions 
are considered cost-effective (£20,000 per QALY) by the National Institute for Health and Care Excellence for 
evaluations using cost-utility analysis (10).  
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The difference in impact between the intervention and control groups at 12-month follow-
up was, therefore, estimated in order to account for deadweight. 
Displacement does not always occur, it is mostly considered relevant to interventions aimed 
at reducing crime where crime may simply move from the area receiving the intervention to 
another (33). Whilst impacts related to crime (i.e. number of arrests) were included in the 
SROI presented in this study, the impact on crime was measured at the individual participant 
level rather than, for example, levels of anti-social behaviour in a particular location. 
Consequently, it was not considered relevant to account for displacement for any of the 
outcomes measured for this SROI.  
The attribution of the intervention to the observed outcomes was considered to be 
accounted for by virtue of the RCT setting (see section 8.2.1). Therefore, the attribution of 
the intervention to outcomes was considered to be 100%. Following the protocol described 
in section 8.2.1, this was examined by also conducting a methodological validation analysis 
using proxy values that were adjusted for baseline characteristics (see Appendix M). 
Finally, no drop-off was accounted for since the time-horizon of the SROI study was 12-
months, thus, it was unnecessary to account for future depreciation of outcomes resulting 
from diminishing returns of the intervention.  
The calculation of the total impact value follows Equation 3.5 in Chapter Three. For the 
impact on health or social services resources, arrests, and school absenteeism the financial 
proxy value was represented by the mean cost of each resource for the group receiving the 
ASBI in the trial33. The value of deadweight for each resource was the mean cost for the 
control group of the trial. In order to calculate a total monetary value of the impact for each 
resource, the mean cost was then multiplied by the quantity of impact, which was 
represented by the number of students in the group receiving the intervention (n=210). This 
reflects an intention-to-treat design, which is recommended for pragmatic clinical trial data 
(335). As the intervention and control groups in the trial differed in size (n=210 and n=233, 
respectively), the total value of deadweight was estimated using the same number of 
students as the group receiving the intervention (n=210) to ensure the value of deadweight 
truly reflected the counterfactual of the intervention’s impact.  
                                                     
33 Mean cost was calculated as the sum of the unit cost of the resource multiplied by quantity of resource use 
for each participant, divided by the number of participants with non-missing data at follow-up.  
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The total monetary value of impact for each resource was then estimated by subtracting the 
value calculated for the group that received the intervention from value calculated for the 
control group to obtain the incremental impact of the intervention over what would have 
occurred in the absence of any intervention. The resulting value represented the financial 
saving from a reduction in resource use as a result of implementing the ASBI. A reduction in 
resource costs would be considered a positive outcome, therefore, total impact was 
calculated in this manner so that the estimated value of impact would be a positive integer if 
the intervention had a favourable effect on outcomes.        
The approach taken to calculate total impact was considered more appropriate than the 
standard SROI approach of estimating impact as the unit cost multiplied by the quantity of 
impact adjusting for deadweight as a percentage (33) since deadweight was not estimated 
as a percentage but via the observation of outcomes from a designated control group within 
the SIPS Jr HIGH trial.  
The impact of the ASBI on health was calculated by first multiplying mean QALY gain over 
the follow-up period for both intervention and control groups by £60,000 to obtain a 
monetary value of QALYs for each group. The corresponding values were then multiplied by 
the number of students in the intervention arm (n=210), as explained previously, in order to 
estimate a total financial value of QALY gain at follow-up for each group. Contrary to the 
impact on resources, a positive outcome for QALY gain is represented by a greater value for 
the intervention group compared to the control group. Thus, in contrast to the calculation 
for total resource impact, the overall health impact was calculated by subtracting the 
financial value of QALY gain of the control group from the intervention group. Thus, if the 
intervention generated greater QALY gain than would be generated in the absence of 
intervention, the total financial value of impact would be a positive integer. 
Step 5: Calculating the SROI 
The SROI calculation is outlined in Equation 3.5 in Chapter Three and requires the present 
value of total impact to be divided by the total investment value. As explained previously, no 
discounting was necessary to obtain the present value of impacts as a 12-month time 
horizon was used. The total present value of impact was estimated by summing the total 
values of impact on resources and impact on health. 
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Intervention delivery cost, the components of which are outlined in section 8.2.2, 
constituted the value of investment. The total investment value was calculated in a similar 
manner to impact described earlier; the mean cost for each element of intervention delivery 
was multiplied by the number of students in the intervention arm (n=210). 
8.3.2 Sensitivity analysis 
As with other forms of economic evaluation, sensitivity analysis is recommended to examine 
whether SROI results are robust to alternative assumptions regarding input parameters (33). 
Two sensitivity analyses were conducted to examine (i) the impact of one of the financial 
proxies (the monetary value of a QALY) and (ii) a component of resource impact (school 
absenteeism).  
The monetary value used to calculate the financial value of health gain was £60,000 per 
QALY. However, there are several alternative values of a QALY used in economic evaluation 
which could be used to value the health gains associated with the intervention. NICE 
consider a value of £20,000 per QALY or less to be considered cost-effective and a recent 
estimation of the value of a QALY by Claxton et al., 2015 (364) estimated a value of £12,936 
per QALY. Both values were used in sensitivity analyses of the financial proxy of health gain. 
The costs estimated to be associated with school absenteeism were based on an assumption 
of reduced literacy and numeracy skills as a result of missed school. However, returns to 
education have been demonstrated much to be much greater in primary school than 
secondary school (283). Therefore, the value attributed to school absence in secondary 
school may be overestimating the impact of that absence. Consequently, sensitivity analysis 
explored a scenario where school absenteeism in the Year 10 students did not compromise 
their education outcomes and future earnings. For this analysis, resource use associated 
with absenteeism was removed from the impact value. 
8.3.3 Results 
The intervention delivery costs outlined are in Table 8.10. This table shows that the value of 
investment was £4,666. 
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materials  £1.58 210 £332 £ 0 £332 
Training costs for 
learning mentors 
and screening 
£14.20 210 £2,982 £ 0 £2,982 
Learning mentor 
time  £6.44 210 £1,352 £ 0 £1,352 
Total £4,666 
*Values rounded to nearest £ 
The calculation of the financial impact of the ASBI on resource use is outlined in Table 8.11. 
The net financial impact of a reduction in service use is positive, indicating that the total 
financial value of resource use was lower for the intervention group at 12-month follow-up 
than what would have occurred without intervention (i.e. deadweight, demonstrated by the 
control group). This outcome is comparable with the cost difference illustrated in the CBA 
sensitivity analysis in which school absenteeism costs were included (see Table 8.5), since 
resources related to time missed from school were considered appropriate to include in the 
base analysis of the SROI as proxy values for improved concentration in school.  
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Table 8.11 Calculation of net financial value of reduced resource use outcomes 
 

















student Students Total  
Health 
services 
GP visits £98 210 £20,616 £125 210 £26,261 £5,645 
Secondary 










£27 210 £5,678 £9 210 £1,805 -£3,874 
Students >5 missed 
school 
days 




£0.12 210 £26 £1.02 210 £214 £189 
Total impact on reduction in services £181,357 
*Values rounded to nearest £, except for arrests where values were extremely small. 
The second part of the impact value is determined by the financial value of health gained as 
a result of the intervention, using monetary values of QALYs gained. Both the impact and 
deadweight values are positive, indicating that both the intervention and control groups 
realised an improvement in health at follow-up compared to baseline; however, the net 
financial value of health improvement is negative (Table 8.12), indicating that the financial 
value of health gain was lower for the intervention group compared to the control group. 
Although a slight difference in mean QALY gain in favour of the control group was identified 
during the SIPS Jr HIGH trial, the 95% CI crossed zero (95% CI around QALY difference: -0.019 
to 0.011) (59) indicating an absence of evidence for a difference.  
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student Students Total  
QALYs  £21,780 210 £4,573,800 £22,020 210 £4,624,200 -£50,400 
 
The total impact constitutes the combined net financial values of resource impact and 
health impact. The net present value of impact is £130,957 (i.e. £181,357 + -£50,400) and 
the value of investment is £4,666. Equation 8.3 outlines the SROI calculation. The results 
indicate that every £1 invested in the ASBI generates approximately £28 in social value. As 
the return is greater than one, the SROI favours implementing the ASBI from the viewpoint 
of students, the NHS & PSS, and the LA. 
SROI = Net present impact value
 Net present investment value = 
£130,957
£4,666  = £28.07 (8.3) 
  
The results of the two sets of sensitivity analyses are displayed in Tables 8.13 and 8.14. The 
first sensitivity analysis investigated the impact of changing the financial value of a QALY on 
the overall SROI. Using either the value of a QALY considered cost-effective by NICE 
(£20,000) or the value of a QALY estimated by Claxton et al., 2015 (364) to represent the 
opportunity cost of spending in the healthcare sector (£12,936) results in a larger SROI 




Table 8.13 Sensitivity analysis for alternative financial values of a QALY 



























Total for 210 
students 
£20,000 




£4,683 £983,395 £4,735 £994,261 -£10,866 £170,491 37:1 
 
The second sensitivity analysis, which examines the impact of excluding the value associated 
with school absenteeism, however, results in a change in the direction of the SROI (Table 
8.14). Removing the financial value of missed school from the impact calculation results in 
the intervention group exhibiting a larger financial value associated with resource use 
compared to the control group. Therefore, once deadweight is accounted for, the net 
financial value of a reduction in resource use is negative; in other words, there is not a net 
reduction in resource use as a result of the ASBI once school absenteeism is removed from 
consideration. The SROI ratio becomes approximately -£15:1; i.e. a loss of £15 per £1 
invested. This result reflects the base-case analysis of the CBA in which the value of resource 
use associated with school absenteeism is excluded (Table 8.3). In the base-case CBA, the 
value of resources used in the intervention group are higher on average compared to the 
control group. 




















The SROI results indicate a positive return from implementing the ASBI, which is driven by 
savings from resource use rather than improvement in health outcomes. However, the 
sensitivity analysis in which the outcome of reduced school absenteeism is excluded from 
the impact value alters the SROI outcome substantially. This sensitivity analysis was 
conducted due to concerns that the value attributed to time missed from school in the base-
case may over-estimate the true financial impact of school absenteeism. Under the 
assumption that there is no impact on the educational attainment and future earnings of a 
Year 10 student who misses more than 5 days of school in 6 months, the return from the 
ASBI is negative, which demonstrates that the ASBI does not provide social value.  
The sensitivity analysis on school absenteeism explored a “worst-case” scenario of no 
impact. Whilst it may be argued that the value attributed to school absenteeism in the base-
analysis is an over-estimate (£102,612 per student missing more than 5 days of school in 6-
months (59)), assuming no impact on educational attainment of school absenteeism is likely 
an under-estimate of the outcome, based on the findings of studies of truancy and missed 
school on educational attainment (285, 365). Therefore, the true value of school 
absenteeism may lie somewhere between zero and £102,612. Probabilistic analysis of the 
value attributed to school absenteeism could provide an indication of the minimum value of 
school absenteeism at which the SROI outcome would remain positive. Decision-makers 
could then use their own judgement on whether they believe that value is an appropriate 
financial proxy.  
Nevertheless, the findings of the current study suggest that the SROI outcome is very 
sensitive to changes in the value associated with school absenteeism. Sensitivity of 
outcomes to assumptions is not uncommon in SROI given the extent to which assumptions 
are necessarily made during an SROI, from attributing appropriate financial proxy values to 
defining the extent of benefit. Hex and Tatlock (366) noted that over a range of 15 SROI 
evaluations that they had conducted, each was highly sensitive to assumptions. Thus, due to 
this uncertainty their results should be viewed as illustrative of the sort of returns that are 
possible rather than definitive. A similar approach could be recommended for the results of 
the current analysis, although, the use of data collected from a clinical trial may have 
resulted in more robust data on the impact of the ASBI. The data used to populate the SROI 
evaluation in this study was directly observed, rather than estimated from stakeholder 
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opinion or via estimates of impact, particularly with reference to the percentage of the 
deadweight for each outcome.  
The sensitivity analysis of the financial valuation of a QALY improved the SROI value. Usually, 
the opposite effect would be expected from attributing a lower financial value to health 
improvement. However, in the current study, the health impact of the deadweight is larger 
than the impact from the intervention because the control group had on average marginally 
higher QALYs at 12-month follow-up compared with the intervention arm (59). Therefore, 
using a lower financial value of the QALY reduces the negative net financial impact on 
health, which increases the numerator of the SROI equation (see Equation 3.5) resulting in a 
larger SROI ratio.  
As with the CBA, it is difficult to provide a comparison of the current SROI study in relation to 
similar studies since no published analyses have been identified. Only one SROI in the 
broader alcohol prevention field was identified in Chapter Four (233) which calculated an 
SROI ratio of 2:1 Thai baht. Whilst positive, this is a smaller return than that identified in the 
current study; however, a criticism of SROI as an evaluative approach is that the extensive 
use of stakeholder involvement makes comparison of SROI ratios across different 
interventions and studies inappropriate due to the variation in indicators and outcomes used 
across studies (33). Therefore, comparing the SROI ratio outcomes of the current study and 
that by Tanaree et al., 2019 (233) is of limited benefit, however, both studies show positive 
returns to alcohol prevention. 
8.3.5 Strengths and limitations 
This study represents a novel approach to evaluating an ASBI programme as no prior SROIs 
of this intervention have been identified in the literature. Nevertheless, the study has some 
limitations.  
Firstly, as discussed in section 8.3, limited stakeholder involvement was undertaken for the 
SROI. Indirect stakeholder involvement was considered via the examination of the results of 
a qualitative study with students and parents of students in the SIPS Jr HIGH trial (59). 
However, the qualitative study was not conducted with the aim of extracting relevant 
outcomes for an SROI, therefore, the qualitative findings were of limited use and did not 
highlight any additional outcomes from parent stakeholders. Consequently, the 
identification of outcomes to include in the SROI was driven by examination of the 
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description of the motivational interview component of the intervention and the outcomes 
that would potentially arise based on the areas of discussion included in the motivational 
interview. This was combined with an examination of the actual outcomes collected during 
the trial.  
As with the qualitative interviews conducted within the trial, the outcomes for which data 
were collected during the trial were not chosen with an SROI in mind, therefore, the final 
outcomes included in the SROI were limited and perhaps not as broad as would be ideal for 
a SROI. The use of clinical trial data as a basis for an SROI is, therefore, also a limitation. It is 
quite unorthodox to conduct a trial-based SROI and there is no guidance for how this should 
be approached. As such, best-practice guidelines for conducting an SROI (84, 164) were 
followed as closely as practicable within this setting; although, it should be noted that 
methods for conducting SROI evaluations are yet to become standardised (33). SROI is still a 
relatively new mode of evaluation, particularly within public health, therefore, there is no 
explicit “best-practice” reference case to follow. Nevertheless, it is possible that additional 
outcomes may have been identified with broader stakeholder involvement, for example, 
outcomes for parents, teachers, or schools. Consequently, the SROI conducted in this study 
is likely to be conservative with regards to the societal impact of the ASBI. However, the 
objective guiding the conduction of the SROI was to present an example of the method to 
PHDMs and indicate examples of outcomes that could be included to demonstrate a holistic 
evaluation. The SROI conducted in the current study was able to achieve this objective, 
albeit with a perhaps narrower collection of outcomes than may be available.  
The use of the raw 12-month follow-up costs as proxy financial values for resource use could 
also be considered a limitation, for the same reasons that were discussed for providing a 
methodological validation analysis of the CBA earlier in section 8.2.1. However, conducting a 
similar validation analysis was not appropriate for the SROI. Due to an extremely large 
proportion of zero observations for some of the outcomes included in the evaluation (e.g. 
school absenteeism, arrests and social worker visits) it was not possible to obtain robust, 
adjusted estimates of these resources using regression analyses for each resource 
separately. The only possible approach would have been to either combine all resource 
outcomes and adjust the total value of outcomes (using similar methods to the adjustment 
of costs for the CBA, reported in section 8.2.3) or, alternatively, exclude the outcomes for 
which robust estimates could not be obtained.  
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The latter option would result in an arbitrary exclusion of relevant outcomes, therefore, was 
not considered. The former was possible in this particular case study since the same 
proportions of attribution and drop-off (100% and 0%, respectively) were applied to all 
outcomes in this study, however, had this not been the case it would have been 
inappropriate to combine all outcomes. As a validation of the primary method used for the 
SROI, an analysis was conducted using adjusted values. However, this has not been reported 
in this chapter since it is not in keeping with the approach to analysis that underpins SROI, in 
which each outcome is evaluated separately. Part of the benefit of SROI is the ability to view 
the disaggregated impact of various outcomes of an intervention and combine these to 
provide a measure of return per pound invested. Using a combined resource outcome does 
not provide this same level of granularity, therefore, would not have suitably showcased the 
advantages of the SROI methodology. For completeness, therefore, see Appendix M for the 
SROI using combined, adjusted values.  
Finally, the sensitivity analysis conducted in the current study explored the impacts of a 
relatively modest number of assumptions on the SROI ratio. Alternative analyses could have 
been done, such as examining the assumption of 100% attribution and exploring alternative 
values of financial proxies. Best and worst-case scenarios could have been explored using 
lower and upper limits of unit costs where these were identified (see Table 20 in Giles et al., 
2019 (59)), however for brevity of the evaluation during the workshop, the number of 
sensitivity analyses were minimised. Furthermore, neither probabilistic nor stochastic 
sensitivity analyses were conducted. Whilst sensitivity analysis is recommended in the 
limited SROI guidance literature (84), only deterministic analysis related to examining the 
impact of assumptions, such as the rate of attribution, or financial proxy values. Complex 
sensitivity analyses are not discussed in the guidance, which reflects the lower expectation 
for rigorous analysis compared to other methods of economic evaluation that was 
highlighted in Chapter Three (83).  
Therefore, the whole SROI analysis was based upon point estimates and deterministic 
analysis. This means that the joint uncertainty caused by imprecision in estimates has not 
been considered. For a contemporary economic evaluation this would be considered 
unacceptable. Methods guides and decision-making organisations making use of economic 
evaluations throughout the world demand that probabilistic sensitivity analysis is performed, 
e.g. NICE (10), CADTH (235), Washington Panel on Cost-Effectiveness in Health and Medicine 
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(86) and the ISPOR Society for Medical Decision Making task force (367). It might be 
considered unfair to assign methods guidance from another set of techniques to SROI but 
the underlying rationale for adopting these techniques was the potential for making biased 
conclusions in their absence. Reporting SROI analyses probabilistically should be explored 
and could have been done here had this been deemed appropriate. However, in keeping 
with current guidelines, and to maintain relative simplicity for the workshop, only 
deterministic analysis was conducted and reported in this study. 
 Economic evaluations discussion 
Two economic evaluations are reported in this chapter, both evaluating the ASBI using 
predominantly data collected as part of the SIPS Jr HIGH trial. However, the ways in which 
each evaluation used the SIPS Jr HIGH data differed. This point is important to raise given the 
similarity in reporting of the results of both analyses as a BCR and an SROI ratio. As discussed 
in Chapter Three, the contents of the numerator and denominator of each ratio differ, which 
makes direct comparisons between the results derived from the CBA and SROI challenging, 
although one would expect the results to lead to generally similar conclusions. For example, 
the CBA considered the value of resource use, including intervention delivery costs for the 
intervention group, as a cost and measured intervention benefit using stated preference 
techniques. Whereas, the SROI considered the value of resource use as an impact of the 
intervention alongside a monetised value of QALY gains and considered the intervention 
delivery costs as the intervention investment.  
Additionally, the base-case of the CBA excluded costs associated with school absenteeism 
due to concerns that the values were inappropriate for the evaluation (see section 8.2.2 for 
details), whilst the value of school absenteeism was considered a relevant financial proxy for 
the outcome of increased focus and concentration in school, therefore, was included in the 
base-case of the SROI evaluation (see section 8.3.1).  
The base-case outcomes for both the CBA and the SROI evaluations favour implementation 
of the ASBI, reporting both a positive NSB and positive SROI ratio. However, the CBA results 
are much more robust to assumptions made during the evaluation than the SROI since 
excluding the value of reduced school absenteeism from the SROI results in a negative ratio, 
whereas the NSB remains positive in all variants of sensitivity analyses conducted (inclusive 
of whether school absenteeism costs are included or not). This difference in the evaluations 
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can be explained by (i) the benefit measure used for the CBA and (ii) the narrow range of 
outcomes considered for the SROI.  
The WTP benefit measure used in the CBA measured the broader value to the general public 
of reduced arrests and school absenteeism from the intervention in addition to capturing 
any financial savings that may have occurred from reduced service use in the cost side of the 
evaluation. On the other hand, the SROI purely considered the financial savings of these 
resources and did not include any broader, non-financial benefits. Therefore, removing the 
financial savings associated with reduced school absenteeism had a greater impact on the 
SROI than the CBA since the CBA also accounted for the more holistic value of this outcome. 
As noted in section 8.3.5, due to the limited stakeholder involvement, the current study 
reports a conservative SROI of the ASBI, therefore, a more comprehensive evaluation would 
include additional outcomes, which could include the non-financial value to the various 
stakeholders (e.g. students and parents) of these outcomes. It could be expected that if 
stated preference measures had been used to additionally capture the value of the ASBI 
impact from these stakeholders, the SROI ratio would likely be greater, and perhaps less 
sensitive, to the assumption of the financial return from school absenteeism.  
With respect to the use of the evaluations reported above for the workshop with PHDMs, 
the primary analysis of the CBA, in which the unadjusted 12-month follow-up costs were 
used, was the example of the CBA used for the workshop. This is consistent with the SROI, 
which used the same raw values. Additionally, unadjusted follow-up outcomes with respect 
to arrests and school absenteeism were reflected in the hypothetical scenarios used in the 
CV survey (see Chapter Six), the result of which was used to generate the benefit measure 
for the CBA. Therefore, the primary analysis is consistent with the WTP value via its use of 
unadjusted follow-up costs. Regardless, the outcomes of the CBA using adjusted cost values 
would not have changed the conclusions drawn about the ASBI, therefore, the choice of 
which is the better approach is academic. As such, the simpler analysis could be argued to be 
the best analysis to present to a non-economist audience, given the relatively short time 
available for PHDMs to digest the information provided to them in the workshop setting. 
 Summary 
This chapter reports the conduction of two economic evaluations: a CBA and an SROI, using 
a combination of data collected from the SIPS Jr HIGH trial and independently generated 
data from the CV survey. The base-case results of these evaluations demonstrate positive 
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benefits to society from the ASBI, on both a national and a local level. Sensitivity analyses 
indicate that the CBA base-case results are robust; however, the SROI base-case is highly 
sensitive to the inclusion of the financial value of school absenteeism.  
Both evaluations are considered conservative analyses of the ASBI; however, both 
evaluations fulfil the objective of providing examples of alternative methods of economic 
evaluation that are available, yet underused, to evaluate public health interventions. 
Consequently, both the CBA and SROI evaluations were presented to PHDMs at the 
workshop, which is detailed in Chapter Nine. 
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 Preparing economic evaluation materials for the workshop with 
PHDMs 
This chapter outlines the preparation of the economic evaluation evidence that was 
presented to PHDMs at the workshop, the details and findings of which are reported in 
Chapter Ten. Section 9.1 outlines the choice of economic evaluation techniques that were 
presented at the workshop. Section 9.2 provides the rationale for adapting each of the 
economic evaluation methods for the purposes of the workshop, followed by details of the 
adaptations made to each evaluation method in turn. The final section summarises the 
content of the chapter.  
 Introduction 
The previous chapter outlined the two novel economic evaluations: the CBA and the SROI 
analysis. The evaluations were conducted in order to present evidence of these methods of 
economic evaluation to PHDMs at a workshop. In addition to evidence of both a CBA and an 
SROI analysis, examples of two other economic evaluation techniques were also presented 
at the workshop: a CUA and a CCA.  
These four methods of economic evaluation were chosen for inclusion at the workshop 
following the findings of the qualitative interview study reported in Chapter Five. The 
interview findings identified no clear preference for one health economic evaluation 
technique; however, interest was expressed in methods that are better suited to addressing 
the multi-sectoral nature of public health. In addition, the qualitative study revealed that 
specialist PHDMs were familiar with CUA and the systematic review reported in Chapter 
Four identified CUA as the most commonly utilised method for the evaluation of alcohol 
prevention interventions. Therefore, CBA, SROI, and CCA were chosen to provide examples 
of alternative methods able to incorporate outcomes broader than health. CUA was chosen 
to present alongside the other methods to represent the status-quo of economic evaluation 
in this area and to facilitate a comparison with these alternative methods.  
The economic evaluations were conducted using the same case study, discussed in Chapter 
Six, as the basis of the evaluation. The intervention of interest is the school-based ASBI 
evaluated in the SIPS Jr HIGH trial (59). Using the same case study for each evaluation 
allowed PHDMs to compare each evaluation on an even footing.  
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 Developing workshop materials 
In order to make the evidence appropriate for the workshop audience, who were non-health 
economists, each of the four economic evaluations of the ASBI were summarised and 
simplified into reports. The reports were less technical than would be found in a typical 
economic evaluation report or journal article and contained a short introduction, an 
explanation of the methods used to conduct the evaluation, base-case results, and results 
from sensitivity analyses where these were conducted. In contrast to published reports of 
economic evaluations, a discussion section was not included in the reports prepared for the 
workshop in order to minimise the information burden on PHDMs at the workshop and to 
reduce the time required for PHDMs to familiarise themselves with the information 
provided. Additionally, since the aim of the workshop was to elicit feedback on the methods 
of evaluation and observe PHDMs’ interpretation of the data presented it was not deemed 
appropriate to include a discussion of the results in the reports as this may have biased the 
feedback from the PHDMs by providing interpretations that may not have aligned with the 
workshop attendees’ own. 
The evaluations from which the workshop evidence was based on for both the CBA and SROI 
are reported in the previous chapter. Both a CUA and CCA were conducted alongside the 
SIPS Jr HIGH trial and have been reported in the trial publication (59). Permission was 
obtained from the trial management team to use the data collected in the trial for this study. 
The within trial CUA (59) was conducted to a high quality, using standard methods for the 
economic analysis of clinical trial data (9, 335); therefore, it was not considered necessary to 
repeat the CUA. The adaptations of the trial based CUA for the workshop evidence were, 
thus, purely presentational (see section 9.2.1 for details).  
The CCA did not conduct any analysis to aggregate outcomes since CCA by definition reports 
costs and outcomes in a disaggregated format (113, 368) to allow decision-makers to form 
their own conclusions about an intervention based on the outcomes of most relevance to 
them. Therefore, as with the CUA, no further analysis was conducted in order to present 
evidence of a CCA at the workshop, any changes from the CCA reported for the SIPS Jr HIGH 
trial were merely presentational (see section 9.2.2 for details). 
In addition to the four economic evaluation reports, a brief outline of the SIPS Jr HIGH case 
study was presented to the PHDMs to provide context for the economic evaluations. Since 
the same case study was used for each evaluation, the information on the SIPS Jr HIGH trial 
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was provided separately in order to exclude an introduction to the trial in each report. This 
prevented unnecessary repetition in each of the pieces of economic evaluation evidence. 
Each report was examined for technical accuracy by one of my health economist supervisors, 
Luke Vale (LV). Additionally, two non-health economist individuals examined the text to 
assess the level of technicality of the text. One member had a basic knowledge of statistics 
and one was a retired GP. They had a basic understanding of the concepts of statistical 
analysis and of cost-efficiency that was expected of the workshop attendees. Minor changes 
to the wording of the text were made following the consultations. 
9.2.1 Adapting the cost-utility analysis 
The main adaptation of the original results was the description of uncertainty around the 
ICER results. In the original CUA conducted by the SIPS Jr HIGH health economist (59), a 
stochastic analysis of the estimates of the difference in costs and QALY gains between the 
control and intervention groups was conducted using bootstrapping to examine the joint 
distribution of cost and effectiveness of the intervention versus control. Standard practice 
for presenting the results of stochastic analysis of incremental costs and outcomes was 
followed (9, 335) by the trial health economist. The results of the bootstrapped estimates 
were reported using a cost-effectiveness plane in which each bootstrap iteration was 
represented as a dot in the relevant quadrant of the plane (i.e. costlier and more effective, 
costlier and less effective, less costly and less effective, and less costly and more effective). 
Additionally, a cost-effectiveness acceptability curve (CEAC) was generated to estimate the 
probability that the ASBI is cost-effective at a range of possible cost-per-QALY thresholds 
(59). 
The qualitative interview study (Chapter Five) found that only specialist PHDMs were familiar 
with CUA. Therefore, it was presumed that the majority of workshop attendees would be 
unfamiliar with either cost-effectiveness planes or CEACs. Presenting the stochastic analysis 
results using the standard approaches was, therefore, considered to be potentially overly 
complex for the workshop. As an alternative, a pie chart was used to represent the 
proportion of the bootstrap repetitions of the ICER that fell into each quadrant of the cost-
effectiveness plane. Each section of the pie chart was clearly labelled to show what it 
represented (e.g. ICER outcomes which are less costly and less effective).  
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The trial CEAC representing the probability of the intervention being cost-effective at 
different cost-per-QALY thresholds was also omitted and replaced with a textual description 
of key outcomes.  
9.2.2 Adapting the cost-consequence analysis 
The CCA reported for the SIPS Jr HIGH trial was presented as a balance sheet in which costs 
and outcomes were presented according to whether they favoured current practice, 
favoured implementing the ASBI, or did not favour either option (59). The outcomes 
presented in the within-trial CCA included outcomes from the CUA (i.e. QALY gains) in 
addition to secondary outcomes collected for the trial and analyses by the trial statisticians 
(59). An alternative way of presenting a CCA balance sheet is to list all costs and outcomes 
for each alternative being evaluated (i.e. the control group compared to the intervention 
group) so that all consequences can be compared to all costs without explicitly specifying 
whether the outcome favours a particular action (113, 368). The latter format was chosen 
for the presentation of the CCA evidence for the workshop, which enabled more information 
to be presented for each outcome compared to the format used for the within-trial CCA (59). 
The CCA presented a range of outcomes collected during the SIPS Jr HIGH trial (QALY gains, 
alcohol intake in units, number of drinking days, mental wellbeing, Adolescent Single Alcohol 
Question (A-SAQ) score, smoking behaviour, and energy drinks consumption) and costs 
related to intervention delivery and resource use (including healthcare, social care, local 
authority and student resources). The data was presented as either mean or median values 
for the intervention group at follow-up, the mean or median values for control group at 
follow-up, and the difference between the two groups adjusted for baseline values and 
sample characteristics. The data used to populate the CCA was taken from results of the CUA 
and statistical analyses that were completed by the trial health economist and trial 
statisticians (59). 
No deterministic sensitivity analysis was included within the CCA, however uncertainty 
around the point estimates reported was represented using 95% CIs and interquartile ranges 
where appropriate to provide an idea of the spread of the data. 
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9.2.3 Adapting the CBA 
The previous chapter reports the CBA of the ASBI. Stochastic analysis was conducted on the 
cost difference between control and intervention groups and the mean WTP value in order 
to explore the distribution of the NSB. Following guidance for the presentation of stochastic 
analyses in CBA (130), cost-benefit planes were produced for both the national and local 
authority level analyses (see Chapter Eight). For the same reasons as explained in section 
9.2.1, the cost-benefit planes were not included in the report of the CBA generated for the 
workshop. Textual descriptions of the outcomes of the stochastic analyses were used to 
represent the proportion of the bootstrap repetitions that were present in the relevant 
quadrants of the cost-benefit plane. In order to examine whether the pie-chart 
representation of the stochastic analysis used for the CUA report was preferred to a simple 
textual explanation, a pie-chart was not included in the CBA report. Additionally, since the 
bootstrap repetitions only populated two of the four available quadrants of the cost-benefit 
plane, a pie-chart was not considered to provide any additional information to the text. 
As explained in Chapter Eight (see section 8.2), the more simplistic version of analysis was 
used to form the CBA report for the workshop in order to reduce the technicality of the 
explanation of the analysis undertaken whilst remaining accurate. Additionally, following the 
justification provided in Chapter Eight (see section 8.2.2), only three of the five deterministic 
sensitivity analyses reported in the analysis in Chapter Eight were included in the final 
report. The deterministic sensitivity analyses included in the final report were scaling WTP to 
parents of Year 10 students, trimmed WTP, and trimmed costs. As demonstrated in Chapter 
Eight, neither the two additional sensitivity analyses reported in the previous chapter 
(including school absenteeism costs and using 2016 WTP values) nor the more complex 
methodological analysis resulted in NSB outcomes that would change the overall conclusion 
around the efficiency of the ASBI. 
9.2.4 Adapting the social return on investment 
The SROI analysis report compiled for the workshop represented a simplified version 
compared to the reporting of the analysis in Chapter Eight. The six stages of a SROI (see 
Chapter Three and Chapter Eight) were not described in the workshop report and 
development of the outcomes and indicators was also excluded. This decision was made to 
minimise the information burden on workshop attendees and minimise the time required to 
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digest the information presented. Methods pertaining to the calculation of the impact and 
investment values, were however, included. The two deterministic sensitivity analyses 
(altering the monetary value of QALY gains and excluding school absenteeism costs) were 
both included in the workshop report as described in Chapter Eight (section 8.3). 
 Summary 
This chapter has outlined the adaptations made to each of the four original economic 
evaluations conducted either previously in this thesis (CBA and SROI, in Chapter Eight) or as 
part of the within-trial economic evaluation for the SIPS Jr HIGH trial (CUA and CCA, see the 
final report by Giles et al., 2019 (59)). Each of the original analyses were summarised into 
condensed reports of less than 2000 words. The reports were necessarily reduced compared 
to the original reports in order to ensure the feasibility of presenting, and allowing 
discussions on, four different economic evaluation methods to non-health economists in a 
session lasting under two hours. 
The simplification of the analyses in terms of both the language used and the explanation of 
statistical methods could be considered a limitation of the reports since the process of 
simplification necessarily resulted in a loss of analytical detail. However, given the 
anticipated level of understanding of the economic evaluation methods informed by the 
qualitative findings in Chapter Five, it was considered a worthwhile trade-off to sacrifice 
some analytical detail to improve the likelihood of engagement from the workshop 
attendees. 
The findings from the workshop, including a post hoc discussion of the limitations of the 
simplification of the reports following the workshop, are presented in Chapter Ten. Copies of 
the final reports and the brief introduction to the SIPS Jr HIGH case study that were 
















PART III. Workshop findings and final discussion  
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 Workshop with public health decision-makers 
The previous chapter (Chapter Nine) described the preparation of each of the economic 
evaluation reports that were shown to the PHDMs at the workshop. This chapter builds on 
the previous chapter and discusses the format of the workshop and the feedback elicited 
from the PHDMs about the economic evaluations that were presented to them. The findings 
from the workshop reported in this chapter address the third overarching research question 
of the thesis, outlined in Chapter One. This chapter, thus, explores whether a particular 
method of economic evaluation, or combination of methods, can be identified as most 
beneficial to PHDMs for their decision-making needs. 
The first section of this chapter outlines the aims and objectives of the workshop. Section 
10.2 provides details of the workshop itself, followed by an outline of the feedback from the 
PHDMs on each method of economic evaluation in section 10.3. Section 10.4 discusses the 
findings and outlines the implications for methods of economic appraisal of public health 
interventions and the presentation of such evidence, implications for practice, and further 
research. The final section summarises the chapter. 
 Introduction 
The aim of the workshop was to explore PHDMs’ opinions about each of the economic 
evaluation reports in order to examine whether a particular method is most appropriate to 
aid public health decision-making. The qualitative study in Chapter Five explored the views 
of a sample of PHDMs about economic evaluation methods. However, any preferences 
displayed by the interviewees were based largely on descriptions of each method rather 
than experience of using the available economic evaluation techniques. The interviews 
revealed that the knowledge and experience of economic evaluation methods was quite 
limited amongst the PHDMs. The workshop, therefore, served to introduce PHDMs to 
examples of each method in order to facilitate a more informed discussion of the merits of 
each method from the point of view of public health decision-making in practice. This 
enabled the generation of feedback on the relative relevance and usefulness of each 
economic evaluation for informing public health decisions. 
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The objectives of the workshop study were as follows: 
1. Elicit the views of PHDMs on how useful the information provided by each method is 
for decision-making in practice 
2. Identify whether there is a consensus amongst PHDMs on a preferred economic 
evaluation method 
3. Explore the presentation of evidence to non-health economist decision-makers and 
identify areas in which this can be improved to engage PHDMs with health economic 
evidence 
 Details of the workshop 
A workshop was hosted for PHDMs in North-East England in September 2018. The session 
consisted of an initial, hour-long training session by SH which introduced workshop 
attendees to economic evaluation methods. The training was followed by an interactive 
group session which was facilitated by three health economists (LV, Jo Gray (JG) and SH) and 
lasted approximately two hours. The group work was intended to stimulate discussion about 
the use, and potential for use, of economic evaluations in public health decision-making.  
PHDMs were defined as anyone working in the field of public health who has influence on 
public health policy, commissioning or funding decisions and included commissioners, public 
health consultants, data analysts, public health specialists (e.g. drugs and alcohol specialty 
leads), and elected members of local councils. Attendees self-selected themselves as PHDMs 
and no exclusion criteria were set for attending the session. 
No prior knowledge of health economics was expected or necessary to attend the workshop.  
The initial training session was, therefore, important to provide attendees with some basic 
information on economic evaluation to prepare them for the group work. The training 
session provided information on the different methods of economic evaluation, how each 
may be used, and some brief instruction on critically appraising economic evaluation 
evidence.  
During the group work phase, workshop attendees selected themselves into one of three 
groups. Each group was facilitated by one of the health economist facilitators who were able 
to answer any questions and provide explanations if anything was unclear to participants. 
The short reports of each of the four economic evaluations discussed in Chapter Nine (CUA, 
CCA, CBA, and SROI, see Appendix O - Appendix R for copies of the reports) were presented 
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in turn to the attendees alongside information about the case study. Reports were 
presented in the same order to each of the groups. The CUA was presented first as this was 
considered to be the most familiar report for the workshop attendees and would allow for a 
discussion of the “status quo” of economic evaluations in public health before moving on to 
alternative, and potentially less familiar, methods. The CCA was presented second, followed 
by the CBA and finally the SROI. This order was chosen to keep the evaluations which use 
monetary outcomes (CBA and SROI) together.  
Each evaluation was discussed separately by the groups; the discussions were assisted via 
the use of crib sheets which posed four questions to consider for each of the four methods 
presented:  
• How easy is the information to understand?  
• How appropriate is the information for your decision-making needs?  
• Is the information useful to you? If not, what additional information would you like to 
see? 
• Imagine you have been given £20,000 to allocate to public health services. If you 
were undertaking a prioritisation exercise to decide how to allocate this additional 
funding, would the information presented be appropriate for use as part of that?  
The final question on the crib sheet was designed to place the discussion in a familiar and 
credible setting for the PHDMs. Setting the discussion within the context of a prioritisation 
exercise had been suggested by a public health specialist at PHE who has experience with 
priority setting and the use of health economic evidence in public health settings. A meeting 
had been arranged with the specialist at PHE to discuss the workshop utilising his expertise 
and knowledge of PHDMs in order to frame the event in a manner that would be engaging to 
attendees. 
The £20,000 figure used in the final question on the crib sheet was chosen to represent an 
amount which was sufficiently large to require careful consideration of its allocation, yet 
sufficiently small to ensure that opportunity costs would be incurred in regard to other 
public health programmes if it was allocated to implement a new programme. Expert 
opinion from health economists with specialist knowledge in public health prioritisation (LV 
and JG) was elicited to finalise the figure presented on the crib sheet (£20,000).   
At the end of the interactive group work session the three groups, each comprising between 
four and six attendees, compared the four evaluations to consider which of the methods 
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they perceived would be most beneficial to assist decision-making in their line of work. Each 
group ranked the methods in order of preference and relayed their ranking to the rest of the 
workshop attendees, which allowed for further discussion regarding the justification for 
each group’s most and least preferred economic evaluation tool. 
Feedback regarding the evaluations was captured by the facilitators who took notes of group 
discussions, comments, and answers to the questions on each crib sheet. Notes were also 
taken from the overall discussion with all three groups at the end of the group work phase. 
The notes from each group were collated following the workshop. A summary of the 
feedback is presented in section 10.3 and the structure of the workshop is outlined below in 
Figure 10.1. 
Figure 10.1 Flow chart of the structure of the workshop with PHDMs 
 
Legend:  
CPH = consultant in public health  PHR = public health registrar 
PHA = public health analyst  PHL = public health lecturer  
PHM = public health manager  PHP = public health practitioner  
PHSL = public health speciality lead SPHM = senior public health manager 
Interactive group work session 
(n=15) 
Full group discussion on preferred method 







2 CPH, 2 PHR, PHA, PHL 
(n=5) 
PhD student, 2 PHR, PHM, PHP  







PHSL, PHP, SPHM, CPH  






Training on economic evaluations 
(n=15) 
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10.2.1 Workshop recruitment 
The workshop was advertised as a Fuse34 workshop on “Critical appraisal of health economic 
decision tools for public health decision-makers” and was promoted via the Fuse network, 
which includes academics and practitioners who work in, or have an interest in, public health 
(see Appendix S for the flyer used to promote the workshop). The workshop was also 
publicised through the PHE continuing professional development network and directly 
advertised to those interviewed in the qualitative interview study (Chapter Five). The 
workshop was marketed to a wide range of individuals although the flier specifically targeted 
LA officers and anyone involved in public health decision-making. Both members of public 
health departments and members of other LA departments were invited, for example those 
in transport or planning departments, since officers in these areas may also be involved in 
decisions regarding the implementation of interventions which have an impact on public 
health (e.g. planning cycle routes or modernisation of council housing). 
Fifteen PHDMs attended the workshop. The attendees had varied backgrounds. There were 
three consultants in public health, a public health specialist/lecturer in public health, four 
public health specialty registrars, two public health practitioners, a public health analyst, a 
public health manager, a public health senior manager, a public health programme lead, and 
a PhD student in health economics who had worked previously as a public health 
practitioner outside of the UK. Nine different LAs from the North-East of England were 
represented in addition to an officer from PHE.  
10.2.2 Ethical approval and consent 
Ethical approval for the study was granted by Newcastle University Ethics Committee (REF: 
6738/2018) on 16/07/2018. Written consent was obtained on the day from the workshop 
attendees to use their feedback for this study (see Appendix T for the consent form).   
 Workshop feedback from PHDMs 
During the group work, each economic evaluation was discussed in turn for approximately 
20 minutes. Feedback was invited from the attendees on both the content of each piece of 
evidence and the manner in which the information was presented. The discussions explored 
what, if any, further desirable information would be useful that was not necessarily related 
                                                     
34 The Centre for Translational Research in Public Health - http://www.fuse.ac.uk/ 
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to the choice of methodology. Such feedback is particularly illuminating for health 
economists with an interest in presenting their findings to decision-makers since the 
guidance for the presentation of economic evaluation evidence (e.g. the CHEERS checklist 
(182), the Drummond checklist (9), and the Washington Panel (86)) may not represent the 
optimal way in which to translate information to PHDMs. The feedback in relation to each of 
the workshop objectives (section 10.1) is presented below with further discussion of it, and 
its implications, presented in section 10.4. 
10.3.1 Objective 1: The usefulness of the information provided by each method for 
decision-making in practice 
Cost-utility analysis 
General feedback about the CUA was neither strongly for nor against the method. However, 
the programme lead and senior manager both felt it was overly complex and lacking in 
information relevant to them. For example, they were unsure how to interpret the ICER and 
questioned whether QALYs were the most appropriate outcome measure for the 
intervention considering the age group of the population involved. Additionally, both PHDMs 
reflected on their experience that QALYs were not used in LA decision-making, therefore, it 
would be difficult to make an implementation decision on the basis of the results from a 
CUA.  
The remainder of the workshop attendees expressed the view that CUA could be used for 
decommissioning services but would only be of use if similar analyses were available for 
alternative interventions to facilitate a comparison. Concern was also expressed about the 
appropriateness of the QALY for the case study. Several attendees agreed with the 
programme lead and a senior manager that the CUA evidence was not intuitive, particularly 
the reporting of the certainty of the ICER outcome. It was agreed that the CUA evidence 
overall would only be appropriate in a LA setting if translated into a narrative that would 
engage other LA stakeholders, suggesting the need for some form of knowledge brokerage 
between health economists and PHDMs. 
Notwithstanding some of the difficulty experienced by PHDMs in grasping the CUA, the 
concluding remarks of the report, in which the ICER was compared to the NICE threshold for 
cost-effectiveness, were greatly appreciated. Attendees expressed that more emphasis 
could have been placed on this over some of the other information that was provided in the 
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report. The PHDMs liked the idea that the ICER could be used to compare cost-effectiveness 
directly with that of other interventions for which a CUA has been conducted through the 
provision of a reference point, i.e. the NICE cost-effectiveness threshold. 
Cost-consequence analysis 
Two elements of the CCA appeared to make it attractive to PHDMs: firstly, the clear and 
simple presentation of the CCA in one table; and secondly, the inclusion of a broad array of 
outcomes and costs would allow decision-makers from public health departments to engage 
with others within the LA who may have an interest in alternative outcomes. It was noted 
that it could be a particularly useful tool to take to Health and Wellbeing Board meetings; 
non-LA partners could engage with the information since at least one of the outcomes 
included should resonate with them.  
Whilst the flexibility of CCA was admired, some workshop attendees felt the lack of 
aggregation of results had to be treated with caution as it left the information open to 
interpretation.  
Cost-benefit analysis 
Attendees were confused over what the WTP outcome represented and questioned why this 
was used as an outcome measure. Some expressed the view that benefits represented in 
this manner drew attention away from effectiveness and focused it more on how the 
intervention would be funded. This view shows a misunderstanding of how effectiveness 
data was used to derive the WTP values. This could have been a fault of the presentation of 
the outcomes or insufficient explanation.  
In addition, mistrust in the validity of the WTP outcome was also a concern. Further 
explanation was desired on how the WTP value was derived in order to trust the measure. 
Since WTP was an unfamiliar outcome measure to the PHDMs, “fear of the unknown” 
potentially played a role in the mistrust conveyed during the workshop. Concern was 
expressed over the public’s ability to value interventions and the attendees were not 
convinced of the robustness of the technique given the apparent subjectivity of the outcome 
measure. Some thought that other decision-makers within the wider LA would challenge the 
methodology. 
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One group did, however, see a redeeming feature in the publicly elicited value of WTP. The 
penchant of elected members for involving the public in decisions, given their role to serve 
their electorate, aligns with the concept of valuing an intervention using public views. Some 
of the workshop attendees, therefore, stated that CBA may be welcomed by their elected 
members on the basis of the evaluation reflecting public opinion. Unfortunately, no elected 
council members were in attendance at the workshop to confirm this statement. Further 
research would be necessary in order to examine whether WTP measures would truly be 
welcomed by council members. 
Social return on investment 
The PHDMs described the SROI results as generally familiar and user-friendly, particularly 
compared to the other methods presented. Nevertheless, areas for improvement were also 
reported. The evaluation was presented in more detail than it transpired that the PHDMs 
were accustomed to. For example, PHE produced an ROI report covering many preventive 
interventions which included limited detail on the analysis conducted to generate the final 
ROI outcome displayed35 (35). Some of the terminology used as part of an SROI evaluation, 
such as “deadweight”, was unfamiliar to PHDMs, who did not appear familiar with the 
methodology underpinning SROI. The concept that “deadweight” (the financial value of the 
intervention counter-factual) was represented by the SIPS Jr HIGH trial control group was 
not well understood by attendees from one group, who expressed interest in comparing the 
SROI of the intervention to that of the control group, despite having it explained that the 
SROI represented the incremental impacts of the intervention compared to control. This may 
have been partly due to the unconventionality of conducting an SROI analysis of a clinical 
trial. However, the concept of deadweight reflecting the counter-factual and its use in SROI 
remains consistent regardless of the nature of the intervention under evaluation. 
Additionally, some attendees were confused over how QALY gains were presented in the 
SROI.  
                                                     
35New ROI reports have been produced by PHE in which the methods of analysis are discussed in detail (e.g. 
Jayatunga., 2018 (369) and Optimity Advisors Ltd., 2018 (370)), however, these reports were published either 
after the workshop or very soon prior to the workshop, therefore, PHDMs in attendance may not have been 
aware of these pieces of evidence. Additionally, the analyses were ROI analyses rather than SROI, thus, the 
analytic methods differ slightly. Terms such as “deadweight” and “attribution”, which are associated 
specifically with SROI methodology, are not present in the reports. 
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In terms of practical use, one group attested to the SROI being most appropriate at a higher 
policy level, rather than at an individual LA level, and that some indication of how soon after 
implementation returns would be realised could be beneficial. Again, this suggests some 
misunderstanding of the methodology since returns represent those expected within the 
time horizon of the evaluation, which was stated as 12-months. However, it was opined by 
members of another group that if SROI was to become a key form of evidence for decision-
making, appropriate training on critical appraisal of the method would be necessary.  
Additional information requirements 
Part of the group work was intended to identify any additional information that would be 
required to improve the quality of evidence for decision-making purposes. There were three 
main aspects on which the attendees required greater information: impact on inequalities, 
longer-term benefits, and sectoral analysis of savings. 
PHDMs requested information on the ASBI’s impact on different populations, perhaps as 
additional sensitivity analysis. This was not featured in the reports due to the constraints of 
the original data collection. However, given the interest in this information it should be 
considered by those designing economic evaluations and projects examining public health 
interventions in future.  
The ASBI case study was conducted with young people, and many of the benefits associated 
with these types of behaviour change interventions are unlikely to be realised for several 
years. The workshop attendees were aware of this fact and wanted evidence of the 
effectiveness of the intervention on longer-term outcomes than the 12-month outcomes 
provided by the trial. This is a common theme for many public health interventions which 
are termed “preventative”, where beneficial outcomes are largely intended to occur at some 
future time-point. Thus, being able to demonstrate long-term outcomes, either via longer 
trials (which is unlikely due to practicalities and cost) or modelling using data from 
longitudinal evidence (more likely yet potentially not as robust as a long-term trial) would be 
greatly beneficial to public health decision-making. 
Finally, there are often spill-over effects from public health outcomes into other sectors 
(both health, e.g. the NHS, and non-health) and vice versa. Given that LAs are responsible for 
multiple sectors, one of the workshop groups expressed that it would be pertinent for 
economic evaluations to be able to demonstrate where savings fall in other sectors and be 
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able to provide this analysis within health economic evaluations. This could be extended to 
include costs (where savings do not occur) and non-financial benefits (where these are 
measurable).  
10.3.2 Objective 2: Identifying consensus amongst PHDMs around preferences for a 
specific economic evaluation method 
Following a review of each of the four economic evaluation methods (CUA, CCA, CBA, and 
SROI), the overall consensus from all three groups was that SROI was the most preferred 
method. Each of the groups liked the presentation of the information in which each of the 
investment and impact elements were clearly broken down to demonstrate the effect each 
component had on the final SROI value. Feedback was particularly positive regarding the 
disaggregated presentation of health sector outcomes and outcomes for other sectors in 
monetary terms. Attendees noted that this could be beneficial in discussions with officers 
from other LA sectors beyond the public health department or with elected members of 
council. Including the broader spectrum of outcomes was welcomed, especially when 
compared to CUA which focused solely on health consequences.  
As complementary evidence, CCA was also ranked highly by all groups. There was consensus 
that it was a valuable tool for providing a broad range of information but, at the same time, 
a recognition that on its own it would be insufficient for decision-making. As a supplement 
to other forms of evidence, however, CCA was highly favoured as it was able to “fill in the 
gaps” of information not provided by the alternative evaluations. Two of the groups 
envisaged scope to combine an SROI and a CCA by presenting the SROI results as one 
outcome within the CCA. Such a venture would require endeavours to ensure that no double 
counting occurred between the impacts and investments included in the SROI and the 
disaggregated results reported in the remainder of the CCA. Nevertheless, from the practical 
perspective of providing desirable information to decision-makers it would be possible to 
present evidence of a SROI alongside additional outcomes which could not be included 
within the SROI analysis.  
A minority of workshop attendees (a programme lead and a senior manager in public health) 
preferred CBA due to the fact they considered it to report a “bottom line” via the overall net 
societal benefit (NSB). This description of the CBA outcome could have two interpretations. 
According to the Oxford English dictionary, a “bottom line” can be defined as “the last line of 
224 
a profit and loss account, showing the final profit (or loss); (also more generally) a net profit.” 
(371). Whether the NSB truly refers to a bottom line in this sense is debateable. The NSB 
resulting from the CBA did not reflect direct financial benefit, since the monetary benefit 
derived from the CV survey is an indirect monetary outcome reflecting value to society. 
Alternatively, the term “bottom line” may have been used in a more colloquial sense, 
referring to a single, final outcome. In the latter interpretation, the attendees would merely 
be expressing a preference for having a single figure outcome compared to the format of the 
outcome from either a CUA or SROI, which both report ratios. 
The same attendees also found the outcomes of the CBA easy to understand and in a 
relatable format (money). Two-thirds of the PHDMs, however, had an opposing view and 
ranked CBA as their least preferred evaluation method. The driving force behind this 
preference was a lack of familiarity with the terminology used in the reporting of the 
evidence (e.g. “willingness to pay"), which they felt made it difficult to engage with.   
Overall, one of the groups fed back that a “one-tool-fits-all” approach was unlikely to be the 
best approach, as they considered different methods to be relevant to different decision-
makers. The reality of public health decision-making was that decisions are made 
collaboratively with decision-makers of varying roles and expertise. Therefore, it was felt 
that different methods would resonate better than others with different audiences. For 
example, a director of public health may prefer CCA, whilst other LA officers may prefer SROI 
and NHS stakeholders would likely prefer CEA or CUA.  
10.3.3 Objective 3: Explore the presentation of evidence and identify areas in which this 
can be improved 
Feedback from the group work regarding the presentation of the evidence produced some 
common themes across all, or most of, the methods of economic evaluation. The findings 
from this aspect of the evidence are pertinent to health economists conducting economic 
evaluations of public health interventions who intend their work to reach, and be utilised by, 
decision-makers in practice.  
Firstly, the PHDMs desired to see a full break-down of costs included in the evaluations. 
Knowing the total cost was only beneficial to their decision-making to a limited extent, and 
they wanted greater information on where the costs were being incurred and whether 
certain costs were substantial compared to others. This detail would typically be presented 
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in an academic journal article or health technology assessment report. It had, however, been 
excluded from the workshop reports for reasons of brevity. 
Secondly, there was a general view that the CUA and CBA reports were “too wordy”. This 
both increased the time the attendees took to read through the evidence, compared to the 
SROI and CCA, but also added to the cognitive burden of deciphering the results of the 
evaluations. Results tables were welcomed as these clearly demonstrated the key outcomes.  
Additionally, some of the attempts to present information graphically were unsuccessful. As 
explained in Chapter Nine, the results from bootstrapping the incremental costs and QALY 
gains were presented via a pie chart in the CUA report for the workshop, rather than on a 
cost-effectiveness plane or using the data to create a CEAC. However, this adaptation did not 
appear to improve comprehension of the concept of bootstrapping the cost and QALY 
outcomes and caused confusion.  
Thirdly, sensitivity analysis was greatly appreciated. Feedback from both the CBA and CUA 
was that the sensitivity analysis was extremely useful in indicating certainty of the 
evaluations’ findings which would help PHDMs decide whether the evidence is sufficient to 
base decisions on. In the CBA in particular, the presentation of a local level analysis was well 
received as it enabled the PHDMs to anticipate the impact of the intervention in a context 
relevant to them.  
Finally, recognising the limitations of PHDMs to be able to interpret health economic 
evidence, feedback was expressed for plain English explanations of the evidence. Attempts 
had been made to minimise the use of jargon in the reports but according to the feedback 
from the groups this could still be improved upon to further engage PHDMs with economic 
evaluation evidence and ensure that analyses are appropriately interpreted. Issues with 
comprehension were identified particularly with the CUA and for certain elements of the 
SROI. The terms “deadweight” and “attribution” in the SROI analysis were not well 
understood and would require either greater explanation or alternative language to convey 
their meaning. Although in general the presentation of the SROI was preferred by most of 
the PHDMs, one of the groups was overwhelmed by the information and stated their 
preference for more concise reporting of the results. 
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 Discussion 
This chapter reports the findings from a workshop with a range of PHDMs in which four 
pieces of economic evaluation evidence (CUA, CCA, CBA, and SROI) were appraised for their 
potential merits in aiding public health decisions. The feedback obtained during the 
workshop assisted in addressing the third overarching research question of the thesis, which 
aimed to explore whether a particular method of economic evaluation, or combination of 
methods, is most beneficial to PHDMs. Overall, the findings from the workshop could not 
identify a single approach to economic evaluation which would be most beneficial to 
PHDMs. SROI was preferred by a majority of the attendees, nevertheless, there were several 
limitations identified regarding the practical use of the method which would require more 
research to address prior to recommending it as principally beneficial for public health 
decision-making. However, a favoured approach of including a CCA in combination with 
another evaluation was reported. The remainder of this section will discuss the implications 
of the workshop findings for the conduct and presentation of economic evaluations in more 
detail. 
10.4.1  Implications for methods of economic evaluation 
A finding which arose most notably during group discussions around the SROI and CCA 
evaluations was that the PHDMs appreciated the inclusion of a broad range of benefits in 
evaluations. Attendees felt that this provided more useful and compelling evidence of 
effectiveness compared with focusing solely on health benefits. Although this feedback was 
primarily given for the SROI analysis and the CCA, it is one of the key academic arguments 
for including CBA in the arsenal of economic evaluations of public health interventions (47). 
Consequently, this provides some evidence of convergence between theoretical arguments 
for CBA and requirements in practice.  
Despite this, however, preferences for using CBA in practice were weak. Many of the PHDMs 
questioned the validity of the benefit measure, expressing mistrust with the WTP survey 
technique. Concern was voiced over the public’s ability to value interventions and the 
robustness of the technique given the apparent subjectivity of the outcome measure. 
Concern over whether stated preference techniques are appropriate methods for evaluating 
goods using individual preferences is not uncommon; debate is ongoing between 
proponents and opponents of CV in the academic literature on this issue (see Borzykowski et 
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al., 2018 (318), Mitchell & Carson., 2013 (124), Diamond & Hausman., 1994 (303) or 
Hausman., 2012 (319) for some examples and discussions of criticisms against CV).  
However, a further potential explanation for the PHDMs’ responses to WTP might in part be 
due to “fear of the unknown”, as suggested earlier in this chapter (section 10.3.1). A lack of 
trust in the public valuation of the ASBI may be attributed to a lack of understanding of the 
CV process and apprehension towards an unfamiliar tool which bears little resemblance, on 
the face of it, to outcome measures which PHDMs may be accustomed to and which may be 
perceived as more objective measures, such as alcohol consumption or years of life gained. 
Despite covering CBA in the short training session at the beginning of the workshop, stated 
preference measures were covered only briefly. Additionally, limited explanation of the CV 
study was provided in the CBA report on the basis of brevity for the workshop. Whether a 
“fear of the unknown” contributes to some of the attendees’ concern regarding public 
valuations of intervention outcomes is unclear currently and further research could examine 
these issues to shed greater light on whether information from CBAs offers value to PHDMs.  
On the other hand, outcome measures such as QALYs, which have been more commonly 
used in evaluations of public health interventions (372), were more familiar to the 
attendees. QALYs as a general outcome measure were not queried by the majority of the 
PHDMs, although several suggested that they may not be the most appropriate measure for 
the school based ASBI. This view could be unique to the choice of case study for the 
workshop, although, as remarked by members of one of the workshop groups, QALYs are 
not considered in LA decisions. Therefore, QALYs seem less relevant to current public health 
decision-making at a local level. 
This disparity in trust between WTP measures and QALY measures, on the basis of 
“subjectivity” is illuminating and reveals a limited knowledge of the QALY measure. For 
instance, estimating QALY gains relies on some level of subjectivity, via public valuation of 
health states extracted from either the EQ-5D or another generic, or condition-specific, 
quality of life survey. The difference between QALYs and WTP values is that in a CBA the 
subjective valuation is brought to the forefront of the evaluation rather than masquerading 
behind the veil of a QALY, which end users may feel they understand.  
A minority of the PHDMs observed positive potential for the WTP measure via the 
hypothesis that elected members may appreciate its elicitation of public viewpoints. 
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However, in order for WTP to be relevant in a specific LA context, evaluations would ideally 
use WTP data captured from the local population, which would have consequences for the 
generalisability and transferability of data to other localities. An alternative approach could 
be to conduct a survey that focuses on obtaining a sample of the general public’s WTP from 
the area of interest or at the very least ensuring that there is a sub-sample from that area 
that is sufficient to provide robust results. If this is not possible then methods of weighting 
the general population WTP measure more heavily towards the values stated by the local 
population could also be explored. 
Both the CBA and CUA did, however, receive positive feedback for their aggregated results. 
A minority of the workshop attendees resonated with the NSB outcome of the CBA and 
reflected that the use of monetary units was relevant and familiar to LA officers. The 
monetary representation of the SROI outcome ratio was also viewed positively for the same 
reason. On the other hand, the comparative ability of the ICER reported in the CUA, 
particularly to a clearly stated reference point for cost-effectiveness such as the NICE cost-
effectiveness threshold, was compelling to many attendees.  
A similar finding was reported by Phillips et al., 2011 (19), nevertheless, it warrants further 
consideration since Owen et al. (372, 373) demonstrated that the vast majority of public 
health interventions fall well below the current cost-effectiveness threshold posited by NICE 
for healthcare technologies (£20,000-£30,000 per QALY) or even the lower threshold 
recently revealed for use by the Department of Health for their impact assessments (£15,000 
per QALY) (374). In such a case, comparing ICERs of alternative interventions to a threshold 
value for cost-effectiveness of healthcare technologies may be moot since the majority of 
interventions would all be considered cost-effective when compared to the current 
threshold. 
Additionally, in England the threshold value is supposedly representative of the opportunity 
cost to the healthcare budget of funding a specific course of action (although the current 
threshold is based on no empirical evidence of this opportunity cost and recent endeavours 
to empirically calculate a threshold suggest a much lower value (364, 375)). Therefore, 
unless there can be a flow of funds from the healthcare budget into public health, 
comparisons to the threshold posited by NICE is perhaps irrelevant for LAs. Recent research 
has been conducted to examine the marginal productivity of public health expenditure in 
English LAs and has calculated a cost per QALY estimate for the public health grant of around 
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£3,800 per QALY (376). If acknowledged as a relevant threshold, there may be a stronger 
argument for the use of CUA in public health to aid efficient resource allocation within the 
constraint of the public health grant. Although, these findings are only preliminary and the 
issue with reliance on health maximisation as a decision criterion in the current CUA 
framework remains. Furthermore, following a removal of the public health grant, public 
health expenditure would be explicitly competing with other LA responsibilities. Thus, 
further work would be required to explore an appropriate cost per QALY threshold in a 
setting where the opportunity cost of public health expenditure explicitly falls on non-public 
health activities.    
The relative comparability between ICERs of alternative interventions may be of greater 
relevance to PHDMs. Following this argument, CUA is not the only method which is able to 
provide this level of comparability; the NSB of substitute interventions may also be a 
relevant yardstick for examining relative efficiency (33, 80). It could be argued that CBA goes 
one step further than ICERs by allowing comparison of public health programmes in other 
sectors of the LA. Since the use of monetised outcomes does not rely on the necessity of 
benefit to be driven by health outcomes, which would be necessary to estimate cost-
effectiveness using current QALY measures, CBA may offer greater applicability within the 
broader field of public health than CUA.  
The pertinence of this was demonstrated in feedback requesting sector specific reporting of 
costs and outcomes. QALYs currently are not able to cross the border from healthcare to 
other sectors, although some recent explorations have been made to examine the possibility 
of cross-sector comparisons using minor adjustments in QALY measurement (24). The 
suggested adjustments, however, limit measurement of outcomes to the space of “quality of 
life” which may not encapsulate all benefits related to other sectors e.g. environmental 
improvements from physical activity interventions which reduce car use.  
On the other hand, the same feature of comparability does not hold true for SROI analysis. 
Due to the extensive use of stakeholder engagement to assign both relevant outcomes for 
analysis and the financial proxy values, the subjectivity of each SROI analysis is considered 
too extensive to allow for robust comparisons of SROI ratios (33). SROI can be used generally 
to inform whether an investment may be worthwhile, however, its use to assist allocating 
resources may be limited.  
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Finally, SROI has only been introduced to the field of public health in recent years (33) with 
efforts from PHE to guide the conduct and collection of data for SROI analyses only coming 
to the fore since 2015 (164, 377). The method’s novelty places it at risk of misinterpretation 
if PHDMs do not receive appropriate training to understand the method and its limitations 
as a decision-aid. Following the preference for the method during the workshop, it is ever 
more important that anyone with a desire to use SROI analysis as a decision-aid understands 
the limits of the tool and is able to accurately interpret its outcomes. This point was raised 
by one group in the workshop but has also been addressed elsewhere (378). The main area 
of concern involves the interpretation of what constitutes the “return” in a SROI and how 
that relates to cost-savings. SROI extends the benefit space beyond pure financial returns, 
yet this is often not well comprehended, and misinterpretation occurs when the outcome of 
an SROI is believed to represent a cash return.  
10.4.2 Implications for the presentation of economic evaluations 
Emphasis was placed on the presentation of information during the group discussions. This 
was evident strongly in the positive feedback for the CCA and SROI evaluations. 
Consequently, it may have been favourable presentation of the evidence, rather than the 
actual methodology, that drove the attendees’ preferences for SROI and CCA. However, it 
was recognised that CCA would only be valuable alongside other tools as supplementary 
evidence. It should be feasible to include CCAs alongside other evaluations in future analysis 
if this is viewed as beneficial to decision-making by PHDMs. Weatherly et al. (48) in fact 
recommend a CCA be conducted prior to other valuation methods when evaluating public 
health programmes due to the broad associated costs and consequences. 
One of the foremost findings from this study was the extent of trade-off between presenting 
sufficient information to be useful and convincingly reliable for decision-making on the one 
hand and providing a concise and navigable report to a non-expert audience on the other. 
Although considerable effort was made to balance these competing elements in the 
production of the material for the workshop, the feedback illustrates that there is still room 
for improvement.  
The CUA prompted the most emphatic comments on the difficulty of following parts of the 
report, particularly the alternative presentation of the bootstrapped incremental costs and 
QALYs, as discussed earlier (section 10.3.3). The PHDMs did not report any difficulty in 
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understanding similar information presented purely as text in the CBA. It remains unclear 
whether presenting the cost-effectiveness plane would have been understood by the 
PHDMs. The feedback suggests that replacing it with an alternative figure did not add value 
to the report and reporting outcomes textually was sufficient to translate the data from the 
stochastic analysis. 
Furthermore, heterogeneity in the level of detail requested for inclusion in the reports was 
identified. As reported in section 10.3.3, plain English and concise summaries of key findings 
were requested. On the other hand, public health consultants and registrars in particular 
sought further information on the statistical methods that had been used. This 
demonstrates the difficulty of providing evidence that meets the informational requirements 
of a range of PHDMs simultaneously and implies that the reporting of results should be able 
to account for this heterogeneity.  
A suggestion may be to produce reports in a format that allows those readers who desire 
limited detail to easily access the key findings whilst also providing access to sufficient 
analytic detail for the more technically minded decision-makers. This could potentially be 
operationalised via the use of plain English executive summaries which include key results in 
a tabular form and discuss key implications of the outcomes. The detail of the analysis could, 
thus, be incorporated into the main body of the report so that it is available for those who 
desire to scrutinise the methods more carefully. In reports for PHDMs, however, it would be 
prudent to make few assumptions regarding end users’ knowledge of health economic 
specific terminology. Consequently, lay terminology could be used where possible and clear 
definitions for all technical terms should be included in the report.  
The feedback from the workshop attendees suggests a need for improved knowledge 
transfer from academia and other research institutions to public health policy-makers. 
Hunter et al. (266) identified issues of a similar nature when evaluating the prioritisation 
framework recently developed by PHE (265). Many of the public policy makers testing out 
the prioritisation framework tool reported difficulty in interpreting the technical terminology 
and commented on a lack of supporting documentation or clear definition of terminology. 
Knowledge transfer between academic and policy-makers is a currently discussed issue (e.g. 
Hunter., 2019 (379), Wilson & Sheldon., 2019 (380), and McAteer et al., 2018 (381)) and is a 
foremost focus of research institutions such as Fuse (382). Including a focus on economic 
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evaluation evidence specifically in these knowledge transfer discussions should be 
encouraged.   
An element of the reports which attendees found beneficial was the presentation of the CBA 
results as a local scenario. An important consideration for public health economic 
evaluations, therefore, is whether more locally relevant analyses can be conducted. It would 
be extremely resource-intensive to conduct separate evaluations for all LAs, however, 
authors could ensure sufficient detail is given about the characteristics of the population and 
context of the evaluation for decision-makers to assess whether it may be relevant to their 
local demographic. Additionally, more commonplace sensitivity analysis to model potential 
outcomes for changes in population characteristics (e.g. the proportion of risky drinkers in 
the population) could be encouraged to promote greater resonance with individual LA 
decisions.  
Sensitivity analysis could also be extended to different population groups to assess the 
potential impact on inequalities, such as: health, socio-economic, or any other basis 
particularly relevant to the intervention. Chapter Four identified that analyses of this kind 
are rare in the evaluation of alcohol prevention interventions and may be often overlooked 
due to lack of available data; it would be worth exploring whether modelling can be used 
when direct empirical data are unavailable. Whilst this would add complexity and require 
greater resources on the part of the economists conducting the evaluations, findings from 
this study indicate that such information would be valued by PHDMs.   
10.4.3 Implications for practice 
The findings reported in this chapter have several implications for health economists 
performing evaluations of public health interventions. Firstly, with reference to the 
presentation of evaluations, the findings indicate the importance of improving knowledge 
transfer between academic research and PHDMs. Regardless of the method of economic 
evaluation used, the current format in which evidence is presented is not optimal for end-
users of the information.  
Secondly, health economists may consider conducting SROI analyses where appropriate, for 
instance where programmes are expected to have considerable social impacts beyond 
health. A caveat of this implication, however, is that appropriate training on interpreting 
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SROI analyses and understanding their limitations should be provided to PHDMs to facilitate 
the appropriate use of SROI findings.  
Thirdly, CCA should be presented alongside other modes of evaluation in order to provide 
information on outcomes that it may not be possible to include in the main economic 
evaluation. This can allow multiple stakeholders to obtain relevant information from the 
evidence.  
Finally, when possible, scenario analysis using local data or assumptions that reflect local 
demographics should be conducted if end-users are expected to be LA officers. If data 
unavailability renders local scenario analysis not possible, detailed reporting of demographic 
data of the study sample should be commonplace in order to assist PHDMs assess the 
relevance of the evidence to their locality.  
10.4.4 Implications for further research 
The discussion of the implications of the workshop findings in sections 10.4.1 and 10.4.2 
identified several areas for further research. Firstly, further examination is required with 
respect to whether CBA would be more acceptable to PHDMs if they received relevant 
training and if reports included more extensive explanation of the WTP measure and how 
WTP was elicited for the evaluation. Since this was the major focus of the attendees’ 
concern, yet they expressed interest in other elements of the evaluation such as the 
incorporation of broader benefits, there may remain scope for CBA if trust is gained in the 
measure of benefit.  
Secondly, since no elected members attended the workshop, an exploration of their views of 
WTP as a measure of benefit could be undertaken to examine whether the feedback 
regarding elected members potentially preferring publicly valued outcomes holds merit. If 
the hypothesis holds true, this would favour the argument for the use of CBA for local public 
health purposes.  
Thirdly, further research should be conducted with PHDMs following adaptations to the 
presentation of the economic evaluations as specified in section 10.4.2, particularly around 
SROI. Reassessment of PHDMs’ ranking of methods should then be considered to examine 
whether the preferences reported in this chapter remain consistent. 
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Finally, the impact of the case study on preferences for methods should also be examined 
since it is not possible to evaluate many public health interventions using RCTs. However, 
the SROI analysis was the most strongly impacted of all the techniques by the use of trial 
data from the perspective of the PHDMs, who misinterpreted the comparison of the control 
group and intervention group. Therefore, the use of a non-trial-based case study may 
strengthen the case for SROI if interpretation of the outcomes can be improved.  
10.4.5 Strengths and limitations 
The greatest strength of this study is the active engagement with PHDMs in order to 
examine economic evaluation tools from their perspective as end-users. This approach 
moves the discussion on the future of health economic tools for public health decision-
making away from a purely academic conversation towards one embedded in practice. The 
engagement of public health decision-makers was beneficial to both the PHDMs themselves, 
via an introduction to health economic decision-aids, and to health economists who 
ultimately want to produce evidence that has practical value in addition to academic 
credibility.  
The workshop itself was successful in bringing together individuals from a range of public 
health decision-making roles who were representative of the majority of LAs in North-East 
England. The variety of responsibilities and localities strengthened the study as it allowed for 
rich and diverse discussions representing the needs of different decision-making levels and 
local priorities. However, despite the diverse range of attendees, the results are limited to a 
relatively small sample of decision-makers from one region in England. The attendees also 
self-selected to attend the workshop so may not fully represent all PHDMs with the results 
potentially biased towards individuals who have a predisposed interest in using economic 
evaluation. However, research examining similar questions has been recently published (57, 
58), which identify similar concerns with regards to the unsuitability of current economic 
evaluation evidence, and the way it is presented, for public health decision-making. 
Therefore, the findings from this empirical study appear to be suitably generalisable to other 
LAs in England.  
Each workshop group was facilitated by a health economist who was likely to have had some 
influence on the feedback given by the attendees. Facilitators were instructed to minimise 
their impact on group opinions and remove themselves from the discussions other than to 
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guide attendees towards the discussion points on the crib sheet. Nevertheless, their 
presence and explanation of concepts may have had unintended consequences in guiding 
the groups’ opinions. Additionally, the workshop groups were mixed in terms of seniority of 
individuals and more senior decision-makers may have “crowded out” the views of more 
junior members to some extent. 
The case study chosen for the evaluations could also be considered a limitation as it 
reported the outcomes of an RCT studying an intervention on a specific population (Year 10 
school students). As discussed in section 10.4.4, further research should be conducted using 
alternative case studies in order to examine whether the results from this workshop are 
transferable to other cases.  
The potential for bias from the order in which the four reports were presented may also 
pose a limitation on the results of the workshop discussions. In the context of surveys, order 
bias has been demonstrated to influence responses on occasion (383). This is typically a 
potential concern when researchers wish for each option to be evaluated independently 
(124). In the context of the current study, when discussing the merits of each evaluation, 
there was potential for workshop attendees’ views of the economic evaluation under review 
to be influenced by the evidence which had been discussed prior. Since the SROI report was 
presented last to each of the groups, the PHDMs had the opportunity to compare it against 
each of the other methods. Presenting the economic evaluations separately was deemed 
essential to minimise cognitive overload and to ensure equal discussion time was allocated 
to each method, however, this may have introduced unintended bias to the discussion. Prior 
to the full group discussion (see Figure 10.1), however, each group was instructed to 
reconsider each method before revealing their preferences. This was intended to minimise 
any bias from the order of reports by allowing each method to be considered relative to all 
others.  
Finally, the presentation of the reports produced for the workshop may have influenced the 
feedback for the methods from the attendees. The simplification of data for the non-
economist audience resulted in the portrayal of limited information, which could have 
contributed to confusion when interpreting the evaluations. Therefore, the reports 
themselves could be considered a limitation in this study. However, this study was a first 
attempt at understanding what, and how, to present economic evaluation information to 
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PHDMs. Therefore, identifying and capturing aspects of the evaluations which were not well 
comprehended is positive in terms of identifying areas for future improvement.  
 Summary 
The aim of this study was to explore PHDMs’ opinions about each of the economic 
evaluation reports in order to address the third overarching research question of the thesis 
which considers whether a particular method is most appropriate to aid public health 
decision-making. A general preferential consensus for SROI was identified; CCA was 
additionally reported as a beneficial supplement to any other evaluation. CBA and CCA were 
less favoured, largely due to their measures of outcome. WTP was not viewed as a reliable 
outcome measure, and the validity of the QALY was also questioned. Despite the preference 
for SROI, some concern still remained over its use and interpretation by PHDMs and certain 
attendees voiced the opinion that a “one-tool-fits-all” approach to economic evaluation is 
unlikely to be appropriate, given the range of expertise and interests of PHDMs. Therefore, a 
particularly beneficial method of economic evaluation could not be identified, however, CCA 
in combination with another evaluation did appear to be a favoured and potentially 
beneficial approach which would aid PHDMs’ decision-making needs. 
Regardless of method, however, the upshot of the feedback is that much greater effort is 
required to present economic evaluation data suitably for PHDMs as non-health economists. 
Further research is required in order to establish how best to translate economic evaluation 
evidence to its end users, the PHDMs. In order to provide appropriate information for 
PHDMs of differing roles and knowledge requirements, health economists may need to 
emphasise producing simplified, plain English reports of their findings alongside detailed 
reports which can provide transparency of methodological rigour. The inclusion of CCA more 
regularly alongside other economic evaluations may also contribute towards providing 
information with which varied stakeholders can engage. 
The workshop reported in this chapter concludes the empirical research for this doctoral 
thesis. The next and final chapter discusses the overall findings of this body of work. 
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 Discussion and conclusions 
This chapter discusses the findings of the thesis. The first section outlines the structure of 
the thesis and research questions addressed. Section 11.2 outlines the contributions made 
to the existing literature from this research study; each research question is addressed 
individually. Section 11.3 presents implications for practice while section 11.4 outlines the 
strengths and limitations of this body of work. Areas for further research are proposed in 
section 11.5 with the final section concluding the thesis.  
  Thesis aims and outline 
This thesis set out to identify the most beneficial health economic evaluation tool(s) to meet 
the decision-making needs of PHDMs. In order to achieve this aim, three key research 
questions were posed: 
1. With respect to current economic evaluation and priority-setting tools: 
a. What evidence is currently available and which methods are used by the 
health economic research community to evaluate public health interventions?  
b. Does the quality of evidence produced meet recommendations for health 
economic evaluations of public health interventions from the available 
guidance? 
2. With respect to the use of health economic evidence by PHDMs: 
a. To what extent is health economic evidence used by PHDMs to aid decision-
making? 
b. To what extent do PHDMs have sufficient knowledge of health economic tools 
to appropriately use the available evidence? 
c. What barriers do PHDMs perceive exist to the use of health economic 
evidence as it is currently produced? 
3. Is a particular method of economic evaluations, or combination of methods, most 
beneficial to PHDMs for their decision-making needs? 
The empirical studies reported in this thesis were designed to explore each of the above 
research questions. Prior to reporting the findings of the empirical studies, the theoretical 
underpinnings of the health economic techniques examined in the thesis were outlined 
(Chapter Two). The methodology relevant to each of the economic evaluation and priority-
setting methods initially considered for exploration in this doctoral study was then 
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presented (Chapter Three). A systematic review was conducted (Chapter Four) in order to 
address the first research question. The review provided baseline knowledge of the methods 
of economic evaluation that have been used. A qualitative exploration of PHDMs’ use and 
understanding of health economic tools was carried out (Chapter Five) in order to address 
research question two. Based on the findings of the qualitative exploration, and other 
research which was being undertaken around the same time focusing on priority-setting 
tools in public health settings (58), the remainder of this doctoral research was dedicated 
solely to economic evaluation methods.  
Four economic evaluation methods were chosen for further exploration (CUA, CCA, CBA, and 
SROI) based on the findings from the interviews with PHDMs. Due to a lack of published CBA 
and SROI studies, it was necessary to conduct two novel evaluations in order to provide the 
necessary exposure for an informed discussion on the merits of alternative methodologies 
with PHDMs. Chapters Six and Seven report the preparation, conduct and analysis of the CV 
survey employed to obtain an estimate of WTP for use in the CBA. The conduct of the novel 
CBA and SROI analyses was reported in Chapter Eight. Feedback on the alternative methods 
of economic evaluation was sought during a workshop with PHDMs. Chapter Nine reports on 
the preparation of evidence reports for the final empirical study of this thesis, the workshop 
with the PHDMs. The workshop and its findings, which addressed research question three, 
are discussed in Chapter Ten.  
Each of the economic evaluations presented at the workshop were based on the same public 
health case study to enable an unbiased comparison of the methods, with respect to the 
intervention under evaluation. The case study was a school-based ASBI programme for 
students in Year 10 (aged 14-15 years) (see Giles et al., 2019 (59) and Chapter Six for further 
details on the case study). Preventing misuse of alcohol is an important public health issue in 
England, particularly for young people (59). Alcohol misuse in young people is associated 
with health problems (60) and also broader social issues such as anti-social behaviour (61), 
reduced educational attainment (62), and risky sexual behaviour (62) to name but a few. A 
case study examining the impact of an intervention to reduce alcohol consumption in young 
people, therefore, provided an example of a complex public health issue. Consequently, this 
case study was relevant to exploring which method of economic evaluation is most 
appropriate for evaluating complex public health interventions.  
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 Contribution of the thesis to existing literature 
This thesis contributes to the existing literature on economic evaluation methods for 
evaluating public health interventions. The precise contribution of the research conducted to 
the knowledge base is explained below. Each research question, listed above, is discussed in 
turn. 
11.2.1 Research question one – What evidence of economic evaluation and priority-setting 
tools is currently available for public health interventions and does it meet 
methodological recommendations? 
Over the past 10 to 15 years, calls have been made for the expansion of the economic 
evaluation framework for public health appraisal. Commentators such as Kelly et al., 2005 
(47), Edwards et al., 2013 (17) and Weatherly et al., 2009 (48) have suggested that greater 
use of methods such as CBA and CCA could account for the broader impacts of public health 
programmes. NICE also updated their guidance for methods of public health appraisal to 
consider method such as CBA and CCA alongside their preferred method, CUA, in addition to 
recommending public health and societal perspectives for analysis (10).  
Additionally, economic evaluation methods outside of the standard health economist’s 
toolbox such as ROI and SROI, alongside prioritisation tools such as PBMA and MCDA, have 
become a focus of attention in the public health field, e.g. Banke-Thomas et al., 2015 (32), 
Edwards et al., 2014 (39) and Hunter et al., 2016 (54). Notably, in light of this focus, PHE 
recently developed a prioritisation framework based on MCDA techniques (265).  
However, the literature examining whether these advances in recommendations for a 
broader framework of evaluation and prioritisation had translated to updated research 
agendas remains sparse. Previous literature reviews that had examined economic 
evaluations of public health interventions either focussed on narrow evidence sources (e.g. 
Owen et al., 2012 (372) who looked only at NICE guidance) or were outdated (e.g. Weatherly 
et al., 2009 (48)).  
The systematic review reported in Chapter Four aimed to fill this gap in the knowledge base. 
The review findings identified that CUA remained the most prominent method of evaluating 
alcohol prevention interventions until March 2019. However, since 2014 a change was 
observed in the prominence of CUAs. The proportion of CUA studies declined and CBAs 
(although, the limitations of these are discussed in the next paragraph) were produced with 
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slightly greater regularity. The first MCDA and SROI studies in the alcohol prevention field 
were identified in 2018 and 2019, respectively. Nevertheless, it is too early to conclude 
whether these findings mark the beginning of a trend for greater heterogeneity in methods 
used to evaluate and prioritise public health interventions. A review update in the near 
future would be beneficial in order to draw conclusions on the development of economic 
evaluation methods for public health interventions.  
In answer to the second part of research question one, examining the methodological 
quality of economic evaluations, improvement was observed in some methodological areas 
as recommended by previous scholars (e.g. Weatherly et al., 2009 (48) and Edwards et al., 
2013 (17)). For example: the use of modelling alongside RCTs, incorporation of broader 
outcomes, the use of sector specific QALYs, and the consideration of equity implications in a 
small number of studies. However, these improvements were not consistently observed 
across all studies and areas for improvement remain, for example the non-existent use of 
WTP values in CBAs and lack of incorporation of intersectoral costs and consequences. None 
of the CBAs identified in the review used methods of monetising benefit that fit with the 
welfarist theoretical grounding of CBA discussed in Chapter Two (i.e. measuring benefit as 
WTP derived from either stated or revealed preferences). Rather, all CBAs identified 
monetised QALYs to obtain a monetary health benefit measure. Additionally, whilst CCAs 
offer potential to report costs and outcomes from different sectors without the challenge of 
appropriately aggregating them (114), only one study using such methodology in the 
examination of alcohol prevention interventions was identified between 2006 and 2019. 
The review reported in Chapter Four provides good evidence in answer to research question 
one, however, it is possible that some grey literature remained unidentified. Additionally, 
potentially relevant published literature in other areas that were not investigated in this 
review, such as transport economics or sexual health, may exist. Furthermore, alcohol 
prevention interventions are only one element of public health, therefore, it would be 
unwise to conclude the findings here definitively reflect the status of economic evaluations 
of public health in general. However, recent reviews of economic evaluations of physical 
activity interventions (384) and childhood and adolescent obesity interventions (385) 
reported similar findings to those reported in Chapter Four. Furthermore, Owen et al. 
recently updated their 2012 review (372) of NICE public health guidelines for the years 2011-
2016 (373) and again in 2019 where they combined updated information with their findings 
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from earlier reviews (21). In the updated reviews, Owen et al. explicitly examined methods 
of economic evaluation used in NICE guidelines in the review update. Whilst their review is 
limited only to guidelines produced by NICE, it covers a broad range of public health 
interventions and their results similarly identify a large majority of CUA and only a handful of 
either CBA, CCA, or CEA evaluations (21, 373). This is not altogether unsurprising given the 
historical emphasis on CUA in NICE public health appraisal methods guides (31, 386); 
however, the inclusion of alternative economic evaluation methods in the guidance 
demonstrates that the new NICE guidelines for public health appraisal, with respect to 
accepted evaluations, are being heeded (10) if only to a small extent currently. 
Consequently, there is reason to believe that the findings regarding alcohol prevention 
interventions are widespread amongst evaluations of all public health interventions.  
The findings from the systematic review reported in this thesis were published in 2017 (114). 
The impact of this research on the wider literature can be observed in the aforementioned 
review by Cochrane et al., 2019 (384), which cited the published findings. Cochrane et al. 
(384) report recommendations for future economic evaluations of physical activity 
interventions and cite recommendations reported in the published version of the review 
conducted for this doctoral research, such as greater use of CCA to report multi-sectoral 
outcomes and the reporting of information to allow for equity impact to be considered.  
11.2.2 Research question two – Examining use, knowledge, and barriers/enablers to use of 
health economic evidence by PHDMs 
The existing literature has identified a divide between the evidence produced by researchers 
and the information required for decision-making by PHDMs (246-250, 387). At the onset of 
the qualitative study reported in Chapter Five (October 2016), the existing literature focused 
on evidence in general and touched only minimally on health economic evidence, with the 
exception of research conducted in LA (or Welsh local health board) settings on the use of 
priority-setting tools (54, 388). There was a paucity, however, of literature examining the use 
of economic evaluation evidence in public health decision-making. The qualitative interview 
study thus aimed to address this gap in knowledge by exploring the use of health economics 
to aid public health decision-making and to consider the barriers and enablers to its use.   
This doctoral research has identified that health economic tools are not extensively used by 
PHDMs in LAs. Several reasons for this were inferred from the qualitative study’s findings 
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(Chapter Five). Firstly, the setting in which public health decisions are made within LAs is 
complex and decisions are based on a multitude of factors, with health economic evidence 
playing only a small part of the decision-making framework. Other scholars examining public 
health decision-making practices have recently reported similar findings (57, 379, 380). 
Secondly, limited availability and relevance of economic evaluation evidence was stated as a 
barrier to its use. Mirroring the findings of the systematic review (Chapter Four) a minority 
of interviewees reported that where evidence was available it typically consisted of CUAs 
looking at outcomes on a national scale. The available evidence was reported as generally 
insufficient for PHDMs’ purposes as neither local contexts were accounted for, nor were 
broader social impacts of public health programmes, which were noted to provide value 
within the context of a LA.  
The interview findings also identified varying degrees of knowledge of health economic tools 
amongst PHDMs of different roles. Overall, however, understanding of the majority of 
economic evaluation tools was limited. These findings were further validated during the 
workshop with PHDMs (Chapter Ten) which also identified gaps in PHDMs’ knowledge of 
economic evaluation. This resulted in issues when interpreting the evidence and also in 
trusting the methods (e.g. the WTP measure). Recently published research by Frew & 
Breheny (56) further serves to validate this point as their study similarly identified 
knowledge limitations around health economic terminology. Frew & Breheny’s (56) findings 
lend support for the argument that more extensive training in health economics for PHDMs 
may be necessitated to ensure economic evaluation evidence can be used effectively for 
decision-making in LAs.  
Nevertheless, the onus should not only be on PHDMs to become better acquainted with 
health economic tools. Health economists should also assume responsibility for ensuring 
that the presentation of information is appropriate for non-health economists. As discussed 
in Chapter Ten, the presentation of economic evaluation information in non-technical 
formats is essential to facilitate greater engagement with health economic evidence. The 
need to improve knowledge transfer from academia and other research institutions to public 
health policy-makers is a currently discussed issue (e.g. Hunter., 2019 (379), Wilson & 
Sheldon., 2019 (380), and McAteer et al., 2018 (381)) and is a foremost focus of research 
institutions such as Fuse (382). However, the findings from this thesis serve to demonstrate 
that health economics is not immune to issues with knowledge transfer and further research 
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should be conducted in order to bridge the gap between the production of evidence and its 
use in public health decision-making. 
In addition to the barriers to the use of economic evaluation already discussed, the 
qualitative study also identified areas in which health economic evidence was perceived by 
PHDMs to be lacking in relevant information. Areas such as the impact of interventions on 
inequalities and long-term outcomes were reported as important points for consideration. 
Considering the equity implications of public health programmes within economic 
evaluations has been an area of discussion in the existing literature (17, 48) and was also 
addressed in Chapter Four. Therefore, the qualitative study findings serve as further 
endorsement for consideration in this area. Whether it is appropriate and feasible to include 
such considerations within an economic evaluation framework (see Asaria et al., 2016 (27) 
and Cookson et al., 2017 (26) for recent research into how this might be possible), or 
whether prioritisation frameworks such as MCDA might better address these considerations 
via the inclusion of equity implications as a decision criterion, remains an area for further 
deliberation.  
Inroads to research examining the use of health economic tools in LAs have been made 
recently which complement the findings of this thesis with respect to the question of how 
health economic evidence is used by PHDMs. Firstly, a substantive research project 
examining the use of priority-setting tools was concluded (58) and a follow-on programme of 
research assessing the use and impact of the prioritisation framework developed by PHE was 
undertaken (266). The political environment in which public health decisions are currently 
made was reported in both studies (58, 266) as a barrier to the adoption of prioritisation 
tools; the same issue was reported by the interviewees in Chapter Five with regards to 
economic evaluation evidence. Additionally, the earlier cited study by Frew & Breheny (56) 
published findings which complement those reported in this thesis with respect to the 
context of current public health decision-making in England and Wales and barriers to the 
use of economic evaluation in such settings. Given the emerging research in this subject 
area, the findings reported in this thesis in answer to my second research question (section 
11.1) are demonstrably relevant and topical.    
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11.2.3 Research question three – Is a particular method most beneficial to PHDMs? 
Following the conduction of a CBA and SROI analysis (Chapter Eight) of the ASBI programme 
evaluated in the SIPS Jr HIGH trial (59) evidence reports for four methods of economic 
evaluation (CUA, CCA, CBA, and SROI) were presented to PHDMs in a workshop and the 
PHDMs’ views of the merits and demerits of each method with respect to their day-to-day 
decision-making were obtained. The workshop findings (Chapter Ten) were considered in 
order to answer the final thesis research question of whether a method of economic 
evaluation can be identified as most beneficial to meet PHDMs’ needs. 
The workshop findings were not sufficient to conclude that a single technique should be 
chosen as a primary method of evaluation for public health interventions. PHDMs in 
attendance at the workshop cautioned that a “one-tool-fits-all” approach was unlikely to be 
the best approach, as they considered the information from different methods to be 
relevant to different decision-makers. However, the suggestions from the existing guidance 
for public health appraisal (10, 17, 47) and the findings from systematic reviews exploring 
the same issue (48, 114, 384) were confirmed to some extent during the workshop. For 
example, PHDMs favoured CCA and perceived it to be welcomed in public health decision-
making in order to facilitate the consideration of outcomes relevant to different 
stakeholders. A caveat was placed on this stating that CCA would be beneficial but only as an 
adjunct to another method of evaluation. This reflects the disadvantage of CCA that it does 
not produce a final aggregated outcome (see Chapter Three). 
The workshop discussions (Chapter Ten) revealed that neither CBA nor CUA were generally 
favoured, although elements from each did provide value. The lack of favour towards CBA 
was based largely on mistrust of the WTP benefit measure, however, the use of monetised 
outcomes was viewed positively as being relatable to LA members. QALYs, on the other 
hand, were reported as less useful with attendees commenting that the measure is not used 
in LA decision-making. Notwithstanding this, the comparative ability of the ICER outcome 
was considered beneficial. An overall preference for SROI was revealed amongst the 
majority of the PHDMs. The fondness for SROI was attributed to both methodological and 
presentational features. Methodologically, workshop attendees expressed the merits of the 
monetary units of outcome and the inclusion of impacts relevant to various LA sectors in 
addition to health outcomes via monetised QALYs. From the perspective of the presentation, 
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the PHDMs liked the disaggregated approach to presenting each element of impact which 
allowed for a relative comparison of how each element contributed to the final SROI ratio.  
However, recommending SROI as the most beneficial method of economic evaluation based 
on the preference displayed at the workshop should come with a caution attached. First, a 
minority of the PHDMs expressed views that SROI would be more useful at a national level 
than at the local level. If this is a commonly shared viewpoint amongst PHDMs, 
recommending SROI as a primary method of economic evaluation would negate the 
objective of improving local public health decision-making. However, this consideration was 
not raised by the majority of the workshop attendees, hence further research would need to 
be conducted specifically examining SROI in LA decision-making contexts in order to 
determine its relevance to local decisions.  
Furthermore, some of the workshop attendees failed to fully understand parts of the SROI 
analysis report, for instance misunderstanding the role of “deadweight” (represented via the 
trial control group) and failing to interpret the 12-month time horizon of the study. Whilst 
some of these issues could be attributed to the approach taken to present the report at the 
workshop, it should not be dismissed that this is a relatively new method in the public health 
field to with which PHDMs are largely unfamiliar (a point reported by the workshop 
attendees). Other common misinterpretations of SROI evidence have been discussed, such 
as misinterpreting the SROI ratio as a direct cashable return rather than a combined return 
which includes both financial savings from reduced resource use and a monetary measure of 
valued impact (378). Therefore, if PHDMs observe value in the use of SROI analysis, 
formalised training on the method, its limitations, and how to critically appraise SROI 
analyses should to be provided to PHDMs.   
A very recently published Delphi study was conducted with local PHDMs to measure 
agreement on a number of economic evaluation methodological elements (57). This study 
was also unable to recommend a particular economic evaluation methodology that would be 
most appropriate to aid local public health decisions, due to large heterogeneity in 
responses to preferences for evaluation outcomes. However, several of the findings from 
the Delphi study validate the preferences expressed within the workshop conducted for this 
research. For example, Frew & Breheny (57) identified high levels of agreement on aspects 
such as ensuring evaluations are relevant to a local context, ensuring that costs and effects 
are transparently reported for different sectors and population subgroups, and preference 
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for a broad evaluative framework that captures both health and non-health costs and 
outcomes. 
In order to definitively answer research question three, further research needs to be 
conducted. As stated in Chapter Ten, the preference for SROI may be due to specific 
presentational choices made when preparing the evidence for the workshop (Chapter Nine). 
Therefore, using the feedback from the workshop attendees regarding their preferred mode 
of presentation, information should be reformatted, and feedback obtained to identify 
whether the mode of presentation or the information reported most influences preferences 
for specific methodologies.  
 Implications of thesis findings  
The research findings reported in this thesis have a number of implications for both health 
economists conducting evaluations of public health interventions and decision-makers as 
end users of the information.  
Whilst no distinct method of economic evaluation can be robustly recommended for the 
appraisal of public health interventions, this research has strengthened the argument for 
broader analyses than are currently used for the majority of evaluations (i.e. either CEA or 
CUA, see Hill et al., 2017 (114) and Cochrane et al., 2019 (384)). This validates 
recommendations that have been made in academic circles for over a decade. This thesis 
suggests that health economists should re-evaluate the status quo of conducting CUA when 
evaluating public health programmes and consider whether an alternative approach, such as 
CBA or SROI, may be relevant in that case. At a minimum, researchers should consider using 
broader analytic perspectives, such as a public health or societal perspective, and consider 
the scope of sensitivity analyses conducted to provide information relevant to different 
population subgroups and locally relevant data where possible. In doing so, health economic 
evidence can provide relevant information for the consideration of intervention impact on 
inequalities and whether a programme may be suited to the locality in which decision-
makers reside. 
Furthermore, health economists should strive to report CCAs as a secondary analysis in all 
evaluations in order to clearly provide relevant information for a range of stakeholders.  
An additional finding from the workshop study (Chapter Ten) was that improvement is 
required with respect to the presentation of health economic information. Whilst this issue 
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has been considered previously (389), limited research has been conducted in conjunction 
with decision-makers, particularly those in the public health field; the guidance identified by 
Sullivan et al., 2015 (389) was typically guiding the reporting of evaluations for HTA or 
pharmaceutical reimbursement.  
Heterogeneity in information requirements was observed during the workshop; some 
PHDMs desired greater detail whilst others sought greater simplification. Common amongst 
all attendees, however, was desire for transparency with regards to the data included in the 
analysis and reporting in plain English. Hence, health economists should consider how best 
to deliver the findings from their evaluations. Whilst publishing in academic journals may 
remain necessary for dissemination to peers, this is unlikely to be an appropriate form of 
dissemination for PHDMs. Frew & Breheny (57) similarly identified high levels of agreement 
from PHDMs regarding dissemination in the form of short briefings and local reports. 
Therefore, in addition to journal publication, the findings from this thesis recommend that 
health economists prepare additional reports for use in decision-making practice. 
Furthermore, greater attention should be paid to presentational styles tailored to different 
stakeholders.  
This thesis also provided insight into the level of knowledge that PHDMs hold around health 
economic concepts. In order for health economic evidence to be most beneficial to public 
health decision-making, PHDMs of all levels would benefit from more training opportunities 
in health economics alongside the efforts described earlier from health economists to 
improve the translation of information to end-users. Whilst some coverage of health 
economics is included in public health specialty registrar training, it may be insufficient for 
the day-to-day needs of decision-makers. Additionally, decision-makers in other roles, such 
as commissioners and practitioners, may not have had similar training opportunities. 
Therefore, the findings from this thesis suggest that education on how to interpret economic 
evaluation evidence and to understand the limitations of different approaches should be 
more widely provided, and taken up, by those in a public health decision-making capacity. 
 Strengths and limitations 
Directly involving PHDMs was a key strength in this research. This project was intended to 
have a positive impact on the practice of local public health decision-making; therefore, it 
was essential that the views of PHDMs were sought and included throughout. Although the 
concept of economic evaluation methodology is largely academic, the findings from this 
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research have enabled the concept to be placed in the context to which end-users would use 
the information. In doing so, the question of what the most beneficial economic evaluation 
method is to aid public health decision-making could be considered more appropriately, 
acknowledging that health economics is only one factor in public health decisions.  
Two unique economic evaluations were also conducted within this doctoral project, a CBA 
and an SROI. As was identified in the systematic review (Chapter Four), CBAs using benefits 
elicited via stated preference techniques are rare in the public health field. This thesis, thus, 
provides a novel evaluation in the domain of public health. In conducting the CBA 
evaluation, limited guidance was identified within the health and public health field on how 
to aggregate costs and outcomes on a national scale, therefore, direction was taken from 
the environmental health literature. The potential limitations of the approach taken were 
discussed in Chapter Eight. The lessons learned from conducting the CBA are important; 
firstly, to provide examples to future researchers, and secondly, to acknowledge that 
standardised guidance on conducting CBAs of public health interventions is required.   
SROI analyses of public health programmes are also infrequently published, therefore, the 
evaluation reported in this thesis offers a novel evaluation of a school based ASBI. Similar to 
the CBA, important lessons were learned during the course of the evaluation which may be 
beneficial for future researchers. Firstly, conducting an SROI using trial-based data is slightly 
unconventional; if future trial-based SROIs are to be conducted, appropriate stakeholder 
engagement should be planned from the beginning of the trial to ensure appropriate 
outcomes can be identified and relevant data collected. Secondly, standardised guidance for 
SROI is yet to be developed (33), therefore, this should be prioritised and should include 
guidance on conducting SROI in various contexts, including alongside trials.  
Finally, presenting evidence of economic evaluations, including those unfamiliar to PHDMs 
was novel. To my knowledge, no other studies have explored PHDMs’ views of different 
economic evaluation methods using this approach. Exposing PHDMs to evidence they may 
encounter if the information was made available to them, as opposed to discussing the 
methods in theory, adds strength to the findings of this research.  
There are also limitations to the research conducted in this thesis. Some of these related to 
each empirical study have been stated earlier in this chapter and within the empirical 
chapters individually (see Chapters Four, Five, Seven, Eight and Ten), nevertheless, there are 
also broader limitations to the overall doctoral research. Firstly, the case study chosen (i.e. 
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the SIPS Jr HIGH trial) could be viewed a limitation as a targeted prevention intervention 
evaluated within a trial. However, one of the complexities of public health programmes is 
their diversity, therefore, no single case study could cover all potential formats in which 
public health programmes may be realised. Additionally, the case study enabled lessons to 
be learned with regards to conducting SROI analyses and CBAs using trial data.  
Secondly, it was not possible to address all of the methodological challenges identified in 
Chapter Four using the data available, for example there was insufficient data on 
socioeconomic status of trial participants to provide subgroup analysis relevant to health 
inequalities. When planning future evaluations, the collection of relevant socioeconomic 
data should be proposed at the beginning of the study to ensure relevant subgroup analysis 
can be conducted. 
Finally, the choice of the stated preference technique used to obtain a measure of WTP 
could also be a limiting factor, particularly with hindsight from the reactions of the workshop 
attendees to the WTP measure. Whether an alternative method such as a DCE would have 
been perceived less controversially is unsure, however, the indirect mode of eliciting a WTP 
value may seem less “subjective” than the direct elicitation from a CV survey. Nevertheless, 
prior to the workshop, a CV study was chosen as it was considered less cognitively 
burdensome for respondents.  
 Future research  
Some areas for future research have been identified earlier in this chapter such as improving 
knowledge transfer between health economists and PHDMs (section 11.2.2) and further 
exploration of the benefit to local decision-making of SROI (section 11.2.3). Both of these 
aspects of future research call for PHDM stakeholder involvement, in which academics work 
with the end-users of economic evaluation evidence to further explore how health economic 
information can be best produced and used in public health decision-making practice.  
Additionally, in response to PHDMs initial reactions to WTP measures, research to examine 
whether CBA would be acceptable to PHDMs using any stated preference measure of benefit 
(e.g. elicited via either CV or DCE) would be beneficial. Furthermore, alternative methods of 
measuring benefit such as using monetised QALYs for different sectors (e.g. health and 
crime, as was conducted in some reports identified in Chapter Four (207, 208, 212-215)) 
could be explored. Although this would result in CBAs that do not follow the welfarist 
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grounding in which CBA emerged (see Chapter Two), this approach was identified in the 
systematic review (Chapter Four) as most commonly used for CBAs of public health 
interventions. Therefore, this could be considered if PHDMs perceive merit in the approach. 
An alternative approach for consideration may also be social CBA, which uses a non-
preference based approach to eliciting benefit measures by attaching a monetary value to 
individuals’ reported “life satisfaction” (390). Caution has been advised with this version of 
CBA, however, due to implausibly high valuations arising from the life-satisfaction approach 
(391). In order to consider social CBA an appropriate alternative to CBA as presented in this 
thesis, further work on the validity of life-satisfaction valuations should be conducted. 
Another area in which further methodological exploration would be beneficial lies with SROI 
and whether it could be, to any extent, standardised in order to improve comparability of 
the method. Some form of a “reference case” for outcomes recommended to be explored in 
SROI analyses of public health programmes could perhaps be introduced to make 
evaluations more comparable, however, this may contradict the underlying methodology of 
SROI.  
Furthermore, Chapter Seven outlined four areas of further research specific to the empirical 
work conducted for examining the WTP outcomes (section 7.4.6). Points for further 
exploration included: investigating the impact of alternative payment vehicles on WTP 
outcomes, examining the impact on the proportion of zero valuations of a different survey 
sample, using alternative methods to address protest responses, and re-analysing the WTP 
taking the assumption of interval, rather than continuous, data.  
Finally, a suggestion was made in section 11.3 that health economists should strive to 
produce CCAs as secondary analyses in order to provide relevant information to a range of 
stakeholders. Since this is not currently the norm (judging by the paucity of CCAs identified 
in the systematic review in Chapter Four), research into the feasibility and acceptability of 
this may be beneficial. It may be prudent to explore the attitudes of health economists who 
are accustomed to conducting CEAs or CUAs towards such a request. Barriers may exist for 
health economists habituated to producing CEAs and CUAs, who may be less familiar with 
capturing a broad range of costs and outcomes, which would be necessary for the 
production of secondary CCAs.  
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 Concluding remarks 
The findings reported in this thesis offer insight into areas worth pursuing further, such as 
the transfer of research from academia to end-users and addressing methodological aspects 
of evaluation that are challenging due to the complexities of public health programmes 
compared to other health technologies. Yet, more research is needed. Fortuitously, recent 
endeavours by PHE (265), academics (e.g. Brown et al., 2017 (58), Frew & Breheny., 2019 
(57), and Edwards & McIntosh., 2019 (55)), and those bridging the gap between academia 
and policy (e.g. Hunter., 2019 (379), Wilson & Sheldon., 2019 (380), Cheetham et al. (382) 
and McAteer et al., 2018 (381)) are bringing to the fore exploration into areas for further 
research identified in this thesis. This demonstrates research momentum in these fields and 
suggests that further investigation may be welcomed and encouraged.  
The complexity of decision-making in public health in England currently has been 
demonstrated in this thesis and addressing this will require more than a single doctoral 
research investigation. However, the findings reported in this dissertation can be used as 
stepping stones to reach the goal of improving the landscape of evidence-informed public 
health decision-making.  
The findings in this thesis indicate that there may not be a single method of economic 
evaluation that should be recommended for all public health programmes; however, a 
number of recommendations for the economic evaluations of public health interventions 
can be made based on this research. Firstly, evaluations should routinely incorporate a CCA  
as a secondary analysis, particularly in cases where the primary analysis is a CUA, which 
would enable the provision of relevant information to a variety of stakeholders involved in 
public health decision-making. Such a recommendation goes beyond that set forth by NICE 
in their recent guidance on public health appraisal (10) which states that secondary analyses, 
such as CCA, are accepted rather than necessarily expected. Secondly, health economists 
should strive to expand sensitivity analyses where practicable to provide information of an 
intervention’s impact on different population subgroups. Such an endeavour could improve 
the relevance of economic evaluation evidence to the current local contexts of public health 
decision-making. 
As has been highlighted during this research project, when addressing the complex system 
that is public health, a “one-tool-fits-all” approach is unlikely to be appropriate. However, it 
has also been identified that the status-quo of relying predominantly on CUA to evaluate 
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public health interventions may not be appropriate in many instances. PHDMs require 
evidence that resonates with, and appeals to, the multi-sectoral nature of LAs. However, the 
precise methodology to achieve this remains to be determined. The natural choice from a 
theoretical economic perspective would be CBA due to the method’s ability to incorporate 
all costs and outcomes on whomsoever they fall, however, in practice it was not necessarily 
favoured.  
Areas for further research that have been identified during the course of this doctoral 
project have been outlined. These include efforts to explore how best to present health 
economic evidence to be engaging to the variety of stakeholders involved in public health 
decision-making and to ensure guidance for methods such as SROI and CBA, which are 
infrequently used to evaluate public health programmes by the academic community 
currently, are standardised to improve the quality of evaluations. Misinterpreted or poor-
quality evidence may be worse than no evidence at all. Therefore, efforts to improve the 
interpretation of evidence by end-users (from both supply and demand side initiatives) and 
to ensure the production of high-quality, transparent, and trustworthy research is a key 
















Appendix A. Full search strategies for systematic review 
The search strategies used in each database search for the original systematic review 
(January 2006- May 2016) reported in Chapter Four are listed in Table A.1 - Table A.6 below. 
The databases searched were NHS EED, Medline, Embase, PsychINFO, CINAHL, and Scopus. 
Table A.1. Search terms for NHS EED database 
((Alcohol* or drink* or intoxica* or beer or wine) ) IN NHSEED 
MeSH DESCRIPTOR Drinking Behavior EXPLODE ALL TREES 
MeSH DESCRIPTOR Alcohol Drinking EXPLODE ALL TREES WITH QUALIFIER PC IN 
NHSEED 
MeSH DESCRIPTOR Alcoholic Beverages EXPLODE ALL TREES 
(Drink* behavio*) IN NHSEED 
("Alcohol* use disorder*") OR ("alcohol* abuse") OR ("alcohol* beverage*") IN 
NHSEED 
#1 OR #2 OR #3 OR #4 OR #5 OR #6 
(PBMA or "option appraisal" or "priority setting" or "return on investment" or 
ROI) IN NHSEED 
#7 AND #8 




Table A.2. Search strategy for Medline database  
Economics/ 
exp "costs and cost analysis"/ 
Economics, Dental/ 




(economic$ or cost or costs or costly or costing or price or prices or pricing or 
pharmacoeconomic$).ti,ab. 
(expenditure$ not energy).ti,ab. 
value for money.ti,ab. 
budget$.ti,ab. 
or/1-11 
((energy or oxygen) adj cost).ti,ab. 
(metabolic adj cost).ti,ab. 
((energy or oxygen) adj expenditure).ti,ab. 
or/13-15 





17 not 21 
exp animals/ not humans/ 
22 not 23 
bmj.jn. 
"cochrane database of systematic reviews".jn. 
health technology assessment winchester england.jn. 
or/25-27 
24 not 28 
Decision Making, Organizational/mt [Methods] 
exp Resource Allocation/mt [Methods] 
(MCDA or PBMA).ti,ab. 
"option appraisal".ti,ab. 
"multi$ criteria decision analys$".ti,ab. 
"program$ budget$ marginal analys$".ti,ab. 
(Priority?setting adj2 method$).ti,ab. 
"social return on investment".ti,ab. 
(SROI or ROI).ti,ab. 
"return on investment".ti,ab. 
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or/30-39 
29 or 40 
(intoxica$ or beer or wine).ti,ab. 
*drinking behavior/ 
Alcoholic Beverages/ 
*Binge Drinking/pc [Prevention & Control] 
Alcohol Drinking/pc [Prevention & Control] 
*Alcoholism/pc [Prevention & Control] 
("Drink$ behavio$" or "binge drink$").ti,ab. 
(Alcohol$ adj2 ("use disorder$" or abuse or beverage$ or addiction$ or 
consumption or drink$)).ti,ab. 
or/42-49 
41 and 50 
limit 51 to (english language and humans and yr="2015 -Current") 




Table A.3. Search strategy for Embase database 
Health Economics/ 
exp Economic Evaluation/ 
exp Healthcare Cost/ 
pharmacoeconomics/ 
1 or 2 or 3 or 4 
(econom$ or cost or costs or costly or costing or price or prices or pricing or 
pharmacoeconomic$).ti,ab. 
(expenditure$ not energy).ti,ab. 
(value adj2 money).ti,ab. 
budget$.ti,ab. 
6 or 7 or 8 or 9 




12 or 13 or 14 
11 not 15 
(metabolic adj cost).ti,ab. 
((energy or oxygen) adj cost).ti,ab. 
((energy or oxygen) adj expenditure).ti,ab. 
17 or 18 or 19 
16 not 20 
animal/ 
exp animal experiment/ 
nonhuman/ 
(rat or rats or mouse or mice or hamster or hamsters or animal or animals or 
dog or dogs or cat or cats or bovine or sheep).ti,ab,sh. 
22 or 23 or 24 or 25 
exp human/ 
human experiment/ 
27 or 28 
26 not (26 and 29) 
21 not 30 
0959-8146.is. 
(1469-493X or 1366-5278).is. 
1756-1833.en. 
32 or 33 or 34 
31 not 35 
conference abstract.pt. 






*"cost benefit analysis"/ 
("program$ budget$ marginal analys$" or PBMA).ti,ab. 
("multi?criteria decision analys$" or MCDA).ti,ab. 
"option appraisal".ti,ab. 
("social return on investment" or SROI or "return on investment" or 
ROI).ti,ab. 
("Priority-setting" adj2 method$).ti,ab. 
39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 
38 or 49 




*binge drinking/pc [Prevention] 
*drinking behavior/pc [Prevention] 
"alcohol use disorder"/pc [Prevention] 
("Drink$ behavio$" or "binge drink$").ti,ab. 
(Alcohol$ adj2 ("use disorder$" or abuse or beverage$ or addiction$ or 
consumption or drink$)).ti,ab. 
51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 
50 and 60 
limit 61 to (human and english language and yr="2015 -Current") 




Table A.4. Search strategy for PsychINFO database 
"Cost Containment"/ 
(economic adj2 evaluation$).ti,ab. 
(economic adj2 analy$).ti,ab. 
(economic adj2 (study or studies)).ti,ab. 
(cost adj2 evaluation$).ti,ab. 
(cost adj2 analy$).ti,ab. 
(cost adj2 (study or studies)).ti,ab. 
(cost adj2 effective$).ti,ab. 
(cost adj2 benefit$).ti,ab. 
(cost adj2 utili$).ti,ab. 
(cost adj2 minimi$).ti,ab. 
(cost adj2 consequence$).ti,ab. 
(cost adj2 comparison$).ti,ab. 
(cost adj2 identificat$).ti,ab. 
(pharmacoeconomic$ or pharmaco-economic$).ti,ab. 
or/1-16 
(task adj2 cost$).ti,ab,id. 
(switch$ adj2 cost$).ti,ab,id. 
(metabolic adj cost).ti,ab,id. 
((energy or oxygen) adj cost).ti,ab,id. 
((energy or oxygen) adj expenditure).ti,ab,id. 
or/18-22 
(animal or animals or rat or rats or mouse or mice or hamster or hamsters or 






(0003-4819 or 0003-9926 or 0959-8146 or 0098-7484 or 0140-6736 or 0028-
4793 or 1469-493X).is. 
17 not (23 or 28 or 29) 
("multi$ criteria decision analys$" or MCDA).ti,ab. 
("program$ budget$ marginal analys$" or PBMA).ti,ab. 
("Priority-setting" adj2 methods).ti,ab. 
"option appraisal".ti,ab. 






30 or 38 
alcohol abuse/ 
binge drinking/ 




(intoxica$ or beer or wine).ti,ab. 
("Drink$ behavio$" or "binge drink$").ti,ab. 
(Alcohol$ adj2 ("use disorder$" or abuse or beverage$ or addiction$ or 
consumption or drink$)).ti,ab. 
or/40-48 
39 and 49 
limit 50 to (human and english language and yr="2015 -Current") 




Table A.5. Search strategy for CINAHL database 
MH "Economics+" 
MH "Financial Management+" 
MH "Financial Support+" 
MH "Financing, Organized+" 
MH "Business+" 
S2 OR S3 or S4 OR S5 
S1 NOT S6 
MH "Health Resource Allocation" 
MH "Health Resource Utilization" 
S8 OR S9 
S7 OR S10 
TI (cost or costs or economic* or pharmacoeconomic* or price* or 
pricing*) OR AB (cost or costs or economic* or pharmacoeconomic* or 
price* or pricing*) 
S11 OR S12 
PT editorial  
PT letter  
PT commentary  
S14 or S15 or S16  
S13 NOT S17  
MH "Animal Studies"  
(ZT "doctoral dissertation") or (ZT "masters thesis") 
 S18 NOT (S19 OR S20) 
MH “decision making” 
MH “resource allocation” 
TI (“multi*criteria decision analys*” or MCDA) or AB (“multi*criteria 
decision analys*” or MCDA) 
TI (“program* budget* marginal analys*” or PBMA) or AB (“program* 
budget* marginal analys*” or PBMA) 
TI (“priority setting” N2 method*) or AB (“priority setting” N2 method*) 
TI (option appraisal) or AB (option appraisal) 
TI (“social return on investment” or “return on investment” or ROI) or AB 
(“Social return on investment” or “return on investment” or ROI) 
S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28  
S21 OR S29 
MH “alcohol abuse” 
MH “alcoholic beverages” 
MH “drinking behavior” 
MH “alcoholism” 
MH “binge drinking” 
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TI (“alcohol abuse” or “alcohol misuse” or “binge drink*”) or AB (“alcohol 
abuse” or “alcohol misuse” or “binge drink*”) 
TI (beer or wine or intoxica*) or AB (beer or wine or intoxica*) 
TI (drink* behavio*) or AB (drink* behavio*) 
TI Alcohol* N2 (“use disorder*” or beverage* or addiction* or 
consumption or drink*) or AB Alcohol* N2 (“use disorder*” or beverage* 
or addiction* or consumption or drink*) 
S31 OR S32 OR S33 OR S34 OR S35 OR S36 or S37 or S38 or S39 





Table A.6. Search strategy for Scopus 2006-2016 database search 
TITLE-ABS-KEY (“return on investment” or ROI)  
TITLE-ABS-KEY (“social return on investment” or SROI) 
TITLE-ABS-KEY (“multi*criteria decision analys*” or MCDA)  
TITLE-ABS-KEY (“option appraisal”) 
TITLE-ABS-KEY (“Program* budget* marginal analys*” or PBMA) 
TITLE-ABS-KEY ("priority setting" w/2 method*) 
TITLE-ABS-KEY (“resource allocate*”) 
TITLE-ABS-KEY (“multi*criteria decision aid”) 
#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 
TITLE-ABS-KEY (“alcohol abuse” or “alcohol misuse” or “binge drink*”) 
TITLE-ABS-KEY (drink* w/1 behavio*) 
TITLE-ABS-KEY (Alcohol* w/2 (“use disorder*” or abuse or beverage* or 
addiction* or consumption or drink*)) 
Or/10-12 




Appendix B. Quality assessment of studies for systematic review  
Quality assessment of each included study in the systematic review reported in Chapter Four 
was based on the CHEERS checklist (182). The completed quality assessment checklist for 
each study is reported below. Due to the number of included studies it was not possible to 
include them all in one table; therefore, quality assessment is split over two tables in 
alphabetical order of authors. Table B.1 covers authors from A-K and Table B.2 covers 
authors from L-Z. The SROI by Tanaree et al., 2019 (233) and the MCDA by Rogeberg et al., 
2018 (193) are included in the CHEERS checklist for completeness. However, the CHEERS 
checklist is not designed for SROI or MCDA evaluations, therefore, the fields may not be 
appropriate to consider the methodological quality of these evaluations. The checklist was 
particularly inapplicable to the MCDA study (60% of the fields were “not applicable”). 
Therefore, it was not considered appropriate to include the proportion score of eligible 
items calculated for the MCDA in the discussion of quality scores in Chapter Four (see 
section 4.4.3). 
 



























































































































































































































































1 Form of economic 
evaluation clearly 
reported 
                     




*  * N/A N/A  *   N/A * *  N/A  N/A N/A * *  * 
2 Target population 
and subgroups are 
reported 
                     
3 Setting of 
evaluation is 
reported 
                     
4 Study perspective 








                     
6 Time horizon for 
evaluation is 
reported 
                     
7 Discount rate is 



































































































































































































































































                     
9 Measurement of 
effectiveness 
described  
                     





N/A N/A N/A N/A N/A N/A N/A N/A  N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
11 Methods of 
estimating 
resource use are 
described 
                    N/A 
12 Methods of 
valuing resources 
in terms of unit 
costs are reported 
                     
13 Details of 






































































































































































































































































14 Description and 
justification of 
decision-analytic 
model (or other 
type of model) 
provided  
       N/A     N/A N/A  N/A N/A   N/A  
15 Assumptions 
related to model 
are described and 
explained  
       N/A     N/A N/A  N/A N/A   N/A  




                     
17 Values and ranges 
of each 
component of 
cost and outcome 
are reported 























































































































































































































































































                     
 Proportion score 
of eligible items 90% 90% 95% 80% 63% 90% 90% 89% 95% 60% 86% 95% 94% 76% 95% 69% 61% 86% 86% 89% 90% 
 = reported,  = not reported, N/A = not applicable 
*Where a CUA is described as a CEA it is considered correct since CUA is a specific type of CEA, however a higher-quality paper would be expected to explain the 
difference in economic evaluation type 
+Partly accurate due to costs included that are broader than would usually be included in a health sector perspective 































































































































































































































































1 Form of economic 
evaluation clearly 
reported 
           N/A          




*   N/A  §    * * N/A N/A  N/A   * N/A *  
2 Target population 
and subgroups are 
reported 
                     
3 Setting of 
evaluation is 
reported 
                     
4 Study perspective 








                     
6 Time horizon for 
evaluation is 
reported 
                     
7 Discount rate is 



































































































































































































































































                     
9 Measurement of 
effectiveness 
described  
           N/A          





N/A N/A N/A N/A N/A N/A N/A N/A N/A  N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A  
11 Methods of 
estimating 
resource use are 
described 
           N/A       N/A   
12 Methods of 
valuing resources 
in terms of unit 
costs are reported 
           N/A          
13 Details of 





































































































































































































































































14 Description and 
justification of 
decision-analytic 
model (or other 
type of model) 
provided  
 N/A N/A              N/A   N/A  
15 Assumptions 
related to model 
are described and 
explained  
 N/A N/A         N/A     N/A   N/A  




           N/A          
17 Values and ranges 
of each 
component of 
cost and outcome 
are reported 





















































































































































































































































































                     
 Proportion score 
of eligible items 71% 57% 67% 68% 80% 81% 71% 89% 90% 91% 95% 44% 58% 76% 89% 90% 89% 90% 79% 94% 95% 
 = reported,  = not reported, N/A = not applicable 
*Where a CUA is described as a CEA it is considered correct since CUA is a specific type of CEA, however a higher-quality paper would be expected to explain the 
difference in economic evaluation type 
§No details are provided on how quality of life was monetised to ascertain the accuracy of the CBA categorisation 
γProductivity costs have not been included in a stated societal perspective. Debate remains over whether these costs should be included 




Appendix C. Data extraction form for systematic review  
Data were extracted for each included study into a pre-designed data extraction form. Table 
C.1 displays the data extraction form template for the initial review conducted in May 2016. 




Table C.1. Data extraction form template for original review (May 2016) 
General Data 
Title Author Publication year Publication type Country of study Source of funding Journal 
       
Study Characteristics 
Intervention Comparator(s) Population Setting Sample size Type of study Follow up length Time horizon Perspective (stated) 
         
Outcomes Data 
Primary outcome Secondary outcome Tertiary outcome Cost-effectiveness estimate  Outcome valuation 
     
Methodological considerations 
Extrapolation Type of economic evaluation stated (actual) Method of priority-setting Justification of EE methods Equity considerations 
     
Reported limitations of method Discounting Reported strengths of method Reported implications for decision-making Details on how to use results from evaluation 
     
Costs by sector 
Healthcare Education Criminal Justice Law enforcement Environment Employment Social care Voluntary Private Out of pocket Government Other 
            
Productivity 





Table C.2. Data extraction form template for review update (March 2019) 
General Data 
Title Author Publication year Publication type Country of study Source of funding Journal 
       
Study Characteristics 
Intervention Comparator(s) Population Setting Sample size Type of study Follow up length Time horizon Perspective (stated) 
         
Outcomes Data 
Primary outcome Secondary outcome Outcome valuation 
   
Methodological considerations 
Extrapolation Type of economic evaluation stated (actual) Method of priority-setting Discounting Equity considerations 
     
Costs by sector 
Healthcare Education Criminal Justice Law enforcement Environment Employment Social care Voluntary Private Out of pocket Government Other 
            
Productivity 





Appendix D. SRQR checklist for qualitative interview study  
The twenty-one item SRQR checklist below was completed for the qualitative study exploring 
PHDMs’ understanding and use of health economic tools reported in Chapter Five. The checklist 
described the standards for reporting qualitative research (252). 
Table D.1. Complete SRQR checklist for qualitative study 
Topic No. Item Evidence 
Title/Abstract    
Title 1 Concise description of the nature and topic of the 
study. Identifying the study as qualitative or 
indicating the approach or data collection 
methods is recommended 
Not applicable 
for a thesis 
chapter 
Abstract 2 Summary of key elements of the study using the 
abstract format of the intended publication; 
typically includes background, purpose, methods, 
results, and conclusions 
Not applicable 
for a thesis 
chapter 
Introduction    
Problem formulation 3 Description and significance of the 
problem/phenomenon studied; review of 
relevant theory and empirical work; problem 
statement 
Section 5.1 
Purpose of research 
question 
4 Purpose of the study and specific objectives or 
questions 
Section 5.2 




5 Qualitative approach (e.g., ethnography, 
grounded theory, case study, phenomenology, 
narrative research) and guiding theory if 






6 Researchers’ characteristics that may influence 
the research, including personal attributes, 
qualifications/experience, relationship with 
participants, assumptions, and/or 
presuppositions. 
Section 5.5.3 
Context 7 Setting/site and salient contextual factors; 
rationale 
Section 5.3 
Sampling strategy 8 How and why research participants, documents, 
or events were selected; criteria for deciding 




    
Table D.1 cont. Complete SRQR checklist for qualitative study 
Topic No. Item Evidence 
Ethical issues 
pertaining to human 
subjects 
9 Documentation of approval by an appropriate 
ethics review board and participant consent, or 




10 Types of data collected; details of data collection 
procedures including start and stop dates of data 
collection and analysis, iterative process and 
modification of procedures in response to 





11 Description of instruments and devices used for 
data collection; if/how the instrument(s) changed 
over the course of the study 
Section 5.3.2 
Units of study 12 Number and relevant characteristics of 




Data processing 13 Methods for processing data prior to and during 
analysis, including transcription, data entry, data 
management and security, verification of data 
integrity, data coding, and anonymization/de-
identification of excerpts 
Section 5.3.2 
Data analysis 14 Process by which inferences, themes, etc., were 
identified and developed, including the 





15 Techniques to enhance trustworthiness and 
credibility of data analysis (e.g., member 
checking, audit trail, triangulation) 
Sections 5.3.3 
and 5.4 
Results/Findings    
Synthesis and 
interpretation 
16 Main findings (e.g., interpretations, inferences, 
and themes); might include development of a 
theory of model. 
 Section 5.4 
Links to empirical data 17 Evidence (e.g., quotes, field notes, text excerpts, 
photographs) to substantiate analytic findings 
 sections 5.4.1 
– 5.4.5 
Discussion    
Integration with prior 
work, implications, 
transferability, and 
contributions to the 
field  
18 Short summary of main findings; explanation of 
how findings and conclusions connect to support, 
elaborate on, or challenge conclusions of earlier 
scholarship 
 Section 5.5 
  
278 
Table D.1 cont. Complete SRQR checklist for qualitative study 
Topic No. Item Evidence 
Limitations 19 Trustworthiness and limitations of findings  Section 5.5.4 
Other    
Conflicts of interest 20 Potential sources of influence or perceived 
influence on study conduct and conclusions 
Not applicable 
for a thesis 
chapter 
Funding 21 Sources of funding and other support; role of 
funders in data collection, interpretation, and 
reporting 
Not applicable 
for a thesis 
chapter 




Appendix E. Qualitative study information sheet 
During the recruitment phase of the qualitative study reported in Chapter Five an 
information sheet (displayed below) was sent to potential interviewees. The information 




Appendix F. Interview schedule and topic guide 
A topic guide was developed to guide the semi-structured interviews with PHDMs during the 
qualitative study reported in Chapter Five. The topic guide was nested within an interview 
schedule which began with an introductory statement to introduce myself and to reiterate 
the purpose of the interview and was concluded with closing remarks to thank the 
participant for their time. The topic guide questions for topics 1 – 6 could be asked in any 
order. The full interview schedule is presented below. 
I. Introduction to interview 
• Introduce myself and the project and reiterate the purpose of interview 
• Thank interviewee for offering to participate 
• Confirm that interviewee has read the information sheet and ask if he/she has any 
questions about the interview before commencing 
• Talk through consent form (explain anonymity, confidentiality, audio recording etc) and 
ask participant if they are happy to continue. If they are happy ask interviewee to sign 
consent form. 
• Inform interviewee that I am going to turn on the audio recorder (turn on recorder) 
 
II. Preliminary questions 
1) “Could you tell me briefly about your current role and responsibilities?” 
 
III. Topic guide questions to address objectives 
 
Topic 1: Role in decision-making  
1) “Do you consider yourself part of the process that makes decisions on which 
interventions or services should be funded with the public health budget? And if so in 
what capacity?” 
2) “Who is/else is involved in that process and in what capacity?” 
Probing points:  
• Who is key to the process? 
• Who makes ultimate decision? 
• What is the political involvement now that public health is in the remit of LAs? 
281 
• Is PHE involved? How? 
3) “How has the integration of public health responsibilities into local government 
impacted your role?” 
 
Topic 2: Decision-making process 
1) “Since funding is limited for public health, how are the choices made over what 
should be funded?” 
Probing points:  
• What basis is an individual intervention/policy/service chosen on? 
• What type of evidence is used to justify those decisions? 
 
Topic 3: Understanding of health economic evidence 
1) “If I were to ask you about ‘economic evidence’ what does that mean to you?” 
2) “Do you consider this sort of information to help inform decisions on investing in 
specific interventions/programmes?” 
3)  “Are you familiar with the terms on the sheet, and if so to what extent?” (Refer to 
glossary document) 
 
Topic 4: Use and opinions of health economic tools 
1) “Do you regularly use any of the tools described to aid in the decision-making process 
we have spoken about so far today?” 
2) “What is your opinion of the economic evaluation tools that you have used in terms of 
how user friendly they are and how well received the information they provide is?” 
3) “From the descriptions on the sheet of the other tools, what would your opinion be of 
those?” (offer time to re-read descriptions carefully) 
 
Topic 5: Barriers to use of health economic tools 
If limited or no use of health economic tools discussed explore barriers: 
1) “What barriers do you perceive to the use of the tools?” 
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Probing points: 
• Is the information they provide not useful or required? 
• Is the information or the tools themselves too technical to understand or use? 
• Is there a lack of available evidence? 
 
Topic 6: Information required to inform decisions 
1) “What kind of information is important for making an argument to invest in a public 
health programme?” 
2) “In terms of expected outcomes or returns, what is important to demonstrate?” 
3) “Do local authority priorities besides health have to be addressed to make the case 
for investment in public health programmes or are predicted health gains sufficient?” 
Probing point: 
• Does the impact on wider outcomes need to be considered to make a case for 
investment? 
 
IV. Closing remarks 
• Ask interviewee if they have anything else they would like to discuss 
• Let interviewee know they can contact me after the interview if they think of anything 
after the interview that they would like to share (provide e-mail details) 
• Ask interviewee if they would be willing to be part of any further related work 
• Ask about further contacts for interviewing – any colleagues they could suggest?  
• Thank again for their time 






Appendix G. Glossary document given to interviewees  
A glossary of health economic tools (including economic evaluation and priority-setting 
tools) was given to interviewees to aid discussions about each of the health economic tools 
during the interview study. The glossary is presented below. 
 
Below are descriptions of some key methods of economic evaluation and priority-setting. To 
aid discussion during the interview could you please read through them. You may be familiar 
with some of the terms; if so please think about how the descriptions compare to your 
current understanding of the terms.  
Economic evaluation terms 
Cost-analysis 
Cost-analysis is a partial economic evaluation which calculates and compares alternative the 
costs of alternative interventions by analysing only their costs. This analysis method does not 
consider outcomes therefore cannot be classed as a full economic evaluation, but rather a 
partial economic evaluation. This method is usually used in cases where the outcomes of 
interventions are unknown.  
Cost-minimisation analysis (CMA) 
In cases where outcomes of alternative programmes are known to be identical their costs 
alone can be calculated and compared to identify the lowest cost intervention and 
incidentally the one which provides the greatest value.   
Cost-effectiveness analysis (CEA) 
A method of evaluation that compares the costs and consequences (outcomes/benefits) of 
two or more interventions. Strictly, CEA measures outcomes in natural units such as the 
number of drinks consumed or the number of alcohol-free days but it is commonly used to 
refer to any form of economic evaluation.  In a CEA the costs and consequences of each 
intervention should be compared with each other incrementally (i.e. in ascending order 
according to cost). The incremental difference in costs and outcomes between each 
intervention is calculated to produce an incremental cost-effectiveness ratio (ICER). The 
results of different CEAs are comparable only if the same outcome measures are used in 
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each analysis, the method of measuring outcomes is the same and they all include at least 
one common comparison.  
Cost-utility analysis (CUA) 
A specific form of CEA where outcomes are measured in quality-adjusted life years (QALYs) 
which are a measure of health-related quality of life. CUAs have the advantage of being 
more readily comparable to other CUAs comparing very different interventions, However, 
QALYs are limited to measuring health-related quality of life and may not capture wider, 
social outcomes of an intervention. 
Cost-consequence analysis (CCA) 
CCA is a method of setting out all the relevant costs and outcomes of an intervention in a 
“balance sheet” format. It is commonly used in economic evaluations alongside another say 
a CUA or CEA as it can clearly present a wide scope of outcomes (health and non-health) 
alongside the costs that may be of interest to decision-makers. CCA alone, however is 
potentially less useful for making decisions as it does not aggregate the costs and outcomes 
to produce a value for the intervention. 
Cost-benefit analysis (CBA) 
CBA values the costs and consequences using a common unit, most commonly money. All 
relevant outcomes of an intervention (health and non-health) are given a monetary value 
and compared to the relevant costs of intervention. Results can be presented as a ratio of 
costs to benefits or as a “net benefit” where costs are subtracted from the value of the 
outcomes; a positive net benefit would indicate that the returns from the intervention are 
greater than its costs and therefore could be considered a good value investment. CBA can 
be used to compare the value of alternative interventions, including those in different 
sectors for example minimum pricing for alcohol compared to improved transport links, due 
to the use of a common metric (money). However, it can often be difficult to attach 
monetary values to all relevant outcomes. Most studies in healthcare that describe 
themselves as a CBA are actually just cost-analyses as they fail to measure or value benefits 
but focus on costs and savings in resources. 
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Social Return on Investment (SROI) 
SROI can be described as an extension of CBA that also includes socio-economic and 
environmental outcomes. Similar to CBA, it provides a ratio of benefits to costs. However, 
this ratio is unique to the intervention being evaluated and is not typically compared with 
SROI ratios for any other intervention. SROI analyses focus on the outcomes and costs of the 
intervention under evaluation, therefore, incremental comparisons with alternative 
interventions are not commonly analysed. 
Priority setting terms 
Programme Budgeting Marginal Analysis (PBMA) 
PBMA is a prioritisation tool that helps decision-makers maximally allocate scarce resources 
in order to meet the needs of a local population or any other specified objective. Programme 
budgeting involves analysing the current expenditure and activity of a set of chosen 
programmes to identify the existing use of resources in the area being examined. Marginal 
analysis investigates the added benefits and costs (or lost benefits and savings) from 
investment, disinvestment or service redesign of the listed programmes. The combination of 
action options are weighed against a set of criteria by a group of stakeholders who 
ultimately decide on a strategy of reallocation of resources within the set of programmes. 
This tool would not be considered a substitute to economic evaluation but rather 
complements it by providing a framework for decision makers to appraise the information 
on the effectiveness, cost-effectiveness and other factors of several programmes. PBMA can 
be used to decide which of a number of competing programmes should be implemented in 
order to represent the optimal allocation of resources.  
Multi-Criteria Decision Analysis (MCDA) 
MCDA is a method of combining both health economic and non-health economic outcomes 
of a programme. Similar to PBMA, it is a prioritisation tool that utilises existing evidence on 
cost-effectiveness alongside other factors important to decision-makers such as budget 





Appendix H. Qualitative study consent form  
Prior to each interview, written consent for participation was obtained from each 
interviewee. Each interviewee was given a unique study identification number which would 
be used to refer to interviewees anonymously for the remainder of the study. A copy of the 




Appendix I. The contingent valuation survey 
The full text of the CV survey is presented below. The survey was administered online with 
each section of the survey displayed in order. The format of the survey displayed below is 
taken from the template provided to the market research company, ResearchNow, who 
were responsible for programming and hosting the survey.  
Introduction 
You are being invited to participate in a research study to find out your views on an 
intervention (i.e. a service) to help young people in the UK who have risky drinking 
behaviour. This study is being done by researchers from Newcastle University. 
This survey will take you approximately 15 minutes to complete.  
Your participation in this study is entirely voluntary and you can stop the survey at any time, 
however please be advised that any data you have given up to that point will be kept. The 
survey is anonymous and we will not ask any personal information that could tell us who you 
are. 
We believe there are no known risks associated with this research study. This study was 
approved by Newcastle University's Research Ethics Committee.  
There are no right or wrong answers, we are just interested in what you think.  
Background Information 
What is the problem? 
In the UK, it is suggested that young people under the age of 18 should not drink alcohol. 
Research has shown links between young people drinking alcohol and a number of health 
and social problems. Health problems in young people linked to alcohol use include: liver 
damage, alcohol poisoning, harm the development of the brain, mental health issues and 
trouble sleeping. Social problems in young people linked to alcohol use include: increased 
risk of accidents and injury, risky sexual behaviour, increased risk of suicide, criminal 
behaviour and poor performance at school. 
Questionnaires about how much and how often young people drink can be used to see if 
someone drinks an amount of alcohol that is considered harmful. This can be called “risky 
drinking behaviour”. For example, a young person who drinks 3 units of alcohol (i.e. 3 
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shots of vodka or 1 pint of cider) 4 or more times in six months would be considered to 
have “risky drinking behaviour”. Research has shown that approximately 25% (¼) of ‘Year 
10’ students (14-15 years old) in England have been identified as having risky drinking 
behaviour. 
 
Why is this survey being carried out? 
There are a number of ways that young people can be helped to reduce risky drinking 
behaviour. We are interested in your views about how we might help young people with 
this. Most of the time, Public Health help to provide services to young people to reduce 
their risky drinking. Public health services are generally paid for by taxation. The views of 
the public are important to us because the public funds public health services through the 
taxes that we all pay. 
In this study, the researchers are looking at one way of measuring how important the 
public think a service is for helping young people who have risky drinking behaviour. The 
researchers also want to find out how valuable the service is to the public. 
We want you to think about how much you would be willing to pay for Public Health to 
provide a described intervention. The amount you are willing to pay tells us how 
important the intervention is to you. The information will only be used for research 
purposes by researchers at Newcastle University. You will not be asked to pay anything at 
the end of the survey and your answers will not be used to add or increase taxes.  
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Before we ask you questions about the alcohol intervention, we will take you through a 
practice question. 
Practice Question 
Imagine you are on holiday abroad in quite a remote place and you get an eye infection 
which is very itchy and uncomfortable – it feels like there is grit in your eye all the time. If 
you don’t take any medication for it, suppose it will last for 3 days. However, someone can 
arrange to have medicine delivered to you that will cure your eye infection within 24 hours, 
saving you 2 of the 3 days of discomfort from the eye infection. Think about what would be 
the MAXIMUM you would be willing to pay as a one-off payment to get the medicine 
delivered.  
Would you be willing to pay something to get this medicine delivered which will reduce your 
eye infection from 3 days to 1 day? Remember the money you spend on medicine cannot be 
spent on other things during your holiday.  
[If “yes” to payment selected] 
You have said you would be willing to pay as a one-off payment for medication for your eye 
infection.  
What is the maximum you would be willing to pay? In order to help you decide you will be 
shown different amounts of money. For each amount please decide if you “definitely 
WOULD pay”, “definitely WOULD NOT pay” and “would MAYBE pay”. 
[Payment values offered in random order] 
£1, £5, £10, £20, £30, £50, £100 
From the list of amounts, you said the highest amount you “definitely WOULD pay” as a one-
off payment is [XX] and the lowest amount you “definitely WOULD NOT pay” as a one-off 
payment is [XX].  
What is the MAXIMUM value you would be willing to pay as a one-off payment for the 
medicine? It could be one of these amounts or something in between. 
Maximum willingness to pay: £______ 
290 
[If “No” to payment selected] 
You have said that you are not willing to pay anything for the medicine to reduce your eye 
infection from 3 days to 1 day. 
Please select from the options below WHY you are not willing to pay: 
• The infection only lasts for 3 days so it is not worth paying for the treatment 
• The symptoms of the infection are not too bad, I could live with it  
• I cannot afford to spend money on medicine 
• I don’t think I should have to pay for healthcare  
Other (please state) ____________________________________________ 
You have completed the practice question. We will now move on to the main survey 
questions.  
Instructions 
We will now ask you some questions about an alcohol intervention to help young people 
who have risky drinking behaviour. You will be shown information about the intervention. 
After that you will be asked questions about 3 different scenarios to do with the 
intervention. Each scenario is separate to the others so please treat each scenario separately 
when you answer the questions. 
The Intervention 
A brief alcohol intervention is carried out in a school setting with ‘Year 10’ students aged 14-
15. The intervention involves an alcohol screening questionnaire and a 30-minute 
personalised interactive worksheet-based session for students who are identified as having 
a risky drinking behaviour. The session contains structured and detailed feedback about the 
student’s drinking behaviour and advice about the health and social consequences of 
continued risky alcohol consumption, such as: weight gain, accidents, violence and impact 
on relationships. 
[Scenario description displayed – see Chapter Six for the scenarios] 
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Payment 
Thinking about the intervention and outcomes that have just been shown to you, would you 
be willing to pay anything for the brief alcohol intervention to be provided to ‘Year 10’ 
students in schools in the UK? A payment would be made in the form of extra monthly 
taxation for one year which would be used to directly fund the intervention.  
[If “Yes” to payment selected] 
You said you would be willing to pay something through extra taxation that would be used 
to directly fund the intervention.  
What is the maximum amount that you would be willing to pay every month for the next 
year? In order to help you decide you will be shown different amounts of money. For each 
amount please decide if you “definitely WOULD pay”, “definitely WOULD NOT pay” and 
“would MAYBE pay”. 
When you are thinking about this, please think about what you would be prepared to pay, 
given your actual income and savings. 
[Random card sort exercise begins – Payment values presented] 
£0.50 per month (equivalent to £6 over one year) 
£1 per month (equivalent to £12 over one year) 
£1.50 per month (equivalent to £18 over one year) 
£2 per month (equivalent to £24 over one year) 
£3.50 per month (equivalent to £42 over one year) 
£5 per month (equivalent to £60 over one year) 
£7.50 per month (equivalent to £90 over one year) 
£10 per month (equivalent to £120 over one year) 
£12.50 per month (equivalent to £150 over one year) 
£15 per month (equivalent to £180 over one year) 
£25 per month (equivalent to £300 over one year) 
£50 per month (equivalent to £600 over one year) 
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From the list of amounts, you said the highest amount you “definitely WOULD pay” as a one-
off payment is [XX] and the lowest amount you “definitely WOULD NOT pay” as a one-off 
payment is [XX].  
What is the MAXIMUM value you would be willing to pay as a one-off payment for the 
intervention? It could be one of these amounts or something in between. 
Maximum willingness to pay: £______ per month  
[If “No” to payment selected] 
You have said that you are not willing to pay anything as a one-off payment to directly fund 
the brief alcohol intervention. 
Please select from the options below WHY you are not willing to pay: 
• Other interventions are more valuable  
• I am not concerned about the issue of risky drinking in young people  
• I think the intervention is valuable but I cannot afford it 
• Parents/guardians of ‘Year 10’ students should pay for it 
• Other (please state) _____________________________________________  
[Following completion of payment task] 
Please state below why you have said that you are willing to pay/not willing to pay for the 
brief alcohol intervention with outcomes described in this scenario.  
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 Alternative wording of open-ended WTP questions 
The wording displayed to respondents differed depending on the placement of payment 
values into the “definitely WOULD pay”, “definitely WOULD NOT pay” and “would MAYBE 
pay” boxes during the random card sort. The text displayed to respondents who did not 
place values in all three boxes is displayed below. 
 
[If no value is placed in the “definitely WOULD NOT pay” box] 
From the list of amounts, you said the highest amount you “definitely WOULD pay” per 
month is [XX].  
What is the MAXIMUM amount you would be willing to pay as extra monthly taxation for 
the intervention? It could be this amount or something higher than this. 
Maximum willingness to pay: £______ per month  
 
[If no value is placed in the “definitely WOULD pay” box] 
From the list of amounts, you said the highest amount you “maybe WOULD pay” per month 
is [XX] and the lowest amount you “definitely WOULD NOT pay” per month is [XX].  
What is the MAXIMUM value you would be willing to pay as extra monthly taxation for the 
intervention? It could be one of these amounts or something in between. 




 Demographic questions asked at the beginning of the survey 
Prior to the survey taking place, demographic questions were asked of respondents to i) 
ensure eligibility for the survey and ensure a representative sample of the UK population 
was obtained, and ii) to provide respondent characteristics for the examination of WTP 
predictors during the analysis of the CV survey data (Chapter Seven). The demographic 
questions and multiple choice responses are presented below. 
Which of the following describes how you think of yourself? 
• Male 
• Female 
• Prefer not to say 
 
How old are you? 








Which region do you live in? 
• East Anglia 
• East Midlands 
• London 
• North East 
• North West 
• Scotland 
• South East 
• South West 
• Wales 
• West Midlands 
• Yorkshire & Humberside 
• Northern Ireland  
• I do not live in the UK 
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What is your marital status? 
• Married/Cohabitating   
• Single 
• Divorced/Widowed 
• Prefer not to say 
 
Which of the following best describes your employment status? (tick one box) 
• Employed Full-Time 
• Employed Part-Time 
• Self-Employed  
• Unemployed 
• Retired  
• Full-time student 
• Part-time student 
• Other (please specify):  ___________________   
 
What is your occupation? (please specify): 
____________________________________________________ 
 
What is your highest educational qualification? 
• Degree or equivalent / NVQ level 4 or 5 (or a higher level qualification)  
• Higher education below a degree   
• GCE A-Level or AS-Level / NVQ level 3  
• GCSE grade A*-C / GCE O-Level / NVQ level 2  
• GCSE grade D-G / CSE / NVQ level 1  
• Foreign qualifications / other (please specify): 
____________________________________________________ 
• No formal qualifications  
 
Which of the following bands does your annual household income from all sources, before 
tax, fit into?  
• Less than £11,850  
• £11,850 - £19,999 
• £20,000 - £29,999 
• £30,000 - £39,999 
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• £40,000 - £49,999 
• £50,000 - £69,999 
• £70,000 - £100,000 
• Above £100,000 
• Prefer not to say 
• Unknown 
 




How often do you drink alcohol? 
• Never 
• Less than once a month 
• 1-2 times a month 
• 1-2 times a week 
• 3-5 times a week 
• Every day 





Appendix J. Histograms of WTP data 
The choice of model used for the regression analysis of the WTP data reported in Chapter 
Seven was based largely on the distribution of the WTP data. The histograms of the WTP 
data for each of the CV study scenarios are displayed below. The histograms evidence the 
skewed distribution of the data, with a spike at £0, which influenced the choice to use a two-
part model for the base-case analysis in Chapter Seven. 




Figure J.2 Histogram of WTP values (in £) for Scenario 2 
 
 




Appendix K. Regression outputs for sensitivity analyses of WTP predictors  
Sensitivity analysis was conducted on the regression analysis using two alternative 
estimators, which are commonly used for the analysis of WTP data. The output from a Tobit 
(Table K.1) and log OLS (Table K.2) regression, respectively, with the value of WTP (in £) as 
the dependent variable are displayed below. The results for all three scenarios are displayed. 
Statistically significant predictors of the value of WTP are highlighted in bold text. Asterisks 
denote the level of statistical significance.   
300 
Table K.1. Tobit model results - dependent variable WTP, £ 
 









      
No formal 
qualifications 







Higher education  








      
Non-English UK 
nations 








      
Under 35 
















      
Male 








      
Less than £20,000 
















      
Parent 








      
Married/cohabiting 








      
No alcohol 















Observations 414 422 426 
A Base factors excluded from regression: (education) school level qualifications, (location) England, 
(age) 35-65, (gender) female, (income) £20,000-£40,000, (parent/guardian) non-parent, (marriage 
status) single/widowed, (drinking frequency) alcohol consumer 
P>|t| = significance level of coefficient 




Table K.2. Log OLS regression model results - dependent variable log WTP, £ 
 








EDUCATION       
No formal 
qualifications 
0.428 0.236 0.060 0.874 0.064 0.852 
(0.361)  (0.380)  (0.345)  
Higher education  
-0.158 0.236 -0.031 0.808 -0.116 0.332 
(0.133)  (0.128)  (0.119)  
NON_ENGLISH       
Non-English UK 
nations 
-0.232 0.165 -0.088 0.595 -0.135 0.366 
(0.167)  (0.165)  (0.149)  
AGE       
Under 35 
0.376 0.019** 0.053 0.724 0.178 0.215 
(0.159)  (0.151)  (0.143)  
Over 65 
-0.164 0.367 -0.329 0.053* -0.163 0.315 
(0.181)  (0.169)  (0.162)  
MALE       
Male 
0.222 0.083* -0.011 0.932 0.124 0.295 
(0.128)  (0.125)  (0.118)  
INCOME       
Less than £20,000 
-0.073 0.673 -0.015 0.927 0.124 0.433 
(0.173)  (0.167)  (0.158)  
Over £40,000 
-0.031 0.840 0.085 0.558 0.169 0.221 
(0.153)  (0.145)  (0.137)  
PARENT_GUARDIA
N       
Parent 
0.087 0.542 0.206 0.152 0.165 0.214 
(0.143)  (0.143)  (0.133)  
MARRIED       
Married/cohabiting 
0.128 0.438 -0.097 0.544 -0.092 0.541 
(0.165)  (0.159)  (0.150)  
NONDRINK -0.033 0.806 -0.192 0.142 -0.092 0.452 
No alcohol 
(0.135)  (0.130)  (0.122)  
      
CONSTANT 
4.166 0.000 4.435 0.000 4.240 0.000 
(0.214)  (0.198)  (0.196)  
Observations 231 248 262 
Adjusted R2 0.021 0.009 0.007 
A Base factors excluded from regression: (education) school level qualifications, (location) England, 
(age) 35-65, (gender) female, (income) £20,000-£40,000, (parent/guardian) non-parent, (marriage 
status) single/widowed, (drinking frequency) alcohol consumer 





Appendix L. Cost-benefit planes from validation analysis excluding outliers 
Figure L.1 and L.2 display the cost-benefit planes generated using the bootstrap estimated 
from the sensitivity analysis examining truncated costs for the CBA validation analysis in 
Chapter Eight. Truncating costs at the 95th percentile removed the extreme outlier values of 
cost difference between control and intervention, which are visible in the cost-benefit 
planes for the base-case analyses in Chapter Eight (Figure 8.3 and Figure 8.4). Figure L.1 and 
Figure L.2 demonstrate that in the absence of the extreme outliers, the cost-benefit planes 
of the validation analysis are largely comparable with those of the primary analysis (see 
Figure 8.1 and Figure 8.2 in Chapter Eight). 
Figure L.1 Cost-benefit plane of national level sensitivity analysis using bootstrap estimates 
of cost-difference truncated at the 95th percentile 
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Figure L.2 Cost-benefit plane of local authority level sensitivity analysis using bootstrap 




Appendix M. SROI validation analysis  
In order to conduct a validation analysis of the SROI using adjusted values, all resource use 
was combined into a single outcome variable. Unlike the CBA, the SROI examines both 
resource and QALY outcomes. In clinical trial data a common method of adjusting costs and 
QALY outcomes is to use a bivariate regression which allows for different covariates to 
influence the estimation of costs and effects (348). The benefits of using this approach have 
been argued by Willan et al., 2004 (394) who promote the use of ‘seemingly unrelated 
regression’ (SUREG) estimation, which accounts for the correlation between the errors 
across equations for each individual in a sample to improve the efficiency of estimation 
(395). This is particularly relevant in the case of cost and effect estimates in clinical trials 
where each outcome is elicited from the same trial participant, thus the errors for both cost 
and QALY estimates would be expected to be correlated.  
A SUREG was employed to estimate the mean financial proxy values for both the combined 
resource outcomes and QALYs. The SUREG estimates multiple linear regressions 
simultaneously, each with a different dependent variable (i.e. resources and QALYs) and a 
different selection of covariates, whilst accounting for the correlated errors for each given 
individual in the sample (395). The selection of covariates necessarily differs for each 
regression when using seemingly unrelated estimation, otherwise estimation reduces to 
ordinary least squares, negating the benefit of using the SUREG model (395). Both QALYs 
and total resources were adjusted by trial arm, gender, location, baseline alcohol use 
disorder identification test (AUDIT) score and a dummy variable indicating that 12-month 
follow-up was either 30 days earlier or later than expected. Total resources were additionally 
adjusted for the value of resources reported at baseline, baseline smoking status and race. 
QALYs were additionally adjusted for baseline EQ-5D-3L score and baseline score for 
emotional wellbeing (WEMWBS).  
The mean financial values of the impact and deadweight for both total resources and QALYs 
were obtained from the coefficients reported by the SUREG. Nonparametric bootstrapping 
with 5000 repetitions of the regression results was used to estimate confidence intervals. 
The same process described in Chapters Seven (footnote 11) and Eight (footnote 21) was 
used to determine the appropriate number of bootstrap repetitions required to generate 
robust confidence intervals. 
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The results of the adjusted analysis are reported below. Table M.1 outlines the calculation of 
the net financial reduction in resource use. The net financial reduction of resources is 
positive, indicating a saving in total resources from implementation of the ASBI. This 
outcome reflects the result of the unadjusted analysis reported in Chapter Eight. However, 
the 95% confidence interval around the net financial reduction crosses zero, indicating 
substantial uncertainty over the outcome. There is a considerable chance that the ASBI could 
actually result in an increase in financial value of resource use. This uncertainty reflects the 
findings of the CBA (see Chapter Eight, sections 8.2.4 and 8.2.5). 
Table M.1. Calculation of net financial value of reduced combined resource use outcomes  
Table M.2 outlines the calculation of the net financial value of QALY gain from the 
intervention using the results from the SUREG. As in the primary analysis using unadjusted 
values reported in Chapter Eight the net financial QALY gain is negative, however, the 95% 
confidence intervals again provide evidence of uncertainty around this outcome. The 
confidence interval crosses zero, which suggests the net financial QALY gain could be 
positive. The point estimate reported in Table M.2 (approximately -£63,000), however, is of 
a similar magnitude to that reported in the primary analysis (approximately -£50,000). 
Table M.2. Calculation of financial value of health improvements 
 
Impact Deadweight 
Net financial value of 
health improvement 













per student N Total  
QALYs  £21,455 210 £4,505,654 £21,759 210 £4,569,375 -£63,721 (-265,549 to 138,108) 
a 95% confidence interval (CI) calculated using 5000 bootstrap repetitions 
N = number of students  
 
Impact Deadweight 
Net financial reduction 
in resource use from 
intervention, 
















£4,365 210 £916,752 £516,440 (-852,875 to 2,156,147) 
a 95% confidence interval (CI) calculated using 5000 bootstrap repetitions  
N = number of students 
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There is no change to the investment value compared to the primary analysis, therefore, the 
same value of £4,666 is used to calculate the SROI ratio for the adjusted analysis. Equation 
M.1 displays the SROI calculation using the total adjusted impact calculated from summing 
the net financial reduction in resources and net financial value of health improvement 
(£516,440 + -£63,721 = £452,719). The resulting ratio is £97:1, which is larger than the ratio 
obtained from the primary analysis. However, given the uncertainty surrounding the health 
and resource impact values, this outcome should be considered with caution. The 
imprecision around the SROI ratio can be examined using the confidence intervals estimated 
for each component of the investment value. Using the lower bound of the 95% confidence 
intervals from Table M.1 and Table M.2 (i.e. -£852,875 + -£265,549), the SROI ratio would be 
approximately -£196:1, whilst using the upper bound (i.e. £2,156,147 + £138,108) the ratio 
would be approximately £491:1. The SROI ratio, therefore, ranges from -£196:1 to £491:1. 
SROI = Net present impact value
 Net present investment value = 
£452,719
£4,666  = £97  (M.1) 
The sensitivity analyses conducted in the primary analysis (see Chapter Eight, section 8.3.2) 
were replicated with the adjusted data. Table M.3 displays the analysis of alternative 
financial values of a QALY. As in the primary analysis, the sensitivity analyses report an 
increase in the SROI ratio due to a reduction in the negative net financial value of health 
improvement.  
Table M.3. Sensitivity analysis for alternative financial values of a QALY 



























Total for 210 
students 
£20,000 




£4,626 £971,419 £4,691 £985,157 -£13,738 £96,444 108:1 
 
Table M.4 displays the re-analysis of the SROI excluding the financial value associated with 
reduced school absenteeism. As in the primary analysis, the net financial value of resources 
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saved from implementing the ASBI is negative, indicating that when the financial savings 
from reduced school absenteeism are excluded from the impact value the intervention 
results in greater incremental spending on resources. However, as in the base-case analysis 
of resource savings, the 95% confidence interval crosses zero, thus there is considerable 
uncertainty over this outcome. Table M.4 reports a SROI ratio of -£16:1 for the ASBI when 
financial savings from reduced school absenteeism are removed from consideration of the 
impact on resource outcomes i.e. a loss of £16 for every £1 invested.  







Net financial value 
of reduction in 
resource use 











£139,654 £127,410 -£12,244 (-52,157 to 28,418) -£63,721 -£75,965 -16:1 
 
Overall, the results of the SROI using financial proxy values that have been adjusted for 
baseline variation amongst participants in the SIPS Jr HIGH trial reflect the results of the SROI 
evaluation using unadjusted values reported in Chapter Eight, section 8.3.3. However, the 
adjusted results indicate significant uncertainty around the impact parameters, a finding that 
was also identified in the CBA for intervention costs and in the within trial CUA conducted 
for the SIPS Jr HIGH trial (59).  
The results reported in this appendix suggest that the primary analysis presented in Chapter 
Eight is a conservative evaluation. However, given the uncertainty surrounding the 
parameter values reported in the adjusted analysis, a conservative analysis would be 




Appendix N. The case study information presented to PHDMs  
The case study: Alcohol screening and brief intervention in schools 
A randomised controlled trial (RCT), SIPS Jr HIGH, was recently conducted to assess the 
effectiveness and cost-effectiveness of alcohol screening and brief interventions provided in 
schools for young people compared to a control group. The intervention was aimed at Year 
10 students (aged 14-15) who display risky drinking behaviour, identified as those who 
screened positively on a single alcohol screening question. The intervention covered four 
locations in the UK (North-East, North-West, London, and Kent). Students who screened 
positive to displaying risky drinking behaviour, who were otherwise eligible for the trial and 
consented to taking part were randomised into either the control group or intervention 
group. 
The intervention involved an alcohol screening questionnaire and a 30-minute personalised 
interactive worksheet-based session for students who were identified as having risky 
drinking behaviour. The session contains structured and detailed feedback about the 
student’s drinking behaviour and advice about the health and social consequences of 
continued risky alcohol consumption, such as: weight gain, accidents, violence and impact on 
relationships. 
The control group received a healthy lifestyle information leaflet which contained general 
advice on healthy living but contained to no information about alcohol consumption. The 
control group were not given feedback on their alcohol screening result.   
Data was collected from trial participants at the start of the trial and at the end of the trial 
(after 12 months). The data collected as part of the trial has been used to conduct the 
economic evaluations you will be presented with today.  
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Appendix O. Cost-utility analysis report presented to PHDMs  
Each of the economic evaluation evidence reports presented to the public health decision-
makers at the workshop are reported in the following four appendices36.  
Methods 
A cost-utility analysis (CUA) was carried out to estimate and compare the costs and 
effectiveness of the brief alcohol intervention against usual practice. The CUA calculated the 
additional cost per child for those who were in the intervention group compared to those 
who were in the control group of the trial and compared those to the outcomes of the trial 
which, for the CUA, are Quality Adjusted Life Years (QALYs) which capture the effect on both 
length of life and quality of life. The CUA outcome is incremental (additional) costs per QALY, 
which is commonly reported as an incremental cost-effectiveness ratio (ICER), which 
provides an estimate of the additional cost associated with achieving one more QALY. 
The perspective of the analyses was the UK public sector (NHS, educational, social, and 
criminal services). The time horizon for the analysis was 12-months, therefore, only costs 
and outcomes of the trial after 12-months are considered in this analysis.  
Costs 
Costs were calculated based on the cost of delivering the brief intervention and the costs 
(and cost savings) in terms of UK public sector resources. The resources assessed were: GP 
visits, social worker visits, Accident & Emergency visits, non-A&E hospital visits, school nurse 
visits, absence from school and arrests. 
Outcomes 
QALYs were calculated by estimating quality of life using the EQ-5D-3L which is a 
questionnaire used commonly in economic evaluations to assess generic health-related 
quality of life.  
  
                                                     


















Control £9077 0.367 - - - - 




(-£1,272 - £2707) 
-0.004 
(-0.019 - 0.011) 
£723,048 
aCosts over a period of 12-months. Costs and QALYS adjusted for baseline data and 
participant characteristics.  
b95% CI stands for 95% confidence interval which is an estimated range of intervals which 
contains the true average value 95% of the time. I.e. one can be 95% confident that the true 
average value lies between the range of values stated in the 95% CI. 
 
Statistical analyses were conducted to calculate costs and QALYs, adjusted for baseline data 
and participant characteristics which might affect outcomes. Table 1 shows that the 
intervention group both had lower costs and fewer QALYs at the end of the intervention 
period on average. In other words, the intervention was less effective but also less costly 
than usual care. The ICER associated with the more effective and costlier control is £723,048 
per QALY. The National Institute for Health and Care Excellence (NICE) typically considers 
interventions which have an ICER of £20,000 per QALY or less acceptable to provide in the 
UK. The ICER for the control (usual care) compared to intervention (brief alcohol 
intervention) is much greater than this acceptable threshold, suggesting that, on average, 
the control is not cost-effective compared to the intervention.  
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Figure 1 Chart showing the proportion of ICER outcomes in statistical analysis results 
 
A statistical method was used to the estimate the possible values of average incremental 
costs and QALYs that might be found if we had a much larger sample. This provides an idea 
of how certain one could be that the results from the analysis of the trial reflect the costs 
and effects of the intervention if data were re-estimated from a much larger sample (which 
would give more certain results). After completing the additional statistical analysis, it was 
found that 54% of the estimated values agreed with our analysis of the trial data that 
intervention is less costly and less effective than usual care. Figure 1 shows the outcome of 
the statistical analysis. The green segment depicts outcomes where the intervention is 
definitively cost-effective, the yellow segment depicts outcomes which may be cost-effective 
if either the extra effect is worth the additional cost or if the cost-saving is worth the loss of 
some effectiveness, and the red segment shows outcomes that are not cost-effective.  
The statistical analysis also considered the probability that the intervention is cost-effective. 
The analysis suggests there was a 76% probability that the brief alcohol intervention is cost-
saving compared to usual practice. At values considered by NICE to represent cost-
effectiveness of £20,000 - £30,000 for an additional QALY gained, the probability that the 
intervention could be cost-effective compared to usual practice was 73%. These results were 
driven by the likelihood that the brief alcohol intervention is cost-saving as the average 







The outcomes of CUA are crucially dependent on the estimated costs of the intervention. In 
order to assess the certainty of the results of the CUA, sensitivity analysis is conducted to 
assess how sensitive the results are to changes in certain costs. Two sensitivity analysis were 
carried out: 1) trimming 5% of the data from the top to remove extremely large values, 2) 
removing the missed school costs as these are based on future lifetime income lost and can 
be considered a type of indirect cost, as opposed to the direct realisable costs of service use 
from being arrested, going to hospital, etc. 
Table 2 shows the results of both sensitivity analyses. Trimming the data did not have much 
effect on the ICER, whereas removing the costs associated with missed school days reduced 
the ICER by ~£400,000/QALY to £334,537/QALY. Removing costs associated with missing 
school reduces the mean net savings of the intervention by about half, however the original 
conclusion that the intervention is less costly and less effective than control is not changed. 
The ICER for control compared to intervention is still far higher than what would be 
considered cost-effective by NICE thresholds.  
Table 2 Sensitivity analysis results 




Missed school days 
Incremental costs  
-£2,865 
(-£11,272 - £2707) 
-£2,911 
(-£9,900 - £4,077) 
-£1,324 









Cost per QALY 
gained  




Appendix P. Cost-consequence analysis report presented to PHDMs  
Methods 
The cost-consequence analysis (CCA) presents the cost data and outcomes data of the 
intervention in the form of a balance sheet. Cost and effects are presented in a 
disaggregated manner to enable inclusion of all potentially relevant costs and outcomes 
from the intervention. No attempt is made to aggregate the data as is done in other forms of 
economic evaluation, the intention is to provide a spectrum of relevant information.  
The costs reported in the CCA are taken from the within-trial cost-utility analysis. Outcomes 
include primary and secondary outcomes from the trial. The time horizon considered for the 
analysis is 12 months. 
Results 
Table 1 displays primary and secondary outcomes from the trial alongside the estimated 
costs of the intervention and control groups. None of the outcomes are statistically 
significant, as can be seen by the confidence intervals crossing zero, indicating it is unclear 
whether there is any meaningful difference in effect between the two arms at the end of the 
trial.  


















Intervention delivery £22.20 0 £22.20 (£21.80 - £22.60) 




Social worker visits 
School nurse visits 
Arrests 
>5 days missing from school  
£6212 £9077 
-£2865  
(-£11,272 - £2707) 
Outcomes (at the end of the trial) 
QALY gains 0.367 0.363 -0.004 (-0.019 - 0.011) 
 Median (Inter-quartile range)  
Alcohol intake (in units) measured by 28 
day follow-back  
7.3 (1.9-18.5) 7.7 (0-18.0) 0.8 (-2.5 - 4.0) 
Drinks per drinking day in past 28 days  4.2 (1.5-7.8) 3.9 (0-7.6) -0.5 ( -1.6 - 0.6) 
Mental wellbeing score measured on 
WEMWBS 







( -0.7 - 4.1) 
AUDIT score  







( -1.0 - 0.8) 
 Percentage %  
A-SAQ results: 
Proportion reducing drinking  
Proportion drinking same 


























Energy drinks consumptionc: 
Consuming more 
Consuming less 
Stopped consuming  












aValues reported for intervention and control are the raw values collected from the trial. They have not 
been adjusted for baseline values of participant characteristics (with the exception of the costs and QALY 
gains). 
bDifference measured as intervention compared to control. Adjusted by baseline values and participant 
characteristics  
cCompared to baseline 
d95% CI stands for 95% confidence interval which is an estimated range of intervals which contains the 
true average value 95% of the time. I.e. one can be 95% confident that the true average value lies 
between the range of values stated in the 95% CI. 
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Appendix Q. Cost-benefit analysis report presented to PHDMs  
Methods 
The cost-benefit analysis compares the costs and benefits of the brief alcohol intervention in 
monetary terms. The total difference in costs between the intervention group and control 
group in the trial are subtracted from the monetarised benefits associated with the 
intervention group outcomes compared to control outcomes. The outcome presented is in 
the form of a net societal benefit (NSB).  
Monetised benefit is derived from a willingness to pay (WTP) survey in which a 
representative sample of the UK population was provided with information on trial 
outcomes and asked to place a monetary value on the intervention. The monetary value in 
the WTP survey was asked in the form of extra monthly taxation (i.e. how much would 
survey respondents be willing to pay in extra monthly taxation for the intervention to be 
provided in schools across the UK). The outcomes valued in the WTP survey include: average 
difference in alcohol consumption, total number of arrests and total number of days missing 
from school between the intervention and control groups. 
The costs included in the CBA are estimated as the costs associated with the difference in 
average resource use at 12-month follow-up between the intervention and control groups. 
The resources measured include: delivery of intervention, GP visits, social worker visits, 
Accident & Emergency visits, non-A&E hospital visits, school nurse visits and arrests. 
The perspective of the analysis is the UK public sector and the time horizon considered for 
costs and outcomes is 12 months. 
Results 
Two sets of analyses are presented below: 1) at a UK societal level, and 2) at a Newcastle 




Table 1 Average cost and benefit 
 Average (S.D.)a 
Annual WTP £65 (126) 
Difference in costs per child  
(intervention compared to control) 
£118 (84) 
aS.D. stands for standard deviation which shows the spread of data in relation to the average 
value. Large values indicate a large spread in the data whereas small values show that the 
data points are close to the average value. 
 
1. UK societal level 
The total welfare on a UK societal level was estimated by aggregating the cost and benefit on 
a UK societal level. In order to do this, the mean cost difference (Table 1) was multiplied by 
the estimated number of Year 10 students with risky-drinking behaviour in the UK (23.5% of 
Year 10 students according to the SIPS Jr HIGH trial findings) and the annual WTP in extra 
taxes (Table 1) was multiplied by the number of UK taxpayers.  
This analysis assumes that the intervention would be funded by all UK taxpayers at an 
average rate commensurate to the average value placed on the intervention from the WTP 
survey (this assumption does not necessitate that the value contributed by each individual 
tax payer is equal, only that the average across tax payers equates to the average WTP value 
identified in the WTP survey). The costs represent the costs to UK public sector from 
implementing the intervention across the UK. In the UK there are approximately 30 million 
taxpayers and approximately 165,000 Year 10 students with risky drinking behaviour 
(calculated as 23.5% of all Year 10 students in the UK).  
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Table 2 UK societal level of Net Societal Benefit 
Category Average (95% CI)a 
Incremental costs  
£19.50 million 
(-£8.05 million - £46.98 million) 
Benefit  
£2.01 billion 
(£1.65 billion - £2.36 billion) 
Net Societal Benefit  
1.98 billion 
(£1.975 billion - £1.989 billion) 
a95% CI stands for 95% confidence interval which is an estimated range of intervals which 
contains the true average value 95% of the time. I.e. one can be 95% confident that the true 
average value lies between the range of values stated in the 95% CI. 
 
Table 2 shows the result of the NSB which is large and positive, indicating that the benefits 
to society of the intervention outweigh the costs to society. The confidence interval for NSB 
does not cross zero indicating that we can be 95% confident that the true NSB lies within the 
range of £1.975 billion to £1.989 billion, therefore, it is very likely that the true NSB is 
positive.   
A statistical method was used to estimate the possible values of the average costs and 
average benefits of the intervention. In the sample of estimated average costs and average 
benefits, 92.8% of the estimates had a monetized benefit greater than zero and showed 
the intervention to be more costly than the control. The minority remainder of the 
estimates (7.2%) showed the intervention to be less costly than the intervention but still 
remained an average monetized benefit greater than zero.  
On a UK societal level assuming all UK tax payers contributing towards funding the 
intervention, if the costs of the intervention remain unchanged, in order for societal benefit 
to be less than the costs the average WTP for the intervention would have to be less than £1 
per year (compared to £65 identified in the WTP survey). Alternatively, assuming the 
intervention is valued at the current rate of £65 over one year, the average cost of the 
intervention compared to usual care would have to be over £12,000 per risky-drinking Year 
10 student in the UK in order for the costs to outweigh the benefits. 
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2. Newcastle Local Authority level 
The societal level results indicate that the intervention is net beneficial if it were funded by 
society and implemented across the UK. However, it may be more relevant to calculate the 
NSB aggregated on an individual local authority level. Analysis here is conducted for 
Newcastle local authority. It is assumed that the intervention will be funded via an addition 
to council tax payments for the highest bands of council tax (bands F-H) and the costs will be 
those associated with the number of risky drinking Year 10 students in Newcastle. The 
estimated proportion of risky drinking students in the North-East (27.4%) was higher than 
the SIPS Jr HIGH trial average used in the UK societal analysis.  
The number of band F-H households in Newcastle is 4020 and the number of risky drinking 
Year 10 students is 725 (27.4% of all Year 10 students in Newcastle).  
Table 3 Newcastle local authority NSB 
Category Average (95% CI) 
Incremental costs  
£85,442 
(-£35,362 - £206,245) 
Benefit  
£261,930 
(£214,846 - £309,015) 
Net Societal Benefit  
£177,000 
(£174,532 - £179,468) 
 
Table 3 shows that the average NSB in Newcastle LA is still positive but not as large as the UK 
societal level. The confidence interval again does not cross zero indicating that we can be 
95% confident that the true NSB lies within the range of £174,532 to £179,468, therefore it 
is very likely that the true NSB is positive.   
As in the previous analysis, the same statistical method is used to estimate the possible 
values of the average costs and average benefits of the intervention. Again, all estimated 
values for benefit were greater than zero and the large majority (92.8%) estimated the 
intervention to be more costly than control. 
In the local authority setting where council tax from households in bands F-H fund the 
intervention, assuming costs remain unchanged, in order for societal benefit to be less than 
the costs the average WTP for the intervention would have to be less than £21 per year 
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(compared to £65 identified in the WTP survey). Alternatively, assuming the intervention is 
valued at the current rate of £65 over one year, the average cost associated with the 
intervention compared to usual care would have to be over £361 per risky-drinking Year 10 
student in the Newcastle in order for the costs to outweigh the benefits. 
Sensitivity analysis 
The results of the CBA are sensitive to a number of factors: the WTP value, the cost value 
and the level in which these values are aggregated. Sensitivity analyses were conducted to 
assess the effect on NSB of aggregating the WTP so that only parents and guardians of Year 
10 students pay for the intervention, trimming the top 5% of WTP values, and trimming the 
top 5% of costs in order to reduce the effect of extremely large values. The sensitivity 
analyses were conducted for both the UK societal and Newcastle LA levels.  
Tables 4 and 5 below show the sensitivity results for the UK and local authority levels, 
respectively. In both cases the NSB is reduced significantly on the assumption that only 
parent and guardians of Year 10 students would fund the intervention. Even in this case 
where the proportion of individuals funding the intervention is fraction of the original 
analysis (~2% in the UK analysis), the net benefit is still positive. Overall, all sensitivity 
analyses demonstrate positive NSB with confidence intervals that do not cross, or get close 
to, zero. Therefore, it could be said with a large degree of confidence that the NSB is positive 
for this intervention, on whichever level it is considered.  




WTP values trimmed Costs trimmed 
Incremental 
costs  
(95% CI)  
£19.5 million 
(-£8.1 million - £47.0 
million) 
£19.5 million 
(-£8.1 million - £47.0 
million) 
£1.18 million 





(£37.6 million - £54.5 
million) 
£1.319 billion 
(£1.164 billion -£1.494 
billion) 
£2.01 billion 






(£25.7 million - £26.8 
million) 
£1.298 billion 
(£1.295 billion - £1.301 
billion) 
£2.00 billion 





Table 5 Sensitivity analysis for the local authority level 
Category 
Parents and guardians 
pay 
WTP values trimmed Costs trimmed 
Incremental costs 
(95% CI to nearest 
£1,000) 
£85,442 
(-£35,000 - £206,000) 
£85,442 
(-£35,000 - £206,000) 
£5,216 
(-£65,000 - £76,000) 
Benefit (95% CI to 
nearest £1,000) 
£172,404 
(£143,000 - £205,000) 
£172,169 
(£150,000 - £194,000) 
£261,930 
(£215,000 - £309,000) 
Net Societal 
Benefit (95% CI to 
nearest £1,000) 
£86,774 
(£84,000 - £89,000) 
£86,773 
(£84,000 - £89,000) 
£256,023 




Appendix R. Social return on investment report presented to PHDMs  
Methods 
A social return on investment (SROI) was conducted to assess the value of the brief alcohol 
intervention compared to the investment required to implement it. The values of the 
investment and the return are taken from the SIPS Jr HIGH trial data. 
The value of investment is equivalent to the intervention delivery costs which include 
materials for use during the alcohol screening and brief intervention (ASBI) interview, 
training costs for those implementing the ASBI with the year 10 students in the trial and the 
costs associated with the time taken to provide the intervention.  
The return of the intervention includes: financial savings from reduced resource use 
associated with the intervention compared to the control (usual care) and a monetarised 
value of the associated health improvements from the intervention. The SROI considers a 
broad perspective of returns, including those attributed to the healthcare sector, social care 
sector, education sector, criminal justice sector and those to the students exhibiting risky 
drinking behaviour.  
Impacts and investments to be included in the SROI calculation are estimated as the financial 
value of each component with any deadweight (the financial value of what would happen 
anyway without the intervention) and attribution (the value that can be attributed to factors 
other than the intervention) subtracted. As the values for this SROI are taken from a 
randomised controlled trial which is designed with the intention of eliminating external 
factors affecting the outcomes, it is assumed that attribution is zero in this analysis. 
Deadweight is calculated using values from the control group of the trial which should 
represent what happens in the absence of the intervention.  
Results 
Investment 
Table 1 shows the calculation of the investment component of the SROI. The average unit 
price of each element contributing to the investment value is multiplied by the total number 
of Year 10 students who were in the intervention group (n=210).  
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Table 1 Calculation of investment value 
 
Impact 
Calculating the impact of the intervention is divided into two parts. Firstly, calculating the 
financial value of health improvement and secondly the financial value of reduced service 
use (i.e. cost savings). The financial value of health improvement is estimated using a value 
of £60,000 per QALY gained, which is the value used by the Department of Health and is 
derived from the value society places on a life.  
Table 2 Calculation of financial value of health improvements 
 
Financial proxy Deadweight    













£21,720 210 £4,561,200 £21,960 210 £4,611,600 -£50,400 
Total health improvement impact  -£50,400 
 
Table 2 outlines the calculation of the financial value of health improvement. The value of 
the impact is negative due to the larger value of health improvement attributed to the 
control group compared to the intervention group. 
  
 
 Financial proxy  Deadweight 
 
 Intervention group  Control group 
 Unit price  Students Total  Unit price  Students Total 
Interview materials  £1.58  210  £331.80  £0 210 £0 
Training costs for 
learning mentors and 
screening 
 £14.20  210  £2,982.00  £0 210 £0 
Learning mentor time  £6.44  210  £1,352.40  £0 210 £0 
Total  £4,666.20  
 
£0 
Total investment value*  £4,666 
*value rounded to nearest £ 
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Table 3 Calculation of financial value of reduced resource use 
 Financial proxy Deadweight   
Resource sector 














GP visits £98 210 £20,616 £125 210 £26,261 £5,645 
Secondary 
care 















£1,134 210 £238,105 £2,083 210 £437,533 £199,428 
Local 
Authority  
Arrests £0 210 £26 £1 210 £214 £189 
Total impact on reduction in services £181,357 
 
Table 3 outlines the calculation of the financial value of resource use. As the interest is in 
savings from implementing the intervention, the total impact is calculated as the costs of 
resource use associated with the intervention group subtracted from the control group. The 
total outcome is positive since of the costs of resource use are larger for the control group 
than the intervention group. 
Calculating the SROI 







The SROI outcome is heavily dependent on certain parameters and assumptions. Sensitivity 
analysis looks at how robust the outcome is to change in these assumptions and parameters. 
Every £1 invested in the brief alcohol intervention generates ~£28 in social value 
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Removing missed school days from analysis  
The financial value associated with absenteeism from school is considered an indirect 
outcome dependent on long term outcomes in terms of wages and productivity. Therefore, 
to assess the effect on SROI of just the direct outcomes of the intervention a sensitivity 
analysis was conducted where the resource associated with absenteeism is removed from 
the intervention impact. 
Table 4 Sensitivity analysis of removing school absenteeism 
Impact without missed school 
days 
 
Resource use reduction -£18,071 
Health improvement -£50,400 
Total impact -£68,471 
 
Assuming the investment value is unchanged the SROI ratio is = -£15:1 
Every £1 invested in the brief alcohol intervention results in a loss of societal value of ~£15  
Using different values to estimate the financial value of health improvement 
The financial value for health gain is determined by multiplying QALY gain by £60,000 per 
QALY. However, there are several alternative values of a QALY used in economic evaluation 
which could be used to value the health gains associated with the intervention. The National 
Institute of Health and Care Excellence (NICE) consider a value of £20,000 per QALY or less to 
be considered cost-effective and a recent estimation of the value of a QALY by Claxton et al. 
(2015) stands at £12,936 per QALY. A sensitivity analysis using both of these values was 
conducted.  
Table 5 Sensitivity analysis using different values of a QALY 
QALY 
values 
















£4,683 210 £983,395 £4,735 210 £994,261 -£10,866 £37:1 
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Assuming the resource costs and investment values remain unchanged the SROI ratios are 
just over £35 for both scenarios. 
The sensitivity analyses demonstrate that the SROI ratio is not greatly affected by the choice 
of financial value of a QALY but the return on the investment is heavily driven by the 
resource savings associated by school absenteeism. 
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Appendix S. Advertisement for workshop 
The flyer distributed via e-mail in order to advertise the workshop with PHDMs (reported in 
Chapter Ten) is inserted below. 
 
Fuse health economics workshop 
Critical appraisal of health economic decision tools for public health decision-makers 
Wednesday 5th September 2018, 1.00pm – 4.00pm 
Baddiley Clark seminar room, The Baddiley Clark building, Newcastle upon Tyne, NE2 4AX 
To register for the workshop please follow this link to a registration form  
What is the workshop about? 
Health economic decision tools can play an important role in public health decision-making. 
Economic evaluations of public health interventions provide information to aid prioritisation 
decisions. Economic evaluation evidence, however is not always designed with public health 
decision-makers in mind. This workshop provides guidance on how to identify relevant 
evidence, to critically appraise the evidence for quality and relevance, and how to interpret 
the evidence for use in decision-making.  
The workshop aims to further develop public health decision-makers’ knowledge of the 
different tools and methods available and how to incorporate these into decision-making. It 
also aims to seek feedback from decision-makers on the usefulness and usability in practice 
of the tools discussed.  
Who is this workshop for? 
The event is intended for local authority officers and anyone involved in public health 
decision-making, from public health teams and broader departments.  
Who is organising the workshop? 
This workshop is being organised by Sarah Hill, a fuse PhD candidate. The resources provided 
are informed by her research with public health decision-makers to date. Feedback from the 
interactive group work session will feature in her final thesis in order to demonstrate the 
opinions of public health decision-makers around the usefulness and usability of available 
health economics tools to aid decision-making. All data collected at the workshop will be 
kept anonymous and no personal identifiable data will be used. Approval for this research 
project has been granted by Newcastle University Ethics Committee. If you have any 
questions about Sarah’s PhD research or how the workshop will feature in her thesis please 
contact her at s.r.hill2@newcastle.ac.uk.  
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Programme 
1.00pm – 2.15pm Critical appraisal training session 
This session will introduce different methods of evaluating public health interventions using 
health economic tools, discuss how to appraise evidence and how to interpret the evidence 
effectively to aid decision-making.  
2.15pm – 2.30pm Coffee break  
Refreshments will be provided 
2.30pm – 4.00pm Interactive group work session 
The second part of the event will be an interactive session allowing participants to work with 
economic evidence of a local case study intervention to practice the skills developed in the 
first part of the event. Attendees will also be invited to provide feedback to the organisers 
on how useable the evidence is and how useful each tool is for decision-making in practice. 
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Appendix T. Consent form used at the workshop  
Prior to the commencement of the interactive workshop with PHDMs (reported in Chapter 
Ten) written consent was obtained from workshop attendees for their feedback to be used 
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